GENE_SYMBOL,GENE_ID_HGNC,DISEASE_LABEL,DISEASE_ID_MONDO,MOI,SOP,CLASSIFICATION,ONLINE_REPORT,CLASSIFICATION_DATE,GCEP
AASS,HGNC:17366,hyperlysinemia,MONDO:0009388,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_92e04f9e-f03e-4295-baac-e9fb6b48a258-2022-10-14T160000.000Z,2022-10-14T16:00:00.000Z,Aminoacidopathy
ACAD8,HGNC:87,isobutyryl-CoA dehydrogenase deficiency,MONDO:0012648,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0d260f0e-df71-420a-9281-92e4bddcddbb-2019-04-26T160000.000Z,2019-04-26T16:00:00.000Z,Aminoacidopathy
ACADSB,HGNC:91,2-methylbutyryl-CoA dehydrogenase deficiency,MONDO:0012392,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8bfa3857-c96c-40ac-b4c1-2cf04fd4eb4f-2019-03-22T160000.000Z,2019-03-22T16:00:00.000Z,Aminoacidopathy
ACSF3,HGNC:27288,combined malonic and methylmalonic acidemia,MONDO:0013661,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b215e20c-7781-49a0-b473-9219cb07e0b9-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Aminoacidopathy
ACY1,HGNC:177,aminoacylase 1 deficiency,MONDO:0012368,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_67196825-d32f-4070-9c15-debaa2287b73-2020-09-25T160000.000Z,2020-09-25T16:00:00.000Z,Aminoacidopathy
ADK,HGNC:257,adenosine kinase deficiency,MONDO:0100255,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c2319ca2-652d-411e-ab6d-5b7fb7e185ea-2021-04-08T160000.000Z,2021-04-08T16:00:00.000Z,Aminoacidopathy
AHCY,HGNC:343,hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase,MONDO:0013404,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d9b3a56b-b188-44d1-9983-a059895c0ba1-2022-12-12T170000.000Z,2022-12-12T17:00:00.000Z,Aminoacidopathy
ALDH18A1,HGNC:9722,P5CS deficiency,MONDO:0100126,SD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7bfbe962-beb3-4553-9909-a83a3aac2d55-2021-05-18T211134.377Z,2021-05-18T21:11:34.377Z,Aminoacidopathy
ALDH4A1,HGNC:406,hyperprolinemia type 2,MONDO:0009401,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5edc3f72-31e0-47f8-bcec-e3e5b81c97ae-2020-10-23T171643.432Z,2020-10-23T17:16:43.432Z,Aminoacidopathy
ALDH6A1,HGNC:7179,methylmalonate semialdehyde dehydrogenase deficiency,MONDO:0013579,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_57ca1521-9336-4769-bc55-240089dab917-2022-12-12T170000.000Z,2022-12-12T17:00:00.000Z,Aminoacidopathy
ALDH7A1,HGNC:877,pyridoxine-dependent epilepsy,MONDO:0009945,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7a982307-d8bd-43d1-b356-ef7ee6f32045-2019-07-26T160000.000Z,2019-07-26T16:00:00.000Z,Aminoacidopathy
AMT,HGNC:473,glycine encephalopathy,MONDO:0011612,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a85e1b07-b975-4c92-b592-7b3e8d35805a-2019-05-24T160000.000Z,2019-05-24T16:00:00.000Z,Aminoacidopathy
ARG1,HGNC:663,hyperargininemia,MONDO:0008814,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0157f793-9232-4700-bbf0-dfb16270f688-2020-06-29T174101.533Z,2020-06-29T17:41:01.533Z,Aminoacidopathy
ASL,HGNC:746,argininosuccinic aciduria,MONDO:0008815,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c16021b9-f6db-4e41-90f3-4786d63a1fa3-2018-09-15T160000.000Z,2018-09-15T16:00:00.000Z,Aminoacidopathy
ASNS,HGNC:753,congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome,MONDO:0014258,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e1cea57d-fe02-469e-8c52-a383c3f5a0c6-2020-06-29T174449.301Z,2020-06-29T17:44:49.301Z,Aminoacidopathy
ASPA,HGNC:756,Canavan disease,MONDO:0010079,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_66306eff-659f-4508-a41b-1820e47e0e1d-2020-10-08T161701.633Z,2020-10-08T16:17:01.633Z,Aminoacidopathy
ASS1,HGNC:758,citrullinemia type I,MONDO:0008988,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5dc5ef32-81ca-478e-be42-436da3416e4d-2018-12-27T170000.000Z,2018-12-27T17:00:00.000Z,Aminoacidopathy
AUH,HGNC:890,3-methylglutaconic aciduria type 1,MONDO:0009610,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_681f6747-37ce-498e-8bb1-eddd55a90e2c-2020-06-29T174231.569Z,2020-06-29T17:42:31.569Z,Aminoacidopathy
BCAT2,HGNC:977,hypervalinemia and hyperleucine-isoleucinemia,MONDO:0100058,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5e16ee6-88c9-4872-8681-dd7fd0156b0f-2020-07-24T172325.905Z,2020-07-24T17:23:25.905Z,Aminoacidopathy
BCKDHA,HGNC:986,maple syrup urine disease type 1A,MONDO:0023691,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5c89a6c7-751a-4a99-8a32-97cc33c5df7c-2018-09-14T160000.000Z,2018-09-14T16:00:00.000Z,Aminoacidopathy
BCKDHB,HGNC:987,maple syrup urine disease type 1B,MONDO:0023692,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0b0d314c-7355-441c-a357-72ba3e566c57-2019-02-08T170000.000Z,2019-02-08T17:00:00.000Z,Aminoacidopathy
BCKDK,HGNC:16902,branched-chain keto acid dehydrogenase kinase deficiency,MONDO:0013970,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f90aaad0-b56a-41dc-8d1f-9d12fc66113f-2019-01-18T170000.000Z,2019-01-18T17:00:00.000Z,Aminoacidopathy
CA5A,HGNC:1377,hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency,MONDO:0014332,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f7c5731a-866e-4a96-abb0-f0747f89280b-2018-09-10T160000.000Z,2018-09-10T16:00:00.000Z,Aminoacidopathy
CBS,HGNC:1550,classic homocystinuria,MONDO:0009352,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a9086d29-767b-4ab8-9274-1249b5480834-2019-04-12T160000.000Z,2019-04-12T16:00:00.000Z,Aminoacidopathy
CPS1,HGNC:2323,carbamoyl phosphate synthetase I deficiency disease,MONDO:0009376,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dbc4dbbe-8827-4d68-a396-8368f3801e78-2018-10-12T160000.000Z,2018-10-12T16:00:00.000Z,Aminoacidopathy
CTH,HGNC:2501,cystathioninuria,MONDO:0009058,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2f5047f7-80ba-4b8f-8009-59d7130e63be-2019-06-14T160000.000Z,2019-06-14T16:00:00.000Z,Aminoacidopathy
DBT,HGNC:2698,maple syrup urine disease,MONDO:0009563,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cfd1ebde-e447-4877-977e-f5b9fe434adc-2018-10-30T160000.000Z,2018-10-30T16:00:00.000Z,Aminoacidopathy
DHTKD1,HGNC:23537,2-aminoadipic 2-oxoadipic aciduria,MONDO:0008774,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d6dd5de3-9819-432d-996c-12a66dff277f-2020-11-03T193815.515Z,2020-11-03T19:38:15.515Z,Aminoacidopathy
DLD,HGNC:2898,pyruvate dehydrogenase E3 deficiency,MONDO:0009529,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a9dfbbc2-cede-491e-9db0-fc5719fbc729-2019-03-08T170000.000Z,2019-03-08T17:00:00.000Z,Aminoacidopathy
DMGDH,HGNC:24475,dimethylglycine dehydrogenase deficiency,MONDO:0011610,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b181250b-bc72-43b7-adec-5b85860b1a62-2022-12-12T170000.000Z,2022-12-12T17:00:00.000Z,Aminoacidopathy
DNAJC12,HGNC:28908,hyperphenylalaninemia due to DNAJC12 deficiency,MONDO:0044304,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_500ad0d5-2871-4b25-a96f-0c0816524a4b-2021-01-11T184823.935Z,2021-01-11T18:48:23.935Z,Aminoacidopathy
FAH,HGNC:3579,tyrosinemia type I,MONDO:0010161,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_39c50699-f422-4bae-89ac-af13ef7cb8cc-2020-06-29T174149.440Z,2020-06-29T17:41:49.440Z,Aminoacidopathy
FMO3,HGNC:3771,trimethylaminuria,MONDO:0011182,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_18ed3960-c745-46f1-aecc-155e713d6ef5-2020-08-14T184718.502Z,2020-08-14T18:47:18.502Z,Aminoacidopathy
GAD1,HGNC:4092,obsolete early infantile epileptic encephalopathy,MONDO:0016021,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_20fdee08-81b0-4957-a18a-8f622e0ab054-2021-05-13T152239.014Z,2021-05-13T15:22:39.014Z,Aminoacidopathy
GAMT,HGNC:4136,guanidinoacetate methyltransferase deficiency,MONDO:0012999,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f0a84d45-57f8-4763-b1c5-7a283cef5f71-2019-01-25T170000.000Z,2019-01-25T17:00:00.000Z,Aminoacidopathy
GATM,HGNC:4175,AGAT deficiency,MONDO:0012996,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d63bfeff-882d-400f-af17-277a702fd09b-2019-03-08T170000.000Z,2019-03-08T17:00:00.000Z,Aminoacidopathy
GCDH,HGNC:4189,glutaryl-CoA dehydrogenase deficiency,MONDO:0009281,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_33a2c95e-a057-4b93-b97e-27b6597516e5-2019-11-08T170000.000Z,2019-11-08T17:00:00.000Z,Aminoacidopathy
GCH1,HGNC:4193,GTP cyclohydrolase I deficiency,MONDO:0100184,SD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ed6c1e6c-5856-48aa-aa8f-47328e6b09eb-2020-12-11T200937.286Z,2020-12-11T20:09:37.286Z,Aminoacidopathy
GLDC,HGNC:4313,glycine encephalopathy,MONDO:0011612,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14d991f3-25f3-40c9-aacd-c1a008d9eaea-2019-02-06T170000.000Z,2019-02-06T17:00:00.000Z,Aminoacidopathy
GLS,HGNC:4331,glutaminase deficiency,MONDO:0600001,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1eedd351-1520-4354-9608-cf8d56ce9bd9-2021-07-09T170141.305Z,2021-07-09T17:01:41.305Z,Aminoacidopathy
GLS,HGNC:4331,"infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development",MONDO:0032685,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c0a699ec-3d67-4e18-a0da-464c2832c4ec-2021-07-09T170349.643Z,2021-07-09T17:03:49.643Z,Aminoacidopathy
GLUD1,HGNC:4335,hyperinsulinism-hyperammonemia syndrome,MONDO:0011717,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_924bd593-ba5a-49a5-bb71-8224271a713b-2020-11-13T170000.000Z,2020-11-13T17:00:00.000Z,Aminoacidopathy
GLUL,HGNC:4341,congenital brain dysgenesis due to glutamine synthetase deficiency,MONDO:0012393,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d71d7866-437d-48bd-8a98-21e67abdd917-2022-12-12T170000.000Z,2022-12-12T17:00:00.000Z,Aminoacidopathy
GNMT,HGNC:4415,glycine N-methyltransferase deficiency,MONDO:0011698,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cafb0200-f6cf-482d-9ffb-69ae7bc43669-2022-12-12T170000.000Z,2022-12-12T17:00:00.000Z,Aminoacidopathy
GSS,HGNC:4624,inherited glutathione synthetase deficiency,MONDO:0017909,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_69a8e645-0e10-4ea9-8545-212ce9b0dcbf-2019-04-26T160000.000Z,2019-04-26T16:00:00.000Z,Aminoacidopathy
GSTZ1,HGNC:4643,maleylacetoacetate isomerase deficiency,MONDO:0060527,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8c287e0b-88be-4fbb-82a6-a8c70d430506-2022-09-09T160000.000Z,2022-09-09T16:00:00.000Z,Aminoacidopathy
HAAO,HGNC:4796,"vertebral, cardiac, renal, and limb defects syndrome 1",MONDO:0060554,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_89484d6b-0af1-4b77-9dcb-95c18331e3b7-2022-06-24T160000.000Z,2022-06-24T16:00:00.000Z,Aminoacidopathy
HAL,HGNC:4806,histidinemia,MONDO:0009345,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c5764eb8-2aad-419e-be57-99f8c6859ebb-2020-09-25T165635.220Z,2020-09-25T16:56:35.220Z,Aminoacidopathy
HGD,HGNC:4892,alkaptonuria,MONDO:0008753,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5186836d-d9c6-4829-a0c9-59548460d6f2-2020-06-29T174125.541Z,2020-06-29T17:41:25.541Z,Aminoacidopathy
HIBCH,HGNC:4908,3-hydroxyisobutyryl-CoA hydrolase deficiency,MONDO:0009603,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_26621ace-7c6b-4a1c-8286-02c4cb8a1544-2019-11-07T222437.403Z,2019-11-07T22:24:37.403Z,Aminoacidopathy
HLCS,HGNC:4976,holocarboxylase synthetase deficiency,MONDO:0009666,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ad306285-9588-48e3-a6fa-183db3f01fe9-2021-02-26T171131.548Z,2021-02-26T17:11:31.548Z,Aminoacidopathy
HPD,HGNC:5147,hawkinsinuria,MONDO:0007700,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6819b0ea-9f21-4f91-ae92-133d97fcf87b-2020-06-26T171501.409Z,2020-06-26T17:15:01.409Z,Aminoacidopathy
HPD,HGNC:5147,tyrosinemia type III,MONDO:0010162,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_89eb4236-9243-490b-bc73-fb3b99675eb9-2020-06-29T173606.841Z,2020-06-29T17:36:06.841Z,Aminoacidopathy
IVD,HGNC:6186,isovaleric acidemia,MONDO:0009475,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_05f5d468-2f46-44f3-ba67-c4e708d2954f-2019-05-10T160000.000Z,2019-05-10T16:00:00.000Z,Aminoacidopathy
KYNU,HGNC:6469,"vertebral, cardiac, renal, and limb defects syndrome 2",MONDO:0060555,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_70d2f25f-b3f0-4f1b-b7bf-ad8d3562c959-2022-10-14T160000.000Z,2022-10-14T16:00:00.000Z,Aminoacidopathy
LMBRD1,HGNC:23038,methylmalonic aciduria and homocystinuria type cblF,MONDO:0010183,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14c077fe-c0ff-43d5-8436-041db18b20b1-2021-03-26T160000.000Z,2021-03-26T16:00:00.000Z,Aminoacidopathy
MAT1A,HGNC:6903,methionine adenosyltransferase deficiency,MONDO:0009607,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_35cff382-98fe-4103-8edc-101f0c565a9e-2019-09-13T160000.000Z,2019-09-13T16:00:00.000Z,Aminoacidopathy
MCCC1,HGNC:6936,3-methylcrotonyl-CoA carboxylase deficiency,MONDO:0018950,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6bd0c545-9ef8-4005-a124-a73be6178745-2019-10-25T160000.000Z,2019-10-25T16:00:00.000Z,Aminoacidopathy
MCCC2,HGNC:6937,3-methylcrotonyl-CoA carboxylase deficiency,MONDO:0018950,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3653ea30-b630-499a-a6f0-65152106ad8c-2019-10-25T160000.000Z,2019-10-25T16:00:00.000Z,Aminoacidopathy
MCEE,HGNC:16732,methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency,MONDO:0009615,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b8546531-fe3d-48fd-8103-f5f84fd04514-2020-07-09T160000.000Z,2020-07-09T16:00:00.000Z,Aminoacidopathy
MMAA,HGNC:18871,"methylmalonic aciduria, cblA type",MONDO:0009613,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5b81bb9e-5f71-47bf-b187-5eef83d91d57-2022-07-13T160000.000Z,2022-07-13T16:00:00.000Z,Aminoacidopathy
MMAB,HGNC:19331,"methylmalonic aciduria, cblB type",MONDO:0009614,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_52b61ff5-afba-4ff7-adbc-51de6a837db7-2022-07-13T160000.000Z,2022-07-13T16:00:00.000Z,Aminoacidopathy
MMACHC,HGNC:24525,methylmalonic aciduria and homocystinuria type cblC,MONDO:0010184,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6feb4bda-539f-4592-acaf-26dc186e953a-2020-06-29T174303.503Z,2020-06-29T17:43:03.503Z,Aminoacidopathy
MMADHC,HGNC:25221,inborn disorder of cobalamin metabolism and transport,MONDO:0019220,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_40ec59af-a143-4424-9218-7fd75deb6a61-2021-05-12T182739.747Z,2021-05-12T18:27:39.747Z,Aminoacidopathy
MMUT,HGNC:7526,methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency,MONDO:0009612,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3c5301da-0dad-417a-8257-5b1c6155e8fa-2019-05-09T160000.000Z,2019-05-09T16:00:00.000Z,Aminoacidopathy
MTHFR,HGNC:7436,homocystinuria due to methylene tetrahydrofolate reductase deficiency,MONDO:0009353,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cbfc5297-ed0d-4d7c-bca6-747114ed2b17-2019-06-18T160000.000Z,2019-06-18T16:00:00.000Z,Aminoacidopathy
MTR,HGNC:7468,methylcobalamin deficiency type cblG,MONDO:0009609,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1572b7da-1736-4a44-9420-d9734d53f950-2021-07-02T160000.000Z,2021-07-02T16:00:00.000Z,Aminoacidopathy
MTRR,HGNC:7473,methylcobalamin deficiency type cblE,MONDO:0009354,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_905575cf-cb80-4038-b82b-1de3ae1c469d-2021-07-02T160000.000Z,2021-07-02T16:00:00.000Z,Aminoacidopathy
NAGS,HGNC:17996,hyperammonemia due to N-acetylglutamate synthase deficiency,MONDO:0009377,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_33dcead1-e3d9-4427-98fd-05a655c8c213-2019-07-26T160000.000Z,2019-07-26T16:00:00.000Z,Aminoacidopathy
NAT8L,HGNC:26742,N-acetylaspartate deficiency,MONDO:0013549,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_854ce0ef-7744-483d-87c7-b2dc436f9f0f-2020-10-23T171820.214Z,2020-10-23T17:18:20.214Z,Aminoacidopathy
OAT,HGNC:8091,ornithine aminotransferase deficiency,MONDO:0009796,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_edbab666-9ae6-46db-b818-809a4bf8333e-2019-07-10T160000.000Z,2019-07-10T16:00:00.000Z,Aminoacidopathy
OTC,HGNC:8512,ornithine carbamoyltransferase deficiency,MONDO:0010703,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_132fafbf-bb34-447c-9f6a-65803679eeb8-2019-10-29T181325.783Z,2019-10-29T18:13:25.783Z,Aminoacidopathy
PAH,HGNC:8582,phenylketonuria,MONDO:0009861,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5a617cb4-94ec-4f34-b97e-10d9808a1581-2020-04-24T160000.000Z,2020-04-24T16:00:00.000Z,Aminoacidopathy
PCBD1,HGNC:8646,pterin-4 alpha-carbinolamine dehydratase 1 deficiency,MONDO:0009908,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d305c30f-50c1-491a-846f-4af6a2ad8aff-2021-07-27T160000.000Z,2021-07-27T16:00:00.000Z,Aminoacidopathy
PCCA,HGNC:8653,propionic acidemia,MONDO:0011628,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_32a55e25-8632-4f31-84af-3eaf8098ca18-2018-12-13T170000.000Z,2018-12-13T17:00:00.000Z,Aminoacidopathy
PCCB,HGNC:8654,propionic acidemia,MONDO:0011628,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1cd49a9b-08c2-49db-8e97-e334f171e34d-2018-12-13T170000.000Z,2018-12-13T17:00:00.000Z,Aminoacidopathy
PHGDH,HGNC:8923,neurometabolic disorder due to serine deficiency,MONDO:0018162,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f1b4e8da-d6e7-4494-abb0-f2953548a722-2020-06-29T174326.589Z,2020-06-29T17:43:26.589Z,Aminoacidopathy
PHYKPL,HGNC:28249,phosphohydroxylysinuria,MONDO:0014008,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_82ba1358-e58c-4187-bbe7-0f1bf41267d0-2020-09-25T165428.427Z,2020-09-25T16:54:28.427Z,Aminoacidopathy
PPM1K,HGNC:25415,"maple syrup urine disease, mild variant",MONDO:0014057,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d2b1c4d4-ca12-4456-afe0-f727106afeaf-2020-09-25T165546.698Z,2020-09-25T16:55:46.698Z,Aminoacidopathy
PRODH,HGNC:9453,hyperprolinemia type 1,MONDO:0009400,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5f28c677-a9b4-4bb3-9aed-14af97ad9896-2021-04-27T160000.000Z,2021-04-27T16:00:00.000Z,Aminoacidopathy
PRODH2,HGNC:17325,hydroxyprolinemia,MONDO:0009374,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d9101c67-2635-4595-b9a8-8e749bba58d1-2022-12-12T170000.000Z,2022-12-12T17:00:00.000Z,Aminoacidopathy
PSAT1,HGNC:19129,neurometabolic disorder due to serine deficiency,MONDO:0018162,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca702099-7dc9-4434-b661-a6f9b8c72d5c-2020-06-29T165656.452Z,2020-06-29T16:56:56.452Z,Aminoacidopathy
PSPH,HGNC:9577,neurometabolic disorder due to serine deficiency,MONDO:0018162,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fa832956-c4e9-4620-a2e7-3d6d6e9eea8c-2022-12-12T170000.000Z,2022-12-12T17:00:00.000Z,Aminoacidopathy
PTS,HGNC:9689,BH4-deficient hyperphenylalaninemia A,MONDO:0009863,AR,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f3f9b683-bd6b-4566-9341-ddd7195b5108-2017-12-22T170000.000Z,2017-12-22T17:00:00.000Z,Aminoacidopathy
PYCR1,HGNC:9721,autosomal recessive cutis laxa type 2B,MONDO:0013051,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca242cd8-1f57-4c7b-ba97-5ec0c97b425b-2020-05-21T191607.864Z,2020-05-21T19:16:07.864Z,Aminoacidopathy
QDPR,HGNC:9752,dihydropteridine reductase deficiency,MONDO:0009862,AR,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3cd45f13-9412-4439-9b68-cf2e3d02a646-2018-06-18T160000.000Z,2018-06-18T16:00:00.000Z,Aminoacidopathy
SARDH,HGNC:10536,sarcosinemia,MONDO:0010008,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2b994b6f-f296-45af-9d52-c1d0b211ef74-2022-12-12T170000.000Z,2022-12-12T17:00:00.000Z,Aminoacidopathy
SELENBP1,HGNC:10719,extraoral halitosis due to methanethiol oxidase deficiency,MONDO:0029144,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fcd063e5-93af-47d2-a59d-3fef995df556-2022-11-11T170000.000Z,2022-11-11T17:00:00.000Z,Aminoacidopathy
SHMT2,HGNC:10852,"neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities",MONDO:0030866,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cf0af939-9015-47dd-bbcd-192114220334-2022-11-11T170000.000Z,2022-11-11T17:00:00.000Z,Aminoacidopathy
SLC1A1,HGNC:10939,dicarboxylic aminoaciduria,MONDO:0009110,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fd6cc720-f37b-4abf-a887-8701ac805343-2022-12-12T170000.000Z,2022-12-12T17:00:00.000Z,Aminoacidopathy
SLC1A2,HGNC:10940,"developmental and epileptic encephalopathy, 41",MONDO:0014916,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ebb83674-206f-461b-b98e-e12420208deb-2020-10-29T160000.000Z,2020-10-29T16:00:00.000Z,Aminoacidopathy
SLC1A3,HGNC:10941,episodic ataxia type 6,MONDO:0012982,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3bcae41b-3438-4e82-8f29-83cca7f142f0-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Aminoacidopathy
SLC1A4,HGNC:10942,spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome,MONDO:0014725,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8cff4bb6-caab-4696-a061-1f9a40c56c80-2021-05-14T160000.000Z,2021-05-14T16:00:00.000Z,Aminoacidopathy
SLC25A13,HGNC:10983,citrin deficiency,MONDO:0016602,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bc373b9e-ec5e-4471-92a1-bbdd9aa3378c-2021-07-23T220742.579Z,2021-07-23T22:07:42.579Z,Aminoacidopathy
SLC25A15,HGNC:10985,ornithine translocase deficiency,MONDO:0009393,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e5cb32c9-d506-484f-b023-1c4f17ef0d93-2019-12-04T170000.000Z,2019-12-04T17:00:00.000Z,Aminoacidopathy
SLC36A2,HGNC:18762,iminoglycinuria,MONDO:0009448,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_38341e13-b026-4a61-a049-5f7ef9df1805-2020-03-13T160000.000Z,2020-03-13T16:00:00.000Z,Aminoacidopathy
SLC3A1,HGNC:11025,cystinuria,MONDO:0009067,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fbde8280-d4bc-47e8-8f3d-aed8bb05e22e-2020-06-29T174347.853Z,2020-06-29T17:43:47.853Z,Aminoacidopathy
SLC6A19,HGNC:27960,Hartnup disease,MONDO:0009324,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_44c34762-450b-4abd-8fe4-3f17ff700630-2020-05-07T160000.000Z,2020-05-07T16:00:00.000Z,Aminoacidopathy
SLC6A8,HGNC:11055,creatine transporter deficiency,MONDO:0010305,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3795f0ae-7668-47b8-b69e-9c686b82bd0a-2020-02-10T170000.000Z,2020-02-10T17:00:00.000Z,Aminoacidopathy
SLC7A7,HGNC:11065,lysinuric protein intolerance,MONDO:0009109,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_207778e3-aff9-427d-ae87-f68fd938af88-2019-11-08T170000.000Z,2019-11-08T17:00:00.000Z,Aminoacidopathy
SLC7A9,HGNC:11067,cystinuria,MONDO:0009067,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a8e706c5-4b10-4c8a-b5ab-dda8545f464a-2020-06-29T174426.491Z,2020-06-29T17:44:26.491Z,Aminoacidopathy
SPR,HGNC:11257,dopa-responsive dystonia due to sepiapterin reductase deficiency,MONDO:0012994,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1c9f2ff6-39f1-4abc-9fdf-de4c0e23120d-2021-06-04T221815.205Z,2021-06-04T22:18:15.205Z,Aminoacidopathy
SUGCT,HGNC:16001,glutaric acidemia type 3,MONDO:0009283,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_10622f19-d307-4fa8-b3ff-a799922e7fea-2022-12-12T170000.000Z,2022-12-12T17:00:00.000Z,Aminoacidopathy
SUOX,HGNC:11460,isolated sulfite oxidase deficiency,MONDO:0010089,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_be1ff294-4444-4d39-a507-a2115bcdcd58-2019-03-22T160000.000Z,2019-03-22T16:00:00.000Z,Aminoacidopathy
TAT,HGNC:11573,tyrosinemia type II,MONDO:0010160,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7a28aa11-78af-4c3b-900e-79c6a1e9339a-2020-06-29T174208.705Z,2020-06-29T17:42:08.705Z,Aminoacidopathy
TDO2,HGNC:11708,familial hypertryptophanemia,MONDO:0010907,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b20a4b6d-c43c-4397-bbd2-3d4c6ea6f0e0-2020-07-10T165838.141Z,2020-07-10T16:58:38.141Z,Aminoacidopathy
TH,HGNC:11782,tyrosine hydroxylase deficiency,MONDO:0100064,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c4bf9fbb-0046-4a90-9e74-0b3b79f28f59-2019-03-22T160000.000Z,2019-03-22T16:00:00.000Z,Aminoacidopathy
TYR,HGNC:12442,oculocutaneous albinism type 1,MONDO:0018135,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c9b52af2-1674-4f3d-9d7f-398a5f7f6875-2020-08-28T160000.000Z,2020-08-28T16:00:00.000Z,Aminoacidopathy
UROC1,HGNC:26444,urocanic aciduria,MONDO:0010167,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_af2ff293-39ce-46b7-af58-01e3685f4334-2020-11-13T170000.000Z,2020-11-13T17:00:00.000Z,Aminoacidopathy
ANG,HGNC:483,amyotrophic lateral sclerosis type 9,MONDO:0012753,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4ee17299-56dd-40a7-8cec-9a316f3e46f2-2022-02-08T000000.000Z,2022-02-08T00:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
ANXA11,HGNC:535,amyotrophic lateral sclerosis type 23,MONDO:0027694,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4dca2f56-87c6-4ac7-97bf-0889883b8e63-2021-11-12T215939.032Z,2021-11-12T21:59:39.032Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
C9orf72,HGNC:28337,frontotemporal dementia and/or amyotrophic lateral sclerosis 1,MONDO:0007105,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_afd5a267-72c8-4a04-8404-4c819efe61c5-2021-09-21T030209.665Z,2021-09-21T03:02:09.665Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
CCNF,HGNC:1591,frontotemporal dementia and/or amyotrophic lateral sclerosis 5,MONDO:0030875,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7d6c258c-ce66-459a-a4ae-7376fcefde0d-2022-04-05T230455.308Z,2022-04-05T23:04:55.308Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
CHCHD10,HGNC:15559,frontotemporal dementia and/or amyotrophic lateral sclerosis 2,MONDO:0014395,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d154f67a-25ce-40d3-9de3-1f001753843a-2022-09-13T160000.000Z,2022-09-13T16:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
CHMP2B,HGNC:24537,frontotemporal dementia and/or amyotrophic lateral sclerosis 7,MONDO:0010936,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_287cab44-b8b6-411c-903a-6214ac5e98af-2022-07-12T160000.000Z,2022-07-12T16:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
DAO,HGNC:2671,amyotrophic lateral sclerosis,MONDO:0004976,AD,SOP8,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_35ac00ac-3279-4c7e-89b6-8a75e3cae414-2022-04-12T103808.867Z,2022-04-12T10:38:08.867Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
DNAJC7,HGNC:12392,amyotrophic lateral sclerosis,MONDO:0004976,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e2a12a19-b37a-4654-87fa-3a921c202c87-2022-10-27T160000.000Z,2022-10-27T16:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
ERBB4,HGNC:3432,amyotrophic lateral sclerosis type 19,MONDO:0014223,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fdd26ab6-0c1f-4322-9f70-cad651bb789f-2021-09-30T143144.993Z,2021-09-30T14:31:44.993Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
ERLIN1,HGNC:16947,amyotrophic lateral sclerosis,MONDO:0004976,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d668c62f-b002-4015-a629-ecbebed40e59-2021-07-27T160919.089Z,2021-07-27T16:09:19.089Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
FIG4,HGNC:16873,amyotrophic lateral sclerosis type 11,MONDO:0012945,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d038fb84-1f98-4047-b6c5-039a53756775-2022-08-09T160000.000Z,2022-08-09T16:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
FUS,HGNC:4010,amyotrophic lateral sclerosis type 6,MONDO:0011951,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b2e8f55b-371e-438f-8923-73ca9b7ec034-2021-10-12T183601.087Z,2021-10-12T18:36:01.087Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
GLT8D1,HGNC:24870,familial amyotrophic lateral sclerosis,MONDO:0005144,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a2c4f919-ccb5-4d9f-a604-5ed19e19057e-2022-11-08T170000.000Z,2022-11-08T17:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
HNRNPA2B1,HGNC:5033,amyotrophic lateral sclerosis,MONDO:0004976,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1ffe711b-1ff6-4b11-b329-c0f820904764-2021-12-15T185159.600Z,2021-12-15T18:51:59.600Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
KIF5A,HGNC:6323,"amyotrophic lateral sclerosis, susceptibility to, 25",MONDO:0060670,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e7d2674-bce3-469c-b1e4-5cf57f5780a8-2022-05-26T110000.000Z,2022-05-26T11:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
MATR3,HGNC:6912,amyotrophic lateral sclerosis type 21,MONDO:0011632,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_97ed1e35-c1b2-40c7-a60e-54b3c24004c4-2021-09-23T160000.000Z,2021-09-23T16:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
NEK1,HGNC:7744,"amyotrophic lateral sclerosis, susceptibility to, 24",MONDO:0054750,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bb4f311c-df33-4d9e-8ac6-731b43b93615-2022-04-29T192526.542Z,2022-04-29T19:25:26.542Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
OPTN,HGNC:17142,amyotrophic lateral sclerosis type 12,MONDO:0013264,SD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1d8edc80-413c-4c76-bf06-89198175ac65-2022-05-10T170000.000Z,2022-05-10T17:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
PFN1,HGNC:8881,amyotrophic lateral sclerosis type 18,MONDO:0013891,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_948de40f-2cef-4235-ae87-491c01ffe803-2021-04-22T160000.000Z,2021-04-22T16:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
PRPH,HGNC:9461,amyotrophic lateral sclerosis,MONDO:0004976,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3d11b04d-508a-4f91-9d9a-b5016fd0b940-2022-12-13T170000.000Z,2022-12-13T17:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
SOD1,HGNC:11179,amyotrophic lateral sclerosis type 1,MONDO:0007103,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_97d17778-d21e-441f-b4b7-49eccaa8cbab-2021-07-13T192226.690Z,2021-07-13T19:22:26.690Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
SQSTM1,HGNC:11280,frontotemporal dementia and/or amyotrophic lateral sclerosis 3,MONDO:0014640,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dae3327f-6381-44cc-8baa-8fa1fc0d31d5-2022-12-13T170000.000Z,2022-12-13T17:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
TAF15,HGNC:11547,amyotrophic lateral sclerosis,MONDO:0004976,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_605446ae-fd1f-4451-bd49-643c24cd652e-2021-11-03T020945.214Z,2021-11-03T02:09:45.214Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
TARDBP,HGNC:11571,amyotrophic lateral sclerosis type 10,MONDO:0012790,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bf8bf781-25c9-4f16-b8cc-b0533390e4e2-2021-07-27T160623.437Z,2021-07-27T16:06:23.437Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
TBK1,HGNC:11584,frontotemporal dementia and/or amyotrophic lateral sclerosis 4,MONDO:0014641,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_509b9e29-d354-4974-96e9-e819c3fee579-2022-11-03T160000.000Z,2022-11-03T16:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
TIA1,HGNC:11802,amyotrophic lateral sclerosis 26 with or without frontotemporal dementia,MONDO:0030885,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_555a0c95-2fb8-44d2-b2bf-c02b16d3fa6f-2022-10-11T170000.000Z,2022-10-11T17:00:00.000Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
TUBA4A,HGNC:12407,amyotrophic lateral sclerosis type 22,MONDO:0014531,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7349d6e4-f351-4a8a-80f6-af62d3e716e5-2021-09-14T191334.954Z,2021-09-14T19:13:34.954Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
UBQLN2,HGNC:12509,amyotrophic lateral sclerosis type 15,MONDO:0010459,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_17c06f6e-6fe1-4a61-bc35-026416e31dbb-2021-04-13T194634.543Z,2021-04-13T19:46:34.543Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
VAPB,HGNC:12649,amyotrophic lateral sclerosis type 8,MONDO:0012077,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_da78d57d-1525-47b3-a649-743186d28eff-2021-12-15T183034.352Z,2021-12-15T18:30:34.352Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
VCP,HGNC:12666,inclusion body myopathy with Paget disease of bone and frontotemporal dementia,MONDO:0000507,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6ea2bc4d-3b58-4b59-a5bc-9d8a96c452cb-2021-12-23T223510.433Z,2021-12-23T22:35:10.433Z,Amyotrophic Lateral Sclerosis Spectrum Disorders
AICDA,HGNC:13203,hyper-IgM syndrome type 2,MONDO:0011528,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b34c451d-03a1-42dd-a439-599428b0eb38-2021-09-17T121716.866Z,2021-09-17T12:17:16.866Z,Antibody Deficiencies GCEP
ARHGEF1,HGNC:681,immunodeficiency 62,MONDO:0032763,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9547c192-135d-48b3-a1c0-2eca5e2608c5-2021-01-19T214711.722Z,2021-01-19T21:47:11.722Z,Antibody Deficiencies GCEP
BLNK,HGNC:14211,"agammaglobulinemia 4, autosomal recessive",MONDO:0013289,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2e1d2e1b-52a6-4371-9055-0e1cc74da39d-2021-03-16T132748.373Z,2021-03-16T13:27:48.373Z,Antibody Deficiencies GCEP
BTK,HGNC:1133,isolated growth hormone deficiency type III,MONDO:0010615,XL,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6341781b-9ba9-41b1-889a-8d65a9b3ebb7-2020-11-17T170000.000Z,2020-11-17T17:00:00.000Z,Antibody Deficiencies GCEP
BTK,HGNC:1133,Bruton-type agammaglobulinemia,MONDO:0010421,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8dc4d594-2103-46ad-a786-f4bda9b95995-2020-10-20T160000.000Z,2020-10-20T16:00:00.000Z,Antibody Deficiencies GCEP
CARD11,HGNC:16393,BENTA disease,MONDO:0014645,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_23dd1a19-585b-46bb-9241-682b200bfd7d-2022-03-15T131318.170Z,2022-03-15T13:13:18.170Z,Antibody Deficiencies GCEP
CARD11,HGNC:16393,severe combined immunodeficiency due to CARD11 deficiency,MONDO:0014081,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ce06b6f-cf7f-43f3-bf9c-5d3978f1db61-2022-03-15T131409.712Z,2022-03-15T13:14:09.712Z,Antibody Deficiencies GCEP
CARD11,HGNC:16393,immunodeficiency 11b with atopic dermatitis,MONDO:0054697,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_603e8c98-82b7-41b5-8174-1fdbfc724a7d-2022-03-15T131220.080Z,2022-03-15T13:12:20.080Z,Antibody Deficiencies GCEP
CD19,HGNC:1633,"immunodeficiency, common variable, 3",MONDO:0013283,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a6576337-703e-4d76-9120-5f6800730774-2022-05-24T160000.000Z,2022-05-24T16:00:00.000Z,Antibody Deficiencies GCEP
CD40,HGNC:11919,hyper-IgM syndrome type 3,MONDO:0011735,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_debbb2e7-89a7-45b8-b5e1-41ccb56a3423-2022-10-18T160000.000Z,2022-10-18T16:00:00.000Z,Antibody Deficiencies GCEP
CD79A,HGNC:1698,"agammaglobulinemia 3, autosomal recessive",MONDO:0013288,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_12a6257c-c9ca-432a-ab76-b05985283381-2020-12-15T135909.057Z,2020-12-15T13:59:09.057Z,Antibody Deficiencies GCEP
CD79B,HGNC:1699,"agammaglobulinemia 6, autosomal recessive",MONDO:0012987,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9c252b2c-2183-4e7d-8ceb-69f7a01cc1d9-2021-01-26T171006.440Z,2021-01-26T17:10:06.440Z,Antibody Deficiencies GCEP
CD81,HGNC:1701,"immunodeficiency, common variable, 6",MONDO:0013286,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e2092b4c-a8ff-4b40-bc09-17fbe33aa3e7-2021-04-29T210806.386Z,2021-04-29T21:08:06.386Z,Antibody Deficiencies GCEP
CR2,HGNC:2336,"immunodeficiency, common variable, 7",MONDO:0013862,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9153b41e-f2ef-453d-883b-187565cf4593-2021-08-03T130056.511Z,2021-08-03T13:00:56.511Z,Antibody Deficiencies GCEP
CTLA4,HGNC:2505,autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency,MONDO:0014493,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e79675bd-3eef-4925-b4ef-3b7c48734f30-2021-04-28T163716.269Z,2021-04-28T16:37:16.269Z,Antibody Deficiencies GCEP
CTNNBL1,HGNC:15879,common variable immunodeficiency,MONDO:0015517,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4e151724-c8a5-4f3e-a7ac-bd0b1d180fae-2022-05-17T160000.000Z,2022-05-17T16:00:00.000Z,Antibody Deficiencies GCEP
CXCR4,HGNC:2561,WHIM syndrome,MONDO:0023880,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_89723de3-8fd8-4e2c-8609-bcd924e2f349-2023-01-17T170000.000Z,2023-01-17T17:00:00.000Z,Antibody Deficiencies GCEP
FNIP1,HGNC:29418,FNIP1-associated syndrome,MONDO:0100432,AR,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_25c930ed-965b-47ae-b9c2-7157b06cb868-2021-12-06T131417.148Z,2021-12-06T13:14:17.148Z,Antibody Deficiencies GCEP
ICOS,HGNC:5351,common variable immunodeficiency,MONDO:0015517,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_51864ec9-27d9-4a94-9524-d6828b17361d-2022-11-29T170000.000Z,2022-11-29T17:00:00.000Z,Antibody Deficiencies GCEP
IGHM,HGNC:5541,autosomal recessive agammaglobulinemia 1,MONDO:0020729,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_51719b80-54fb-4a55-a63c-7d7a943da1e3-2021-06-15T120659.636Z,2021-06-15T12:06:59.636Z,Antibody Deficiencies GCEP
IGKC,HGNC:5716,recurrent infections associated with rare immunoglobulin isotypes deficiency,MONDO:0013576,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_017e48b4-45d1-4bba-b51c-0f372dbe3a6d-2021-05-18T160657.607Z,2021-05-18T16:06:57.607Z,Antibody Deficiencies GCEP
IGLL1,HGNC:5870,"agammaglobulinemia 2, autosomal recessive",MONDO:0013287,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b483cc35-0599-4313-b71a-835cb1096ca5-2021-12-21T133220.444Z,2021-12-21T13:32:20.444Z,Antibody Deficiencies GCEP
IKZF1,HGNC:13176,autoimmune disease,MONDO:0007179,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a839a0c3-f5c6-4286-9d04-cd9347fefb00-2022-08-16T170000.000Z,2022-08-16T17:00:00.000Z,Antibody Deficiencies GCEP
IKZF1,HGNC:13176,pancytopenia due to IKZF1 mutations,MONDO:0014810,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_be4b4555-477b-477b-bff9-7fcc8883806a-2022-09-13T170000.000Z,2022-09-13T17:00:00.000Z,Antibody Deficiencies GCEP
IL21,HGNC:6005,common variable immunodeficiency,MONDO:0015517,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_82664dca-783a-4ed9-abe5-c77b082a0684-2022-12-30T120000.000Z,2022-12-30T12:00:00.000Z,Antibody Deficiencies GCEP
IL21R,HGNC:6006,immunodeficiency disease,MONDO:0021094,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4dbeac16-997c-43c0-9fb6-eaa98d0816f9-2022-12-31T120000.000Z,2022-12-31T12:00:00.000Z,Antibody Deficiencies GCEP
INO80,HGNC:26956,"immunodeficiency, common variable, 1",MONDO:0011864,AR,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_16d9f828-f6fa-4e35-bc23-c9f1b1138b9a-2021-01-22T014826.188Z,2021-01-22T01:48:26.188Z,Antibody Deficiencies GCEP
IRF2BP2,HGNC:21729,"immunodeficiency, common variable, 14",MONDO:0054691,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_025487e5-9447-4c7b-88ad-f650103e09cf-2021-03-16T125403.252Z,2021-03-16T12:54:03.252Z,Antibody Deficiencies GCEP
LRBA,HGNC:1742,combined immunodeficiency due to LRBA deficiency,MONDO:0013863,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b12eaaeb-cc9d-48b8-b9cd-c0b243f48287-2022-05-18T121409.964Z,2022-05-18T12:14:09.964Z,Antibody Deficiencies GCEP
MS4A1,HGNC:7315,"immunodeficiency, common variable, 5",MONDO:0013285,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eba48c0f-53fa-48c9-8f4e-9892d095b515-2022-03-02T185714.677Z,2022-03-02T18:57:14.677Z,Antibody Deficiencies GCEP
NFKB1,HGNC:7794,"immunodeficiency, common variable, 12",MONDO:0014697,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e922c85d-f51a-4394-8906-cf01978d8154-2021-05-14T152859.709Z,2021-05-14T15:28:59.709Z,Antibody Deficiencies GCEP
NFKB2,HGNC:7795,"immunodeficiency, common variable, 10",MONDO:0014260,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_61b546f1-5683-4588-a5bc-030ebbd5b401-2021-10-13T132601.192Z,2021-10-13T13:26:01.192Z,Antibody Deficiencies GCEP
PIK3CD,HGNC:8977,"immunodeficiency 14b, autosomal recessive",MONDO:0023655,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_00e2cc94-311b-44d8-9c41-e41c12ebd8f2-2022-04-19T192558.184Z,2022-04-19T19:25:58.184Z,Antibody Deficiencies GCEP
PIK3CD,HGNC:8977,immunodeficiency 14,MONDO:0014222,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c37954fd-7d7c-4ca9-9cd0-7681c1edf8d3-2022-04-19T150547.546Z,2022-04-19T15:05:47.546Z,Antibody Deficiencies GCEP
PIK3R1,HGNC:8979,immunodeficiency 36,MONDO:0014453,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_40c5f722-d25e-46b1-8a52-c407d1c64e63-2021-07-22T195122.034Z,2021-07-22T19:51:22.034Z,Antibody Deficiencies GCEP
PIK3R1,HGNC:8979,"agammaglobulinemia 7, autosomal recessive",MONDO:0014083,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e019aaad-09a8-44c4-9fc0-12a1d53e79db-2021-05-20T153438.351Z,2021-05-20T15:34:38.351Z,Antibody Deficiencies GCEP
POU2AF1,HGNC:9211,agammaglobulinemia,MONDO:0015977,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cfebbac7-4e4e-4bd6-8977-1b490e915f45-2022-09-20T160000.000Z,2022-09-20T16:00:00.000Z,Antibody Deficiencies GCEP
RAC2,HGNC:9802,immunodeficiency 73c with defective neutrophil chemotaxis and hypogammaglobulinemia,MONDO:0033555,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8191c879-cc6a-4c5e-9ceb-7101aa7cbc15-2021-10-19T154613.500Z,2021-10-19T15:46:13.500Z,Antibody Deficiencies GCEP
RAC2,HGNC:9802,immunodeficiency 73b with defective neutrophil chemotaxis and lymphopenia,MONDO:0033554,AD,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a6c1e0b1-de02-4899-9825-acc950bedcc3-2021-10-19T155522.241Z,2021-10-19T15:55:22.241Z,Antibody Deficiencies GCEP
RAC2,HGNC:9802,neutrophil immunodeficiency syndrome,MONDO:0011988,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f415e195-889f-4812-becd-5b3e7fe6b84f-2021-12-21T135017.284Z,2021-12-21T13:50:17.284Z,Antibody Deficiencies GCEP
SEC61A1,HGNC:18276,SEC61A1 deficiency,MONDO:0100337,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1ff61d15-19f9-42a2-8dc4-0a4071b562eb-2021-07-27T154837.287Z,2021-07-27T15:48:37.287Z,Antibody Deficiencies GCEP
SERPING1,HGNC:1228,hereditary angioedema with C1Inh deficiency,MONDO:0033946,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bb571a69-47a6-4e28-a837-b9df492526c9-2022-12-15T170000.000Z,2022-12-15T17:00:00.000Z,Antibody Deficiencies GCEP
SH3KBP1,HGNC:13867,immunodeficiency 61,MONDO:0010296,XL,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3cc42cdd-5484-467b-9e35-7529716114dd-2021-11-16T170000.000Z,2021-11-16T17:00:00.000Z,Antibody Deficiencies GCEP
SLC39A7,HGNC:4927,agammaglobulinemia,MONDO:0015977,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_69ebdc60-2bdd-4020-9d20-7c0ea0fd3cdd-2021-09-21T130638.465Z,2021-09-21T13:06:38.465Z,Antibody Deficiencies GCEP
SPI1,HGNC:11241,"agammaglobulinemia 10, autosomal dominant",MONDO:0030529,AD,SOP9,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_76a93861-b7d3-4d08-8882-6a7a1456b51a-2022-08-16T170000.000Z,2022-08-16T17:00:00.000Z,Antibody Deficiencies GCEP
TCF3,HGNC:11633,autosomal agammaglobulinemia,MONDO:0011096,SD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_402ff7db-2e09-4e76-9284-1e7c4ae84fb3-2023-01-07T120000.000Z,2023-01-07T12:00:00.000Z,Antibody Deficiencies GCEP
TNFRSF13B,HGNC:18153,"immunodeficiency, common variable, 2",MONDO:0009413,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3049236b-8132-4dfa-8cda-2a328962a0a4-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Antibody Deficiencies GCEP
TNFRSF13C,HGNC:17755,"immunodeficiency, common variable, 4",MONDO:0013284,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1408411b-9d28-4308-b2bc-dbada3660898-2021-04-13T003359.028Z,2021-04-13T00:33:59.028Z,Antibody Deficiencies GCEP
TNFSF12,HGNC:11927,common variable immunodeficiency,MONDO:0015517,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b943345a-024d-401d-a147-470c0ea0381c-2022-07-22T160000.000Z,2022-07-22T16:00:00.000Z,Antibody Deficiencies GCEP
TNFSF13,HGNC:11928,common variable immunodeficiency,MONDO:0015517,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c181d44b-5c48-441b-95ad-b4d06572596d-2022-09-20T160000.000Z,2022-09-20T16:00:00.000Z,Antibody Deficiencies GCEP
TOP2B,HGNC:11990,"B-cell immunodeficiency, distal limb anomalies, and urogenital malformations",MONDO:0012243,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_677a64c1-b005-44f6-9846-a7f371222667-2021-10-19T125736.122Z,2021-10-19T12:57:36.122Z,Antibody Deficiencies GCEP
TRNT1,HGNC:17341,congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome,MONDO:0014487,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6df64a62-650c-4659-b2e8-ee51263fcdbc-2022-10-30T120000.000Z,2022-10-30T12:00:00.000Z,Antibody Deficiencies GCEP
UNG,HGNC:12572,hyper-IgM syndrome type 5,MONDO:0011971,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_336745e2-39bc-429c-8b0d-fd73216522a5-2021-08-17T160000.000Z,2021-08-17T16:00:00.000Z,Antibody Deficiencies GCEP
ACTC1,HGNC:143,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_748d4255-ef43-4b42-b9f1-1cdbc50de763-2019-03-15T160000.000Z,2019-03-15T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
CDH2,HGNC:1759,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c7a03805-bf73-4d2d-9756-c666c67be119-2018-07-13T160000.000Z,2018-07-13T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
CTNNA3,HGNC:2511,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0f1dd946-f2bb-496f-8fea-3dea303e2e76-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
DES,HGNC:2770,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aef9a60b-a94f-4318-824e-e748c5c20ecb-2018-09-11T160000.000Z,2018-09-11T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
DSC2,HGNC:3036,familial isolated arrhythmogenic right ventricular dysplasia,MONDO:0016342,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_74238dee-a847-4f27-9d30-3050c7bf9bf2-2018-09-14T160000.000Z,2018-09-14T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
DSG2,HGNC:3049,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f679611d-6e25-45f9-aac3-4a8ad37b1592-2018-09-14T160000.000Z,2018-09-14T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
DSP,HGNC:3052,arrhythmogenic cardiomyopathy with woolly hair and keratoderma,MONDO:0011581,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b23da580-269c-4e5d-8f13-91dbe7ea6a57-2019-07-12T160000.000Z,2019-07-12T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
LDB3,HGNC:15710,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8ebdc3e8-2e0a-4a5e-8906-8e616d14008b-2019-09-12T160000.000Z,2019-09-12T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
LMNA,HGNC:6636,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ef503af9-9d10-4714-848b-34cfa0049c23-2019-09-06T160000.000Z,2019-09-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
MYBPC3,HGNC:7551,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0639d989-8415-425c-ab89-e8a3a0b6ea49-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
MYH7,HGNC:7577,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0265f091-a67d-4521-b6bd-5a110bd5356f-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
MYL2,HGNC:7583,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1db17cf-199d-4bd7-9673-e8f06219fc26-2019-05-24T160000.000Z,2019-05-24T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
MYL3,HGNC:7584,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1d5e9bf-ca57-445a-a432-27fe221484bf-2019-09-13T160000.000Z,2019-09-13T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
PKP2,HGNC:9024,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6f97b6cd-5225-4076-b67a-2f609908e6fe-2018-03-08T170000.000Z,2018-03-08T17:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
PLN,HGNC:9080,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_13027de9-c84a-4968-936b-6356265193a6-2020-12-17T213224.631Z,2020-12-17T21:32:24.631Z,Arrhythmogenic Right Ventricular Cardiomyopathy
RYR2,HGNC:10484,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_52fa7dee-4daa-4685-9461-f39c57a22f05-2019-07-19T160000.000Z,2019-07-19T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
SCN5A,HGNC:10593,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3c1cdce2-c8de-442d-b0c4-5936919b310f-2019-06-06T160000.000Z,2019-06-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
TGFB3,HGNC:11769,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_36ed9be9-2854-49e5-801c-a8fd65fec98e-2019-08-16T160000.000Z,2019-08-16T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
TJP1,HGNC:11827,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_435951df-5a0d-4596-b112-ccd6d6204409-2019-02-08T170000.000Z,2019-02-08T17:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
TMEM43,HGNC:28472,arrhythmogenic right ventricular dysplasia 5,MONDO:0011459,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_675dc788-9749-413f-93ce-8c1fc3adbe84-2018-10-26T160000.000Z,2018-10-26T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
TNNC1,HGNC:11943,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bea34b8c-4260-4dce-bcb3-69be7eb1aa21-2019-09-13T160000.000Z,2019-09-13T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
TNNI3,HGNC:11947,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_21c990ca-e407-4a21-a3e2-237700a75d43-2019-07-16T160000.000Z,2019-07-16T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
TNNT2,HGNC:11949,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d2bde3ff-f75f-40c3-a8fe-10a72e883b3c-2019-07-16T160000.000Z,2019-07-16T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
TPM1,HGNC:12010,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8e69d885-a5c6-48de-bb65-0943a6c2268d-2019-09-13T160000.000Z,2019-09-13T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
TTN,HGNC:12403,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a93ab74d-c9fa-4e74-b849-c8c6e8366050-2019-08-06T160000.000Z,2019-08-06T16:00:00.000Z,Arrhythmogenic Right Ventricular Cardiomyopathy
ACTB,HGNC:132,Baraitser-Winter cerebrofrontofacial syndrome,MONDO:0017579,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fa13dfad-ab93-4521-874a-5ede8f608fe4-2021-10-26T165835.977Z,2021-10-26T16:58:35.977Z,Brain Malformations
AHI1,HGNC:21575,Joubert syndrome 3,MONDO:0012078,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d0d8d22f-cea6-4f4f-bc71-e85303dccac1-2021-10-26T143345.589Z,2021-10-26T14:33:45.589Z,Brain Malformations
AKT3,HGNC:393,overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes,MONDO:0100283,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_52b1df18-387f-4c38-a655-682e4d2eb378-2021-07-29T213439.431Z,2021-07-29T21:34:39.431Z,Brain Malformations
AKT3,HGNC:393,microcephaly,MONDO:0001149,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6e3b524c-5d27-43d6-a0db-4f8f7cf1f872-2021-10-26T150030.155Z,2021-10-26T15:00:30.155Z,Brain Malformations
CDK5RAP2,HGNC:18672,autosomal recessive primary microcephaly,MONDO:0016660,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_70dace84-4d61-44f5-9de5-a81b5c70cad4-2022-01-25T170000.000Z,2022-01-25T17:00:00.000Z,Brain Malformations
DCC,HGNC:2701,mirror movements 1 and/or agenesis of the corpus callosum,MONDO:0100515,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f923f025-a973-4af8-b2c2-00dc39ed3026-2022-07-26T160000.000Z,2022-07-26T16:00:00.000Z,Brain Malformations
DCX,HGNC:2714,lissencephaly spectrum disorders,MONDO:0018838,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3b0d23d1-5ca6-4584-9d74-cf78ca21b0e1-2021-02-23T150911.296Z,2021-02-23T15:09:11.296Z,Brain Malformations
DISP1,HGNC:19711,holoprosencephaly,MONDO:0016296,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ef9d5a3b-d4ec-473b-b5a2-aaa25cf9babd-2022-09-27T090000.000Z,2022-09-27T09:00:00.000Z,Brain Malformations
DOCK6,HGNC:19189,Adams-Oliver syndrome,MONDO:0007034,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ea64d74c-583d-4ed1-af91-6a7c6f80a1d3-2022-06-28T160000.000Z,2022-06-28T16:00:00.000Z,Brain Malformations
KIF21A,HGNC:19349,congenital fibrosis of extraocular muscles,MONDO:0007614,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cc32bbc2-de76-42d0-8a6b-b3c3393ddd30-2021-10-26T144854.679Z,2021-10-26T14:48:54.679Z,Brain Malformations
KIF5C,HGNC:6325,complex cortical dysplasia with other brain malformations 2,MONDO:0014116,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c22eb3e1-4a72-480f-a360-20788fe1d9cd-2022-01-25T170000.000Z,2022-01-25T17:00:00.000Z,Brain Malformations
MTOR,HGNC:3942,overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes,MONDO:0100283,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_92ce0145-031d-41c4-8b74-0f9411629b64-2021-07-29T213256.506Z,2021-07-29T21:32:56.506Z,Brain Malformations
NEDD4L,HGNC:7728,periventricular nodular heterotopia 7,MONDO:0014966,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b131d46a-069b-4c2e-a290-e7df2519a2df-2021-11-30T170000.000Z,2021-11-30T17:00:00.000Z,Brain Malformations
PIK3CA,HGNC:8975,overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes,MONDO:0100283,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c670e6ce-97b6-4383-bea6-5c216ab2a4a0-2021-07-29T213157.366Z,2021-07-29T21:31:57.366Z,Brain Malformations
PIK3R2,HGNC:8980,overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes,MONDO:0100283,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fc9a451e-0e75-47d2-a090-a2409732c465-2021-07-29T213616.452Z,2021-07-29T21:36:16.452Z,Brain Malformations
PROK2,HGNC:18455,hypogonadotropic hypogonadism 4 with or without anosmia,MONDO:0012528,SD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2305ec95-325d-4ebe-9401-121705e49660-2022-03-22T160000.000Z,2022-03-22T16:00:00.000Z,Brain Malformations
PROKR2,HGNC:15836,hypogonadotropic hypogonadism 3 with or without anosmia,MONDO:0009482,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1ed279e5-f1a6-4f02-818e-e34aaf8c9947-2022-04-26T160000.000Z,2022-04-26T16:00:00.000Z,Brain Malformations
QARS1,HGNC:9751,diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome,MONDO:0014335,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6b0cbc0e-c97c-4f6d-a351-0ac23a4ba8a5-2020-05-26T150033.131Z,2020-05-26T15:00:33.131Z,Brain Malformations
RAB3GAP1,HGNC:17063,Warburg micro syndrome,MONDO:0016649,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1e4a47e-757a-442f-b82f-2ddfd69d0854-2020-05-26T160000.000Z,2020-05-26T16:00:00.000Z,Brain Malformations
ROBO3,HGNC:13433,"gaze palsy, familial horizontal, with progressive scoliosis 1",MONDO:0020790,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_257a59f3-1f00-4bd8-b255-793bc692bc9c-2022-07-12T170000.000Z,2022-07-12T17:00:00.000Z,Brain Malformations
TUBB2B,HGNC:30829,complex cortical dysplasia with other brain malformations,MONDO:0000904,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_81ced164-4ef1-4256-a727-84e79930efcc-2020-04-26T040000.000Z,2020-04-26T04:00:00.000Z,Brain Malformations
TUBG1,HGNC:12417,lissencephaly spectrum disorders,MONDO:0018838,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f773acb3-c59f-4c34-90f7-b5396b2dbfac-2022-04-26T160000.000Z,2022-04-26T16:00:00.000Z,Brain Malformations
WDR62,HGNC:24502,"microcephaly 2, primary, autosomal recessive, with or without cortical malformations",MONDO:0011435,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bdbcb9de-2ded-46a0-a6d0-16b34ea22008-2020-05-26T160000.000Z,2020-05-26T16:00:00.000Z,Brain Malformations
ATM,HGNC:795,familial ovarian cancer,MONDO:0016248,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10080,2017-07-12T00:00:00,Breast/Ovarian Cancer
ATM,HGNC:795,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9908,2017-07-12T00:00:00,Breast/Ovarian Cancer
BARD1,HGNC:952,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10081,2017-08-09T00:00:00,Breast/Ovarian Cancer
BARD1,HGNC:952,familial ovarian cancer,MONDO:0016248,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9909,2017-08-09T00:00:00,Breast/Ovarian Cancer
BRCA1,HGNC:1100,"breast-ovarian cancer, familial, susceptibility to, 1",MONDO:0011450,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9972,2017-09-13T00:00:00,Breast/Ovarian Cancer
BRCA2,HGNC:1101,"breast-ovarian cancer, familial, susceptibility to, 2",MONDO:0012933,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8397,2017-09-13T00:00:00,Breast/Ovarian Cancer
BRIP1,HGNC:20473,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9910,2017-05-10T00:00:00,Breast/Ovarian Cancer
BRIP1,HGNC:20473,familial ovarian cancer,MONDO:0016248,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9911,2016-10-12T00:00:00,Breast/Ovarian Cancer
CDH1,HGNC:1748,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8502,2017-01-25T00:00:00,Breast/Ovarian Cancer
CDH1,HGNC:1748,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8503,2017-08-03T00:00:00,Breast/Ovarian Cancer
CHEK1,HGNC:1925,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8504,2016-10-12T00:00:00,Breast/Ovarian Cancer
CHEK1,HGNC:1925,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8505,2016-10-12T00:00:00,Breast/Ovarian Cancer
CHEK2,HGNC:16627,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8522,2016-12-14T00:00:00,Breast/Ovarian Cancer
CHEK2,HGNC:16627,familial ovarian cancer,MONDO:0016248,AD,SOP4,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8523,2016-12-14T00:00:00,Breast/Ovarian Cancer
CHEK2,HGNC:16627,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9862,2017-03-13T00:00:00,Breast/Ovarian Cancer
EPCAM,HGNC:11529,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8527,2017-04-12T00:00:00,Breast/Ovarian Cancer
GEN1,HGNC:26881,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8691,2017-12-13T00:00:00,Breast/Ovarian Cancer
GEN1,HGNC:26881,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8692,2017-01-11T00:00:00,Breast/Ovarian Cancer
MCPH1,HGNC:6954,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8524,2017-01-11T00:00:00,Breast/Ovarian Cancer
MCPH1,HGNC:6954,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8525,2017-01-11T00:00:00,Breast/Ovarian Cancer
MLH1,HGNC:7127,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8526,2017-06-14T00:00:00,Breast/Ovarian Cancer
MRE11,HGNC:7230,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9900,2017-10-25T00:00:00,Breast/Ovarian Cancer
MRE11,HGNC:7230,familial ovarian cancer,MONDO:0016248,AD,SOP4,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9901,2017-10-25T00:00:00,Breast/Ovarian Cancer
MSH2,HGNC:7325,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10084,2017-10-11T00:00:00,Breast/Ovarian Cancer
MSH6,HGNC:7329,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8531,2017-07-26T00:00:00,Breast/Ovarian Cancer
MUTYH,HGNC:7527,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9902,2017-05-25T00:00:00,Breast/Ovarian Cancer
MUTYH,HGNC:7527,familial ovarian cancer,MONDO:0016248,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9903,2017-11-29T00:00:00,Breast/Ovarian Cancer
MUTYH,HGNC:7527,hereditary breast carcinoma,MONDO:0016419,AR,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9904,2017-05-24T00:00:00,Breast/Ovarian Cancer
MUTYH,HGNC:7527,familial ovarian cancer,MONDO:0016248,AR,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9905,2017-11-29T00:00:00,Breast/Ovarian Cancer
NBN,HGNC:7652,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9906,2017-09-27T00:00:00,Breast/Ovarian Cancer
NF1,HGNC:7765,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10082,2017-02-22T00:00:00,Breast/Ovarian Cancer
PALB2,HGNC:26144,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3213,2016-12-01T00:00:00,Breast/Ovarian Cancer
PALB2,HGNC:26144,familial ovarian cancer,MONDO:0016248,AD,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9940,2017-11-08T00:00:00,Breast/Ovarian Cancer
PIK3CA,HGNC:8975,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8693,2017-02-08T00:00:00,Breast/Ovarian Cancer
PIK3CA,HGNC:8975,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8694,2017-02-08T00:00:00,Breast/Ovarian Cancer
PMS2,HGNC:9122,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10085,2017-11-08T00:00:00,Breast/Ovarian Cancer
RAD50,HGNC:9816,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8695,2016-12-14T00:00:00,Breast/Ovarian Cancer
RAD50,HGNC:9816,familial ovarian cancer,MONDO:0016248,AD,SOP4,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8696,2016-10-26T00:00:00,Breast/Ovarian Cancer
RAD51C,HGNC:9820,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8697,2017-05-10T00:00:00,Breast/Ovarian Cancer
RAD51C,HGNC:9820,familial ovarian cancer,MONDO:0016248,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8699,2017-04-12T00:00:00,Breast/Ovarian Cancer
RAD51D,HGNC:9823,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3215,2017-11-08T00:00:00,Breast/Ovarian Cancer
RAD51D,HGNC:9823,familial ovarian cancer,MONDO:0016248,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9957,2017-10-11T00:00:00,Breast/Ovarian Cancer
RECQL,HGNC:9948,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8700,2016-09-28T00:00:00,Breast/Ovarian Cancer
RECQL,HGNC:9948,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8701,2016-09-14T00:00:00,Breast/Ovarian Cancer
RINT1,HGNC:21876,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8702,2016-09-26T00:00:00,Breast/Ovarian Cancer
RINT1,HGNC:21876,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8703,2016-09-14T00:00:00,Breast/Ovarian Cancer
SLX4,HGNC:23845,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8704,2017-03-08T00:00:00,Breast/Ovarian Cancer
SLX4,HGNC:23845,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8705,2017-03-08T00:00:00,Breast/Ovarian Cancer
STK11,HGNC:11389,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8708,2016-10-26T00:00:00,Breast/Ovarian Cancer
TP53,HGNC:11998,familial ovarian cancer,MONDO:0016248,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9991,2018-01-10T00:00:00,Breast/Ovarian Cancer
XRCC2,HGNC:12829,hereditary breast carcinoma,MONDO:0016419,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8706,2017-05-10T00:00:00,Breast/Ovarian Cancer
XRCC2,HGNC:12829,familial ovarian cancer,MONDO:0016248,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8707,2017-04-26T00:00:00,Breast/Ovarian Cancer
ANK2,HGNC:493,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10145,2017-11-21T00:00:00,Brugada Syndrome
CACNA1C,HGNC:1390,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10146,2017-11-21T00:00:00,Brugada Syndrome
CACNA2D1,HGNC:1399,Brugada syndrome 1,MONDO:0011001,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10147,2017-11-21T00:00:00,Brugada Syndrome
CACNB2,HGNC:1402,Brugada syndrome 1,MONDO:0011001,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10148,2017-11-21T00:00:00,Brugada Syndrome
GPD1L,HGNC:28956,Brugada syndrome 1,MONDO:0011001,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10149,2017-11-21T00:00:00,Brugada Syndrome
HCN4,HGNC:16882,Brugada syndrome 1,MONDO:0011001,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10150,2017-11-21T00:00:00,Brugada Syndrome
KCND3,HGNC:6239,Brugada syndrome 1,MONDO:0011001,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10151,2017-11-21T00:00:00,Brugada Syndrome
KCNE3,HGNC:6243,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10152,2017-11-21T00:00:00,Brugada Syndrome
KCNE5,HGNC:6241,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10153,2017-11-21T00:00:00,Brugada Syndrome
KCNH2,HGNC:6251,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10154,2017-11-21T17:00:00,Brugada Syndrome
KCNJ8,HGNC:6269,Brugada syndrome 1,MONDO:0011001,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10155,2017-11-21T00:00:00,Brugada Syndrome
PKP2,HGNC:9024,Brugada syndrome 1,MONDO:0011001,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10156,2017-11-21T00:00:00,Brugada Syndrome
RANGRF,HGNC:17679,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10157,2017-11-21T00:00:00,Brugada Syndrome
SCN10A,HGNC:10582,Brugada syndrome 1,MONDO:0011001,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10161,2017-11-21T00:00:00,Brugada Syndrome
SCN1B,HGNC:10586,Brugada syndrome 1,MONDO:0011001,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10158,2017-11-21T00:00:00,Brugada Syndrome
SCN2B,HGNC:10589,Brugada syndrome 1,MONDO:0011001,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10159,2017-11-21T00:00:00,Brugada Syndrome
SCN3B,HGNC:20665,Brugada syndrome 1,MONDO:0011001,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10160,2017-11-21T00:00:00,Brugada Syndrome
SCN5A,HGNC:10593,Brugada syndrome,MONDO:0015263,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10165,2017-11-21T00:00:00,Brugada Syndrome
SLMAP,HGNC:16643,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10163,2017-11-21T00:00:00,Brugada Syndrome
TRPM4,HGNC:17993,Brugada syndrome,MONDO:0015263,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10164,2017-11-21T00:00:00,Brugada Syndrome
ANK2,HGNC:493,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c7e5e43e-1596-4c15-bf14-e9388b204e88-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia
CALM1,HGNC:1442,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1ca1d8df-10fa-48ef-aea4-fb4dc6564dd0-2021-06-17T160000.000Z,2021-06-17T16:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia
CALM2,HGNC:1445,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_42d280da-accc-46f2-8832-47d5a3eeeba7-2021-06-17T160000.000Z,2021-06-17T16:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia
CALM3,HGNC:1449,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b7fc965-a109-4448-94a0-00a9b078b484-2021-06-17T160000.000Z,2021-06-17T16:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia
CASQ2,HGNC:1513,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_991ee32e-280d-4bea-a638-aa1b6fa6f781-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia
CASQ2,HGNC:1513,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c778b145-fcfc-4252-8dd8-33f982b288e8-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia
KCNJ2,HGNC:6263,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5f2490f-215e-427e-be7b-6a68e3f89e32-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia
PKP2,HGNC:9024,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1231ec3b-3570-48dd-bea4-f7cd7fc54811-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia
RYR2,HGNC:10484,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1da07a67-9d04-448b-843b-39dac372cb59-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia
SCN5A,HGNC:10593,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_caef7504-ac08-43d4-8512-86f344a888a6-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia
TECRL,HGNC:27365,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6889dc44-eef0-4a4d-8fdb-aef2dc570f29-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia
TRDN,HGNC:12261,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a86167e8-9010-488d-b5bb-1f29e805bd91-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Catecholaminergic Polymorphic Ventricular Tachycardia
ADD3,HGNC:245,complex neurodevelopmental disorder with motor features,MONDO:0100516,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8a858435-3e50-406f-8ec3-9f4e40b1c392-2022-08-15T180000.000Z,2022-08-15T18:00:00.000Z,Cerebral Palsy
AP5Z1,HGNC:22197,hereditary spastic paraplegia,MONDO:0019064,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_020a234e-180c-4d9f-8f04-bd79eac6046e-2022-09-19T160000.000Z,2022-09-19T16:00:00.000Z,Cerebral Palsy
DDHD1,HGNC:19714,hereditary spastic paraplegia,MONDO:0019064,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0ba9bbb1-e36f-41db-9e56-23496613e46d-2022-12-01T200000.000Z,2022-12-01T20:00:00.000Z,Cerebral Palsy
EMC1,HGNC:28957,complex neurodevelopmental disorder with motor features,MONDO:0100516,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_659c7312-5d0a-44d0-9bd0-3e2b2ba385ce-2022-11-03T013000.000Z,2022-11-03T01:30:00.000Z,Cerebral Palsy
EMC1,HGNC:28957,complex neurodevelopmental disorder with motor features,MONDO:0100516,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ab319081-d3bf-436a-af1e-fce77cf8837a-2022-10-06T013000.000Z,2022-10-06T01:30:00.000Z,Cerebral Palsy
FITM2,HGNC:16135,Siddiqi syndrome,MONDO:0032842,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0a18aeda-fbe1-49b3-9542-6402ea61b4c0-2022-10-17T160000.000Z,2022-10-17T16:00:00.000Z,Cerebral Palsy
ARHGEF10,HGNC:14103,autosomal dominant slowed nerve conduction velocity,MONDO:0011998,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b23121f9-57e1-48ac-a2bc-d5a293829530-2020-10-05T160423.090Z,2020-10-05T16:04:23.090Z,Charcot-Marie-Tooth
ATL1,HGNC:11231,"neuropathy, hereditary sensory, type 1D",MONDO:0013381,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0c0282d1-5ab4-4a86-b1f6-165a3dbd515a-2022-02-10T020857.711Z,2022-02-10T02:08:57.711Z,Charcot-Marie-Tooth
ATL3,HGNC:24526,"neuropathy, hereditary sensory, type 1F",MONDO:0014286,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_132d0be7-2003-43ed-a934-1cf60cf45773-2021-07-13T160000.000Z,2021-07-13T16:00:00.000Z,Charcot-Marie-Tooth
ATP1A1,HGNC:799,"charcot-marie-tooth disease, axonal, type 2DD",MONDO:0054833,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_65182954-6603-4880-85fa-352700bd784b-2022-10-10T160000.000Z,2022-10-10T16:00:00.000Z,Charcot-Marie-Tooth
ATP7A,HGNC:869,X-linked distal spinal muscular atrophy type 3,MONDO:0010338,XL,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec7c42f3-3cad-4020-aa75-cf103c5381ba-2023-01-10T170000.000Z,2023-01-10T17:00:00.000Z,Charcot-Marie-Tooth
BSCL2,HGNC:15832,distal hereditary motor neuropathy,MONDO:0018894,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_02472719-c26d-40ff-8ad4-897ef7a6800a-2022-09-23T160000.000Z,2022-09-23T16:00:00.000Z,Charcot-Marie-Tooth
DNAJB2,HGNC:5228,Charcot-Marie-Tooth disease axonal type 2T,MONDO:0014866,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6d726e4f-6edb-4d04-b2ae-2cd05ecdd8db-2022-02-10T022350.942Z,2022-02-10T02:23:50.942Z,Charcot-Marie-Tooth
DNM2,HGNC:2974,Charcot-Marie-Tooth disease,MONDO:0015626,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7bc54e5d-eed5-4d40-9e0d-143bfeb88cac-2020-10-27T131827.010Z,2020-10-27T13:18:27.010Z,Charcot-Marie-Tooth
DST,HGNC:1090,hereditary sensory and autonomic neuropathy type 6,MONDO:0013839,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d90c7de8-a72a-4c54-bab8-fe9d4aef0409-2021-12-14T170000.000Z,2021-12-14T17:00:00.000Z,Charcot-Marie-Tooth
EGR2,HGNC:3239,Charcot-Marie-Tooth disease,MONDO:0015626,SD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a6e83e27-0c9a-4475-92f5-745303931858-2021-11-17T033516.468Z,2021-11-17T03:35:16.468Z,Charcot-Marie-Tooth
FBXO38,HGNC:28844,distal hereditary motor neuropathy,MONDO:0018894,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_350c1f45-5afd-4f36-8973-94acaf7bb961-2023-01-10T170000.000Z,2023-01-10T17:00:00.000Z,Charcot-Marie-Tooth
FGD4,HGNC:19125,Charcot-Marie-Tooth disease,MONDO:0015626,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e0aae8cd-9d57-4d8c-83ae-ed968cf186bc-2020-04-14T131822.010Z,2020-04-14T13:18:22.010Z,Charcot-Marie-Tooth
FIG4,HGNC:16873,Charcot-Marie-Tooth disease,MONDO:0015626,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cbc44812-5fe4-4e11-ac89-58e4175d4463-2021-09-23T003544.594Z,2021-09-23T00:35:44.594Z,Charcot-Marie-Tooth
GAN,HGNC:4137,giant axonal neuropathy 1,MONDO:0009749,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9f65afa-5cb1-457e-abff-ab110145a32d-2022-02-10T021239.651Z,2022-02-10T02:12:39.651Z,Charcot-Marie-Tooth
GARS1,HGNC:4162,Charcot-Marie-Tooth disease type 2D,MONDO:0011091,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_168242d1-ef2e-486a-a45a-ed96187bd4d2-2023-01-10T170000.000Z,2023-01-10T17:00:00.000Z,Charcot-Marie-Tooth
GDAP1,HGNC:15968,Charcot-Marie-Tooth disease,MONDO:0015626,SD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c6d93637-02f5-4f5d-b7a9-17356f084149-2020-07-28T144211.873Z,2020-07-28T14:42:11.873Z,Charcot-Marie-Tooth
GJB1,HGNC:4283,Charcot-Marie-Tooth disease X-linked dominant 1,MONDO:0010549,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fcacd858-2376-4cc0-983a-156145e36595-2020-01-14T170000.000Z,2020-01-14T17:00:00.000Z,Charcot-Marie-Tooth
GNB4,HGNC:20731,Charcot-Marie-Tooth disease,MONDO:0015626,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a8cecdd7-06d8-4697-8cd9-32900c366371-2020-04-14T132010.930Z,2020-04-14T13:20:10.930Z,Charcot-Marie-Tooth
HINT1,HGNC:4912,Charcot-Marie-Tooth disease,MONDO:0015626,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_170aae71-9b16-49b1-be29-44f98db2f72e-2021-03-22T201109.360Z,2021-03-22T20:11:09.360Z,Charcot-Marie-Tooth
HSPB1,HGNC:5246,Charcot-Marie-Tooth disease axonal type 2F,MONDO:0011687,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1bec365e-7832-41f1-89cc-48b8ab570c76-2022-08-03T160000.000Z,2022-08-03T16:00:00.000Z,Charcot-Marie-Tooth
HSPB8,HGNC:30171,autosomal dominant distal hereditary motor neuropathy,MONDO:0015362,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_044a2465-8e0a-44ff-8d00-1ec3a76183c8-2021-03-22T201855.441Z,2021-03-22T20:18:55.441Z,Charcot-Marie-Tooth
INF2,HGNC:23791,Charcot-Marie-Tooth disease dominant intermediate E,MONDO:0013758,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5215f2cf-99c9-405a-b221-18f412abd1f0-2021-03-22T202012.410Z,2021-03-22T20:20:12.410Z,Charcot-Marie-Tooth
KIF1B,HGNC:16636,Charcot-Marie-Tooth disease type 2A1,MONDO:0007308,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ae6ffeae-9609-47bf-89a9-4863cf6ef05c-2020-10-05T161930.420Z,2020-10-05T16:19:30.420Z,Charcot-Marie-Tooth
LITAF,HGNC:16841,Charcot-Marie-Tooth disease,MONDO:0015626,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e7106097-314c-487a-9770-b7dea3f25f37-2020-04-07T160000.000Z,2020-04-07T16:00:00.000Z,Charcot-Marie-Tooth
MARS1,HGNC:6898,Charcot-Marie-Tooth disease,MONDO:0015626,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8f042c42-893b-4c98-a719-0f778a54be43-2020-10-05T160651.479Z,2020-10-05T16:06:51.479Z,Charcot-Marie-Tooth
MED25,HGNC:28845,Charcot-Marie-Tooth disease type 2B2,MONDO:0011570,AR,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c0e0d66f-c68d-4df3-bab2-71afc448e4b0-2021-03-22T201527.084Z,2021-03-22T20:15:27.084Z,Charcot-Marie-Tooth
MFN2,HGNC:16877,axonal hereditary motor and sensory neuropathy,MONDO:0018775,SD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a04350b3-5fe9-438a-9e90-db0055ed15e7-2022-10-10T160000.000Z,2022-10-10T16:00:00.000Z,Charcot-Marie-Tooth
MME,HGNC:7154,Charcot-Marie-Tooth disease axonal type 2T,MONDO:0014866,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6d426d95-70b5-4537-809f-9f2520fc39e9-2022-08-03T160000.000Z,2022-08-03T16:00:00.000Z,Charcot-Marie-Tooth
MPZ,HGNC:7225,Charcot-Marie-Tooth disease,MONDO:0015626,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_11f638d2-d8d2-4fe4-ab79-acff5cf32a18-2020-08-25T160000.000Z,2020-08-25T16:00:00.000Z,Charcot-Marie-Tooth
MTMR2,HGNC:7450,demyelinating hereditary motor and sensory neuropathy,MONDO:0018776,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_44a837e2-ae06-4e4d-b7cf-ae2a3009b47d-2020-02-11T170000.000Z,2020-02-11T17:00:00.000Z,Charcot-Marie-Tooth
NEFH,HGNC:7737,Charcot-Marie-Tooth disease axonal type 2CC,MONDO:0014836,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8e1390ea-fd6c-4fa4-9b43-0eccff9e2829-2020-10-05T161645.817Z,2020-10-05T16:16:45.817Z,Charcot-Marie-Tooth
NEFL,HGNC:7739,Charcot-Marie-Tooth disease type 2,MONDO:0018993,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_49d4cf82-b365-456e-9e35-2b28a66b71ec-2023-01-10T170000.000Z,2023-01-10T17:00:00.000Z,Charcot-Marie-Tooth
NEFL,HGNC:7739,Charcot-Marie-Tooth disease,MONDO:0015626,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_57ec533a-b1cb-4d1d-b12a-61ee6ac6ab07-2023-01-10T170000.000Z,2023-01-10T17:00:00.000Z,Charcot-Marie-Tooth
NTRK1,HGNC:8031,hereditary sensory and autonomic neuropathy type 4,MONDO:0009746,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e716345f-08da-4a06-b3e1-d07974a4305d-2021-11-17T030955.951Z,2021-11-17T03:09:55.951Z,Charcot-Marie-Tooth
PMP2,HGNC:9117,Charcot-Marie-Tooth disease,MONDO:0015626,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aa4c5730-f807-45d7-afe7-573a3960916f-2021-03-22T201734.319Z,2021-03-22T20:17:34.319Z,Charcot-Marie-Tooth
PMP22,HGNC:9118,Charcot-Marie-Tooth disease type 1A,MONDO:0007309,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_169edbc0-b942-43f1-885d-8d47ccdb6d90-2022-10-10T160000.000Z,2022-10-10T16:00:00.000Z,Charcot-Marie-Tooth
PRX,HGNC:13797,Charcot-Marie-Tooth disease type 4,MONDO:0018995,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_471d2fcc-f9d4-49d7-92b9-d16f5f751d83-2023-01-10T170000.000Z,2023-01-10T17:00:00.000Z,Charcot-Marie-Tooth
RAB7A,HGNC:9788,Charcot-Marie-Tooth disease type 2,MONDO:0018993,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_222dbfa6-db75-42a0-bab6-338b46a316c3-2022-02-10T021034.172Z,2022-02-10T02:10:34.172Z,Charcot-Marie-Tooth
SBF1,HGNC:10542,Charcot-Marie-Tooth disease type 4B3,MONDO:0014117,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c0f814d9-02db-4c0c-8e1c-20a7759d993f-2021-11-20T022238.296Z,2021-11-20T02:22:38.296Z,Charcot-Marie-Tooth
SBF2,HGNC:2135,Charcot-Marie-Tooth disease type 4B2,MONDO:0011475,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_01893bf4-e95d-4206-9d2e-e3822f778b7a-2021-03-22T201309.257Z,2021-03-22T20:13:09.257Z,Charcot-Marie-Tooth
SCN11A,HGNC:10583,autosomal dominant hereditary sensory and autonomic neuropathy,MONDO:0015365,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_abe8c0db-503c-46fa-a2a6-e4d6071219d0-2022-02-25T020007.355Z,2022-02-25T02:00:07.355Z,Charcot-Marie-Tooth
SETX,HGNC:445,distal hereditary motor neuropathy,MONDO:0018894,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1f355b8f-1cd9-401c-8f34-b9b3e2fe939b-2022-08-03T160000.000Z,2022-08-03T16:00:00.000Z,Charcot-Marie-Tooth
SH3TC2,HGNC:29427,autosomal recessive hereditary demyelinating motor and sensory neuropathy,MONDO:0015361,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8d2b214f-3086-4012-bf4b-a6e651618f0b-2022-02-10T020711.223Z,2022-02-10T02:07:11.223Z,Charcot-Marie-Tooth
SLC25A46,HGNC:25198,"neuropathy, hereditary motor and sensory, type 6B",MONDO:0014671,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9852fb40-0df1-4668-ba57-38a4971cb244-2020-05-26T160000.000Z,2020-05-26T16:00:00.000Z,Charcot-Marie-Tooth
SLC5A7,HGNC:14025,"neuronopathy, distal hereditary motor, type 7A",MONDO:0008024,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c6e46608-98f5-4e4d-9bcf-22e42997af6e-2021-11-20T022003.630Z,2021-11-20T02:20:03.630Z,Charcot-Marie-Tooth
SPTLC2,HGNC:11278,"neuropathy, hereditary sensory and autonomic, type 1C",MONDO:0013337,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2294e1cf-3aad-471e-a360-9f6f8c3b4d8f-2023-01-10T170000.000Z,2023-01-10T17:00:00.000Z,Charcot-Marie-Tooth
TRPV4,HGNC:18083,neuromuscular disease,MONDO:0019056,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b89b03c3-24c7-4424-989c-abd65eb2b7ec-2021-12-14T145310.482Z,2021-12-14T14:53:10.482Z,Charcot-Marie-Tooth
WARS1,HGNC:12729,distal hereditary motor neuropathy,MONDO:0018894,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_93643521-0988-4c4b-b458-988044cfad6f-2022-02-10T020458.490Z,2022-02-10T02:04:58.490Z,Charcot-Marie-Tooth
YARS1,HGNC:12840,Charcot-Marie-Tooth disease,MONDO:0015626,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9c326f90-be08-4bb3-9593-b2df48f29ca1-2020-04-28T160000.000Z,2020-04-28T16:00:00.000Z,Charcot-Marie-Tooth
ATM,HGNC:795,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9861,2017-08-28T00:00:00,Colon Cancer
AXIN2,HGNC:904,oligodontia-cancer predisposition syndrome,MONDO:0012075,AD,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8439,2017-06-08T00:00:00,Colon Cancer
BARD1,HGNC:952,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8430,2017-06-08T00:00:00,Colon Cancer
BMPR1A,HGNC:1076,generalized juvenile polyposis/juvenile polyposis coli,MONDO:0008276,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10029,2017-06-12T00:00:00,Colon Cancer
CDH1,HGNC:1748,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8433,2017-06-08T00:00:00,Colon Cancer
CDKN1B,HGNC:1785,hereditary nonpolyposis colon cancer,MONDO:0018630,AR,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8434,2017-06-08T00:00:00,Colon Cancer
CTNNA1,HGNC:2509,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9868,2017-04-24T00:00:00,Colon Cancer
ENG,HGNC:3349,generalized juvenile polyposis/juvenile polyposis coli,MONDO:0008276,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9859,2017-12-11T00:00:00,Colon Cancer
EPHX1,HGNC:3401,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8431,2016-11-08T00:00:00,Colon Cancer
EXO1,HGNC:3511,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8432,2017-06-08T00:00:00,Colon Cancer
FAN1,HGNC:29170,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9863,2017-10-23T00:00:00,Colon Cancer
GALNT12,HGNC:19877,"colorectal cancer, susceptibility to, 1",MONDO:0012132,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8435,2017-06-08T00:00:00,Colon Cancer
MSH3,HGNC:7326,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9897,2017-11-13T00:00:00,Colon Cancer
MSH6,HGNC:7329,Lynch syndrome,MONDO:0005835,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9850,2017-09-25T00:00:00,Colon Cancer
MUTYH,HGNC:7527,familial adenomatous polyposis 2,MONDO:0012041,AD,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10072,2017-10-09T00:00:00,Colon Cancer
NFKBIZ,HGNC:29805,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9867,2017-07-10T00:00:00,Colon Cancer
PALB2,HGNC:26144,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10073,2018-03-12T00:00:00,Colon Cancer
PMS1,HGNC:9121,Lynch syndrome,MONDO:0005835,AD,SOP4,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9853,2017-05-22T00:00:00,Colon Cancer
POLD1,HGNC:9175,Polymerase proofreading-related adenomatous polyposis,MONDO:0018653,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8441,2017-04-10T00:00:00,Colon Cancer
POLE,HGNC:9177,Polymerase proofreading-related adenomatous polyposis,MONDO:0018653,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8442,2017-12-11T00:00:00,Colon Cancer
RPS20,HGNC:10405,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8436,2017-06-08T00:00:00,Colon Cancer
SEMA4A,HGNC:10729,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9864,2017-11-13T00:00:00,Colon Cancer
SMAD4,HGNC:6770,generalized juvenile polyposis/juvenile polyposis coli,MONDO:0008276,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9856,2017-06-26T00:00:00,Colon Cancer
SMARCA4,HGNC:11100,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9866,2017-05-08T00:00:00,Colon Cancer
STK11,HGNC:11389,Peutz-Jeghers syndrome,MONDO:0008280,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9992,2017-02-22T00:00:00,Colon Cancer
XRCC4,HGNC:12831,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9865,2017-05-08T00:00:00,Colon Cancer
ACTA1,HGNC:129,alpha-actinopathy,MONDO:0100084,SD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9a8d04be-c08f-444b-b9cd-cd7de2e282c2-2020-01-13T170000.000Z,2020-01-13T17:00:00.000Z,Congenital Myopathies
BIN1,HGNC:1052,centronuclear myopathy,MONDO:0018947,SD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1a2b9d96-97da-473d-8147-a425a5364fcb-2020-04-27T160000.000Z,2020-04-27T16:00:00.000Z,Congenital Myopathies
CCDC78,HGNC:14153,centronuclear myopathy,MONDO:0018947,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_886b45ae-232d-4635-ab94-88a0d15bbcca-2019-12-09T170000.000Z,2019-12-09T17:00:00.000Z,Congenital Myopathies
CFL2,HGNC:1875,nemaline myopathy 7,MONDO:0012538,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3c04b972-6797-42e7-87e8-ee97eb0bbad7-2019-11-25T150139.061Z,2019-11-25T15:01:39.061Z,Congenital Myopathies
COL6A1,HGNC:2211,collagen 6-related myopathy,MONDO:0100225,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_95ee3b63-8083-49e2-9e20-a1006ac168dd-2022-09-26T160000.000Z,2022-09-26T16:00:00.000Z,Congenital Myopathies
COL6A1,HGNC:2211,collagen 6-related myopathy,MONDO:0100225,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9de84294-8404-4bd0-a7c6-89a9a70eb408-2022-09-26T160000.000Z,2022-09-26T16:00:00.000Z,Congenital Myopathies
COL6A2,HGNC:2212,collagen 6-related myopathy,MONDO:0100225,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7a4dad5-f179-44ac-adcb-c5e15c11a1ec-2022-06-27T160000.000Z,2022-06-27T16:00:00.000Z,Congenital Myopathies
COL6A2,HGNC:2212,collagen 6-related myopathy,MONDO:0100225,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c523dbfa-e08e-4bdc-82d4-6bf43480697c-2022-06-27T160000.000Z,2022-06-27T16:00:00.000Z,Congenital Myopathies
COL6A3,HGNC:2213,collagen 6-related myopathy,MONDO:0100225,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_37d30e5c-61f5-4e4a-9ee7-573a2ed704b3-2022-06-27T160000.000Z,2022-06-27T16:00:00.000Z,Congenital Myopathies
COL6A3,HGNC:2213,collagen 6-related myopathy,MONDO:0100225,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_516ffd6c-c9ea-4d8a-8364-8ec4892ad464-2022-06-27T160000.000Z,2022-06-27T16:00:00.000Z,Congenital Myopathies
COL6A3,HGNC:2213,dystonia 27,MONDO:0014627,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8a109763-6fff-4da9-b826-7c2544d3f878-2021-05-24T160000.000Z,2021-05-24T16:00:00.000Z,Congenital Myopathies
DNM2,HGNC:2974,autosomal dominant centronuclear myopathy,MONDO:0008048,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e4156721-f6b9-482c-b610-97753f3f722d-2019-12-20T170000.000Z,2019-12-20T17:00:00.000Z,Congenital Myopathies
HACD1,HGNC:9639,congenital myopathy,MONDO:0019952,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_10c52aaf-cd58-4448-bac7-12b653bfa962-2021-06-28T160000.000Z,2021-06-28T16:00:00.000Z,Congenital Myopathies
KBTBD13,HGNC:37227,nemaline myopathy 6,MONDO:0012237,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ff2f157e-741b-447d-a6c5-1d003e2e98e1-2020-06-22T142022.592Z,2020-06-22T14:20:22.592Z,Congenital Myopathies
KLHL40,HGNC:30372,nemaline myopathy 8,MONDO:0014138,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dd1008a8-dd54-43d0-962c-82453975dc3a-2019-11-05T134603.480Z,2019-11-05T13:46:03.480Z,Congenital Myopathies
KLHL41,HGNC:16905,nemaline myopathy 9,MONDO:0014326,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b6bd51c2-e7b8-4938-a700-fd0e393143a7-2019-11-05T134928.155Z,2019-11-05T13:49:28.155Z,Congenital Myopathies
LAMA2,HGNC:6482,LAMA2-related muscular dystrophy,MONDO:0100228,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53f18520-6a7c-4781-ad0e-09250570f10e-2022-03-14T204607.096Z,2022-03-14T20:46:07.096Z,Congenital Myopathies
LMOD3,HGNC:6649,nemaline myopathy 10,MONDO:0014513,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_af248a78-5ef6-4c0b-b174-f43cc4688ec9-2019-09-09T160000.000Z,2019-09-09T16:00:00.000Z,Congenital Myopathies
MAP3K20,HGNC:17797,"myopathy, centronuclear, 6, with fiber-type disproportion",MONDO:0054695,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_03628749-51d6-437e-9816-1e32852645cf-2020-06-08T141802.817Z,2020-06-08T14:18:02.817Z,Congenital Myopathies
MEGF10,HGNC:29634,MEGF10-Related Myopathy,MONDO:0013731,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1d00193c-b0fd-40b4-b5d5-51eecece9669-2020-01-27T170000.000Z,2020-01-27T17:00:00.000Z,Congenital Myopathies
MTM1,HGNC:7448,X-linked centronuclear myopathy,MONDO:0010683,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2b60f008-871f-4c5f-aa46-099d09fb66df-2019-11-22T170000.000Z,2019-11-22T17:00:00.000Z,Congenital Myopathies
MYH2,HGNC:7572,"myopathy, proximal, and ophthalmoplegia",MONDO:0011577,SD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_72e37c65-570c-4d1c-b749-61d8981a6f21-2020-03-09T160000.000Z,2020-03-09T16:00:00.000Z,Congenital Myopathies
MYH7,HGNC:7577,MYH7-related skeletal myopathy,MONDO:0008050,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8974721a-f333-4fb7-b8b7-043233d3d100-2021-05-13T160000.000Z,2021-05-13T16:00:00.000Z,Congenital Myopathies
MYL1,HGNC:7582,congenital myopathy,MONDO:0019952,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1c69fb71-4553-473e-94b7-a8c34af84739-2020-04-13T190000.000Z,2020-04-13T19:00:00.000Z,Congenital Myopathies
MYO18B,HGNC:18150,Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome,MONDO:0014689,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_00998e50-dd3f-4bfa-8500-34d34980d5c8-2021-06-28T160000.000Z,2021-06-28T16:00:00.000Z,Congenital Myopathies
MYPN,HGNC:23246,MYPN-related myopathy,MONDO:0015023,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6aeb67cc-c960-4511-a708-b0acadb34588-2020-06-17T194636.472Z,2020-06-17T19:46:36.472Z,Congenital Myopathies
NEB,HGNC:7720,nemaline myopathy 2,MONDO:0009725,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_796dd762-f35c-425a-be3f-05424324ade0-2019-10-21T160000.000Z,2019-10-21T16:00:00.000Z,Congenital Myopathies
ORAI1,HGNC:25896,tubular aggregate myopathy,MONDO:0008051,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bb8d614e-e8ff-4f16-bba3-6fc35ea56e8a-2020-07-13T164919.164Z,2020-07-13T16:49:19.164Z,Congenital Myopathies
PYROXD1,HGNC:26162,myofibrillar myopathy 8,MONDO:0014993,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_44f4197c-2004-4d10-81dc-e61190eba909-2019-11-05T134731.947Z,2019-11-05T13:47:31.947Z,Congenital Myopathies
RYR1,HGNC:10483,RYR1-related myopathy,MONDO:0100150,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d5e4ff9a-94ad-453f-b2de-76deb98fe4ca-2020-07-27T160000.000Z,2020-07-27T16:00:00.000Z,Congenital Myopathies
RYR1,HGNC:10483,RYR1-related myopathy,MONDO:0100150,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fbd82373-705c-4b60-8b73-147ed461d357-2020-10-26T160000.000Z,2020-10-26T16:00:00.000Z,Congenital Myopathies
RYR3,HGNC:10485,congenital myopathy,MONDO:0019952,AR,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f234219f-23fd-449f-9d7e-4c1731af3309-2020-01-27T170000.000Z,2020-01-27T17:00:00.000Z,Congenital Myopathies
SCN4A,HGNC:10591,"SCN4A-related myopathy, autosomal recessive",MONDO:0100121,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f71b22d2-1ee8-46f6-9488-a86588edd7d3-2021-05-13T160000.000Z,2021-05-13T16:00:00.000Z,Congenital Myopathies
SELENON,HGNC:15999,SELENON-related myopathy,MONDO:0100100,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7485529e-a573-4a47-aa0f-7c0d7067ae49-2020-04-27T190000.000Z,2020-04-27T19:00:00.000Z,Congenital Myopathies
SPEG,HGNC:16901,"myopathy, centronuclear, 5",MONDO:0014418,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3a8f91f1-da1e-489d-84e1-46aa543b3df9-2020-01-12T213416.305Z,2020-01-12T21:34:16.305Z,Congenital Myopathies
STAC3,HGNC:28423,Bailey-Bloch congenital myopathy,MONDO:0009722,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_940572b9-6a5a-4de1-8ee1-6394f589515f-2020-04-25T160000.000Z,2020-04-25T16:00:00.000Z,Congenital Myopathies
STIM1,HGNC:11386,tubular aggregate myopathy,MONDO:0008051,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9419adda-b3fb-4c2d-8562-6a0318260bbd-2021-04-01T160000.000Z,2021-04-01T16:00:00.000Z,Congenital Myopathies
TNNT1,HGNC:11948,nemaline myopathy 5,MONDO:0011539,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8f993d88-c2f6-42c8-8c2e-c1bb63e1416a-2020-05-07T160000.000Z,2020-05-07T16:00:00.000Z,Congenital Myopathies
TNNT1,HGNC:11948,nemaline myopathy,MONDO:0018958,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5e1f9d1-b21e-46f6-94ce-10cb551ea92a-2020-06-22T141002.152Z,2020-06-22T14:10:02.152Z,Congenital Myopathies
TNNT3,HGNC:11950,nemaline myopathy,MONDO:0018958,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9617fa6c-fcb4-460a-be4b-2e437267f608-2020-02-24T141842.425Z,2020-02-24T14:18:42.425Z,Congenital Myopathies
TPM2,HGNC:12011,TPM2-related myopathy,MONDO:0100196,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f137b6cf-247a-4af0-b41f-6cb976239175-2021-01-04T170000.000Z,2021-01-04T17:00:00.000Z,Congenital Myopathies
TPM3,HGNC:12012,TPM3-related myopathy,MONDO:0100108,SD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2d76d08c-446b-42d6-ab9c-064fa1b4433f-2020-11-03T212439.729Z,2020-11-03T21:24:39.729Z,Congenital Myopathies
TTN,HGNC:12403,TTN-related myopathy,MONDO:0100175,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_41ead80d-f134-43e5-9373-ac55bdcfc0a1-2022-01-11T170000.000Z,2022-01-11T17:00:00.000Z,Congenital Myopathies
TTN,HGNC:12403,"myopathy, myofibrillar, 9, with early respiratory failure",MONDO:0011362,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bade9ef3-17fa-42ee-a2d7-9c9b985b1503-2022-03-14T205117.630Z,2022-03-14T20:51:17.630Z,Congenital Myopathies
TTN,HGNC:12403,tibial muscular dystrophy,MONDO:0010870,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec556f45-8dbc-43f0-96df-29e69d7f3411-2022-03-14T205017.462Z,2022-03-14T20:50:17.462Z,Congenital Myopathies
ALX1,HGNC:1494,frontonasal dysplasia - severe microphthalmia - severe facial clefting syndrome,MONDO:0013271,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ade0e1d8-3f68-4276-bc1d-173ca2d4936f-2022-10-13T160000.000Z,2022-10-13T16:00:00.000Z,Craniofacial Malformations
EFNB1,HGNC:3226,craniofrontonasal syndrome,MONDO:0010570,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_31ffbd0b-5c6b-4396-a84c-9330d81e4a08-2020-10-26T154650.453Z,2020-10-26T15:46:50.453Z,Craniofacial Malformations
ERF,HGNC:3444,craniosynostosis 4,MONDO:0010929,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1954ba97-532a-4ef3-9d62-c4ebfd252084-2021-06-12T062024.684Z,2021-06-12T06:20:24.684Z,Craniofacial Malformations
FGFR1,HGNC:3688,Pfeiffer syndrome type 1,MONDO:0019659,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4fef65d0-f73c-45fe-968e-86073674cb7e-2021-05-21T224433.397Z,2021-05-21T22:44:33.397Z,Craniofacial Malformations
FGFR1,HGNC:3688,osteoglophonic dwarfism,MONDO:0008150,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d958e743-2ca0-4bb9-a198-364dd58005c3-2021-03-22T203501.315Z,2021-03-22T20:35:01.315Z,Craniofacial Malformations
FGFR1,HGNC:3688,Hartsfield-Bixler-Demyer syndrome,MONDO:0014196,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec5034c6-70cb-4ba3-bbb9-f65f6cad393d-2021-03-16T235509.401Z,2021-03-16T23:55:09.401Z,Craniofacial Malformations
FGFR2,HGNC:3689,apert syndrome,MONDO:0007041,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2aa63602-d820-4fee-893b-b807e7b62f28-2021-12-14T221137.192Z,2021-12-14T22:11:37.192Z,Craniofacial Malformations
FGFR2,HGNC:3689,Beare-Stevenson cutis gyrata syndrome,MONDO:0007412,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7805e806-44ee-4339-a078-d62c204bff00-2022-03-31T163711.748Z,2022-03-31T16:37:11.748Z,Craniofacial Malformations
FGFR2,HGNC:3689,Crouzon syndrome,MONDO:0007405,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c2cfa70a-750f-4357-98b9-f5c30ca4dc26-2021-12-23T165345.170Z,2021-12-23T16:53:45.170Z,Craniofacial Malformations
FGFR2,HGNC:3689,Pfeiffer syndrome,MONDO:0007043,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eccfe56b-15d7-4ba9-abf2-163dfd3dab3c-2022-03-21T210958.425Z,2022-03-21T21:09:58.425Z,Craniofacial Malformations
FGFR3,HGNC:3690,Crouzon syndrome-acanthosis nigricans syndrome,MONDO:0012833,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_98727c21-26dd-4e65-b75e-8ec82d95ba97-2021-11-18T170000.000Z,2021-11-18T17:00:00.000Z,Craniofacial Malformations
FGFR3,HGNC:3690,Muenke syndrome,MONDO:0011274,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e94c1870-5413-4f75-8925-8bea54199d47-2022-03-29T172023.530Z,2022-03-29T17:20:23.530Z,Craniofacial Malformations
MEGF8,HGNC:3233,MEGF8-related Carpenter syndrome,MONDO:0013998,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dd9400f1-2c0b-4ffd-989a-486b81779a53-2021-12-23T193047.075Z,2021-12-23T19:30:47.075Z,Craniofacial Malformations
MSX2,HGNC:7392,parietal foramina,MONDO:0018953,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2bb862dd-e6d2-4dc8-a7f3-3a03d58f9ade-2020-07-08T170000.000Z,2020-07-08T17:00:00.000Z,Craniofacial Malformations
MSX2,HGNC:7392,craniosynostosis 2,MONDO:0011481,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ac8a9313-9ef2-4556-9a25-db7fa2ed99ed-2020-09-28T170000.000Z,2020-09-28T17:00:00.000Z,Craniofacial Malformations
POR,HGNC:9208,Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis,MONDO:0008726,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6275d46a-f005-45f8-b3ec-e9722f8dd39e-2022-03-23T193729.312Z,2022-03-23T19:37:29.312Z,Craniofacial Malformations
RAB23,HGNC:14263,RAB23-related Carpenter syndrome,MONDO:0008710,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_46756b21-4bb5-4384-a42c-cf10c76e98c8-2021-04-22T160000.000Z,2021-04-22T16:00:00.000Z,Craniofacial Malformations
SKI,HGNC:10896,Shprintzen-Goldberg syndrome,MONDO:0008426,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_019ffb7a-be5f-482d-9adf-e28d5aadaede-2020-10-29T160000.000Z,2020-10-29T16:00:00.000Z,Craniofacial Malformations
TCF12,HGNC:11623,TCF12-related craniosynostosis,MONDO:0014128,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_11e46ed0-dbfb-4151-ba1c-cc56214d6ca6-2021-01-28T170000.000Z,2021-01-28T17:00:00.000Z,Craniofacial Malformations
TWIST1,HGNC:12428,Sweeney-Cox syndrome,MONDO:0060592,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14ba10ad-ebb5-491f-b4d6-639890ab7ab9-2021-03-26T213222.762Z,2021-03-26T21:32:22.762Z,Craniofacial Malformations
TWIST1,HGNC:12428,Saethre-Chotzen syndrome,MONDO:0007042,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1730a1bb-49c2-4c11-8c45-e8747d8fb91d-2021-01-28T180000.000Z,2021-01-28T18:00:00.000Z,Craniofacial Malformations
TWIST1,HGNC:12428,TWIST1-related craniosynostosis,MONDO:0007399,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bda425f8-b760-4484-9336-b3e572d402ab-2021-06-10T160000.000Z,2021-06-10T16:00:00.000Z,Craniofacial Malformations
ABCC9,HGNC:60,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8be22ebc-f0f5-4de5-9c2a-382ebd02c533-2020-11-13T170000.000Z,2020-11-13T17:00:00.000Z,Dilated Cardiomyopathy
ACTC1,HGNC:143,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3e9b4048-3003-4180-b891-fcf10d25a814-2020-08-12T160000.000Z,2020-08-12T16:00:00.000Z,Dilated Cardiomyopathy
ANKRD1,HGNC:15819,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3dcc6918-d7e7-4385-b343-bc8b8678b3a4-2020-08-12T160000.000Z,2020-08-12T16:00:00.000Z,Dilated Cardiomyopathy
BAG3,HGNC:939,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1bec07e1-0186-4f45-bd8e-7d8a0f2547a9-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy
CSRP3,HGNC:2472,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_beaafc90-20ef-4c81-ad8f-cfcf69d269ca-2020-11-06T165245.603Z,2020-11-06T16:52:45.603Z,Dilated Cardiomyopathy
CTF1,HGNC:2499,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ef19cc13-543b-451e-b278-ec1fc04f694c-2020-08-12T040000.000Z,2020-08-12T04:00:00.000Z,Dilated Cardiomyopathy
DES,HGNC:2770,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_91b2595a-5eb9-4ac3-aa3d-d5f99cacad84-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy
DSG2,HGNC:3049,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7df1018-593f-481f-9dd0-77ce3ea829a6-2020-08-07T160000.000Z,2020-08-07T16:00:00.000Z,Dilated Cardiomyopathy
DTNA,HGNC:3057,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cdac9dca-0cc7-4cca-9af7-d2767d917fd4-2020-08-12T160000.000Z,2020-08-12T16:00:00.000Z,Dilated Cardiomyopathy
EYA4,HGNC:3522,dilated cardiomyopathy 1J,MONDO:0011541,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e0a0bad-1f7a-402e-af19-a80453653b86-2020-11-30T170000.000Z,2020-11-30T17:00:00.000Z,Dilated Cardiomyopathy
FLNC,HGNC:3756,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_edb5197f-05dc-42a4-a497-fff472985c6b-2020-11-06T170000.000Z,2020-11-06T17:00:00.000Z,Dilated Cardiomyopathy
GATAD1,HGNC:29941,dilated cardiomyopathy,MONDO:0005021,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_56933afb-863f-46f5-884d-17522adb31a8-2020-09-04T160000.000Z,2020-09-04T16:00:00.000Z,Dilated Cardiomyopathy
ILK,HGNC:6040,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_540f2706-1c1a-452e-b5b9-334728b11e40-2020-09-04T160000.000Z,2020-09-04T16:00:00.000Z,Dilated Cardiomyopathy
JPH2,HGNC:14202,dilated cardiomyopathy,MONDO:0005021,SD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_242181ea-8909-4b38-a6bd-9a6552935c74-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy
LAMA4,HGNC:6484,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e937f98e-7577-48bd-a24a-361634ba0a8d-2020-08-12T160000.000Z,2020-08-12T16:00:00.000Z,Dilated Cardiomyopathy
LDB3,HGNC:15710,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7756e3c0-5a16-49b8-ac0f-220e79a4fa99-2020-09-25T160000.000Z,2020-09-25T16:00:00.000Z,Dilated Cardiomyopathy
LMNA,HGNC:6636,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_132ea1ec-caa9-409a-8670-3edb2ec9c889-2020-11-06T175304.195Z,2020-11-06T17:53:04.195Z,Dilated Cardiomyopathy
LRRC10,HGNC:20264,dilated cardiomyopathy,MONDO:0005021,AR,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7403d325-ff12-4c92-a308-b2054e9861c5-2020-09-04T160000.000Z,2020-09-04T16:00:00.000Z,Dilated Cardiomyopathy
MIB1,HGNC:21086,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d97cecce-b9a7-42fb-bc2d-034468094949-2020-09-04T160000.000Z,2020-09-04T16:00:00.000Z,Dilated Cardiomyopathy
MYBPC3,HGNC:7551,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_652d0370-9574-450c-b7c4-eec86ade9046-2020-09-04T160000.000Z,2020-09-04T16:00:00.000Z,Dilated Cardiomyopathy
MYH6,HGNC:7576,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6d55ac7b-e9d8-4a97-bb20-92beeffaed96-2020-09-04T160000.000Z,2020-09-04T16:00:00.000Z,Dilated Cardiomyopathy
MYH7,HGNC:7577,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4ec27d4f-70ea-4c6a-ad67-d6260ecadcde-2020-11-13T170000.000Z,2020-11-13T17:00:00.000Z,Dilated Cardiomyopathy
MYL2,HGNC:7583,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8405609b-1664-4849-848e-bec138350c92-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy
MYL3,HGNC:7584,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6fdf5074-f853-473c-bd04-2c95c172b98a-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy
MYPN,HGNC:23246,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ffd924ad-55ce-4b05-8a91-584ef49b4e80-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy
NEBL,HGNC:16932,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29bc6c4f-3f2d-45e2-b796-a79616857094-2020-09-25T160000.000Z,2020-09-25T16:00:00.000Z,Dilated Cardiomyopathy
NEXN,HGNC:29557,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ffe00b43-a449-4476-b7e0-f24cf6613766-2020-08-12T160000.000Z,2020-08-12T16:00:00.000Z,Dilated Cardiomyopathy
NKX2-5,HGNC:2488,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6335de7f-71db-4768-8fa0-6faebd0ea0e8-2020-11-06T170000.000Z,2020-11-06T17:00:00.000Z,Dilated Cardiomyopathy
NPPA,HGNC:7939,dilated cardiomyopathy,MONDO:0005021,AR,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d85124b6-b754-4a0f-bbe4-3bbf1ca95283-2020-09-04T160000.000Z,2020-09-04T16:00:00.000Z,Dilated Cardiomyopathy
OBSCN,HGNC:15719,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e1b69281-f3d0-4efe-998d-db080868b57e-2020-11-06T180624.436Z,2020-11-06T18:06:24.436Z,Dilated Cardiomyopathy
PDLIM3,HGNC:20767,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_78f8d362-f690-4319-912f-1bdceceacccd-2020-09-16T160000.000Z,2020-09-16T16:00:00.000Z,Dilated Cardiomyopathy
PKP2,HGNC:9024,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2a8e26ad-c4ce-48d7-acab-1198d3b12ce5-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy
PLEKHM2,HGNC:29131,dilated cardiomyopathy,MONDO:0005021,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_44c534b9-16d1-435b-9eca-fb7d1de6ea26-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy
PRDM16,HGNC:14000,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c0a3445a-5bb0-4d77-a4f0-5b7cfceb837f-2020-08-12T160000.000Z,2020-08-12T16:00:00.000Z,Dilated Cardiomyopathy
PSEN1,HGNC:9508,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d71e8591-dece-4855-ae6c-d43e20cbf836-2020-11-06T170000.000Z,2020-11-06T17:00:00.000Z,Dilated Cardiomyopathy
PSEN2,HGNC:9509,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9e20579f-efc7-4ccd-8653-85c0aafe788f-2020-09-04T160000.000Z,2020-09-04T16:00:00.000Z,Dilated Cardiomyopathy
RBM20,HGNC:27424,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3e123751-078a-4d30-9f83-847119982342-2020-08-20T160000.000Z,2020-08-20T16:00:00.000Z,Dilated Cardiomyopathy
SCN5A,HGNC:10593,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53c90d2e-4d40-48ab-8761-b0158102c977-2020-11-06T181622.881Z,2020-11-06T18:16:22.881Z,Dilated Cardiomyopathy
SGCD,HGNC:10807,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_59326e1b-5cc1-4dfe-8d67-3379aa305c40-2020-09-04T160000.000Z,2020-09-04T16:00:00.000Z,Dilated Cardiomyopathy
TBX20,HGNC:11598,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_58a014d9-2d97-4041-961d-cfd09fa11adf-2020-08-12T160000.000Z,2020-08-12T16:00:00.000Z,Dilated Cardiomyopathy
TCAP,HGNC:11610,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4c8ab9d8-919a-443f-b027-5aec92b273d1-2020-08-12T160000.000Z,2020-08-12T16:00:00.000Z,Dilated Cardiomyopathy
TNNC1,HGNC:11943,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6ad71467-74c0-4a7c-932d-c5ca5747e59e-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy
TNNI3,HGNC:11947,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_668087ea-0d2f-42c2-a291-f73400d34023-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy
TNNI3K,HGNC:19661,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f5ce5790-8940-4d7a-a85c-8682be86939d-2020-08-12T160000.000Z,2020-08-12T16:00:00.000Z,Dilated Cardiomyopathy
TNNT2,HGNC:11949,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_20fbdfad-b2d2-45f1-9658-e2e3e02cb413-2020-10-09T160000.000Z,2020-10-09T16:00:00.000Z,Dilated Cardiomyopathy
TPM1,HGNC:12010,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1173d239-23cf-4c9c-9ea5-f95d9356e6c7-2020-11-13T170000.000Z,2020-11-13T17:00:00.000Z,Dilated Cardiomyopathy
TTN,HGNC:12403,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1ec53217-814e-44b3-a7b7-0f18311c20f3-2020-11-06T182152.992Z,2020-11-06T18:21:52.992Z,Dilated Cardiomyopathy
VCL,HGNC:12665,dilated cardiomyopathy,MONDO:0005021,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2d46699a-5f8c-460d-9233-bec4e2ecf560-2020-11-06T182645.766Z,2020-11-06T18:26:45.766Z,Dilated Cardiomyopathy
AARS1,HGNC:20,undetermined early-onset epileptic encephalopathy,MONDO:0018614,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ac62fe65-ee56-4146-9fe4-00dc1db2d958-2018-11-20T170000.000Z,2018-11-20T17:00:00.000Z,Epilepsy
ABAT,HGNC:23,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3a5138ad-d4b8-4ea1-aa78-b5d1f07b2b82-2022-04-19T160000.000Z,2022-04-19T16:00:00.000Z,Epilepsy
ALG13,HGNC:30881,developmental and epileptic encephalopathy,MONDO:0100062,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f14dd634-ec5c-48cc-a375-e3cfd0c6e832-2018-04-19T160000.000Z,2018-04-19T16:00:00.000Z,Epilepsy
ARX,HGNC:18060,developmental and epileptic encephalopathy,MONDO:0100062,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3a5357ce-2161-4a7f-a8e1-a1dba4550e57-2019-06-04T160000.000Z,2019-06-04T16:00:00.000Z,Epilepsy
ATP1A2,HGNC:800,familial or sporadic hemiplegic migraine,MONDO:0018925,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fe788a45-b8da-4377-acdb-5dd55fcc3130-2021-03-02T183446.232Z,2021-03-02T18:34:46.232Z,Epilepsy
BRAT1,HGNC:21701,neonatal-onset encephalopathy with rigidity and seizures,MONDO:0013784,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_698a4cb3-df52-432b-9d3e-d3d76111db25-2022-09-13T170000.000Z,2022-09-13T17:00:00.000Z,Epilepsy
BRAT1,HGNC:21701,neurodevelopmental disorder with cerebellar atrophy and with or without seizures,MONDO:0020841,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_93a7b6f1-75e5-4f97-be9d-62fb5770b8cb-2022-09-06T170000.000Z,2022-09-06T17:00:00.000Z,Epilepsy
CACNA1H,HGNC:1395,epilepsy,MONDO:0005027,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c3208279-a38d-4b38-b4f9-3af2610c4936-2018-07-30T040000.000Z,2018-07-30T04:00:00.000Z,Epilepsy
CACNB4,HGNC:1404,epilepsy,MONDO:0005027,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d2fad131-8e91-4874-9394-8b86d6d62abb-2022-07-05T160000.000Z,2022-07-05T16:00:00.000Z,Epilepsy
CASR,HGNC:1514,epilepsy,MONDO:0005027,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ddebf083-3434-4401-9b6b-9ec24aceec89-2021-03-03T123827.967Z,2021-03-03T12:38:27.967Z,Epilepsy
CHD2,HGNC:1917,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5af80ea6-31c6-47d2-a5a5-299380f5593c-2018-07-18T160000.000Z,2018-07-18T16:00:00.000Z,Epilepsy
CHRNA2,HGNC:1956,sleep-related hypermotor epilepsy,MONDO:0000030,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0f832b8a-af5a-494e-bfdb-70cc619addf1-2020-12-25T015652.186Z,2020-12-25T01:56:52.186Z,Epilepsy
CHRNA2,HGNC:1956,benign familial infantile epilepsy,MONDO:0017615,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7916abab-d963-4e9c-8913-1decc21b680c-2020-01-07T050000.000Z,2020-01-07T05:00:00.000Z,Epilepsy
CHRNA4,HGNC:1958,sleep-related hypermotor epilepsy,MONDO:0000030,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e3aa0108-5514-48ba-a09c-5506b2030d1f-2020-02-18T170000.000Z,2020-02-18T17:00:00.000Z,Epilepsy
CLN5,HGNC:2076,neuronal ceroid lipofuscinosis,MONDO:0016295,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a522b1d6-5ade-4749-94b8-d5426bbe5961-2021-09-08T023930.981Z,2021-09-08T02:39:30.981Z,Epilepsy
CLN6,HGNC:2077,neuronal ceroid lipofuscinosis,MONDO:0016295,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_09654b45-6649-4d11-b43e-aeb6d20fb86d-2020-12-01T170000.000Z,2020-12-01T17:00:00.000Z,Epilepsy
CLN8,HGNC:2079,neuronal ceroid lipofuscinosis,MONDO:0016295,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_68775ed0-576e-4ee7-90f2-d16329ecd7c1-2020-09-07T220116.243Z,2020-09-07T22:01:16.243Z,Epilepsy
CNTNAP2,HGNC:13830,complex neurodevelopmental disorder,MONDO:0100038,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3af732e2-062d-4bb3-a3cd-2045e460dc8f-2021-06-15T160000.000Z,2021-06-15T16:00:00.000Z,Epilepsy
CPA6,HGNC:17245,epilepsy,MONDO:0005027,AD,SOP8,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1cb32379-82a8-425d-ac80-3d740e1cc10b-2021-07-29T132527.108Z,2021-07-29T13:25:27.108Z,Epilepsy
CPA6,HGNC:17245,epilepsy,MONDO:0005027,AR,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7b3ebd58-dccb-4c73-b5e4-1ec55171f2fe-2021-07-29T135909.720Z,2021-07-29T13:59:09.720Z,Epilepsy
CRH,HGNC:2355,epilepsy,MONDO:0005027,AD,SOP8,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e1719f97-0d6c-4ed3-93bc-13cc8e1f1d6e-2021-09-21T160000.000Z,2021-09-21T16:00:00.000Z,Epilepsy
CSTB,HGNC:2482,Unverricht-Lundborg syndrome,MONDO:0009698,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2926506c-5b75-4340-b821-e3ac846b6621-2020-06-16T160000.000Z,2020-06-16T16:00:00.000Z,Epilepsy
CSTB,HGNC:2482,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_accafcd4-ba3c-4049-9285-1de877d256ec-2020-12-01T170000.000Z,2020-12-01T17:00:00.000Z,Epilepsy
CTSD,HGNC:2529,neuronal ceroid lipofuscinosis,MONDO:0016295,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d74b1b2a-52a3-4192-b5b4-e4fd46ffc0ba-2020-11-03T180000.000Z,2020-11-03T18:00:00.000Z,Epilepsy
CTSF,HGNC:2531,adult neuronal ceroid lipofuscinosis,MONDO:0019260,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a9079835-78f4-4759-a43a-9786270dc02e-2022-04-21T142141.505Z,2022-04-21T14:21:41.505Z,Epilepsy
DEPDC5,HGNC:18423,focal epilepsy,MONDO:0005384,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_82a82c75-f9a5-4f51-a15c-6513c13df57c-2018-08-07T040000.000Z,2018-08-07T04:00:00.000Z,Epilepsy
DNAJC5,HGNC:16235,adult neuronal ceroid lipofuscinosis,MONDO:0019260,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_67f55ef1-b312-4aac-bc04-67beb2405b4f-2021-07-30T052005.845Z,2021-07-30T05:20:05.845Z,Epilepsy
DNM1,HGNC:2972,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_31f598a3-7efd-4e43-83f3-587e98924260-2016-12-13T170000.000Z,2016-12-13T17:00:00.000Z,Epilepsy
DOCK7,HGNC:19190,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0b6ed421-950b-4862-bade-dc545555ac29-2021-07-28T192512.688Z,2021-07-28T19:25:12.688Z,Epilepsy
EEF1A2,HGNC:3192,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_17551147-b62c-47a9-a12a-f425c23d90ff-2019-03-19T160000.000Z,2019-03-19T16:00:00.000Z,Epilepsy
EFHC1,HGNC:16406,epilepsy,MONDO:0005027,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a2338bd8-c9ea-464b-8281-84472771a657-2018-07-27T160000.000Z,2018-07-27T16:00:00.000Z,Epilepsy
EPM2A,HGNC:3413,Lafora disease,MONDO:0009697,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f970ced6-0164-41ed-9e1f-1fb9f892bca6-2020-05-23T190000.000Z,2020-05-23T19:00:00.000Z,Epilepsy
GABRA1,HGNC:4075,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_60478d36-384e-4246-ba8a-730755d6f216-2019-05-21T160000.000Z,2019-05-21T16:00:00.000Z,Epilepsy
GABRB3,HGNC:4083,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a9327dac-6f76-4881-8a23-ef2b210f92e7-2019-02-05T170000.000Z,2019-02-05T17:00:00.000Z,Epilepsy
GABRG2,HGNC:4087,epilepsy,MONDO:0005027,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3a3176e9-ac0c-41fe-ae40-0750726c33d8-2020-01-21T170000.000Z,2020-01-21T17:00:00.000Z,Epilepsy
GNAO1,HGNC:4389,movement disorder,MONDO:0005395,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_418a5a18-3d0e-4cef-84b4-74c5accc0df1-2019-02-19T170000.000Z,2019-02-19T17:00:00.000Z,Epilepsy
GNAO1,HGNC:4389,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b56856e2-8e6f-4f01-a6bd-1642fee71e5b-2018-12-18T170000.000Z,2018-12-18T17:00:00.000Z,Epilepsy
GRIN1,HGNC:4584,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b98e5df5-8f39-4fd6-9715-bb8da7dc1806-2018-11-20T050000.000Z,2018-11-20T05:00:00.000Z,Epilepsy
GRIN2A,HGNC:4585,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0c405372-b99b-42fc-836d-65d7c0cbd279-2019-07-16T160000.000Z,2019-07-16T16:00:00.000Z,Epilepsy
GRIN2B,HGNC:4586,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ff8d9346-2ab7-4ef1-9071-9b8ae4178174-2019-03-19T170000.000Z,2019-03-19T17:00:00.000Z,Epilepsy
GRIN2D,HGNC:4588,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a52befb3-e9e0-46f1-9abf-8ead03151230-2022-03-15T190000.000Z,2022-03-15T19:00:00.000Z,Epilepsy
GRN,HGNC:4601,neuronal ceroid lipofuscinosis,MONDO:0016295,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_49eb0915-acff-423d-a70f-d00d4319d404-2023-01-03T170000.000Z,2023-01-03T17:00:00.000Z,Epilepsy
KCNA2,HGNC:6220,undetermined early-onset epileptic encephalopathy,MONDO:0018614,AD,SOP5,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10049,2017-10-20T00:00:00,Epilepsy
KCNA2,HGNC:6220,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1a825f85-585a-4086-8118-ce912d4c1469-2022-05-18T130146.911Z,2022-05-18T13:01:46.911Z,Epilepsy
KCNB1,HGNC:6231,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_986348ad-e8bb-4391-9478-7834a19415cb-2019-04-16T160000.000Z,2019-04-16T16:00:00.000Z,Epilepsy
KCNC1,HGNC:6233,progressive myoclonus epilepsy,MONDO:0020074,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_35d2beba-40f6-472d-842c-41925f486ba9-2022-11-07T200000.000Z,2022-11-07T20:00:00.000Z,Epilepsy
KCNC1,HGNC:6233,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5146494e-71e7-4e06-b10f-cc126429e3fb-2022-11-07T200000.000Z,2022-11-07T20:00:00.000Z,Epilepsy
KCNMA1,HGNC:6284,generalized epilepsy-paroxysmal dyskinesia syndrome,MONDO:0012276,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4bd10bb7-67d0-4c30-a944-9a46fd2f361a-2022-03-08T104405.484Z,2022-03-08T10:44:05.484Z,Epilepsy
KCNMA1,HGNC:6284,generalized epilepsy-paroxysmal dyskinesia syndrome,MONDO:0012276,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9aabc05e-8452-4b72-bd07-ae1a1fc40dfc-2022-03-08T114915.435Z,2022-03-08T11:49:15.435Z,Epilepsy
KCTD7,HGNC:21957,progressive myoclonus epilepsy,MONDO:0020074,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e6068b08-413e-4105-b8dc-97426d64c6c4-2022-09-07T160000.000Z,2022-09-07T16:00:00.000Z,Epilepsy
LGI1,HGNC:6572,Autosomal dominant epilepsy with auditory features,MONDO:0010898,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_662936d4-11a7-43f3-9daf-4ba1a7c92ffe-2020-07-07T183907.849Z,2020-07-07T18:39:07.849Z,Epilepsy
MAGI2,HGNC:18957,epilepsy,MONDO:0005027,XL,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7d622b88-9c77-47f8-93b1-808517da0cff-2018-06-19T160000.000Z,2018-06-19T16:00:00.000Z,Epilepsy
MFSD8,HGNC:28486,neuronal ceroid lipofuscinosis,MONDO:0016295,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0f42cb66-5f28-4674-8f5a-76e15880bbfc-2020-12-15T170000.000Z,2020-12-15T17:00:00.000Z,Epilepsy
NECAP1,HGNC:24539,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8fa4d835-8c26-4b30-9f26-7b6fb64d6a0b-2023-01-17T200000.000Z,2023-01-17T20:00:00.000Z,Epilepsy
NHLRC1,HGNC:21576,Lafora disease,MONDO:0009697,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c4dbe715-b897-482d-afeb-b05c0653a79a-2020-03-03T170000.000Z,2020-03-03T17:00:00.000Z,Epilepsy
NPRL3,HGNC:14124,focal epilepsy,MONDO:0005384,AD,SOP9,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_19a476ce-334f-4727-bbf2-ea4cfa37a223-2022-10-18T160000.000Z,2022-10-18T16:00:00.000Z,Epilepsy
PCDH19,HGNC:14270,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c00aad39-c6c4-4a46-af84-613592b166a3-2018-09-04T160000.000Z,2018-09-04T16:00:00.000Z,Epilepsy
PIGA,HGNC:8957,developmental and epileptic encephalopathy,MONDO:0100062,XL,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1fbb591b-eb34-4b73-a741-2f101886c896-2019-04-26T160000.000Z,2019-04-26T16:00:00.000Z,Epilepsy
PIGO,HGNC:23215,complex neurodevelopmental disorder,MONDO:0100038,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_830b11ca-6ec1-4aa9-bb44-379f03f738c7-2021-10-21T004641.341Z,2021-10-21T00:46:41.341Z,Epilepsy
PLCB1,HGNC:15917,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c7887c3b-332b-4586-93cf-4098796ab66f-2020-09-18T040000.000Z,2020-09-18T04:00:00.000Z,Epilepsy
PNKP,HGNC:9154,"microcephaly, seizures, and developmental delay",MONDO:0013254,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_901a984a-c678-4f35-81c2-9436785d3698-2020-04-17T165304.309Z,2020-04-17T16:53:04.309Z,Epilepsy
PNPO,HGNC:30260,pyridoxal phosphate-responsive seizures,MONDO:0012407,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f3ff7b38-dd26-458a-afbb-4870785c42ec-2020-12-15T170000.000Z,2020-12-15T17:00:00.000Z,Epilepsy
PRICKLE1,HGNC:17019,epilepsy,MONDO:0005027,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_71a3c632-fd63-4103-a069-5e9e413043e7-2020-09-01T160000.000Z,2020-09-01T16:00:00.000Z,Epilepsy
PRICKLE1,HGNC:17019,progressive myoclonus epilepsy,MONDO:0020074,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4e1195f-21ea-4721-b94b-99604e7c6554-2020-08-18T170000.000Z,2020-08-18T17:00:00.000Z,Epilepsy
PRICKLE2,HGNC:20340,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d1713884-4e19-4810-b73f-871645cfc0c3-2022-12-29T170000.000Z,2022-12-29T17:00:00.000Z,Epilepsy
PRRT2,HGNC:30500,infantile convulsions and choreoathetosis,MONDO:0011178,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_62af25b8-b9a4-421f-b897-4fc222569618-2020-01-21T213814.191Z,2020-01-21T21:38:14.191Z,Epilepsy
PURA,HGNC:9701,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6819633c-e488-4856-8dec-3981cd14db9b-2018-12-18T170000.000Z,2018-12-18T17:00:00.000Z,Epilepsy
ROGDI,HGNC:29478,amelocerebrohypohidrotic syndrome,MONDO:0009185,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dc4132b5-fd80-440b-b7ae-65f4d28f33f1-2022-06-21T160000.000Z,2022-06-21T16:00:00.000Z,Epilepsy
RORB,HGNC:10259,epilepsy,MONDO:0005027,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_88c55f22-3f6f-467a-b38b-267f93d6cc9a-2022-09-21T190000.000Z,2022-09-21T19:00:00.000Z,Epilepsy
RYR3,HGNC:10485,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a277276e-7efa-45c9-ad01-74e9aa2dea63-2018-06-19T160000.000Z,2018-06-19T16:00:00.000Z,Epilepsy
SCARB2,HGNC:1665,progressive myoclonus epilepsy,MONDO:0020074,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dc556613-cf24-44ee-8354-98ce91f78d7d-2020-08-23T190000.000Z,2020-08-23T19:00:00.000Z,Epilepsy
SCN1A,HGNC:10585,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_529f9cae-ac00-47d1-94d5-52c98bf6e2a2-2019-10-25T040000.000Z,2019-10-25T04:00:00.000Z,Epilepsy
SCN1A,HGNC:10585,generalized epilepsy with febrile seizures plus,MONDO:0018214,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5ac39f7a-0743-47b1-8efd-21e0ca836840-2019-09-06T194357.485Z,2019-09-06T19:43:57.485Z,Epilepsy
SCN1A,HGNC:10585,Dravet syndrome,MONDO:0100135,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_60334a15-c73e-42ce-b7d2-4796c2affde4-2019-08-20T160000.000Z,2019-08-20T16:00:00.000Z,Epilepsy
SCN1A,HGNC:10585,familial hemiplegic migraine,MONDO:0000700,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c8c1e158-983d-4547-a739-7781961e5bb8-2021-09-14T163408.306Z,2021-09-14T16:34:08.306Z,Epilepsy
SCN1B,HGNC:10586,generalized epilepsy with febrile seizures plus,MONDO:0018214,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_91fb4b50-478b-4e3a-ac8a-a5cb7634a492-2022-12-13T170000.000Z,2022-12-13T17:00:00.000Z,Epilepsy
SCN1B,HGNC:10586,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4c35c20-6e59-46cf-9347-852b80af8dcc-2022-01-04T211051.949Z,2022-01-04T21:10:51.949Z,Epilepsy
SCN2A,HGNC:10588,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2a1b7361-5c9e-4803-844d-ad6606a0acdb-2019-05-07T160000.000Z,2019-05-07T16:00:00.000Z,Epilepsy
SCN3A,HGNC:10590,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9750183-c66c-4dd8-855e-9509fc9c25c6-2022-05-09T233102.697Z,2022-05-09T23:31:02.697Z,Epilepsy
SCN8A,HGNC:10596,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f52993aa-ddee-483d-b15e-dbf21608d5a9-2018-07-18T125000.560Z,2018-07-18T12:50:00.560Z,Epilepsy
SCN9A,HGNC:10597,epilepsy,MONDO:0005027,AD,SOP8,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_72a91ef6-e052-44a4-b14e-6a5ba93393ff-2021-03-09T163649.218Z,2021-03-09T16:36:49.218Z,Epilepsy
SERPINI1,HGNC:8943,progressive myoclonus epilepsy,MONDO:0020074,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b31db78-6595-440d-a3f1-b3b5ca361611-2022-06-05T190000.000Z,2022-06-05T19:00:00.000Z,Epilepsy
SIK1,HGNC:11142,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cd76888e-9502-48f3-af06-56f1ae5ed975-2018-10-02T160000.000Z,2018-10-02T16:00:00.000Z,Epilepsy
SLC25A22,HGNC:19954,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9a7ba06-6ddf-4a94-a0df-0b6c164f72b9-2020-05-19T160000.000Z,2020-05-19T16:00:00.000Z,Epilepsy
SLC35A2,HGNC:11022,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e8173aea-692d-4f50-aca4-228e3df16e80-2021-04-23T160000.000Z,2021-04-23T16:00:00.000Z,Epilepsy
SPTAN1,HGNC:11273,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6737ac52-8177-4be1-95fe-92ddecbf5636-2019-01-17T170000.000Z,2019-01-17T17:00:00.000Z,Epilepsy
SRPX2,HGNC:30668,epilepsy,MONDO:0005027,XL,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9555886-a248-4bd4-b3dc-50ff503d6e7a-2018-07-19T160000.000Z,2018-07-19T16:00:00.000Z,Epilepsy
ST3GAL5,HGNC:10872,GM3 synthase deficiency,MONDO:0018274,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e5ea65e3-6a02-4435-9ef5-100564d3497c-2022-04-05T160000.000Z,2022-04-05T16:00:00.000Z,Epilepsy
STXBP1,HGNC:11444,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a8d21800-652f-431b-a5d8-4208d4e91d46-2017-10-20T160000.000Z,2017-10-20T16:00:00.000Z,Epilepsy
SYNGAP1,HGNC:11497,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b19f2a30-5538-4339-9018-150fd1bcd9c8-2019-04-02T160000.000Z,2019-04-02T16:00:00.000Z,Epilepsy
SYNJ1,HGNC:11503,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a283140a-5d8d-47bb-9dff-32d091a16c7c-2022-02-10T044803.180Z,2022-02-10T04:48:03.180Z,Epilepsy
SZT2,HGNC:29040,developmental and epileptic encephalopathy,MONDO:0100062,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5c3ef40-481f-4e10-a99c-9d208ae9574b-2021-02-02T170000.000Z,2021-02-02T17:00:00.000Z,Epilepsy
TPP1,HGNC:2073,neuronal ceroid lipofuscinosis,MONDO:0016295,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9b2f3b20-fb9a-4b5e-ad8e-e03be5ebb8e5-2020-09-26T005342.102Z,2020-09-26T00:53:42.102Z,Epilepsy
WDR45,HGNC:28912,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_85a54036-4d36-414d-8d26-944b9763a039-2019-06-28T160000.000Z,2019-06-28T16:00:00.000Z,Epilepsy
ACAD9,HGNC:21497,acyl-CoA dehydrogenase 9 deficiency,MONDO:0012624,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5fad1866-75ce-470f-984c-e64bb7e11168-2018-03-27T160000.000Z,2018-03-27T16:00:00.000Z,Fatty Acid Oxidation Disorders
ACADL,HGNC:88,long chain acyl-CoA dehydrogenase deficiency,MONDO:0020531,AR,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d95637bf-c628-4d23-a0d5-656db55a09a4-2021-01-25T194827.344Z,2021-01-25T19:48:27.344Z,Fatty Acid Oxidation Disorders
ACADM,HGNC:89,medium chain acyl-CoA dehydrogenase deficiency,MONDO:0008721,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fb987774-0e5b-4466-924f-6f19fccc6599-2018-01-23T170000.000Z,2018-01-23T17:00:00.000Z,Fatty Acid Oxidation Disorders
ACADS,HGNC:90,short chain acyl-CoA dehydrogenase deficiency,MONDO:0008722,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c6bc94e9-cdf2-4efb-b654-004541efc344-2018-01-23T170000.000Z,2018-01-23T17:00:00.000Z,Fatty Acid Oxidation Disorders
ACADVL,HGNC:92,very long chain acyl-CoA dehydrogenase deficiency,MONDO:0008723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_130ca053-9f40-4fd5-b89c-b9b374694fda-2018-02-20T170000.000Z,2018-02-20T17:00:00.000Z,Fatty Acid Oxidation Disorders
ACAT1,HGNC:93,beta-ketothiolase deficiency,MONDO:0008760,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_99bcab0a-de59-479d-8fe6-8b76cbce90ee-2018-05-22T160000.000Z,2018-05-22T16:00:00.000Z,Fatty Acid Oxidation Disorders
ACAT2,HGNC:94,acetyl-CoA acetyltransferase-2 deficiency,MONDO:0013548,Undetermined,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7cb46678-6e33-4d34-86ba-fdf59e59fb80-2021-01-25T194853.212Z,2021-01-25T19:48:53.212Z,Fatty Acid Oxidation Disorders
CPT1A,HGNC:2328,carnitine palmitoyl transferase 1A deficiency,MONDO:0009705,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dcea255c-11e4-46fd-b0f7-2de68311a75c-2018-01-23T170000.000Z,2018-01-23T17:00:00.000Z,Fatty Acid Oxidation Disorders
CPT1B,HGNC:2329,inherited fatty acid metabolism disorder,MONDO:0037858,Undetermined,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cfcd80c7-d806-41cf-8c3a-7ba955919537-2021-01-25T194946.827Z,2021-01-25T19:49:46.827Z,Fatty Acid Oxidation Disorders
CPT2,HGNC:2330,carnitine palmitoyltransferase II deficiency,MONDO:0015515,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1a57ea10-6ca0-4311-94f1-0ad036a38ca6-2018-03-27T160000.000Z,2018-03-27T16:00:00.000Z,Fatty Acid Oxidation Disorders
DECR1,HGNC:2753,progressive encephalopathy with leukodystrophy due to DECR deficiency,MONDO:0014464,Undetermined,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1d25dfe8-8d0b-4b45-b04c-b315ebdceaaa-2021-01-25T194921.121Z,2021-01-25T19:49:21.121Z,Fatty Acid Oxidation Disorders
ECHS1,HGNC:3151,mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency,MONDO:0014563,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dad38816-be17-4d59-bbfd-3e79221911a4-2018-10-09T160000.000Z,2018-10-09T16:00:00.000Z,Fatty Acid Oxidation Disorders
ETFA,HGNC:3481,multiple acyl-CoA dehydrogenase deficiency,MONDO:0009282,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3d6848e7-6e9e-4545-9f97-69480face058-2018-05-22T160000.000Z,2018-05-22T16:00:00.000Z,Fatty Acid Oxidation Disorders
ETFB,HGNC:3482,multiple acyl-CoA dehydrogenase deficiency,MONDO:0009282,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d9a8d844-c82a-4258-bd48-10e2d977273e-2020-12-16T181720.992Z,2020-12-16T18:17:20.992Z,Fatty Acid Oxidation Disorders
ETFDH,HGNC:3483,multiple acyl-CoA dehydrogenase deficiency,MONDO:0009282,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_062e336e-cfda-45f7-b509-cd44a5079034-2018-05-22T160000.000Z,2018-05-22T16:00:00.000Z,Fatty Acid Oxidation Disorders
FLAD1,HGNC:24671,myopathy with abnormal lipid metabolism,MONDO:0009703,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_769764bf-09c5-4a7d-8501-5fcf154fcdda-2020-12-16T181902.981Z,2020-12-16T18:19:02.981Z,Fatty Acid Oxidation Disorders
HADH,HGNC:4799,obsolete hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency,MONDO:0009278,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c2f238b9-4eb5-426c-a27a-ecb7b468d9e4-2018-06-26T160000.000Z,2018-06-26T16:00:00.000Z,Fatty Acid Oxidation Disorders
HADHA,HGNC:4801,long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,MONDO:0012173,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c8a5e15b-21f7-49cc-987c-5f3585742bbe-2018-02-12T170000.000Z,2018-02-12T17:00:00.000Z,Fatty Acid Oxidation Disorders
HADHB,HGNC:4803,mitochondrial trifunctional protein deficiency,MONDO:0012172,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_65cb0124-8476-422c-924f-15fac7c95592-2018-05-08T160000.000Z,2018-05-08T16:00:00.000Z,Fatty Acid Oxidation Disorders
HMGCL,HGNC:5005,3-hydroxy-3-methylglutaric aciduria,MONDO:0009520,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f4d084e5-a740-4bfd-a850-d6db900d4a4e-2018-06-26T160000.000Z,2018-06-26T16:00:00.000Z,Fatty Acid Oxidation Disorders
HMGCS2,HGNC:5008,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,MONDO:0011614,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b3f49254-4635-4961-83b9-31c7ebc7f159-2018-05-22T160000.000Z,2018-05-22T16:00:00.000Z,Fatty Acid Oxidation Disorders
HSD17B10,HGNC:4800,HSD10 mitochondrial disease,MONDO:0010327,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9232b352-a845-4404-8a98-34cb6ad6ff0e-2018-10-09T160000.000Z,2018-10-09T16:00:00.000Z,Fatty Acid Oxidation Disorders
LPIN1,HGNC:13345,"myoglobinuria, acute recurrent, autosomal recessive",MONDO:0009992,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_642c8d4a-d498-4739-957d-a4e0d457362a-2018-09-25T160000.000Z,2018-09-25T16:00:00.000Z,Fatty Acid Oxidation Disorders
MLYCD,HGNC:7150,malonic aciduria,MONDO:0009556,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_70af8ffa-430b-4c69-bfa9-d6ba2f7b4f32-2018-06-26T160000.000Z,2018-06-26T16:00:00.000Z,Fatty Acid Oxidation Disorders
NADK2,HGNC:26404,progressive encephalopathy with leukodystrophy due to DECR deficiency,MONDO:0014464,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_285bdfcd-10c2-48f9-9be9-d77894b26f19-2020-12-01T170000.000Z,2020-12-01T17:00:00.000Z,Fatty Acid Oxidation Disorders
SLC22A5,HGNC:10969,systemic primary carnitine deficiency disease,MONDO:0008919,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2beee8a9-193c-41ca-92c4-484c8e034b02-2018-04-24T160000.000Z,2018-04-24T16:00:00.000Z,Fatty Acid Oxidation Disorders
SLC25A20,HGNC:1421,carnitine-acylcarnitine translocase deficiency,MONDO:0008918,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_95c9aece-49b5-496f-9547-f6d03dd69b4f-2018-05-22T160000.000Z,2018-05-22T16:00:00.000Z,Fatty Acid Oxidation Disorders
SLC52A1,HGNC:30225,maternal riboflavin deficiency,MONDO:0014013,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f44e2049-ade2-464c-a4e5-eaf851252082-2020-12-01T170000.000Z,2020-12-01T17:00:00.000Z,Fatty Acid Oxidation Disorders
ABCB4,HGNC:45,progressive familial intrahepatic cholestasis type 3,MONDO:0011214,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_009134d7-b79c-4a90-9bae-c1f302439258-2022-11-23T170000.000Z,2022-11-23T17:00:00.000Z,General Gene Curation
ANGPTL3,HGNC:491,familial hypobetalipoproteinemia 2,MONDO:0011505,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_df7eb35c-09a3-4df2-bf05-22aee7de3855-2022-09-22T160000.000Z,2022-09-22T16:00:00.000Z,General Gene Curation
ANK1,HGNC:492,hereditary spherocytosis,MONDO:0019350,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_55457b0b-370e-466d-b2da-1cb8d67aecc8-2021-06-23T160000.000Z,2021-06-23T16:00:00.000Z,General Gene Curation
ANK1,HGNC:492,hereditary spherocytosis,MONDO:0019350,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_82460b48-c4a5-4496-92ce-6fbad632d6d7-2021-03-24T160000.000Z,2021-03-24T16:00:00.000Z,General Gene Curation
APOB,HGNC:603,"hypercholesterolemia, autosomal dominant, type B",MONDO:0007751,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1c26b83b-409e-47c7-9c53-6ca79472d6fc-2018-11-14T180000.000Z,2018-11-14T18:00:00.000Z,General Gene Curation
APOB,HGNC:603,familial hypobetalipoproteinemia 1,MONDO:0014252,SD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e7382aae-83d5-4a23-b1fe-e3d6acea8584-2020-02-26T170000.000Z,2020-02-26T17:00:00.000Z,General Gene Curation
ATF6,HGNC:791,achromatopsia,MONDO:0018852,AR,SOP4,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_4842,2016-11-16T00:00:00,General Gene Curation
ATP7B,HGNC:870,Wilson disease,MONDO:0010200,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f0ac0a41-d7d5-4377-a622-1ee9bc4ed9f3-2019-03-27T160000.000Z,2019-03-27T16:00:00.000Z,General Gene Curation
BAG3,HGNC:939,myofibrillar myopathy,MONDO:0018943,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5466,2016-12-18T00:00:00,General Gene Curation
C1QB,HGNC:1242,C1Q deficiency,MONDO:0013343,AR,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3216,2017-01-09T00:00:00,General Gene Curation
CHD1L,HGNC:1916,congenital anomaly of kidney and urinary tract,MONDO:0019719,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3220,2016-11-18T00:00:00,General Gene Curation
COL2A1,HGNC:2200,"spondyloepiphyseal dysplasia, Stanescu type",MONDO:0014701,AD,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_4843,2016-12-01T00:00:00,General Gene Curation
COL3A1,HGNC:2201,"Ehlers-Danlos syndrome, vascular type",MONDO:0017314,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ce795591-1c7c-4a52-886a-a294293c67c3-2019-02-27T170000.000Z,2019-02-27T17:00:00.000Z,General Gene Curation
COL5A1,HGNC:2209,"Ehlers-Danlos syndrome, classic type",MONDO:0007522,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3133eacb-2ef9-4463-8031-11d10f0e91b9-2021-03-24T151331.225Z,2021-03-24T15:13:31.225Z,General Gene Curation
COL5A2,HGNC:2210,"Ehlers-Danlos syndrome, classic type",MONDO:0007522,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1901d495-d33f-4741-88fd-4b66ac43bbad-2021-03-24T184245.711Z,2021-03-24T18:42:45.711Z,General Gene Curation
DICER1,HGNC:17098,pleuropulmonary blastoma,MONDO:0011014,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3212,2017-01-08T00:00:00,General Gene Curation
FBN1,HGNC:3603,Marfan syndrome,MONDO:0007947,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d3fc0bea-4d6e-449e-885c-b204e6a0b2bf-2019-03-04T170000.000Z,2019-03-04T17:00:00.000Z,General Gene Curation
FGFR3,HGNC:3690,achondroplasia,MONDO:0007037,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3221,2016-12-01T00:00:00,General Gene Curation
GAA,HGNC:4065,glycogen storage disease II,MONDO:0009290,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0554320e-6a8f-4c39-be7f-99959a8341ee-2019-01-23T170000.000Z,2019-01-23T17:00:00.000Z,General Gene Curation
GBA,HGNC:4177,Gaucher disease,MONDO:0018150,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fbc5a876-f97e-4f9c-be99-664e2f6c8470-2020-06-24T160000.000Z,2020-06-24T16:00:00.000Z,General Gene Curation
GLA,HGNC:4296,Fabry disease,MONDO:0010526,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eb4bb6f4-89de-4586-af6b-3f218b8cb4dc-2019-01-23T170000.000Z,2019-01-23T17:00:00.000Z,General Gene Curation
HEXA,HGNC:4878,Tay-Sachs disease,MONDO:0010100,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1f7530b5-af31-40f9-ac18-a1b4d404285a-2020-05-27T160000.000Z,2020-05-27T16:00:00.000Z,General Gene Curation
HTT,HGNC:4851,Huntington disease,MONDO:0007739,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_617c18ee-9476-4bc0-b403-20bc55150c7c-2021-11-08T193955.489Z,2021-11-08T19:39:55.489Z,General Gene Curation
IDUA,HGNC:5391,mucopolysaccharidosis type 1,MONDO:0001586,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_042f8964-a8e1-4880-b873-73460088e8bf-2020-05-27T160000.000Z,2020-05-27T16:00:00.000Z,General Gene Curation
LAMB1,HGNC:6486,cobblestone lissencephaly without muscular or ocular involvement,MONDO:0014077,AR,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5461,2016-11-15T00:00:00,General Gene Curation
LBR,HGNC:6518,regressive spondylometaphyseal dysplasia,MONDO:0018663,AR,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5462,2016-12-01T00:00:00,General Gene Curation
LDLR,HGNC:6547,"hypercholesterolemia, familial, 1",MONDO:0007750,SD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_81788cfe-7520-4821-b80b-3ee0b2018909-2021-02-24T170000.000Z,2021-02-24T17:00:00.000Z,General Gene Curation
LDLRAP1,HGNC:18640,"hypercholesterolemia, familial, 4",MONDO:0011374,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7ade5ed9-10e4-44f4-b02e-cc17ba68f1ab-2022-09-22T160000.000Z,2022-09-22T16:00:00.000Z,General Gene Curation
MEFV,HGNC:6998,familial Mediterranean fever,MONDO:0018088,SD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d811d62e-7063-481a-922e-a3d1eb884971-2022-02-23T170000.000Z,2022-02-23T17:00:00.000Z,General Gene Curation
MYO9A,HGNC:7608,arthrogryposis syndrome,MONDO:0015225,AR,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5465,2016-11-24T00:00:00,General Gene Curation
NF1,HGNC:7765,neurofibromatosis type 1,MONDO:0018975,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_367a3958-ce81-47fa-a505-a451ca67aab5-2019-03-05T170000.000Z,2019-03-05T17:00:00.000Z,General Gene Curation
NF2,HGNC:7773,neurofibromatosis type 2,MONDO:0007039,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a185a859-a499-4c4a-bebe-996b16fb3cf3-2019-02-27T170000.000Z,2019-02-27T17:00:00.000Z,General Gene Curation
NGLY1,HGNC:17646,congenital disorder of deglycosylation 1,MONDO:0800044,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3d9f5127-4673-4cc2-99b4-5f220274bc90-2022-10-18T160000.000Z,2022-10-18T16:00:00.000Z,General Gene Curation
NHP2,HGNC:14377,dyskeratosis congenita,MONDO:0015780,AR,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3201,2017-01-25T00:00:00,General Gene Curation
OCA2,HGNC:8101,oculocutaneous albinism type 2,MONDO:0008746,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7433c1e2-a3a6-4351-88e0-cb3edcf39910-2021-08-25T160000.000Z,2021-08-25T16:00:00.000Z,General Gene Curation
PCSK9,HGNC:20001,"hypercholesterolemia, autosomal dominant, 3",MONDO:0011369,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bf710ddc-c189-419f-ab70-25300b067db2-2018-11-14T170000.000Z,2018-11-14T17:00:00.000Z,General Gene Curation
PSD3,HGNC:19093,antecubital pterygium syndrome,MONDO:0008339,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_4845,2016-11-24T00:00:00,General Gene Curation
RAD51C,HGNC:9820,Fanconi anemia,MONDO:0019391,AR,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3202,2017-01-05T00:00:00,General Gene Curation
RPS10,HGNC:10383,Diamond-Blackfan anemia,MONDO:0015253,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3205,2017-01-19T00:00:00,General Gene Curation
RPS24,HGNC:10411,Diamond-Blackfan anemia,MONDO:0015253,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3206,2017-01-19T00:00:00,General Gene Curation
RYR1,HGNC:10483,"malignant hyperthermia, susceptibility to, 1",MONDO:0007783,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bcd5e6ba-ef77-434c-9ec6-47f72f597bfe-2020-11-25T170000.000Z,2020-11-25T17:00:00.000Z,General Gene Curation
SMAD3,HGNC:6769,aneurysm-osteoarthritis syndrome,MONDO:0013426,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3210,2016-12-01T00:00:00,General Gene Curation
TGFBR1,HGNC:11772,Loeys-Dietz syndrome,MONDO:0018954,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8a546ce2-432c-4c8a-90e5-97293d7938be-2019-03-27T160000.000Z,2019-03-27T16:00:00.000Z,General Gene Curation
TGFBR2,HGNC:11773,Loeys-Dietz syndrome 2,MONDO:0012427,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_73be8b4f-d823-44e5-ab76-faa3bc8eca84-2020-11-25T180000.000Z,2020-11-25T18:00:00.000Z,General Gene Curation
TMPO,HGNC:11875,familial isolated dilated cardiomyopathy,MONDO:0015470,AD,SOP4,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3211,2016-11-30T00:00:00,General Gene Curation
TSC1,HGNC:12362,tuberous sclerosis,MONDO:0001734,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_61b07bb0-1385-4344-8b6c-571f6a271000-2019-01-23T170000.000Z,2019-01-23T17:00:00.000Z,General Gene Curation
TSC2,HGNC:12363,tuberous sclerosis,MONDO:0001734,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0b0a33ff-44ca-497c-8499-cc1f50cead93-2019-01-23T170000.000Z,2019-01-23T17:00:00.000Z,General Gene Curation
VPS8,HGNC:29122,arthrogryposis multiplex congenita,MONDO:0015168,AR,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5463,2016-11-24T00:00:00,General Gene Curation
WRAP53,HGNC:25522,dyskeratosis congenita,MONDO:0015780,AR,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_3207,2017-01-25T00:00:00,General Gene Curation
ACOX2,HGNC:120,congenital bile acid synthesis defect 6,MONDO:0015015,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5627eadb-12f9-4768-915c-3da73c425650-2022-05-20T171935.296Z,2022-05-20T17:19:35.296Z,General Inborn Errors of Metabolism
ALAD,HGNC:395,porphyria due to ALA dehydratase deficiency,MONDO:0013000,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0ac683af-ca8d-46ab-8641-66ab9b537d16-2022-03-11T170000.000Z,2022-03-11T17:00:00.000Z,General Inborn Errors of Metabolism
ALAS2,HGNC:397,X-linked erythropoietic protoporphyria,MONDO:0010420,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_61e658f9-fdc9-4b3c-8788-80eb1ad83b0b-2022-03-27T181700.091Z,2022-03-27T18:17:00.091Z,General Inborn Errors of Metabolism
AP1S1,HGNC:559,MEDNIK syndrome,MONDO:0012251,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9559de4-1945-47fa-bea5-336d376eec0e-2022-06-10T160000.000Z,2022-06-10T16:00:00.000Z,General Inborn Errors of Metabolism
ATP6AP1,HGNC:868,congenital disorder of glycosylation type II,MONDO:0005501,XL,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c6bfce2b-c20c-40f9-b2f5-d81f76a328f7-2021-09-17T122311.885Z,2021-09-17T12:23:11.885Z,General Inborn Errors of Metabolism
CD320,HGNC:16692,methylmalonic acidemia due to transcobalamin receptor defect,MONDO:0013341,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d98515f5-4296-4d41-95a9-adac90c00349-2022-09-23T160000.000Z,2022-09-23T16:00:00.000Z,General Inborn Errors of Metabolism
DDC,HGNC:2719,aromatic L-amino acid decarboxylase deficiency,MONDO:0012084,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1dea33e3-7cf6-47f9-aa52-2525b439031a-2022-02-25T170000.000Z,2022-02-25T17:00:00.000Z,General Inborn Errors of Metabolism
DNAJC19,HGNC:30528,3-methylglutaconic aciduria type 5,MONDO:0012435,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fa7f8087-632d-4044-9e20-722085c3b42c-2021-09-24T024347.391Z,2021-09-24T02:43:47.391Z,General Inborn Errors of Metabolism
GALK1,HGNC:4118,galactokinase deficiency,MONDO:0009255,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ecd4568c-966e-4ac3-b3d2-b4ac119a7d80-2021-09-30T161317.166Z,2021-09-30T16:13:17.166Z,General Inborn Errors of Metabolism
GALT,HGNC:4135,galactosemia,MONDO:0018116,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7c4b67f6-4084-48bc-9f71-536b23d45511-2022-06-03T160000.000Z,2022-06-03T16:00:00.000Z,General Inborn Errors of Metabolism
GK,HGNC:4289,inborn glycerol kinase deficiency,MONDO:0010613,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b8965e78-8d6a-4b8a-af2d-e05097d791e0-2022-01-14T174134.555Z,2022-01-14T17:41:34.555Z,General Inborn Errors of Metabolism
GPT2,HGNC:18062,glutamate pyruvate transaminase 2 deficiency,MONDO:0014567,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_42a70a83-40da-4acc-b6a3-9ef3942abd14-2021-10-05T115427.845Z,2021-10-05T11:54:27.845Z,General Inborn Errors of Metabolism
HMBS,HGNC:4982,acute intermittent porphyria,MONDO:0008294,SD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eab4b1f6-2902-4ed3-9002-37c578aeaaba-2022-05-27T160000.000Z,2022-05-27T16:00:00.000Z,General Inborn Errors of Metabolism
HSD3B7,HGNC:18324,congenital bile acid synthesis defect 1,MONDO:0011906,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca1a2268-641c-422f-b065-8866af654d94-2022-07-11T160000.000Z,2022-07-11T16:00:00.000Z,General Inborn Errors of Metabolism
HTRA2,HGNC:14348,3-methylglutaconic aciduria type 8,MONDO:0044723,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d0e86ea2-d848-442c-8bef-0818e39f3752-2022-07-11T160000.000Z,2022-07-11T16:00:00.000Z,General Inborn Errors of Metabolism
MOCOS,HGNC:18234,xanthinuria type II,MONDO:0011346,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_04a1363e-0d51-4797-9358-0e48e362ea5f-2022-08-12T160000.000Z,2022-08-12T16:00:00.000Z,General Inborn Errors of Metabolism
MOCS1,HGNC:7190,sulfite oxidase deficiency due to molybdenum cofactor deficiency type A,MONDO:0009643,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1c7c418c-3aea-415f-9953-c84526232963-2022-04-08T160000.000Z,2022-04-08T16:00:00.000Z,General Inborn Errors of Metabolism
MOCS2,HGNC:7193,sulfite oxidase deficiency due to molybdenum cofactor deficiency type B,MONDO:0009644,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cd8d7002-1f0a-4fa7-9311-9d63b31b0125-2022-12-09T170000.000Z,2022-12-09T17:00:00.000Z,General Inborn Errors of Metabolism
MOGS,HGNC:24862,MOGS-congenital disorder of glycosylation,MONDO:0011629,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5a628248-c2f9-4d31-b614-e082e3f83416-2021-07-20T130742.194Z,2021-07-20T13:07:42.194Z,General Inborn Errors of Metabolism
SLC6A3,HGNC:11049,SLC6A3-related dopamine transporter deficiency syndrome,MONDO:0700117,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bb7a8001-1bc9-4cdf-bb99-1979737bda79-2023-01-09T170000.000Z,2023-01-09T17:00:00.000Z,General Inborn Errors of Metabolism
TAFAZZIN,HGNC:11577,Barth syndrome,MONDO:0010543,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1629e6ab-9749-4949-bf54-fe1addf4dcfd-2021-02-12T170000.000Z,2021-02-12T17:00:00.000Z,General Inborn Errors of Metabolism
TIMM50,HGNC:23656,3-methylglutaconic aciduria type 9,MONDO:0044724,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_92bd34f9-b744-4246-b50f-cfa8ab95597b-2021-10-25T202158.414Z,2021-10-25T20:21:58.414Z,General Inborn Errors of Metabolism
UROD,HGNC:12591,UROD-related inherited porphyria,MONDO:0100498,SD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_992eb049-9b4f-4163-bcb0-c7a0656cb93e-2022-08-12T160000.000Z,2022-08-12T16:00:00.000Z,General Inborn Errors of Metabolism
CPAMD8,HGNC:23228,anterior segment dysgenesis 8,MONDO:0015017,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bc4d2b2a-08d6-4869-a56e-55721fd4c9dc-2022-11-18T170000.000Z,2022-11-18T17:00:00.000Z,Glaucoma and Neuro-Ophthalmology
FOXC1,HGNC:3800,anterior segment dysgenesis 3,MONDO:0024456,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b2271229-84ea-4aff-81b4-3428c173ed7b-2021-12-15T031246.818Z,2021-12-15T03:12:46.818Z,Glaucoma and Neuro-Ophthalmology
FOXD3,HGNC:3804,aniridia,MONDO:0019172,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4b3b44d-26d8-4519-9d0d-2259022e79c6-2022-12-15T170000.000Z,2022-12-15T17:00:00.000Z,Glaucoma and Neuro-Ophthalmology
NTF4,HGNC:8024,"glaucoma 1, open angle, O",MONDO:0013134,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_144eb479-2c08-47cd-a6d2-8e1abef5cf54-2022-12-15T170000.000Z,2022-12-15T17:00:00.000Z,Glaucoma and Neuro-Ophthalmology
OPA1,HGNC:8140,OPA1-related optic atrophy with or without extraocular features,MONDO:0800181,SD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fc3f3ec8-0394-4732-bb4b-d75aaa5bdbcb-2022-11-17T170000.000Z,2022-11-17T17:00:00.000Z,Glaucoma and Neuro-Ophthalmology
OPTN,HGNC:17142,"glaucoma, normal tension, susceptibility to",MONDO:0011693,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_22efb828-c989-4584-97f9-e1d795b7468f-2022-11-17T170000.000Z,2022-11-17T17:00:00.000Z,Glaucoma and Neuro-Ophthalmology
PAX6,HGNC:8620,PAX6-related ocular dysgenesis,MONDO:0800183,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9e83f7da-f70f-4f06-a9f9-52bd20219088-2022-06-02T160000.000Z,2022-06-02T16:00:00.000Z,Glaucoma and Neuro-Ophthalmology
SSBP1,HGNC:11317,optic atrophy 13 with retinal and foveal abnormalities,MONDO:0008135,AD,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_51701b05-3956-4d7b-adc7-7ba4192e8283-2021-05-20T160000.000Z,2021-05-20T16:00:00.000Z,Glaucoma and Neuro-Ophthalmology
TEK,HGNC:11724,TEK-related primary glaucoma,MONDO:0800182,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_20f13e3f-f927-46c1-b5ed-919f696a7687-2022-08-18T160000.000Z,2022-08-18T16:00:00.000Z,Glaucoma and Neuro-Ophthalmology
WDR36,HGNC:30696,"glaucoma 1, open angle, G",MONDO:0012357,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_173858d9-f695-470f-b8b0-22940c60c074-2022-08-18T160000.000Z,2022-08-18T16:00:00.000Z,Glaucoma and Neuro-Ophthalmology
APOL1,HGNC:618,"focal segmental glomerulosclerosis 4, susceptibility to",MONDO:0012931,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_47d0f13d-5122-4762-82c9-08db3ba104d1-2021-09-28T023000.000Z,2021-09-28T02:30:00.000Z,Glomerulopathy
CD2AP,HGNC:14258,"focal segmental glomerulosclerosis 3, susceptibility to",MONDO:0011917,SD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cae2640-258f-4ba1-8510-2b4db97cf36c-2021-12-13T013000.000Z,2021-12-13T01:30:00.000Z,Glomerulopathy
COL4A3,HGNC:2204,Alport syndrome,MONDO:0018965,SD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e1ed7d3b-4366-4f4a-98f2-80e431e2d8da-2021-07-26T023000.000Z,2021-07-26T02:30:00.000Z,Glomerulopathy
COL4A4,HGNC:2206,Alport syndrome,MONDO:0018965,SD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c235830a-a6f5-4cf6-b015-902da62f1b2e-2021-08-24T023000.000Z,2021-08-24T02:30:00.000Z,Glomerulopathy
CRB2,HGNC:18688,focal segmental glomerulosclerosis 9,MONDO:0014539,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_98f54e8c-a81c-4b3b-8dbb-05dd24c5dbcc-2021-10-26T013000.000Z,2021-10-26T01:30:00.000Z,Glomerulopathy
PAX2,HGNC:8616,focal segmental glomerulosclerosis 7,MONDO:0014451,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ed6df631-4153-4f76-9bdd-073ed4cb68a2-2021-09-13T023000.000Z,2021-09-13T02:30:00.000Z,Glomerulopathy
ABHD12,HGNC:15868,PHARC syndrome,MONDO:0012984,AR,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ccd68c20-2024-4239-be51-26697e19a6b4-2018-06-26T160000.000Z,2018-06-26T16:00:00.000Z,Hearing Loss
ACTG1,HGNC:144,Baraitser-winter syndrome 2,MONDO:0013812,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9969a221-1ce9-44c6-8ab7-2ad5f7ccd5ab-2019-01-07T170000.000Z,2019-01-07T17:00:00.000Z,Hearing Loss
ACTG1,HGNC:144,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_db9f5d19-5ebc-4a1a-a4c3-79ff27f69a0e-2019-01-07T170000.000Z,2019-01-07T17:00:00.000Z,Hearing Loss
ADCY1,HGNC:232,"hearing loss, autosomal recessive",MONDO:0019588,AR,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8152,2017-05-10T00:00:00,Hearing Loss
ADGRV1,HGNC:17416,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1f3dc96a-8fd3-4d30-98fd-1b1cf264e818-2019-03-19T160000.000Z,2019-03-19T16:00:00.000Z,Hearing Loss
ADGRV1,HGNC:17416,Usher syndrome type 2,MONDO:0016484,AR,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_992d2cd7-5305-4278-9601-3e59ac1a8770-2017-02-15T170000.000Z,2017-02-15T17:00:00.000Z,Hearing Loss
AIFM1,HGNC:8768,X-linked hereditary sensory and autonomic neuropathy with hearing loss,MONDO:0010378,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7afc3bb-7fce-45fd-a275-87277e22b1eb-2018-07-09T160000.000Z,2018-07-09T16:00:00.000Z,Hearing Loss
ALMS1,HGNC:428,Alstrom syndrome,MONDO:0008763,AR,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_6238,2017-02-10T00:00:00,Hearing Loss
ATP6V1B1,HGNC:853,"renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss",MONDO:0009968,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c74d3789-9cfc-4be3-b23d-baf610620e6c-2017-12-19T050000.000Z,2017-12-19T05:00:00.000Z,Hearing Loss
BCS1L,HGNC:1020,Bjornstad syndrome,MONDO:0009872,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7a26b6b5-e703-43fc-bcd0-eaff67ef8107-2018-07-09T160000.000Z,2018-07-09T16:00:00.000Z,Hearing Loss
BDP1,HGNC:13652,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d300a54b-171c-4445-a138-a24409e99aae-2021-03-26T160000.000Z,2021-03-26T16:00:00.000Z,Hearing Loss
BSND,HGNC:16512,Bartter disease type 4a,MONDO:0011242,AR,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9b69acb1-93bc-4bc0-8a33-77bf64179c32-2018-07-10T160000.000Z,2018-07-10T16:00:00.000Z,Hearing Loss
BTD,HGNC:1122,biotinidase deficiency,MONDO:0009665,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_847f7f2b-575f-4a90-bf02-179d464e4841-2020-02-10T180000.000Z,2020-02-10T18:00:00.000Z,Hearing Loss
CABP2,HGNC:1385,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_20de88d2-6681-4522-9e11-26cdf66a2c15-2020-02-06T170000.000Z,2020-02-06T17:00:00.000Z,Hearing Loss
CACNA1D,HGNC:1391,sinoatrial node dysfunction and deafness,MONDO:0013960,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8249f2c1-ff59-4ea2-8e7e-11256c73433e-2018-05-01T160000.000Z,2018-05-01T16:00:00.000Z,Hearing Loss
CCDC50,HGNC:18111,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cf656dcb-6644-41bb-a29a-d7bdf54b28f7-2021-11-17T170000.000Z,2021-11-17T17:00:00.000Z,Hearing Loss
CD164,HGNC:1632,autosomal dominant nonsyndromic hearing loss,MONDO:0019587,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9524ca4-7d17-4691-b650-0d457531c7fd-2022-04-26T153012.127Z,2022-04-26T15:30:12.127Z,Hearing Loss
CDC14A,HGNC:1718,hearing impairment and infertile male syndrome,MONDO:0100069,AR,SOP5,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_144089d2-83ec-4c6c-8b43-9a4cae801d51-2020-03-11T132601.755Z,2020-03-11T13:26:01.755Z,Hearing Loss
CDC14A,HGNC:1718,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e869e4b1-30e2-4d9b-9b69-124903d7b307-2018-02-26T170000.000Z,2018-02-26T17:00:00.000Z,Hearing Loss
CDH23,HGNC:13733,Usher syndrome type 1,MONDO:0010168,AR,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5610,2017-01-30T00:00:00,Hearing Loss
CDH23,HGNC:13733,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f5799772-f233-4004-99a8-e6a0dddf0e8b-2018-05-22T040000.000Z,2018-05-22T04:00:00.000Z,Hearing Loss
CEACAM16,HGNC:31948,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP9,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bcc9ab02-1df0-485a-a806-2651171120cd-2022-12-21T170000.000Z,2022-12-21T17:00:00.000Z,Hearing Loss
CEACAM16,HGNC:31948,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e25cadf1-752a-495d-aaf2-30565519518a-2022-09-21T160000.000Z,2022-09-21T16:00:00.000Z,Hearing Loss
CEMIP,HGNC:29213,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_27d840d2-1f58-4d1c-9f6e-307db9f41b60-2018-07-17T160000.000Z,2018-07-17T16:00:00.000Z,Hearing Loss
CEP78,HGNC:25740,cone-rod dystrophy and hearing loss,MONDO:0014980,AR,SOP4,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8149,2017-04-12T00:00:00,Hearing Loss
CHD7,HGNC:20626,CHARGE syndrome,MONDO:0008965,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_26ae5799-567b-431b-b981-3bc2f8635802-2018-08-22T160000.000Z,2018-08-22T16:00:00.000Z,Hearing Loss
CIB2,HGNC:24579,Usher syndrome type 1,MONDO:0010168,AR,SOP6,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_95709038-78a4-4043-a054-9cbe245d2588-2019-02-19T170000.000Z,2019-02-19T17:00:00.000Z,Hearing Loss
CIB2,HGNC:24579,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4187cb6-182f-43fc-aeec-d27297c36bdb-2018-02-20T170000.000Z,2018-02-20T17:00:00.000Z,Hearing Loss
CISD2,HGNC:24212,Wolfram syndrome,MONDO:0018105,AR,SOP6,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0a18d59c-c00c-4bb3-b6d6-1e59b92d1313-2018-03-27T160000.000Z,2018-03-27T16:00:00.000Z,Hearing Loss
CLDN14,HGNC:2035,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_17528cdb-97e0-4128-92de-9e419902aa62-2018-05-01T160000.000Z,2018-05-01T16:00:00.000Z,Hearing Loss
CLPP,HGNC:2084,Perrault syndrome 3,MONDO:0013588,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_15291cb2-a541-4f88-91c8-0b441e3b64cb-2018-03-27T160000.000Z,2018-03-27T16:00:00.000Z,Hearing Loss
CLRN1,HGNC:12605,Usher syndrome type 3,MONDO:0016485,AR,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8400,2017-03-02T00:00:00,Hearing Loss
COCH,HGNC:2180,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_998da390-3e32-4b80-a733-d64d87d5357b-2018-01-05T170000.000Z,2018-01-05T17:00:00.000Z,Hearing Loss
COL11A2,HGNC:2187,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0665772a-ba94-4561-b597-364f7db7e4ca-2018-12-20T170000.000Z,2018-12-20T17:00:00.000Z,Hearing Loss
COL11A2,HGNC:2187,otospondylomegaepiphyseal dysplasia,MONDO:0008975,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_177bddd8-0566-4f80-a9f1-679ca96a7c60-2018-12-20T170000.000Z,2018-12-20T17:00:00.000Z,Hearing Loss
COL11A2,HGNC:2187,otospondylomegaepiphyseal dysplasia,MONDO:0008975,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_27b13a91-0a04-4393-bf1c-4f8418154c9b-2018-12-20T170000.000Z,2018-12-20T17:00:00.000Z,Hearing Loss
COL11A2,HGNC:2187,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_561327b9-7c55-40c3-b83c-5a3ed9d75606-2018-12-20T170000.000Z,2018-12-20T17:00:00.000Z,Hearing Loss
COL4A5,HGNC:2207,Alport syndrome,MONDO:0018965,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0407dc2e-1cab-4043-889d-4695b043d7b3-2019-03-19T160000.000Z,2019-03-19T16:00:00.000Z,Hearing Loss
COL4A6,HGNC:2208,"hearing loss, X-linked 6",MONDO:0010484,XL,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d026ef00-c6f3-4aa8-a61a-b354b68fe043-2022-03-22T160000.000Z,2022-03-22T16:00:00.000Z,Hearing Loss
COL9A2,HGNC:2218,Stickler syndrome,MONDO:0019354,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_697ae26e-2b07-4f87-b42c-121684c89bc0-2019-02-19T170000.000Z,2019-02-19T17:00:00.000Z,Hearing Loss
COL9A3,HGNC:2219,Stickler syndrome,MONDO:0019354,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a436c41e-0873-4e4c-b2f2-d56f75ca737a-2019-09-17T160000.000Z,2019-09-17T16:00:00.000Z,Hearing Loss
CRYM,HGNC:2418,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d15cf48a-3696-467a-b3c8-a45ef5a577bf-2021-09-21T160000.000Z,2021-09-21T16:00:00.000Z,Hearing Loss
DCDC2,HGNC:18141,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_86802e37-e2a5-43b9-8538-e104859b4c55-2020-08-31T170000.000Z,2020-08-31T17:00:00.000Z,Hearing Loss
DIABLO,HGNC:21528,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f5903c3b-b2d7-4c14-b196-37533187d807-2021-09-21T160000.000Z,2021-09-21T16:00:00.000Z,Hearing Loss
DIAPH1,HGNC:2876,diaph1-related sensorineural hearing loss-thrombocytopenia syndrome,MONDO:0044635,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_43c017fd-ce70-4fbe-ad30-90f216adaa7d-2018-01-05T170000.000Z,2018-01-05T17:00:00.000Z,Hearing Loss
DIAPH3,HGNC:15480,auditory neuropathy,MONDO:0021944,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fc54aaf6-8e1b-4c98-bcbe-e1f337f6eadc-2020-02-06T170000.000Z,2020-02-06T17:00:00.000Z,Hearing Loss
DMXL2,HGNC:2938,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_746b46e8-0621-4879-80a1-4fb1679975be-2020-02-06T170000.000Z,2020-02-06T17:00:00.000Z,Hearing Loss
DNMT1,HGNC:2976,"autosomal dominant cerebellar ataxia, deafness and narcolepsy",MONDO:0011397,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_6235,2017-02-10T00:00:00,Hearing Loss
DSPP,HGNC:3054,dentinogenesis imperfecta,MONDO:0018849,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_39f5492a-97a3-49a6-929d-f24f23b51217-2018-04-17T160000.000Z,2018-04-17T16:00:00.000Z,Hearing Loss
EDN3,HGNC:3178,Waardenburg syndrome type 4B,MONDO:0013201,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_04e39ada-cd77-43f0-98f3-7b4a37668a96-2018-05-08T160000.000Z,2018-05-08T16:00:00.000Z,Hearing Loss
EDN3,HGNC:3178,Waardenburg syndrome type 4B,MONDO:0013201,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7f88c34c-a093-4fc8-b84a-49c7d2dd327f-2018-05-08T160000.000Z,2018-05-08T16:00:00.000Z,Hearing Loss
EDNRB,HGNC:3180,Waardenburg syndrome type 4A,MONDO:0010192,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_73ee9727-60c1-40fd-830f-08c2b513d2ee-2018-05-08T160000.000Z,2018-05-08T16:00:00.000Z,Hearing Loss
EDNRB,HGNC:3180,Waardenburg syndrome type 4A,MONDO:0010192,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d7abbd45-7915-437b-849b-dea876bfc2f5-2018-05-08T160000.000Z,2018-05-08T16:00:00.000Z,Hearing Loss
ELMOD3,HGNC:26158,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_86999665-43b6-4824-b5e5-81b2a6dd8034-2021-11-17T170000.000Z,2021-11-17T17:00:00.000Z,Hearing Loss
ELMOD3,HGNC:26158,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_95f5efe3-e0d1-4cef-b475-7ff1cd3c417c-2021-11-17T170000.000Z,2021-11-17T17:00:00.000Z,Hearing Loss
EPS8,HGNC:3420,autosomal recessive nonsyndromic hearing loss 102,MONDO:0014428,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7a6bd2bf-8ede-45cb-a1c1-65ee5221b440-2020-02-06T171614.553Z,2020-02-06T17:16:14.553Z,Hearing Loss
EPS8L2,HGNC:21296,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e0022ad7-8497-4139-94a7-2546ba482c88-2020-02-05T170000.000Z,2020-02-05T17:00:00.000Z,Hearing Loss
ESPN,HGNC:13281,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7c63a581-ad69-4f18-b68b-d1b2cef5e699-2018-02-27T170000.000Z,2018-02-27T17:00:00.000Z,Hearing Loss
ESPN,HGNC:13281,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9bdbd958-1ad2-447a-9ccd-ed86f308577a-2018-02-27T170000.000Z,2018-02-27T17:00:00.000Z,Hearing Loss
ESRRB,HGNC:3473,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_03c875bb-70aa-4652-a7f2-35df1065165b-2018-04-24T160000.000Z,2018-04-24T16:00:00.000Z,Hearing Loss
EYA1,HGNC:3519,branchio-oto-renal syndrome,MONDO:0007029,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dca41ef6-ee63-4b1f-93d3-8b114dafcc58-2017-11-21T170000.000Z,2017-11-21T17:00:00.000Z,Hearing Loss
EYA4,HGNC:3522,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_21c75059-bd7b-48ef-a828-28ffebe52ca0-2018-01-05T170000.000Z,2018-01-05T17:00:00.000Z,Hearing Loss
FGF3,HGNC:3681,"deafness with labyrinthine aplasia, microtia, and microdontia",MONDO:0012541,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5ca11e8c-6703-4be5-a8c2-82e6dcc865e4-2019-05-21T160000.000Z,2019-05-21T16:00:00.000Z,Hearing Loss
FOXI1,HGNC:3815,hearing loss disorder,MONDO:0005365,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0bb41557-8ccc-4084-b4b0-d4ede42d8f36-2022-03-16T160000.000Z,2022-03-16T16:00:00.000Z,Hearing Loss
FOXI1,HGNC:3815,enlarged vestibular aqueduct syndrome,MONDO:0023069,AR,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d3a6b8fa-01d1-4f32-a45e-9c9582e14280-2018-02-27T170000.000Z,2018-02-27T17:00:00.000Z,Hearing Loss
GATA3,HGNC:4172,hypoparathyroidism-deafness-renal disease syndrome,MONDO:0007797,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_afb6e0d5-81a5-439a-a498-9edc8505a367-2019-06-18T160000.000Z,2019-06-18T16:00:00.000Z,Hearing Loss
GIPC3,HGNC:18183,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e5feebe1-59a9-4e28-ad85-aec5cad6b54e-2017-08-22T160000.000Z,2017-08-22T16:00:00.000Z,Hearing Loss
GJA1,HGNC:4274,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9e428d8c-42a2-430b-babd-8beceb26197e-2022-03-22T132224.159Z,2022-03-22T13:22:24.159Z,Hearing Loss
GJB2,HGNC:4284,"hearing loss, autosomal recessive",MONDO:0019588,AR,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8399,2017-03-02T00:00:00,Hearing Loss
GJB3,HGNC:4285,erythrokeratodermia variabilis,MONDO:0017851,AD,SOP6,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1d48c959-31d8-44e2-985c-c48921e8f08a-2018-03-05T050000.000Z,2018-03-05T05:00:00.000Z,Hearing Loss
GJB3,HGNC:4285,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f83e013a-685f-405b-89d6-a8e80aefaf6e-2018-02-27T170000.000Z,2018-02-27T17:00:00.000Z,Hearing Loss
GJB6,HGNC:4288,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP5,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f281869c-25e5-44ad-94e7-c7d6374755fd-2018-04-17T160000.000Z,2018-04-17T16:00:00.000Z,Hearing Loss
GJB6,HGNC:4288,Clouston syndrome,MONDO:0007510,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ff18d307-80a8-44b8-8b1a-e26e8a7d912a-2018-04-17T160000.000Z,2018-04-17T16:00:00.000Z,Hearing Loss
GPSM2,HGNC:29501,Chudley-McCullough syndrome,MONDO:0011411,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cd40cf49-a25c-450b-be6b-b80eef958f4c-2018-05-01T160000.000Z,2018-05-01T16:00:00.000Z,Hearing Loss
GRHL2,HGNC:2799,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP6,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a2ca9952-b611-4e6f-bbf8-aa5175248d01-2018-01-16T170000.000Z,2018-01-16T17:00:00.000Z,Hearing Loss
GRXCR1,HGNC:31673,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4becaf23-4b72-4dd1-a5aa-4deccbb394ea-2018-04-24T040000.000Z,2018-04-24T04:00:00.000Z,Hearing Loss
GRXCR2,HGNC:33862,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_207f12b7-3148-4a8f-88f8-f78ac5bb294c-2021-03-26T155748.643Z,2021-03-26T15:57:48.643Z,Hearing Loss
GSDME,HGNC:2810,autosomal dominant nonsyndromic hearing loss,MONDO:0019587,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9b0a844b-f968-48e0-8940-35584eb3454b-2017-11-21T170000.000Z,2017-11-21T17:00:00.000Z,Hearing Loss
HARS1,HGNC:4816,Usher syndrome type 3,MONDO:0016485,AR,SOP5,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca3372fa-f205-44e5-8bd9-6c64c40ebd93-2018-02-27T170000.000Z,2018-02-27T17:00:00.000Z,Hearing Loss
HARS2,HGNC:4817,Perrault syndrome 2,MONDO:0013972,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5c5ed5f6-4068-4e15-a195-6098e4ee2093-2018-05-15T160000.000Z,2018-05-15T16:00:00.000Z,Hearing Loss
HGF,HGNC:4893,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8828a306-1262-4bbf-9661-f3d13d0f44a7-2022-04-20T160000.000Z,2022-04-20T16:00:00.000Z,Hearing Loss
HOMER2,HGNC:17513,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9158c2a6-f11b-47b4-ac7d-45471f7255a1-2020-08-31T170000.000Z,2020-08-31T17:00:00.000Z,Hearing Loss
HSD17B4,HGNC:5213,Perrault syndrome,MONDO:0017312,AR,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dbc9308c-2310-4e0a-9354-667dbd3c7d5d-2018-05-22T160000.000Z,2018-05-22T16:00:00.000Z,Hearing Loss
ILDR1,HGNC:28741,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e5e1a608-edc3-405c-805f-a7ed162c2bbc-2017-11-21T170000.000Z,2017-11-21T17:00:00.000Z,Hearing Loss
KARS1,HGNC:6215,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f5239ac3-1506-4b0e-9055-632ba895ca0c-2018-02-27T170000.000Z,2018-02-27T17:00:00.000Z,Hearing Loss
KCNE1,HGNC:6240,Jervell and Lange-Nielsen syndrome 2,MONDO:0012871,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1d7672c-743f-4b93-b620-e20db96e47bd-2018-06-22T040000.000Z,2018-06-22T04:00:00.000Z,Hearing Loss
KCNJ10,HGNC:6256,enlarged vestibular aqueduct syndrome,MONDO:0023069,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_09f81c95-1213-4029-a6bd-279e52f240c7-2018-02-20T170000.000Z,2018-02-20T17:00:00.000Z,Hearing Loss
KCNQ1,HGNC:6294,Jervell and Lange-Nielsen syndrome,MONDO:0002441,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cb5cd32-6663-48bc-b8b0-3b9ca34e2cb7-2017-12-19T050000.000Z,2017-12-19T05:00:00.000Z,Hearing Loss
KCNQ4,HGNC:6298,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_88196c6d-4bd7-4aff-ba98-c7b4411c562d-2017-11-21T170000.000Z,2017-11-21T17:00:00.000Z,Hearing Loss
KITLG,HGNC:6343,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d2934de4-e4d7-41b7-8d12-83372e3b1b28-2018-01-16T170000.000Z,2018-01-16T17:00:00.000Z,Hearing Loss
LARS2,HGNC:17095,Perrault syndrome,MONDO:0017312,AR,SOP5,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8afe11e7-7c53-46e2-b48e-37ee2bc144ce-2018-06-26T160000.000Z,2018-06-26T16:00:00.000Z,Hearing Loss
LHFPL5,HGNC:21253,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8a029f02-3524-4932-9293-9c02304fdd2b-2018-04-24T160000.000Z,2018-04-24T16:00:00.000Z,Hearing Loss
LOXHD1,HGNC:26521,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a35c0909-7546-465c-a069-47e901fce483-2018-05-08T040000.000Z,2018-05-08T04:00:00.000Z,Hearing Loss
LRTOMT,HGNC:25033,autosomal recessive nonsyndromic hearing loss 63,MONDO:0012670,AR,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5662,2017-02-15T00:00:00,Hearing Loss
MARVELD2,HGNC:26401,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ba6df3f7-a000-401c-94d9-0dc5cb901f32-2018-01-05T170000.000Z,2018-01-05T17:00:00.000Z,Hearing Loss
MCM2,HGNC:6944,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29172723-c896-4cbf-a20b-9921fc72547f-2020-04-21T190000.000Z,2020-04-21T19:00:00.000Z,Hearing Loss
MET,HGNC:7029,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f0e6f9ac-f807-48fd-a5b6-bf67c4607e14-2021-03-26T160000.000Z,2021-03-26T16:00:00.000Z,Hearing Loss
MIR96,HGNC:31648,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_01d1a7f4-8421-4be3-8fe7-2c2025f03ac9-2018-12-04T170000.000Z,2018-12-04T17:00:00.000Z,Hearing Loss
MITF,HGNC:7105,Waardenburg syndrome type 2,MONDO:0019517,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bc5d40d2-44b5-49b6-97a9-7bdfc39bee49-2017-11-21T170000.000Z,2017-11-21T17:00:00.000Z,Hearing Loss
MPZL2,HGNC:3496,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_046d28d7-60d8-4c7e-a901-37c86fa6a77e-2021-03-26T160000.000Z,2021-03-26T16:00:00.000Z,Hearing Loss
MSRB3,HGNC:27375,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ea7c7e0-dc56-4484-b2b6-5e3899d04013-2021-11-30T170000.000Z,2021-11-30T17:00:00.000Z,Hearing Loss
MYH14,HGNC:23212,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_007697a5-2f83-40d0-b2ea-914e458a1452-2020-08-31T170000.000Z,2020-08-31T17:00:00.000Z,Hearing Loss
MYH9,HGNC:7579,macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss,MONDO:0015912,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d6801442-c490-44a0-9a60-84ab5b20f7ac-2018-02-20T050000.000Z,2018-02-20T05:00:00.000Z,Hearing Loss
MYO15A,HGNC:7594,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cf0898e-5e63-4327-9341-fdf26490beee-2017-11-21T170000.000Z,2017-11-21T17:00:00.000Z,Hearing Loss
MYO1A,HGNC:7595,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP6,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3dcc24f7-4cf7-413b-a956-16ad58bcbd36-2018-01-16T170000.000Z,2018-01-16T17:00:00.000Z,Hearing Loss
MYO1C,HGNC:7597,autosomal dominant nonsyndromic hearing loss,MONDO:0019587,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f27e3d88-0a3d-44f8-bbbc-1f668e596541-2018-06-26T160000.000Z,2018-06-26T16:00:00.000Z,Hearing Loss
MYO1F,HGNC:7600,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c422abbd-4f16-4da0-8569-d5d7138be488-2017-06-16T160000.000Z,2017-06-16T16:00:00.000Z,Hearing Loss
MYO3A,HGNC:7601,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a8fa3d7b-73a2-43a3-8f13-7dac3fd27737-2017-11-15T170000.000Z,2017-11-15T17:00:00.000Z,Hearing Loss
MYO6,HGNC:7605,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_50d408fe-e298-4683-985c-57a37b30e273-2018-02-20T170000.000Z,2018-02-20T17:00:00.000Z,Hearing Loss
MYO7A,HGNC:7606,Usher syndrome type 1,MONDO:0010168,AR,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1e897a2f-d4cf-4e13-85d8-f37405a09b18-2018-06-28T160000.000Z,2018-06-28T16:00:00.000Z,Hearing Loss
MYO7A,HGNC:7606,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_598b33f0-cdad-4290-b6eb-f9c2304c7bb6-2018-03-19T160000.000Z,2018-03-19T16:00:00.000Z,Hearing Loss
NARS2,HGNC:26274,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9db16e79-4c14-437f-9723-749f99053d5c-2021-11-17T170000.000Z,2021-11-17T17:00:00.000Z,Hearing Loss
OSBPL2,HGNC:15761,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a493a4c4-3a9f-431a-a68e-d90d9a11b6f0-2020-02-06T172031.658Z,2020-02-06T17:20:31.658Z,Hearing Loss
OTOA,HGNC:16378,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_87661be2-f024-49bb-a60e-a906f7f113b7-2018-05-01T040000.000Z,2018-05-01T04:00:00.000Z,Hearing Loss
OTOF,HGNC:8515,autosomal recessive nonsyndromic hearing loss 9,MONDO:0010986,AR,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5613,2017-01-30T00:00:00,Hearing Loss
OTOG,HGNC:8516,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0fac4fd4-d674-4017-a9a6-1d6793162c6b-2018-06-28T160000.000Z,2018-06-28T16:00:00.000Z,Hearing Loss
OTOGL,HGNC:26901,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_28b962a1-8394-4366-8746-4b71a59cd60b-2018-01-05T170000.000Z,2018-01-05T17:00:00.000Z,Hearing Loss
P2RX2,HGNC:15459,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c1dae6b6-4ed7-4c5a-ba4e-bcfaba026be8-2022-09-21T160000.000Z,2022-09-21T16:00:00.000Z,Hearing Loss
PAX3,HGNC:8617,Waardenburg syndrome,MONDO:0018094,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_594ef026-3730-43bc-b721-d15cf0bbbf26-2017-11-15T050000.000Z,2017-11-15T05:00:00.000Z,Hearing Loss
PCDH15,HGNC:14674,Usher syndrome type 1,MONDO:0010168,AR,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5657,2017-02-15T00:00:00,Hearing Loss
PCDH15,HGNC:14674,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_48910592-40d6-4eb7-a53c-4b0883070287-2018-06-19T040000.000Z,2018-06-19T04:00:00.000Z,Hearing Loss
PDZD7,HGNC:26257,"hearing loss, autosomal recessive",MONDO:0019588,AR,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8406,2017-04-26T00:00:00,Hearing Loss
PJVK,HGNC:29502,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b3e304c3-33fd-41ec-81f9-1c0725a5549f-2017-12-19T050000.000Z,2017-12-19T05:00:00.000Z,Hearing Loss
POU3F4,HGNC:9217,nonsyndromic genetic hearing loss,MONDO:0019497,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4ab4f4a3-757d-4de3-90e7-42a229c360a0-2018-01-05T170000.000Z,2018-01-05T17:00:00.000Z,Hearing Loss
POU4F3,HGNC:9220,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1476f1d9-7538-40bd-b602-b76781630cee-2017-11-21T170000.000Z,2017-11-21T17:00:00.000Z,Hearing Loss
PRPS1,HGNC:9462,phosphoribosylpyrophosphate synthetase superactivity,MONDO:0010395,XL,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_76dc3f8d-e1c9-4506-9381-d2b5ab3df300-2020-02-14T170000.000Z,2020-02-14T17:00:00.000Z,Hearing Loss
PRPS1,HGNC:9462,PRPS1 deficiency disorder,MONDO:0100061,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9416f6e2-8de3-48b0-9a1c-9bd11a59315c-2020-02-14T170000.000Z,2020-02-14T17:00:00.000Z,Hearing Loss
PTPRQ,HGNC:9679,"hearing loss, autosomal recessive",MONDO:0019588,AR,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8404,2017-02-23T00:00:00,Hearing Loss
RDX,HGNC:9944,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cf494e5-7335-4e2a-8b50-75cf8412a9d0-2018-01-02T170000.000Z,2018-01-02T17:00:00.000Z,Hearing Loss
RIPOR2,HGNC:13872,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ed7e0813-4e94-40a9-b3ef-ef90d5c4dce4-2018-09-18T160000.000Z,2018-09-18T16:00:00.000Z,Hearing Loss
ROR1,HGNC:10256,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fdee1ffc-d8bd-4188-acb6-5fad8f5902a6-2018-03-20T160000.000Z,2018-03-20T16:00:00.000Z,Hearing Loss
S1PR2,HGNC:3169,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP4,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8405,2017-03-02T00:00:00,Hearing Loss
SERPINB6,HGNC:8950,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b84c49a8-3b02-4e07-a0c7-80394c0cf991-2022-11-22T170000.000Z,2022-11-22T17:00:00.000Z,Hearing Loss
SIX1,HGNC:10887,branchio-oto-renal syndrome,MONDO:0007029,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e2587f3b-52e1-4765-a9ac-82d8cc5ae45b-2017-06-22T160000.000Z,2017-06-22T16:00:00.000Z,Hearing Loss
SIX5,HGNC:10891,branchio-oto-renal syndrome,MONDO:0007029,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0667561f-aa48-4ad5-b4ff-45aac933b255-2018-01-16T170000.000Z,2018-01-16T17:00:00.000Z,Hearing Loss
SLC17A8,HGNC:20151,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP6,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8c399400-090a-4b2e-93ff-0c4915ce81c7-2018-09-18T160000.000Z,2018-09-18T16:00:00.000Z,Hearing Loss
SLC26A4,HGNC:8818,Pendred syndrome,MONDO:0010134,AR,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_49e794f4-8725-4499-a0a2-82591b42cab5-2017-06-07T040000.000Z,2017-06-07T04:00:00.000Z,Hearing Loss
SLC26A5,HGNC:9359,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2f835f34-fe68-49a8-9399-bccebba540d4-2022-01-26T204254.928Z,2022-01-26T20:42:54.928Z,Hearing Loss
SLC44A4,HGNC:13941,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ddbe083-55c3-483b-8c32-fc9bdbef10c6-2022-11-22T170000.000Z,2022-11-22T17:00:00.000Z,Hearing Loss
SLC52A2,HGNC:30224,brown-Vialetto-van Laere syndrome 2,MONDO:0013867,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5a500078-4cd5-49db-b22e-c5628ee07304-2018-07-09T160000.000Z,2018-07-09T16:00:00.000Z,Hearing Loss
SLC52A3,HGNC:16187,Brown-Vialetto-van Laere syndrome 1,MONDO:0024537,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b0ae82e2-4c39-45b2-ba2d-6fe2570dbcfc-2018-12-06T050000.000Z,2018-12-06T05:00:00.000Z,Hearing Loss
SLITRK6,HGNC:23503,high myopia-sensorineural deafness syndrome,MONDO:0009082,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9b9e41c-1b12-4159-9729-8de648e747b0-2020-04-21T211522.429Z,2020-04-21T21:15:22.429Z,Hearing Loss
SMPX,HGNC:11122,nonsyndromic genetic hearing loss,MONDO:0019497,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29773bee-1f13-43f6-bda0-c5a646efccd7-2017-09-12T160000.000Z,2017-09-12T16:00:00.000Z,Hearing Loss
SNAI2,HGNC:11094,Waardenburg syndrome,MONDO:0018094,AR,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9c01d8d8-40a4-4b11-ad9c-8283bb937c55-2017-12-19T170000.000Z,2017-12-19T17:00:00.000Z,Hearing Loss
SOX10,HGNC:11190,Waardenburg syndrome type 4C,MONDO:0013202,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_00a5b707-a265-4af0-a7e1-f15734ea42b9-2018-06-19T160000.000Z,2018-06-19T16:00:00.000Z,Hearing Loss
STRC,HGNC:16035,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_977b98b7-00f4-4200-9b17-f37303889ab4-2017-12-19T050000.000Z,2017-12-19T05:00:00.000Z,Hearing Loss
SYNE4,HGNC:26703,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7ba8e80d-ccfe-4c9d-a2a9-6abaa9dfacc6-2020-02-06T171016.249Z,2020-02-06T17:10:16.249Z,Hearing Loss
TBC1D24,HGNC:29203,DOORS syndrome,MONDO:0009079,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0fcb9839-6798-4195-8959-08d45bc63339-2020-03-11T132031.642Z,2020-03-11T13:20:31.642Z,Hearing Loss
TBC1D24,HGNC:29203,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cd496a45-5ae0-4e56-8a3d-2c410a5bd0c8-2022-07-26T160000.000Z,2022-07-26T16:00:00.000Z,Hearing Loss
TCOF1,HGNC:11654,Treacher-Collins syndrome,MONDO:0002457,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3f91c5fe-8e58-4c98-9878-e428e2e41dd7-2019-09-17T160000.000Z,2019-09-17T16:00:00.000Z,Hearing Loss
TECTA,HGNC:11720,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0c7395aa-89bb-40e2-a226-0500fef478bb-2018-01-02T170000.000Z,2018-01-02T17:00:00.000Z,Hearing Loss
TECTA,HGNC:11720,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_95b38b73-f807-4401-9600-fe1f319b9dd9-2018-01-02T170000.000Z,2018-01-02T17:00:00.000Z,Hearing Loss
TIMM8A,HGNC:11817,deafness dystonia syndrome,MONDO:0010578,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a21d3842-b39e-4f98-860a-61a9aa4e2d2b-2017-12-19T050000.000Z,2017-12-19T05:00:00.000Z,Hearing Loss
TJP2,HGNC:11828,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bb5c5be5-918d-4ba5-b4ad-e243119a7e6a-2022-01-19T170000.000Z,2022-01-19T17:00:00.000Z,Hearing Loss
TMC1,HGNC:16513,autosomal recessive nonsyndromic hearing loss 7,MONDO:0010967,AR,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5658,2017-02-15T00:00:00,Hearing Loss
TMC1,HGNC:16513,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_966d2fa1-5245-420d-9bf0-4a36aab29d74-2018-06-22T160000.000Z,2018-06-22T16:00:00.000Z,Hearing Loss
TMEM132E,HGNC:26991,"hearing loss, autosomal recessive",MONDO:0019588,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_867fc085-f2f4-40f6-8b96-565d131fd964-2022-01-26T163240.414Z,2022-01-26T16:32:40.414Z,Hearing Loss
TMIE,HGNC:30800,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b025a472-0a48-469c-a5f3-70df12ade334-2017-09-29T040000.000Z,2017-09-29T04:00:00.000Z,Hearing Loss
TMPRSS3,HGNC:11877,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ee13ba8c-7986-4e6c-8a39-4ee197ba4023-2017-08-22T160000.000Z,2017-08-22T16:00:00.000Z,Hearing Loss
TMTC2,HGNC:25440,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0e56b4d6-4947-4de5-a3a7-373145019239-2022-04-26T160000.000Z,2022-04-26T16:00:00.000Z,Hearing Loss
TNC,HGNC:5318,nonsyndromic genetic hearing loss,MONDO:0019497,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fce4988a-fb20-4f95-b73a-799c47b67e3b-2022-07-13T160000.000Z,2022-07-13T16:00:00.000Z,Hearing Loss
TPRN,HGNC:26894,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a4dce399-9aeb-452e-a917-3603eb09d11f-2017-09-12T040000.000Z,2017-09-12T04:00:00.000Z,Hearing Loss
TRIOBP,HGNC:17009,"hearing loss, autosomal recessive",MONDO:0019588,AR,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9543,2017-06-06T00:00:00,Hearing Loss
TSPEAR,HGNC:1268,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f0928b06-d3bb-41fe-8222-d7f0e6c0a25a-2017-09-26T040000.000Z,2017-09-26T04:00:00.000Z,Hearing Loss
TUBB4B,HGNC:20771,Leber congenital amaurosis with early-onset deafness,MONDO:0060650,AD,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3b80d55d-0060-4b1c-849b-648011337400-2018-06-26T160000.000Z,2018-06-26T16:00:00.000Z,Hearing Loss
USH1C,HGNC:12597,Usher syndrome type 1,MONDO:0010168,AR,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5664,2017-02-15T00:00:00,Hearing Loss
USH1C,HGNC:12597,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f4194490-1b41-4d6d-be63-4a2a8827bb85-2018-06-11T040000.000Z,2018-06-11T04:00:00.000Z,Hearing Loss
USH1G,HGNC:16356,Usher syndrome type 1,MONDO:0010168,AR,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5660,2017-02-15T00:00:00,Hearing Loss
USH1G,HGNC:16356,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_02c62d06-b496-4a48-a514-56a772fae071-2019-05-21T160000.000Z,2019-05-21T16:00:00.000Z,Hearing Loss
USH2A,HGNC:12601,Usher syndrome type 2,MONDO:0016484,AR,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_5661,2017-02-15T00:00:00,Hearing Loss
WBP2,HGNC:12738,"hearing loss, autosomal recessive",MONDO:0019588,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_baa7931c-1d6a-4260-9816-fbca764c5a0e-2018-12-09T170000.000Z,2018-12-09T17:00:00.000Z,Hearing Loss
WFS1,HGNC:12762,Wolfram-like syndrome,MONDO:0013673,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_17637c9d-03fb-496a-a00c-ae2431f441e8-2018-04-17T040000.000Z,2018-04-17T04:00:00.000Z,Hearing Loss
WFS1,HGNC:12762,Wolfram syndrome,MONDO:0018105,AR,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1e81eeda-4dd0-431c-ad52-90304fb761c8-2018-04-17T160000.000Z,2018-04-17T16:00:00.000Z,Hearing Loss
WHRN,HGNC:16361,Usher syndrome type 2D,MONDO:0012662,AR,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8151,2017-05-10T00:00:00,Hearing Loss
WHRN,HGNC:16361,nonsyndromic genetic hearing loss,MONDO:0019497,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3188ec93-954a-4daa-b99d-7c5fccad8e1a-2018-12-26T170000.000Z,2018-12-26T17:00:00.000Z,Hearing Loss
ABCC4,HGNC:55,qualitative platelet defect,MONDO:0001197,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2828abac-5b4a-4dad-a703-10c0daf35dbd-2022-05-25T160000.000Z,2022-05-25T16:00:00.000Z,Hemostasis Thrombosis
ABCG5,HGNC:13886,sitosterolemia,MONDO:0008863,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c52c7403-8975-4a3f-8796-a966e977f708-2020-07-10T160000.000Z,2020-07-10T16:00:00.000Z,Hemostasis Thrombosis
ABCG8,HGNC:13887,sitosterolemia,MONDO:0008863,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_af59edc2-1148-4dca-b804-192639017b65-2020-07-14T202806.911Z,2020-07-14T20:28:06.911Z,Hemostasis Thrombosis
ACTB,HGNC:132,ACTB-associated syndromic thrombocytopenia,MONDO:0100433,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9cee7fd2-09f7-41dc-9742-542917d856b0-2022-05-25T160000.000Z,2022-05-25T16:00:00.000Z,Hemostasis Thrombosis
ACTN1,HGNC:163,platelet-type bleeding disorder 15,MONDO:0014078,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_215f3113-cfb6-44cc-a68b-1eb6539c9fa0-2020-11-25T170000.000Z,2020-11-25T17:00:00.000Z,Hemostasis Thrombosis
ACVRL1,HGNC:175,"telangiectasia, hereditary hemorrhagic, type 2",MONDO:0010880,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fbbb72c5-84a0-4096-8d49-6df506cfee0e-2022-12-05T170000.000Z,2022-12-05T17:00:00.000Z,Hemostasis Thrombosis
ADAMTS13,HGNC:1366,congenital thrombotic thrombocytopenic purpura,MONDO:0010122,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6442c328-21be-482d-9ea9-ce694c1a5dd9-2020-03-25T160000.000Z,2020-03-25T16:00:00.000Z,Hemostasis Thrombosis
ANKRD26,HGNC:29186,thrombocytopenia 2,MONDO:0008555,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e86bee2b-8353-48c2-8ea3-a6b2b26cdb2f-2019-09-25T160000.000Z,2019-09-25T16:00:00.000Z,Hemostasis Thrombosis
ANO6,HGNC:25240,Scott syndrome,MONDO:0009885,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c2d3c125-1938-4295-82bb-b2851a3b2c8d-2022-06-22T160000.000Z,2022-06-22T16:00:00.000Z,Hemostasis Thrombosis
AP3B1,HGNC:566,Hermansky-Pudlak syndrome 2,MONDO:0011997,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_00ce813c-9493-48f9-9351-b70defb71d75-2020-02-26T170000.000Z,2020-02-26T17:00:00.000Z,Hemostasis Thrombosis
AP3D1,HGNC:568,Hermansky-Pudlak syndrome 10,MONDO:0014885,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ec9ffa2-efda-446d-a848-e6d4d5b92fb6-2020-02-26T170000.000Z,2020-02-26T17:00:00.000Z,Hemostasis Thrombosis
ARPC1B,HGNC:704,platelet abnormalities with eosinophilia and immune-mediated inflammatory disease,MONDO:0060583,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_13909f11-a592-41cc-ade9-c77a5b49b253-2020-07-22T160000.000Z,2020-07-22T16:00:00.000Z,Hemostasis Thrombosis
BLOC1S3,HGNC:20914,Hermansky-Pudlak syndrome 8,MONDO:0013560,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bdeec503-f903-4507-89e7-33c9255b5ad1-2022-09-28T160000.000Z,2022-09-28T16:00:00.000Z,Hemostasis Thrombosis
BLOC1S6,HGNC:8549,Hermansky-Pudlak syndrome 9,MONDO:0013606,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_984682a2-afb9-48b3-afe8-20e0f633022d-2022-05-25T165516.466Z,2022-05-25T16:55:16.466Z,Hemostasis Thrombosis
CDC42,HGNC:1736,macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome,MONDO:0014757,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_95177a3a-0dca-4945-8a44-f63697739cef-2021-10-27T162623.932Z,2021-10-27T16:26:23.932Z,Hemostasis Thrombosis
CYCS,HGNC:19986,thrombocytopenia 4,MONDO:0012775,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_772f2ad2-5d8c-41f6-95c4-39063daf77be-2021-06-23T170356.081Z,2021-06-23T17:03:56.081Z,Hemostasis Thrombosis
DTNBP1,HGNC:17328,Hermansky-Pudlak syndrome 7,MONDO:0013559,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_785a39b1-9c7b-4745-94b6-be6a9376ac97-2021-02-24T170000.000Z,2021-02-24T17:00:00.000Z,Hemostasis Thrombosis
ENG,HGNC:3349,hereditary hemorrhagic telangiectasia,MONDO:0019180,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4d13b4a-f97b-45d0-9b82-07bcb6685a0a-2022-12-05T170000.000Z,2022-12-05T17:00:00.000Z,Hemostasis Thrombosis
ETV6,HGNC:3495,thrombocytopenia 5,MONDO:0014536,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_92a8c1cb-91c1-45cd-adbe-4180b1f6da7d-2020-01-22T170000.000Z,2020-01-22T17:00:00.000Z,Hemostasis Thrombosis
F10,HGNC:3528,congenital factor X deficiency,MONDO:0009212,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4adcc848-b354-4975-801f-4b55bbca64ad-2019-11-27T170000.000Z,2019-11-27T17:00:00.000Z,Hemostasis Thrombosis
F11,HGNC:3529,congenital factor XI deficiency,MONDO:0012897,SD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a57ba9d9-45c5-48bc-b939-7593f67a86ed-2019-10-23T160000.000Z,2019-10-23T16:00:00.000Z,Hemostasis Thrombosis
F12,HGNC:3530,congenital factor XII deficiency,MONDO:0009315,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_50bbe8d0-4feb-43c7-8573-9d7f85c82e54-2020-01-22T170000.000Z,2020-01-22T17:00:00.000Z,Hemostasis Thrombosis
F12,HGNC:3530,hereditary angioedema type 3,MONDO:0012526,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f40992c9-1172-4528-ab53-95108094d4b6-2022-05-25T160000.000Z,2022-05-25T16:00:00.000Z,Hemostasis Thrombosis
F13A1,HGNC:3531,"factor XIII, A subunit, deficiency of",MONDO:0013187,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dd9321a7-f45d-419e-94ce-101ab545a847-2020-07-22T160000.000Z,2020-07-22T16:00:00.000Z,Hemostasis Thrombosis
F13B,HGNC:3534,"factor XIII, b subunit, deficiency of",MONDO:0013190,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_403b3588-323c-4103-9207-cc9c8be12281-2020-07-22T160000.000Z,2020-07-22T16:00:00.000Z,Hemostasis Thrombosis
F2,HGNC:3535,thrombophilia due to thrombin defect,MONDO:0008559,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6389b3a3-ef86-4588-9be8-eb79dcb8d3cd-2020-06-24T160000.000Z,2020-06-24T16:00:00.000Z,Hemostasis Thrombosis
F2,HGNC:3535,congenital prothrombin deficiency,MONDO:0013361,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6ba9c4b9-9984-4d31-a9ae-bf638838f201-2020-06-24T160000.000Z,2020-06-24T16:00:00.000Z,Hemostasis Thrombosis
F5,HGNC:3542,thrombophilia due to activated protein C resistance,MONDO:0008560,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ab28e09c-08ff-4149-a536-3cdb9cc4099f-2019-09-30T160000.000Z,2019-09-30T16:00:00.000Z,Hemostasis Thrombosis
F5,HGNC:3542,congenital factor V deficiency,MONDO:0009210,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_beaa3af3-7d91-4d53-b081-de0e660c16c6-2020-03-25T160000.000Z,2020-03-25T16:00:00.000Z,Hemostasis Thrombosis
F7,HGNC:3544,factor VII deficiency,MONDO:0002244,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_43fb4e99-e97a-4d9c-af11-79c2b09ecd2e-2019-07-24T160000.000Z,2019-07-24T16:00:00.000Z,Hemostasis Thrombosis
F8,HGNC:3546,hemophilia A,MONDO:0010602,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4578f11-b635-45f4-8034-310fca5fe960-2019-07-24T160000.000Z,2019-07-24T16:00:00.000Z,Hemostasis Thrombosis
F9,HGNC:3551,hemophilia B,MONDO:0010604,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3d56d08d-48d0-4523-b433-dbd44c5b9e45-2019-05-22T190226.728Z,2019-05-22T19:02:26.728Z,Hemostasis Thrombosis
F9,HGNC:3551,"thrombophilia, X-linked, due to factor 9 defect",MONDO:0010432,XL,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9b3a7f2c-a07a-4a10-b1f7-78642ebdaa5d-2020-06-24T160000.000Z,2020-06-24T16:00:00.000Z,Hemostasis Thrombosis
FERMT3,HGNC:23151,leukocyte adhesion deficiency 3,MONDO:0013016,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_df792161-5efb-45f7-91ed-5fe76045fa06-2019-08-28T160000.000Z,2019-08-28T16:00:00.000Z,Hemostasis Thrombosis
FGA,HGNC:3661,congenital fibrinogen deficiency,MONDO:0018060,SD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d34ded98-dbf7-4dc7-bea4-803db1857bf8-2020-01-22T170000.000Z,2020-01-22T17:00:00.000Z,Hemostasis Thrombosis
FGB,HGNC:3662,congenital fibrinogen deficiency,MONDO:0018060,SD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_638c1588-9674-4bc3-a39c-2fc8f8b0ef09-2020-01-22T170000.000Z,2020-01-22T17:00:00.000Z,Hemostasis Thrombosis
FGG,HGNC:3694,congenital fibrinogen deficiency,MONDO:0018060,SD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9ef37f0f-a5ae-402c-b319-7f7d731ecbb1-2020-01-23T173301.596Z,2020-01-23T17:33:01.596Z,Hemostasis Thrombosis
FLI1,HGNC:3749,"bleeding disorder, platelet-type, 21",MONDO:0054577,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dd0eaa15-3ee7-4db7-9920-c380757ece33-2021-04-28T160000.000Z,2021-04-28T16:00:00.000Z,Hemostasis Thrombosis
FYB1,HGNC:4036,thrombocytopenia 3,MONDO:0010120,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0e4e83fb-516b-43f8-a0af-687b9d938f74-2021-12-15T183305.227Z,2021-12-15T18:33:05.227Z,Hemostasis Thrombosis
GATA1,HGNC:4170,GATA1-Related X-Linked Cytopenia,MONDO:0100089,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ad980194-b275-4bbb-b3df-73c1a50d3eac-2020-05-27T040000.000Z,2020-05-27T04:00:00.000Z,Hemostasis Thrombosis
GFI1B,HGNC:4238,platelet-type bleeding disorder 17,MONDO:0008553,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_62841ea9-5bd8-4250-ab41-31d7cf82d2e3-2019-11-27T170000.000Z,2019-11-27T17:00:00.000Z,Hemostasis Thrombosis
GGCX,HGNC:4247,"vitamin K-dependent clotting factors, combined deficiency of, type 1",MONDO:0010187,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_87ceae1d-b329-4c29-b6f2-8a94a127204e-2021-02-24T175200.635Z,2021-02-24T17:52:00.635Z,Hemostasis Thrombosis
GNE,HGNC:23657,isolated hereditary giant platelet disorder,MONDO:0016361,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_335d18ae-50ef-49a8-abb2-79799833b544-2022-05-25T160000.000Z,2022-05-25T16:00:00.000Z,Hemostasis Thrombosis
GP1BA,HGNC:4439,Bernard-Soulier syndrome,MONDO:0009276,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7e3aa94f-1e87-4806-bc47-2f8c40e3d1bc-2020-05-27T160000.000Z,2020-05-27T16:00:00.000Z,Hemostasis Thrombosis
GP1BA,HGNC:4439,pseudo-von Willebrand disease,MONDO:0008332,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8fef91aa-8c41-4044-b601-da24c2bab351-2020-05-27T160000.000Z,2020-05-27T16:00:00.000Z,Hemostasis Thrombosis
GP1BB,HGNC:4440,Bernard-Soulier syndrome,MONDO:0009276,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2064876d-ea54-4ace-be76-f700cfefbf90-2019-06-06T160000.000Z,2019-06-06T16:00:00.000Z,Hemostasis Thrombosis
GP6,HGNC:14388,platelet-type bleeding disorder 11,MONDO:0013623,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_76262cf5-f2cd-4466-b542-bf2334a96c73-2019-10-23T160000.000Z,2019-10-23T16:00:00.000Z,Hemostasis Thrombosis
GP9,HGNC:4444,Bernard-Soulier syndrome,MONDO:0009276,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_af66eb15-10fe-4c2b-bff2-b8c8bf813174-2019-11-27T170000.000Z,2019-11-27T17:00:00.000Z,Hemostasis Thrombosis
HOXA11,HGNC:5101,radioulnar synostosis with amegakaryocytic thrombocytopenia 1,MONDO:0024558,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_48ef111f-28fc-4970-a0ca-8387e9ec2d0e-2021-04-28T181451.054Z,2021-04-28T18:14:51.054Z,Hemostasis Thrombosis
HPS1,HGNC:5163,Hermansky-Pudlak syndrome 1,MONDO:0008748,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f6d44a89-527f-4864-a1e1-dcd0a17000ca-2019-07-22T142842.174Z,2019-07-22T14:28:42.174Z,Hemostasis Thrombosis
HPS3,HGNC:15597,Hermansky-Pudlak syndrome 3,MONDO:0013555,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_80370671-df62-4330-89f4-216d350e5958-2020-02-26T170000.000Z,2020-02-26T17:00:00.000Z,Hemostasis Thrombosis
HPS4,HGNC:15844,Hermansky-Pudlak syndrome 4,MONDO:0013556,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3649fe18-730d-4d46-ad60-b70d421abc02-2020-05-27T160000.000Z,2020-05-27T16:00:00.000Z,Hemostasis Thrombosis
HPS5,HGNC:17022,Hermansky-Pudlak syndrome 5,MONDO:0013557,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a761e746-824f-496c-8d9f-4f8cd50423c3-2020-10-28T160000.000Z,2020-10-28T16:00:00.000Z,Hemostasis Thrombosis
HPS6,HGNC:18817,Hermansky-Pudlak syndrome 6,MONDO:0013558,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_602ae8f1-9e7f-4cc6-bf70-d572d98828c5-2020-11-25T170000.000Z,2020-11-25T17:00:00.000Z,Hemostasis Thrombosis
HRG,HGNC:5181,hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency,MONDO:0013143,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a2604a64-e36e-4512-83a7-e8202ccdb593-2021-12-15T173040.572Z,2021-12-15T17:30:40.572Z,Hemostasis Thrombosis
IKZF5,HGNC:14283,thrombocytopenia 7,MONDO:0030867,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b3d7d24b-1fb8-4951-9508-b27035a000a0-2021-05-26T160000.000Z,2021-05-26T16:00:00.000Z,Hemostasis Thrombosis
ITGA2B,HGNC:6138,platelet-type bleeding disorder 16,MONDO:0008552,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_380c4fb9-aa51-4d34-9349-7938667612b7-2021-06-23T160000.000Z,2021-06-23T16:00:00.000Z,Hemostasis Thrombosis
ITGA2B,HGNC:6138,Glanzmann thrombasthenia,MONDO:0100326,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9fa894f5-f9e4-4b6d-bdde-eeb7ad9507e2-2019-09-04T040000.000Z,2019-09-04T04:00:00.000Z,Hemostasis Thrombosis
ITGB3,HGNC:6156,Glanzmann thrombasthenia,MONDO:0100326,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e16b727e-c4c6-4d1d-8e66-8acab2b605fa-2019-08-28T040000.000Z,2019-08-28T04:00:00.000Z,Hemostasis Thrombosis
ITGB3,HGNC:6156,platelet-type bleeding disorder 16,MONDO:0008552,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eda416fa-6e15-40df-bfd0-46a111e99ba0-2020-09-23T160000.000Z,2020-09-23T16:00:00.000Z,Hemostasis Thrombosis
KDSR,HGNC:4021,erythrokeratodermia variabilis et progressiva 4,MONDO:0033014,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0a5d1542-feb7-4aaf-9079-55da7fb99a4a-2020-07-22T160000.000Z,2020-07-22T16:00:00.000Z,Hemostasis Thrombosis
KLKB1,HGNC:6371,inherited prekallikrein deficiency,MONDO:0012901,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ada3e3e0-165c-4bfb-af20-d811b7b8d9b8-2022-12-05T170000.000Z,2022-12-05T17:00:00.000Z,Hemostasis Thrombosis
KNG1,HGNC:6383,congenital high-molecular-weight kininogen deficiency,MONDO:0009234,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6dbf4bc1-b04f-4f1d-8c11-2b7998370293-2021-06-23T160000.000Z,2021-06-23T16:00:00.000Z,Hemostasis Thrombosis
LMAN1,HGNC:6631,"factor V and factor VIII, combined deficiency of, type 1",MONDO:0009206,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_31792b8d-aca4-4832-b7f7-1993611777d7-2019-11-27T170000.000Z,2019-11-27T17:00:00.000Z,Hemostasis Thrombosis
LYST,HGNC:1968,Chediak-Higashi syndrome,MONDO:0008963,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5d752f7c-43d2-4ba9-910f-f286f5443012-2020-05-27T160000.000Z,2020-05-27T16:00:00.000Z,Hemostasis Thrombosis
MCFD2,HGNC:18451,"factor 5 and Factor VIII, combined deficiency of, 2",MONDO:0013331,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_afa4ae2a-c40d-4f25-affe-852a67144cdd-2020-06-24T160000.000Z,2020-06-24T16:00:00.000Z,Hemostasis Thrombosis
MECOM,HGNC:3498,MECOM-associated syndrome,MONDO:0100458,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d1d25a48-f664-49c6-8ea4-dfddd0651209-2021-11-08T170000.000Z,2021-11-08T17:00:00.000Z,Hemostasis Thrombosis
MPIG6B,HGNC:13937,"thrombocytopenia, anemia, and myelofibrosis",MONDO:0044316,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_03b93956-5abe-41f2-ba14-1e57952606b3-2020-10-28T160000.000Z,2020-10-28T16:00:00.000Z,Hemostasis Thrombosis
MPL,HGNC:7217,thrombocythemia 2,MONDO:0011173,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_23b39955-2760-46aa-978b-d27d4a212567-2020-07-22T160000.000Z,2020-07-22T16:00:00.000Z,Hemostasis Thrombosis
MPL,HGNC:7217,congenital amegakaryocytic thrombocytopenia,MONDO:0011469,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d97f51ea-0148-483b-a18e-e61ee2e30690-2020-07-22T160000.000Z,2020-07-22T16:00:00.000Z,Hemostasis Thrombosis
NBEAL2,HGNC:31928,gray platelet syndrome,MONDO:0007686,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ae8bd4d6-8810-423b-83e0-98667f06426d-2019-06-26T160000.000Z,2019-06-26T16:00:00.000Z,Hemostasis Thrombosis
P2RY12,HGNC:18124,platelet-type bleeding disorder 8,MONDO:0012354,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6b61af44-1fb4-4c7d-94b2-f21903793162-2020-08-26T160000.000Z,2020-08-26T16:00:00.000Z,Hemostasis Thrombosis
P2RY12,HGNC:18124,platelet-type bleeding disorder 8,MONDO:0012354,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_81c56aba-1414-4365-a8de-847c080251f3-2020-08-26T160000.000Z,2020-08-26T16:00:00.000Z,Hemostasis Thrombosis
PLA2G4A,HGNC:9035,cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder,MONDO:0018794,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ff7f6f85-cca7-4eb2-9957-9023c94402f0-2022-06-22T160000.000Z,2022-06-22T16:00:00.000Z,Hemostasis Thrombosis
PLAU,HGNC:9052,Quebec platelet disorder,MONDO:0011136,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6ffd0133-1004-4a53-b38d-940c257e56c1-2022-01-05T160123.087Z,2022-01-05T16:01:23.087Z,Hemostasis Thrombosis
PLG,HGNC:9071,hypoplasminogenemia,MONDO:0009009,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2c9320e7-9f02-4b54-beba-0ca781a442eb-2019-10-23T160000.000Z,2019-10-23T16:00:00.000Z,Hemostasis Thrombosis
PROC,HGNC:9451,hereditary thrombophilia due to congenital protein C deficiency,MONDO:0019145,SD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c6fe2f63-36ad-40c2-beb6-8804de17409d-2020-01-22T170000.000Z,2020-01-22T17:00:00.000Z,Hemostasis Thrombosis
PROS1,HGNC:9456,hereditary thrombophilia due to congenital protein S deficiency,MONDO:0019144,SD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_10e3af9d-80aa-4934-b592-594b1bd1cd92-2020-01-22T170000.000Z,2020-01-22T17:00:00.000Z,Hemostasis Thrombosis
PTGS1,HGNC:9604,platelet-type bleeding disorder 12,MONDO:0011588,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_24dc7cc9-f3f6-421e-ad78-016e89e6220b-2022-03-24T171350.179Z,2022-03-24T17:13:50.179Z,Hemostasis Thrombosis
PTGS1,HGNC:9604,platelet-type bleeding disorder 12,MONDO:0011588,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_48fe311d-94be-4953-adb2-9fdbab31e7be-2022-03-24T180544.792Z,2022-03-24T18:05:44.792Z,Hemostasis Thrombosis
RAP1B,HGNC:9857,syndromic constitutional thrombocytopenia,MONDO:0018795,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6140482f-8f93-47b2-9915-597da34a5975-2022-09-28T160000.000Z,2022-09-28T16:00:00.000Z,Hemostasis Thrombosis
RASGRP2,HGNC:9879,platelet-type bleeding disorder 18,MONDO:0014386,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f4401e99-145a-4b93-aa73-6854b8037895-2019-09-27T135300.165Z,2019-09-27T13:53:00.165Z,Hemostasis Thrombosis
RBM8A,HGNC:9905,thrombocytopenia-absent radius syndrome,MONDO:0010121,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_56c276a7-3068-48db-9baa-6f178eb9c3a7-2020-05-15T160000.000Z,2020-05-15T16:00:00.000Z,Hemostasis Thrombosis
SERPINC1,HGNC:775,hereditary antithrombin deficiency,MONDO:0013144,SD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dd6376b1-1593-461f-bfc8-cec5cfb1c3f8-2020-02-26T170000.000Z,2020-02-26T17:00:00.000Z,Hemostasis Thrombosis
SERPIND1,HGNC:4838,heparin cofactor 2 deficiency,MONDO:0012876,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0888745c-f1e6-4af7-bdcd-bd229f043f07-2020-11-18T170000.000Z,2020-11-18T17:00:00.000Z,Hemostasis Thrombosis
SERPINE1,HGNC:8583,congenital plasminogen activator inhibitor type 1 deficiency,MONDO:0013227,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_33baf899-f63b-42ed-b2fd-689cca44a7b6-2021-01-05T170000.000Z,2021-01-05T17:00:00.000Z,Hemostasis Thrombosis
SERPINF2,HGNC:9075,alpha-2-plasmin inhibitor deficiency,MONDO:0009883,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a8fa2353-ff89-41f1-b030-bde64517edbb-2020-09-23T160000.000Z,2020-09-23T16:00:00.000Z,Hemostasis Thrombosis
SLFN14,HGNC:32689,platelet-type bleeding disorder 20,MONDO:0014830,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f31ec838-fc84-47a2-9341-1fe494788a09-2022-05-25T160000.000Z,2022-05-25T16:00:00.000Z,Hemostasis Thrombosis
SMAD4,HGNC:6770,juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,MONDO:0008278,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9b79d0f-4259-49d7-882d-4ca23bb7e8cf-2020-12-16T170000.000Z,2020-12-16T17:00:00.000Z,Hemostasis Thrombosis
SRC,HGNC:11283,thrombocytopenia 6,MONDO:0014837,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3420133d-7a37-4f76-a3e7-6b9a0bc3803e-2022-06-22T160000.000Z,2022-06-22T16:00:00.000Z,Hemostasis Thrombosis
TBXA2R,HGNC:11608,qualitative platelet defect,MONDO:0001197,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ab65570e-c07b-402c-99c0-322df4a86ee4-2020-12-16T170000.000Z,2020-12-16T17:00:00.000Z,Hemostasis Thrombosis
TBXAS1,HGNC:11609,ghosal hematodiaphyseal dysplasia,MONDO:0009274,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_612c46e2-8b4f-4bff-9d8b-28769d8854e2-2020-10-28T160000.000Z,2020-10-28T16:00:00.000Z,Hemostasis Thrombosis
THBD,HGNC:11784,thrombomodulin-related bleeding disorder,MONDO:0013775,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_358cb384-4303-425d-9b92-509c600c2d03-2021-10-27T160000.000Z,2021-10-27T16:00:00.000Z,Hemostasis Thrombosis
THBD,HGNC:11784,thrombomodulin-related bleeding disorder,MONDO:0013775,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_65204ffc-d2bd-4334-bf9f-eaea618593dd-2021-10-27T160000.000Z,2021-10-27T16:00:00.000Z,Hemostasis Thrombosis
THPO,HGNC:11795,congenital amegakaryocytic thrombocytopenia,MONDO:0011469,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1f69370e-5f85-4006-b600-75be2d5f482f-2022-03-23T160000.000Z,2022-03-23T16:00:00.000Z,Hemostasis Thrombosis
THPO,HGNC:11795,thrombocythemia 1,MONDO:0008554,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e99d3899-efbe-4cb9-9170-748ea92892ce-2022-03-23T160000.000Z,2022-03-23T16:00:00.000Z,Hemostasis Thrombosis
TPM4,HGNC:12013,TPM4-related platelet disorder,MONDO:0100487,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0b8bb90f-f190-4e20-8f65-27d236cb7d79-2022-02-23T170000.000Z,2022-02-23T17:00:00.000Z,Hemostasis Thrombosis
TUBB1,HGNC:16257,"macrothrombocytopenia, isolated, 1, autosomal dominant",MONDO:0800047,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dbf068c4-8e07-4861-8eee-8e7d9572b122-2019-10-23T040000.000Z,2019-10-23T04:00:00.000Z,Hemostasis Thrombosis
VIPAS39,HGNC:20347,"arthrogryposis, renal dysfunction, and cholestasis 2",MONDO:0013255,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b87d2443-a34d-41b1-8712-bcd346e3cf52-2020-12-16T170000.000Z,2020-12-16T17:00:00.000Z,Hemostasis Thrombosis
VKORC1,HGNC:23663,"vitamin K-dependent clotting factors, combined deficiency of, type 2",MONDO:0011837,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_84145ffe-9835-4a3a-a2ae-6d0c6bd34007-2020-06-24T160000.000Z,2020-06-24T16:00:00.000Z,Hemostasis Thrombosis
VPS33B,HGNC:12712,"arthrogryposis, renal dysfunction, and cholestasis 1",MONDO:0008822,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d38d685c-9aee-4660-9228-4119a4fd583d-2021-03-24T160534.056Z,2021-03-24T16:05:34.056Z,Hemostasis Thrombosis
VWF,HGNC:12726,hereditary von Willebrand disease,MONDO:0019565,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4899c76e-7d5e-4b00-a47f-7e1f1b0ba664-2020-09-23T160000.000Z,2020-09-23T16:00:00.000Z,Hemostasis Thrombosis
VWF,HGNC:12726,von Willebrand disease type 2B,MONDO:0015629,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ecfe8bc1-5a4b-4d41-80d1-217af5b5b77f-2020-09-23T160000.000Z,2020-09-23T16:00:00.000Z,Hemostasis Thrombosis
ALK,HGNC:427,"neuroblastoma, susceptibility to, 3",MONDO:0013083,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ba9f692d-9b6d-4d46-8bfa-009ec20ae538-2022-12-30T180000.000Z,2022-12-30T18:00:00.000Z,Hereditary Cancer
APC,HGNC:583,gastric adenocarcinoma and proximal polyposis of the stomach,MONDO:0017790,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_22036d0d-71a8-4824-894b-0de40c412e15-2022-06-20T170000.000Z,2022-06-20T17:00:00.000Z,Hereditary Cancer
APC,HGNC:583,classic or attenuated familial adenomatous polyposis,MONDO:0021057,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cdf062b6-6abf-49f6-a2dc-43b0e535f1b6-2022-06-20T170000.000Z,2022-06-20T17:00:00.000Z,Hereditary Cancer
ATM,HGNC:795,ataxia telangiectasia,MONDO:0008840,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_02a69e27-77dc-41bd-83d2-dda9c224ee43-2021-07-27T205239.729Z,2021-07-27T20:52:39.729Z,Hereditary Cancer
BAP1,HGNC:950,BAP1-related tumor predisposition syndrome,MONDO:0013692,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d70c33af-2e4f-4489-9c29-797655015b1d-2019-03-21T175713.803Z,2019-03-21T17:57:13.803Z,Hereditary Cancer
BLM,HGNC:1058,Bloom syndrome,MONDO:0008876,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e0a20b67-5a62-462c-894b-76b60a66e979-2019-04-19T160000.000Z,2019-04-19T16:00:00.000Z,Hereditary Cancer
BMPR1A,HGNC:1076,juvenile polyposis syndrome,MONDO:0017380,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7004b10e-0eb6-4517-8deb-2d4b7264d2f8-2022-12-30T180000.000Z,2022-12-30T18:00:00.000Z,Hereditary Cancer
BRCA1,HGNC:1100,"Fanconi anemia, complementation group S",MONDO:0054748,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aa39798d-9b6e-430d-8bc1-2a01f81f1f72-2020-05-14T003137.538Z,2020-05-14T00:31:37.538Z,Hereditary Cancer
BRCA2,HGNC:1101,Fanconi anemia complementation group D1,MONDO:0011584,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_48faf04b-ffc4-4163-8570-22f5c29c4064-2019-04-19T160000.000Z,2019-04-19T16:00:00.000Z,Hereditary Cancer
BRIP1,HGNC:20473,Fanconi anemia complementation group J,MONDO:0012187,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_40aae4ea-8c9b-42a7-9d02-0f52a184712f-2019-08-18T160442.255Z,2019-08-18T16:04:42.255Z,Hereditary Cancer
BUB1B,HGNC:1149,mosaic variegated aneuploidy syndrome 1,MONDO:0009759,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_59147f27-d5a3-4760-ba8d-0429bae3c906-2019-11-22T145326.352Z,2019-11-22T14:53:26.352Z,Hereditary Cancer
CDC73,HGNC:16783,hyperparathyroidism 2 with jaw tumors,MONDO:0007768,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a5bd498b-dc86-4f2d-a51b-48baf7017a02-2019-04-19T160000.000Z,2019-04-19T16:00:00.000Z,Hereditary Cancer
CDH1,HGNC:1748,hereditary diffuse gastric adenocarcinoma,MONDO:0007648,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14223ff7-e6b0-4c60-bee6-df55301d2017-2019-04-19T160000.000Z,2019-04-19T16:00:00.000Z,Hereditary Cancer
CDK4,HGNC:1773,"melanoma, cutaneous malignant, susceptibility to, 3",MONDO:0012183,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca76579b-1432-4edc-84e8-b3332dce4ede-2020-01-13T194434.667Z,2020-01-13T19:44:34.667Z,Hereditary Cancer
CDKN1B,HGNC:1785,multiple endocrine neoplasia type 4,MONDO:0012552,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b07f8882-dd5e-4831-9926-f8b4c2a8c265-2018-12-21T154854.477Z,2018-12-21T15:48:54.477Z,Hereditary Cancer
CDKN2A,HGNC:1787,melanoma-pancreatic cancer syndrome,MONDO:0011713,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0c0d2fc0-12b2-4855-b537-60394d0987dd-2019-08-14T194547.089Z,2019-08-14T19:45:47.089Z,Hereditary Cancer
CEBPA,HGNC:1833,acute myeloid leukemia,MONDO:0018874,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4234367e-149b-4f13-9243-341396fb4ccf-2019-08-18T155916.225Z,2019-08-18T15:59:16.225Z,Hereditary Cancer
CEP57,HGNC:30794,mosaic variegated aneuploidy syndrome 2,MONDO:0013582,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c44921de-14cf-4907-8bef-1525329ee89c-2019-11-22T145303.972Z,2019-11-22T14:53:03.972Z,Hereditary Cancer
COL7A1,HGNC:2214,recessive dystrophic epidermolysis bullosa,MONDO:0009179,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_940fac3e-2586-4d49-a6f3-db12e865cc65-2022-06-20T170000.000Z,2022-06-20T17:00:00.000Z,Hereditary Cancer
CYLD,HGNC:2584,Brooke-Spiegler syndrome,MONDO:0011512,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_434ddb72-ee88-47af-9fa2-8dee9fa0a388-2019-04-19T160000.000Z,2019-04-19T16:00:00.000Z,Hereditary Cancer
DDB2,HGNC:2718,xeroderma pigmentosum group E,MONDO:0010213,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cf2a4254-51ec-467a-9194-3962d39a6b20-2019-04-19T160000.000Z,2019-04-19T16:00:00.000Z,Hereditary Cancer
DDX41,HGNC:18674,DDX41-related hematologic malignancy predisposition syndrome,MONDO:0014809,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e3db8214-a39d-408d-a3c2-7b4e817b1cc1-2020-07-30T202935.621Z,2020-07-30T20:29:35.621Z,Hereditary Cancer
DIS3L2,HGNC:28648,Perlman syndrome,MONDO:0009965,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e68b93df-e0e7-4d46-8934-8b86064c0b37-2019-11-21T193052.781Z,2019-11-21T19:30:52.781Z,Hereditary Cancer
DKC1,HGNC:2890,"dyskeratosis congenita, X-linked",MONDO:0010584,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bb90bea1-16e7-44da-8551-91fb5fd7088a-2021-06-15T234140.163Z,2021-06-15T23:41:40.163Z,Hereditary Cancer
EGFR,HGNC:3236,non-small cell lung carcinoma,MONDO:0005233,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_49342c73-96d7-45ba-9c90-d2d5e5710636-2020-07-30T202207.418Z,2020-07-30T20:22:07.418Z,Hereditary Cancer
ELANE,HGNC:3309,neutropenia,MONDO:0001475,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_259c43d2-b114-43bd-9e4e-a7beeb644323-2020-05-14T000924.456Z,2020-05-14T00:09:24.456Z,Hereditary Cancer
ENG,HGNC:3349,juvenile polyposis syndrome,MONDO:0017380,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_08c5b377-a2a1-44ac-9b7e-dc2141ee7a04-2022-12-30T180000.000Z,2022-12-30T18:00:00.000Z,Hereditary Cancer
EPCAM,HGNC:11529,Lynch syndrome,MONDO:0005835,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3c071c7e-ba5c-46c7-b46b-fee6acf3a43f-2022-06-20T170000.000Z,2022-06-20T17:00:00.000Z,Hereditary Cancer
ERCC2,HGNC:3434,xeroderma pigmentosum group D,MONDO:0010212,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_91d0c244-d958-4358-8b92-cefefbce3843-2019-04-19T160000.000Z,2019-04-19T16:00:00.000Z,Hereditary Cancer
ERCC3,HGNC:3435,xeroderma pigmentosum group B,MONDO:0012531,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bf09deab-9612-4b13-8bb7-4c2a25dde868-2019-04-19T160000.000Z,2019-04-19T16:00:00.000Z,Hereditary Cancer
ERCC4,HGNC:3436,xeroderma pigmentosum group F,MONDO:0010215,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_89544dc5-2d3b-4b7f-b835-3fec714bf7a5-2019-08-14T194406.189Z,2019-08-14T19:44:06.189Z,Hereditary Cancer
ERCC5,HGNC:3437,xeroderma pigmentosum group G,MONDO:0010216,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fc08c954-8ded-449b-8f67-e4f044b26cda-2019-04-19T160000.000Z,2019-04-19T16:00:00.000Z,Hereditary Cancer
EXT1,HGNC:3512,"exostoses, multiple, type 1",MONDO:0007585,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0ced1387-c0a8-4f03-bd70-1595cb7683fd-2018-06-04T170000.000Z,2018-06-04T17:00:00.000Z,Hereditary Cancer
EXT2,HGNC:3513,"exostoses, multiple, type 2",MONDO:0007586,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9e6829ce-3e0b-44c5-a214-756f33b1e948-2018-12-21T153126.680Z,2018-12-21T15:31:26.680Z,Hereditary Cancer
FANCA,HGNC:3582,Fanconi anemia complementation group A,MONDO:0009215,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ceecf6ee-6700-40e5-a0d3-f7891805daac-2019-04-19T160000.000Z,2019-04-19T16:00:00.000Z,Hereditary Cancer
FANCB,HGNC:3583,Fanconi anemia complementation group B,MONDO:0010351,XL,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eb559b04-602e-42cc-aad3-ce634c145c26-2022-12-30T180000.000Z,2022-12-30T18:00:00.000Z,Hereditary Cancer
FANCC,HGNC:3584,Fanconi anemia complementation group C,MONDO:0009213,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cf4881c3-15b3-4e10-bd24-2da80433863b-2019-04-19T160000.000Z,2019-04-19T16:00:00.000Z,Hereditary Cancer
FANCD2,HGNC:3585,Fanconi anemia complementation group D2,MONDO:0009214,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5f0c260f-52d2-4225-9044-608f066ccfb2-2021-06-15T231506.767Z,2021-06-15T23:15:06.767Z,Hereditary Cancer
FANCE,HGNC:3586,Fanconi anemia complementation group E,MONDO:0010953,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6da55a6e-2cf8-499c-b842-b5a435dbff3f-2020-05-14T001745.604Z,2020-05-14T00:17:45.604Z,Hereditary Cancer
FANCF,HGNC:3587,Fanconi anemia complementation group F,MONDO:0011325,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_60719ed8-36fa-4d11-93b2-8036133510a6-2021-02-03T225456.822Z,2021-02-03T22:54:56.822Z,Hereditary Cancer
FANCG,HGNC:3588,Fanconi anemia complementation group G,MONDO:0013565,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1913bd10-1355-4067-93b6-9068924d77df-2019-04-19T160000.000Z,2019-04-19T16:00:00.000Z,Hereditary Cancer
FANCI,HGNC:25568,Fanconi anemia complementation group I,MONDO:0012186,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a103db2f-a8b3-403b-993a-ac4215c118df-2021-06-15T233841.081Z,2021-06-15T23:38:41.081Z,Hereditary Cancer
FANCL,HGNC:20748,Fanconi anemia complementation group L,MONDO:0013566,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_93d0cb5f-4859-4b28-b647-3f8226fe5921-2020-07-30T203845.671Z,2020-07-30T20:38:45.671Z,Hereditary Cancer
FH,HGNC:3700,hereditary leiomyomatosis and renal cell cancer,MONDO:0007888,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_59e42ccd-2b0b-441c-8529-6eb1e9dde330-2020-05-14T002334.007Z,2020-05-14T00:23:34.007Z,Hereditary Cancer
FLCN,HGNC:27310,Birt-Hogg-Dube syndrome,MONDO:0007607,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c96620e8-f9c9-41a0-a979-31fb9928abb6-2019-04-19T160000.000Z,2019-04-19T16:00:00.000Z,Hereditary Cancer
GATA2,HGNC:4171,GATA2 deficiency with susceptibility to MDS/AML,MONDO:0042982,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7c0449f7-e20b-4610-95ad-896eee265492-2022-12-30T180000.000Z,2022-12-30T18:00:00.000Z,Hereditary Cancer
GREM1,HGNC:2001,hereditary mixed polyposis syndrome,MONDO:0011023,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9e702a1e-b700-4364-bf4b-9ad0d05af89f-2022-06-20T170000.000Z,2022-06-20T17:00:00.000Z,Hereditary Cancer
ITK,HGNC:6171,lymphoproliferative syndrome 1,MONDO:0013081,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_63552229-5e8c-4a94-b428-ec9a56a0aa5f-2019-11-21T193148.945Z,2019-11-21T19:31:48.945Z,Hereditary Cancer
KIT,HGNC:6342,gastrointestinal stromal tumor,MONDO:0011719,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fa076c63-8ffe-46ff-ba44-255a6fca07e5-2020-01-14T184619.396Z,2020-01-14T18:46:19.396Z,Hereditary Cancer
MAX,HGNC:6913,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f3ae9a06-6429-4b4b-b008-e1454511d5be-2021-06-16T144632.357Z,2021-06-16T14:46:32.357Z,Hereditary Cancer
MEN1,HGNC:7010,multiple endocrine neoplasia type 1,MONDO:0007540,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a40ef20e-115c-4667-b4a2-6c7c8fb07a49-2020-05-13T170000.000Z,2020-05-13T17:00:00.000Z,Hereditary Cancer
MET,HGNC:7029,papillary renal cell carcinoma,MONDO:0017884,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a71d9990-7202-487a-b7a3-4e659e0be73c-2018-10-11T184745.818Z,2018-10-11T18:47:45.818Z,Hereditary Cancer
MLH1,HGNC:7127,Lynch syndrome,MONDO:0005835,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_24c5d3f4-2bb6-4beb-a781-52bd6962ca41-2022-06-20T170000.000Z,2022-06-20T17:00:00.000Z,Hereditary Cancer
MLH1,HGNC:7127,mismatch repair cancer syndrome 1,MONDO:0010159,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a313ad2e-5c2a-4bb4-bed4-3b4f9b5095df-2018-10-09T150623.105Z,2018-10-09T15:06:23.105Z,Hereditary Cancer
MLH3,HGNC:7128,"colorectal cancer, hereditary nonpolyposis, type 7",MONDO:0013725,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4fa28f74-c7c8-40f3-908f-63b74bea9d94-2022-06-20T170000.000Z,2022-06-20T17:00:00.000Z,Hereditary Cancer
MSH2,HGNC:7325,Lynch syndrome,MONDO:0005835,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0f3acd9a-e2e5-498a-8974-399969ffa2d1-2022-06-20T170000.000Z,2022-06-20T17:00:00.000Z,Hereditary Cancer
MSH2,HGNC:7325,mismatch repair cancer syndrome 1,MONDO:0010159,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7ce2b2b9-9b04-4a47-b6fa-b85c60ba1c08-2018-10-09T144400.302Z,2018-10-09T14:44:00.302Z,Hereditary Cancer
MSH3,HGNC:7326,MSH3-related attenuated familial adenomatous polyposis,MONDO:0018812,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ec777aa-af6a-4cc6-ace1-b22e4b493457-2022-06-20T170000.000Z,2022-06-20T17:00:00.000Z,Hereditary Cancer
MSH6,HGNC:7329,mismatch repair cancer syndrome 1,MONDO:0010159,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b7d02927-ac93-4a43-a86d-01cd381f4e9f-2018-10-09T145726.378Z,2018-10-09T14:57:26.378Z,Hereditary Cancer
MTAP,HGNC:7413,diaphyseal medullary stenosis-bone malignancy syndrome,MONDO:0007205,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3c2243ec-a10f-4aab-aaf9-99153d805455-2021-06-15T232951.915Z,2021-06-15T23:29:51.915Z,Hereditary Cancer
MUTYH,HGNC:7527,familial adenomatous polyposis 2,MONDO:0012041,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4330fde4-0116-4781-a5ac-40c387a0b41f-2022-06-20T170000.000Z,2022-06-20T17:00:00.000Z,Hereditary Cancer
NBN,HGNC:7652,Nijmegen breakage syndrome,MONDO:0009623,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_de6fa1fe-a86e-4f0d-8da8-7690debe9aec-2022-06-21T170000.000Z,2022-06-21T17:00:00.000Z,Hereditary Cancer
NTHL1,HGNC:8028,NTHL1-deficiency tumor predisposition syndrome,MONDO:0100502,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7a612b05-25f2-4e60-90a5-70ad6363c1fc-2022-12-30T180000.000Z,2022-12-30T18:00:00.000Z,Hereditary Cancer
PALB2,HGNC:26144,Fanconi anemia complementation group N,MONDO:0012565,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ebabbf1-1a43-4a57-b0b8-2b29bb57ade1-2019-08-18T160312.829Z,2019-08-18T16:03:12.829Z,Hereditary Cancer
PDGFRA,HGNC:8803,gastrointestinal stromal tumor,MONDO:0011719,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_08bbf13f-bc04-47a7-a3c5-1ec6abfc9190-2020-01-13T195509.878Z,2020-01-13T19:55:09.878Z,Hereditary Cancer
PHOX2B,HGNC:9143,Haddad syndrome,MONDO:0020493,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_07133a39-00fb-43c4-a7e2-a465c3c0c4ca-2021-06-15T152906.892Z,2021-06-15T15:29:06.892Z,Hereditary Cancer
PHOX2B,HGNC:9143,"central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease",MONDO:0800026,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5ed68efa-cafc-4e28-ab56-ab9b65666c15-2022-12-30T180000.000Z,2022-12-30T18:00:00.000Z,Hereditary Cancer
PMS2,HGNC:9122,Lynch syndrome,MONDO:0005835,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_213ba61e-a4a5-4e4f-945d-f0fef691a9ba-2022-12-30T180000.000Z,2022-12-30T18:00:00.000Z,Hereditary Cancer
PMS2,HGNC:9122,mismatch repair cancer syndrome 1,MONDO:0010159,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_38bc9d1d-a436-4f21-9952-bd5e7790a797-2022-12-30T180000.000Z,2022-12-30T18:00:00.000Z,Hereditary Cancer
POLH,HGNC:9181,xeroderma pigmentosum variant type,MONDO:0010214,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bdb29404-0c05-4519-b6ee-8591368ad1ff-2018-11-02T215846.146Z,2018-11-02T21:58:46.146Z,Hereditary Cancer
PRKAR1A,HGNC:9388,"Carney complex, type 1",MONDO:0008057,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fc16b2a9-c8dc-4a04-a029-2f6af049404d-2018-12-21T154044.801Z,2018-12-21T15:40:44.801Z,Hereditary Cancer
PRSS1,HGNC:9475,hereditary chronic pancreatitis,MONDO:0008185,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d271c52b-b0bb-4e9b-a745-ea03dc716fa0-2020-07-30T205014.833Z,2020-07-30T20:50:14.833Z,Hereditary Cancer
PTCH1,HGNC:9585,nevoid basal cell carcinoma syndrome,MONDO:0007187,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2a3f55f5-e39b-4571-a41f-e46ddb8e298d-2018-06-04T170000.000Z,2018-06-04T17:00:00.000Z,Hereditary Cancer
PTCH2,HGNC:9586,nevoid basal cell carcinoma syndrome,MONDO:0007187,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d189ca00-ba80-49af-9b2e-8523c8d29a44-2018-10-12T213908.660Z,2018-10-12T21:39:08.660Z,Hereditary Cancer
PTPRJ,HGNC:9673,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_051bd795-fea1-4d6d-8947-348b7f0be80a-2018-10-12T210742.630Z,2018-10-12T21:07:42.630Z,Hereditary Cancer
RB1,HGNC:9884,retinoblastoma,MONDO:0008380,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f8c79621-7ace-4c0c-874e-a315a2e6c872-2020-07-30T213929.219Z,2020-07-30T21:39:29.219Z,Hereditary Cancer
RECQL4,HGNC:9949,Rothmund-Thomson syndrome,MONDO:0010002,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dbf00cfa-ac36-4eb0-94c4-69b05014e0f6-2018-10-11T170000.000Z,2018-10-11T17:00:00.000Z,Hereditary Cancer
RET,HGNC:9967,multiple endocrine neoplasia type 2B,MONDO:0008082,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e4425f0-0900-43c3-aac4-5b37554be386-2020-05-14T010345.543Z,2020-05-14T01:03:45.543Z,Hereditary Cancer
RET,HGNC:9967,multiple endocrine neoplasia type 2A,MONDO:0008234,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c5f3c875-2438-4bfe-b785-b86d7d3e6507-2020-05-14T005952.060Z,2020-05-14T00:59:52.060Z,Hereditary Cancer
RHBDF2,HGNC:20788,palmoplantar keratoderma-esophageal carcinoma syndrome,MONDO:0007856,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b7e72765-1a53-44fb-bfee-9e5923507bbe-2020-07-30T212232.808Z,2020-07-30T21:22:32.808Z,Hereditary Cancer
RNF43,HGNC:18505,sessile serrated polyposis cancer syndrome,MONDO:0014919,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9abf2a1d-21a7-4ef7-99c7-b0b37d5acf38-2022-12-30T180000.000Z,2022-12-30T18:00:00.000Z,Hereditary Cancer
RUNX1,HGNC:10471,hereditary thrombocytopenia and hematologic cancer predisposition syndrome,MONDO:0011071,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_06aed341-58db-459b-a750-7142e29b420b-2018-06-04T170000.000Z,2018-06-04T17:00:00.000Z,Hereditary Cancer
SBDS,HGNC:19440,Shwachman-Diamond syndrome,MONDO:0009833,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7c2a84f0-e42d-487f-a2af-5b536a30d30c-2020-07-30T210401.699Z,2020-07-30T21:04:01.699Z,Hereditary Cancer
SDHA,HGNC:10680,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4833b4b4-071c-4062-9007-8b0f6896a54e-2021-06-17T011716.456Z,2021-06-17T01:17:16.456Z,Hereditary Cancer
SDHAF2,HGNC:26034,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f70f16ee-a8b5-4f81-bd98-270fda25ffa4-2021-06-17T020032.120Z,2021-06-17T02:00:32.120Z,Hereditary Cancer
SDHB,HGNC:10681,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5b8852d-1641-4c45-8aa2-57c2dfbac4ea-2021-06-17T012105.373Z,2021-06-17T01:21:05.373Z,Hereditary Cancer
SDHC,HGNC:10682,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8c6e49d4-8117-4fc2-88cd-aad0017ce2c4-2021-06-17T013125.314Z,2021-06-17T01:31:25.314Z,Hereditary Cancer
SDHD,HGNC:10683,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9d0b732e-81e4-4834-8fe6-fe71f694399e-2021-06-17T015316.638Z,2021-06-17T01:53:16.638Z,Hereditary Cancer
SMARCA4,HGNC:11100,rhabdoid tumor predisposition syndrome 2,MONDO:0013224,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e5edb191-f515-47a3-b1d8-cc723eaef665-2018-06-29T160000.000Z,2018-06-29T16:00:00.000Z,Hereditary Cancer
SMARCB1,HGNC:11103,rhabdoid tumor predisposition syndrome 1,MONDO:0012252,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8d7390e7-0bb1-4ba1-b97e-7f666b52c86b-2018-10-12T205953.762Z,2018-10-12T20:59:53.762Z,Hereditary Cancer
SMARCE1,HGNC:11109,familial meningioma,MONDO:0011789,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_01e68b67-987e-48ec-a167-cb659cc245e9-2020-07-30T211630.144Z,2020-07-30T21:16:30.144Z,Hereditary Cancer
SUFU,HGNC:16466,medulloblastoma,MONDO:0007959,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1408d8b1-015c-48b3-a28e-d99b5545fce8-2018-10-11T184215.077Z,2018-10-11T18:42:15.077Z,Hereditary Cancer
TERT,HGNC:11730,"dyskeratosis congenita, autosomal dominant 2",MONDO:0013521,SD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_afb6ea76-e8ac-4a38-b42c-23fc18a9623b-2020-07-30T205843.081Z,2020-07-30T20:58:43.081Z,Hereditary Cancer
TGFBR1,HGNC:11772,multiple self-healing squamous epithelioma,MONDO:0007566,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_570947a0-3e45-419c-bc22-0fdc60ca6009-2019-12-20T212550.834Z,2019-12-20T21:25:50.834Z,Hereditary Cancer
TMEM127,HGNC:26038,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9b965b4e-c909-41da-995b-cdc2af9b3183-2021-06-16T143347.758Z,2021-06-16T14:33:47.758Z,Hereditary Cancer
TP53,HGNC:11998,Li-Fraumeni syndrome 1,MONDO:0007903,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_78494aba-bb52-4b33-bf1d-ebbb5374df4b-2020-05-14T005523.974Z,2020-05-14T00:55:23.974Z,Hereditary Cancer
VHL,HGNC:12687,von Hippel-Lindau disease,MONDO:0008667,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_30c04ced-b74d-465a-8d7d-eb822109b7f1-2020-05-14T004116.004Z,2020-05-14T00:41:16.004Z,Hereditary Cancer
WAS,HGNC:12731,Wiskott-Aldrich syndrome,MONDO:0010518,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a936b3ba-f1d0-4f14-bd56-14f64ad4de3a-2018-10-12T205425.459Z,2018-10-12T20:54:25.459Z,Hereditary Cancer
WRN,HGNC:12791,Werner syndrome,MONDO:0010196,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d9c04f29-bc94-40c5-95d7-d25d21cd387f-2018-10-09T170000.000Z,2018-10-09T17:00:00.000Z,Hereditary Cancer
WT1,HGNC:12796,Wilms tumor 1,MONDO:0008679,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_65010002-ff97-4dc0-a89f-6c77abf0982a-2020-07-30T205501.047Z,2020-07-30T20:55:01.047Z,Hereditary Cancer
WT1,HGNC:12796,Denys-Drash syndrome,MONDO:0008682,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cccc7a42-a49c-4a8d-8b9e-f16b81e9ee07-2021-07-27T210557.993Z,2021-07-27T21:05:57.993Z,Hereditary Cancer
XPA,HGNC:12814,xeroderma pigmentosum group A,MONDO:0010210,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5cd298eb-1e1a-4283-851e-2dd24059ba22-2018-11-02T213651.734Z,2018-11-02T21:36:51.734Z,Hereditary Cancer
XPC,HGNC:12816,xeroderma pigmentosum group C,MONDO:0010211,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8352d38c-7fb3-4a82-8f8b-7cd08fded1f4-2018-11-02T214221.860Z,2018-11-02T21:42:21.860Z,Hereditary Cancer
ALPK3,HGNC:17574,hypertrophic cardiomyopathy,MONDO:0005045,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6312d79f-df12-4ec6-8ce6-0f38f19e617d-2022-02-09T170000.000Z,2022-02-09T17:00:00.000Z,Hereditary Cardiovascular Disease
CACNB2,HGNC:1402,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e7a08ba4-6024-449c-b824-c762a85277a1-2022-04-13T160000.000Z,2022-04-13T16:00:00.000Z,Hereditary Cardiovascular Disease
CASQ2,HGNC:1513,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_07177c89-7845-4df5-ba3e-bdd415b5c8b3-2022-05-10T160000.000Z,2022-05-10T16:00:00.000Z,Hereditary Cardiovascular Disease
DSP,HGNC:3052,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_83a9ea83-5dec-4496-a5d8-9b5fdf9373d7-2022-06-22T160000.000Z,2022-06-22T16:00:00.000Z,Hereditary Cardiovascular Disease
KCNQ1,HGNC:6294,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5b44eee3-56ea-4596-8d3e-e4d5c0ad8d60-2022-05-09T160000.000Z,2022-05-09T16:00:00.000Z,Hereditary Cardiovascular Disease
KLF10,HGNC:11810,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_524bb91c-07d4-4f65-bdc0-fc568a5930c8-2022-09-14T160000.000Z,2022-09-14T16:00:00.000Z,Hereditary Cardiovascular Disease
MYBPC3,HGNC:7551,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7e65896e-33f5-439d-8749-aba08a539dd0-2021-10-07T160000.000Z,2021-10-07T16:00:00.000Z,Hereditary Cardiovascular Disease
MYOZ2,HGNC:1330,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d74395ba-66ee-43c6-8d3c-c353bd8e5e82-2022-10-27T160000.000Z,2022-10-27T16:00:00.000Z,Hereditary Cardiovascular Disease
OBSCN,HGNC:15719,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_94265ca9-cf6a-468e-b12c-6ea173d09e51-2022-06-22T160000.000Z,2022-06-22T16:00:00.000Z,Hereditary Cardiovascular Disease
TCAP,HGNC:11610,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c35abc20-c04c-49ec-af02-1bd270b0b50b-2022-09-14T160000.000Z,2022-09-14T16:00:00.000Z,Hereditary Cardiovascular Disease
ACTA2,HGNC:130,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8249,2016-09-27T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
BGN,HGNC:1044,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8260,2016-12-22T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
COL9A1,HGNC:2217,Stickler syndrome,MONDO:0019354,AR,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9807,2018-03-26T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
EFEMP2,HGNC:3219,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AR,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8267,2016-12-22T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
FBN1,HGNC:3603,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8251,2017-01-23T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
FBN2,HGNC:3604,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8268,2016-12-22T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
FLNA,HGNC:3754,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,XL,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8274,2016-12-22T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
FOXE3,HGNC:3808,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8261,2016-06-15T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
HCN4,HGNC:16882,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8262,2016-12-22T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
LOX,HGNC:6664,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8258,2016-07-25T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
MAT2A,HGNC:6904,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8263,2016-07-03T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
MFAP5,HGNC:29673,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8264,2016-12-22T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
MYH11,HGNC:7569,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8252,2016-07-03T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
MYLK,HGNC:7590,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8257,2016-12-18T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
NOTCH1,HGNC:7881,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8269,2016-04-06T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
PRKG1,HGNC:9414,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8259,2016-12-22T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
SLC2A10,HGNC:13444,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8270,2016-04-17T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
SMAD2,HGNC:6768,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8265,2017-04-10T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
SMAD3,HGNC:6769,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8253,2016-12-22T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
TGFB2,HGNC:11768,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8254,2016-05-06T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
TGFB3,HGNC:11769,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8266,2016-12-22T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
TGFBR1,HGNC:11772,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8255,2016-10-12T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
TGFBR2,HGNC:11773,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8256,2016-02-15T00:00:00,Heritable Thoracic Aortic Aneurysm and Dissection
ACTA1,HGNC:129,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f2459efe-385d-4056-b7e3-3a4a0c0d5edd-2020-05-01T124447.908Z,2020-05-01T12:44:47.908Z,Hypertrophic Cardiomyopathy
ACTC1,HGNC:143,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2f62793b-0015-46eb-bb51-bddbae25ba0d-2021-06-23T201616.296Z,2021-06-23T20:16:16.296Z,Hypertrophic Cardiomyopathy
ACTN2,HGNC:164,intrinsic cardiomyopathy,MONDO:0000591,AD,SOP5,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6710e329-d391-4355-85a5-02d03f8791a3-2018-08-06T131255.615Z,2018-08-06T13:12:55.615Z,Hypertrophic Cardiomyopathy
ANKRD1,HGNC:15819,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10043,2017-09-18T00:00:00,Hypertrophic Cardiomyopathy
ANKRD1,HGNC:15819,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8f241e6c-2fc8-4f23-b976-3b79d90fad3e-2020-05-01T125214.646Z,2020-05-01T12:52:14.646Z,Hypertrophic Cardiomyopathy
CALR3,HGNC:20407,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fd8036e5-bf01-4b89-b4fc-94080d835d99-2018-08-06T131427.771Z,2018-08-06T13:14:27.771Z,Hypertrophic Cardiomyopathy
CSRP3,HGNC:2472,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP5,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_130d778f-f756-4f3d-b6b2-909e40836c5a-2017-12-19T170000.000Z,2017-12-19T17:00:00.000Z,Hypertrophic Cardiomyopathy
FLNC,HGNC:3756,myofibrillar myopathy 5,MONDO:0012289,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10057,2017-12-12T16:00:00,Hypertrophic Cardiomyopathy
FXN,HGNC:3951,Friedreich ataxia,MONDO:0100339,AR,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec3f674b-1e71-4254-a0f9-f8909becff59-2017-12-22T170000.000Z,2017-12-22T17:00:00.000Z,Hypertrophic Cardiomyopathy
JPH2,HGNC:14202,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP5,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_378a727d-0c5b-4563-9c96-ac18a2902742-2017-07-18T160000.000Z,2017-07-18T16:00:00.000Z,Hypertrophic Cardiomyopathy
LAMP2,HGNC:6501,Danon disease,MONDO:0010281,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1f0d4050-f510-438d-a477-0a12669945d8-2017-10-11T040000.000Z,2017-10-11T04:00:00.000Z,Hypertrophic Cardiomyopathy
MYH6,HGNC:7576,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10074,2017-11-01T00:00:00,Hypertrophic Cardiomyopathy
MYH7,HGNC:7577,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_31325c90-05cb-4db0-9372-e4f705cd5c82-2021-03-16T004905.482Z,2021-03-16T00:49:05.482Z,Hypertrophic Cardiomyopathy
MYL2,HGNC:7583,hypertrophic cardiomyopathy 10,MONDO:0012112,AD,SOP4,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8768,2017-02-07T16:00:00,Hypertrophic Cardiomyopathy
MYL2,HGNC:7583,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7b25ff6c-3ede-46a3-a637-3eab7aa18569-2021-07-13T154913.625Z,2021-07-13T15:49:13.625Z,Hypertrophic Cardiomyopathy
MYL3,HGNC:7584,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d74b9d56-4f2a-4479-8913-1d96ddc28592-2021-06-07T145050.605Z,2021-06-07T14:50:50.605Z,Hypertrophic Cardiomyopathy
MYLK2,HGNC:16243,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6f0f41e3-7b5b-477c-b45d-598b5f8f3df0-2017-04-17T160000.000Z,2017-04-17T16:00:00.000Z,Hypertrophic Cardiomyopathy
MYOM1,HGNC:7613,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8ff00fbf-6b20-49cd-8af8-0f6404240db5-2017-07-20T040000.000Z,2017-07-20T04:00:00.000Z,Hypertrophic Cardiomyopathy
MYPN,HGNC:23246,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d992d892-856b-4f25-bab1-997f6493018c-2020-05-01T133957.037Z,2020-05-01T13:39:57.037Z,Hypertrophic Cardiomyopathy
NEXN,HGNC:29557,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9456bdef-7708-45b2-a698-c897167d7f5b-2016-10-28T160000.000Z,2016-10-28T16:00:00.000Z,Hypertrophic Cardiomyopathy
PDLIM3,HGNC:20767,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_76cba060-8080-42b1-b9ea-2193fea658b0-2016-11-01T040000.000Z,2016-11-01T04:00:00.000Z,Hypertrophic Cardiomyopathy
PLN,HGNC:9080,intrinsic cardiomyopathy,MONDO:0000591,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f49f65fb-a2df-4e86-9a89-da2325b207c8-2021-02-12T170000.000Z,2021-02-12T17:00:00.000Z,Hypertrophic Cardiomyopathy
PRKAG2,HGNC:9386,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10051,2017-01-30T00:00:00,Hypertrophic Cardiomyopathy
RYR2,HGNC:10484,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ac9dd09-674f-4d67-94da-234ffb4e5070-2019-07-19T160000.000Z,2019-07-19T16:00:00.000Z,Hypertrophic Cardiomyopathy
SLC25A4,HGNC:10990,"mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive",MONDO:0014175,AR,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10062,2017-08-30T00:00:00,Hypertrophic Cardiomyopathy
TMPO,HGNC:11875,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP5,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1e1bb21-c617-4aac-b9d8-1c2054d76c55-2017-04-04T040000.000Z,2017-04-04T04:00:00.000Z,Hypertrophic Cardiomyopathy
TNNC1,HGNC:11943,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP5,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5d832673-8acb-4a02-ae34-35e0d9981b70-2016-11-01T160000.000Z,2016-11-01T16:00:00.000Z,Hypertrophic Cardiomyopathy
TNNC2,HGNC:11944,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP5,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8760,2017-04-04T00:00:00,Hypertrophic Cardiomyopathy
TNNI3,HGNC:11947,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4a7e6901-d478-44c4-bd03-2c344029d4bb-2017-09-05T160000.000Z,2017-09-05T16:00:00.000Z,Hypertrophic Cardiomyopathy
TNNT2,HGNC:11949,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ef922dc4-4e41-422b-ac3d-605fea375005-2021-02-04T170000.000Z,2021-02-04T17:00:00.000Z,Hypertrophic Cardiomyopathy
TPM1,HGNC:12010,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_8771,2016-12-20T16:00:00,Hypertrophic Cardiomyopathy
TRIM63,HGNC:16007,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d9f35d3c-2d30-4947-9d10-87d21405586e-2016-12-20T050000.000Z,2016-12-20T05:00:00.000Z,Hypertrophic Cardiomyopathy
TTN,HGNC:12403,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10077,2017-12-14T00:00:00,Hypertrophic Cardiomyopathy
TTN,HGNC:12403,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c17e22eb-c6fc-487d-bcf6-001bb85fdabd-2016-12-12T170000.000Z,2016-12-12T17:00:00.000Z,Hypertrophic Cardiomyopathy
TTR,HGNC:12405,hereditary ATTR amyloidosis,MONDO:0017132,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8a189cf4-767c-405c-80dc-4aa1727f6f73-2017-12-11T050000.000Z,2017-12-11T05:00:00.000Z,Hypertrophic Cardiomyopathy
VCL,HGNC:12665,hypertrophic cardiomyopathy,MONDO:0005045,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_27365fd2-1203-4e2b-8830-3277e965d8bc-2021-06-17T142636.354Z,2021-06-17T14:26:36.354Z,Hypertrophic Cardiomyopathy
ACSL4,HGNC:3571,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP5,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9507,2017-10-20T00:00:00,Intellectual Disability and Autism
ADNP,HGNC:15766,ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder,MONDO:0014379,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_837200e1-ed55-415b-bd9e-6649e4abab1d-2020-01-15T170000.000Z,2020-01-15T17:00:00.000Z,Intellectual Disability and Autism
ADSL,HGNC:291,adenylosuccinate lyase deficiency,MONDO:0007068,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d282f565-84e4-4a47-9acc-77ee31bbe9f6-2020-09-07T160000.000Z,2020-09-07T16:00:00.000Z,Intellectual Disability and Autism
AFF2,HGNC:3776,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ab4216e3-61b7-4542-ad3a-8788a7ef8b63-2017-10-20T040000.000Z,2017-10-20T04:00:00.000Z,Intellectual Disability and Autism
AGTR2,HGNC:338,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d7cfa2a0-e6a7-49b8-a773-b32a1dfbcd57-2020-06-02T160000.000Z,2020-06-02T16:00:00.000Z,Intellectual Disability and Autism
AHDC1,HGNC:25230,AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome,MONDO:0014358,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_59a6c010-95ac-4813-9cf4-5ff60fa5c7e9-2021-11-16T170000.000Z,2021-11-16T17:00:00.000Z,Intellectual Disability and Autism
ALDH5A1,HGNC:408,succinic semialdehyde dehydrogenase deficiency,MONDO:0010083,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c3e57466-df2f-4045-b374-010dbd334bfc-2021-04-27T160000.000Z,2021-04-27T16:00:00.000Z,Intellectual Disability and Autism
ALG6,HGNC:23157,ALG6-congenital disorder of glycosylation 1C,MONDO:0011291,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8a243ba1-c323-4fde-a7d2-74892c6ab367-2022-11-11T190000.000Z,2022-11-11T19:00:00.000Z,Intellectual Disability and Autism
ANK2,HGNC:493,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_097e646b-467f-4c08-95d6-958ed324562b-2020-12-15T175241.108Z,2020-12-15T17:52:41.108Z,Intellectual Disability and Autism
ANK3,HGNC:494,intellectual disability,MONDO:0001071,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_668a89e3-477d-434c-8ab4-0bc9ec3504de-2020-10-07T160000.000Z,2020-10-07T16:00:00.000Z,Intellectual Disability and Autism
ANKRD11,HGNC:21316,KBG syndrome,MONDO:0007846,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cf3e887e-8da4-45ea-bec8-9565f8246bc9-2019-11-26T170000.000Z,2019-11-26T17:00:00.000Z,Intellectual Disability and Autism
AP1S2,HGNC:560,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9caaaacd-e262-421c-826b-8433848721ff-2017-10-20T160000.000Z,2017-10-20T16:00:00.000Z,Intellectual Disability and Autism
AP4B1,HGNC:572,AP-4 deficiency syndrome,MONDO:0100176,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4436344a-e0da-4c42-b06a-cdf8a2581ce5-2021-07-26T160000.000Z,2021-07-26T16:00:00.000Z,Intellectual Disability and Autism
AP4E1,HGNC:573,AP-4 deficiency syndrome,MONDO:0100176,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_be93d2e7-f302-41a7-9675-032510e46ad2-2021-02-18T155050.880Z,2021-02-18T15:50:50.880Z,Intellectual Disability and Autism
AP4M1,HGNC:574,AP-4 deficiency syndrome,MONDO:0100176,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f49be3e4-4e1f-478b-b4e0-f41623e5b548-2021-04-07T160000.000Z,2021-04-07T16:00:00.000Z,Intellectual Disability and Autism
ARHGEF6,HGNC:685,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d248ef99-6ff8-43d8-a24e-dfce6b2db1c8-2020-10-20T160000.000Z,2020-10-20T16:00:00.000Z,Intellectual Disability and Autism
ARHGEF9,HGNC:14561,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9305fb2c-6cdf-492d-9dd0-8b03dd4fab1c-2019-11-21T170000.000Z,2019-11-21T17:00:00.000Z,Intellectual Disability and Autism
ARID1A,HGNC:11110,Coffin-Siris syndrome,MONDO:0015452,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aaf6d47a-656a-49ca-ba9e-169f25bf03e7-2021-07-07T160000.000Z,2021-07-07T16:00:00.000Z,Intellectual Disability and Autism
ARID1B,HGNC:18040,Coffin-Siris syndrome,MONDO:0015452,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d487e6c4-9727-4315-90a2-11338128a8e5-2019-12-04T200734.569Z,2019-12-04T20:07:34.569Z,Intellectual Disability and Autism
ARX,HGNC:18060,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ccf3ab49-ee8f-4980-aa04-ca13c21c124a-2020-12-01T170000.000Z,2020-12-01T17:00:00.000Z,Intellectual Disability and Autism
ASXL1,HGNC:18318,Bohring-Opitz syndrome,MONDO:0011510,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_31e0ce4d-aeb7-4983-9ec2-85178d7f40f0-2021-07-30T160000.000Z,2021-07-30T16:00:00.000Z,Intellectual Disability and Autism
ASXL2,HGNC:23805,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cedd313e-b43b-4212-840b-7d4172258b16-2021-09-28T115443.696Z,2021-09-28T11:54:43.696Z,Intellectual Disability and Autism
ASXL3,HGNC:29357,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_947933aa-f0f8-4909-abd8-2984dd11dcb8-2021-10-06T040000.000Z,2021-10-06T04:00:00.000Z,Intellectual Disability and Autism
ATP13A2,HGNC:30213,Kufor-Rakeb syndrome,MONDO:0011706,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0ba5cb4f-3f7f-44dc-b2a5-0a2d62e510d4-2022-04-14T160000.000Z,2022-04-14T16:00:00.000Z,Intellectual Disability and Autism
ATP6AP2,HGNC:18305,ATP6AP2-related disorder,MONDO:0100146,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ac33652a-dd98-46f4-ba4e-d3d5a482a22e-2020-09-14T160000.000Z,2020-09-14T16:00:00.000Z,Intellectual Disability and Autism
ATP7A,HGNC:869,Menkes disease,MONDO:0010651,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9bc50734-316b-47db-ba10-61f3fde46cca-2018-02-07T170000.000Z,2018-02-07T17:00:00.000Z,Intellectual Disability and Autism
ATRX,HGNC:886,ATR-X-related syndrome,MONDO:0016980,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5296ecdf-b709-47bd-9032-daec8b91e300-2021-09-29T160000.000Z,2021-09-29T16:00:00.000Z,Intellectual Disability and Autism
AUTS2,HGNC:14262,syndromic intellectual disability,MONDO:0000508,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_582999f6-b3b4-46de-90a0-8f44e22df469-2020-09-01T160000.000Z,2020-09-01T16:00:00.000Z,Intellectual Disability and Autism
AVPR1A,HGNC:895,autism spectrum disorder,MONDO:0005258,Undetermined,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8ea232de-063f-489a-b00a-8c5d11dbe43a-2022-03-01T050000.000Z,2022-03-01T05:00:00.000Z,Intellectual Disability and Autism
BAZ2B,HGNC:963,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_be8c5c40-5fe7-4247-b1d2-b11ca339b365-2022-10-19T040000.000Z,2022-10-19T04:00:00.000Z,Intellectual Disability and Autism
BCL11A,HGNC:13221,Dias-Logan syndrome,MONDO:0014914,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9630f9a3-3f90-49c6-ae8b-6313c950b1b2-2020-09-13T171807.228Z,2020-09-13T17:18:07.228Z,Intellectual Disability and Autism
BPTF,HGNC:3581,syndromic intellectual disability,MONDO:0000508,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_08521bf8-a5a2-4a44-941b-12d9eae7aa4f-2022-07-06T160000.000Z,2022-07-06T16:00:00.000Z,Intellectual Disability and Autism
BRD4,HGNC:13575,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8b28cda3-bce6-4a8f-b359-0ab398a1111d-2022-04-20T160000.000Z,2022-04-20T16:00:00.000Z,Intellectual Disability and Autism
BRSK2,HGNC:11405,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_327881a5-52fd-42bd-a500-c94514a7aed3-2021-02-03T170000.000Z,2021-02-03T17:00:00.000Z,Intellectual Disability and Autism
BRWD3,HGNC:17342,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b8a924e2-e76b-4363-bf38-d95fd53d6141-2018-07-18T160000.000Z,2018-07-18T16:00:00.000Z,Intellectual Disability and Autism
CACNG2,HGNC:1406,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a61ad78f-0f37-4221-82f4-710275033666-2021-07-29T210333.496Z,2021-07-29T21:03:33.496Z,Intellectual Disability and Autism
CASK,HGNC:1497,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca0e703c-3fe1-44a1-8632-036554b2f158-2019-07-09T160000.000Z,2019-07-09T16:00:00.000Z,Intellectual Disability and Autism
CC2D1A,HGNC:30237,complex neurodevelopmental disorder,MONDO:0100038,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_63def86b-765e-4f12-93a3-94ef911c3190-2020-01-08T170000.000Z,2020-01-08T17:00:00.000Z,Intellectual Disability and Autism
CDH15,HGNC:1754,intellectual disability,MONDO:0001071,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9295bddb-d61c-47c2-b186-97296b9c4d94-2021-02-17T170000.000Z,2021-02-17T17:00:00.000Z,Intellectual Disability and Autism
CDK13,HGNC:1733,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c594bcfa-2b2c-425a-8285-74bae8e01da8-2021-12-31T225720.705Z,2021-12-31T22:57:20.705Z,Intellectual Disability and Autism
CDK16,HGNC:8749,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_93557c1a-c141-4833-bcbb-83fccbd7d761-2021-10-28T160000.000Z,2021-10-28T16:00:00.000Z,Intellectual Disability and Autism
CHD3,HGNC:1918,Snijders Blok-Campeau syndrome,MONDO:0032600,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0e94c7c1-9c13-4189-8a9f-e9808916526f-2022-03-02T170000.000Z,2022-03-02T17:00:00.000Z,Intellectual Disability and Autism
CHD8,HGNC:20153,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3134b4e1-2fee-4025-99af-b2146cc2ccf8-2018-07-16T160000.000Z,2018-07-16T16:00:00.000Z,Intellectual Disability and Autism
CLCN4,HGNC:2022,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_54fbcbc8-77d7-4496-8527-1171cdd7452c-2017-10-20T160000.000Z,2017-10-20T16:00:00.000Z,Intellectual Disability and Autism
CLIC2,HGNC:2063,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3e8ec6b8-5189-43eb-a741-833c77e7ce91-2021-02-16T170000.000Z,2021-02-16T17:00:00.000Z,Intellectual Disability and Autism
CNKSR2,HGNC:19701,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_420ee599-c745-43b9-b9a9-c80dfd7f68a8-2020-12-16T170000.000Z,2020-12-16T17:00:00.000Z,Intellectual Disability and Autism
CNOT3,HGNC:7879,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_585384c5-8958-4934-af26-4040774a644c-2021-08-24T160000.000Z,2021-08-24T16:00:00.000Z,Intellectual Disability and Autism
CNTNAP2,HGNC:13830,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e91dc4be-821d-4f54-acdd-755a25070eec-2021-03-16T160000.000Z,2021-03-16T16:00:00.000Z,Intellectual Disability and Autism
CRADD,HGNC:2340,syndromic intellectual disability,MONDO:0000508,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7f64ee7f-13a7-4a2d-b1a2-ad6c9e63cab3-2021-06-16T180000.000Z,2021-06-16T18:00:00.000Z,Intellectual Disability and Autism
CRBN,HGNC:30185,intellectual disability,MONDO:0001071,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_158c9b6b-2ac8-4ee3-bd89-a57d567e675f-2021-05-21T135046.004Z,2021-05-21T13:50:46.004Z,Intellectual Disability and Autism
CREBBP,HGNC:2348,Rubinstein-Taybi syndrome,MONDO:0019188,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d16df64b-26ed-4f1c-b8dc-f27be773b102-2018-04-27T160000.000Z,2018-04-27T16:00:00.000Z,Intellectual Disability and Autism
CTCF,HGNC:13723,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f1cbcd7b-83e2-47c1-b708-c9052502e639-2021-07-21T160000.000Z,2021-07-21T16:00:00.000Z,Intellectual Disability and Autism
CTNNB1,HGNC:2514,severe intellectual disability-progressive spastic diplegia syndrome,MONDO:0014035,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e119aceb-a011-4811-9abd-6731c5b3d15d-2021-02-03T170000.000Z,2021-02-03T17:00:00.000Z,Intellectual Disability and Autism
CUL3,HGNC:2553,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fb529ace-86b5-4209-9974-9c07a1c32956-2021-01-16T030942.670Z,2021-01-16T03:09:42.670Z,Intellectual Disability and Autism
CUL4B,HGNC:2555,"X-linked intellectual disability, Cabezas type",MONDO:0010306,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cc93f3b2-3124-40f8-a86e-c929b09c6f68-2018-02-21T050000.000Z,2018-02-21T05:00:00.000Z,Intellectual Disability and Autism
DDX3X,HGNC:2745,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3b7c89d4-ccb2-4d4e-ad11-9d6051a40b6d-2020-05-05T160000.000Z,2020-05-05T16:00:00.000Z,Intellectual Disability and Autism
DHCR7,HGNC:2860,Smith-Lemli-Opitz syndrome,MONDO:0010035,AR,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d5ed71c9-a76b-44c0-b5c0-44d604f2e0e9-2018-09-09T160000.000Z,2018-09-09T16:00:00.000Z,Intellectual Disability and Autism
DKC1,HGNC:2890,DKC1-related disorder,MONDO:0100152,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_afd6a4ca-7a1c-42ef-a9cf-bef557128f12-2020-09-13T153338.000Z,2020-09-13T15:33:38.000Z,Intellectual Disability and Autism
DLG3,HGNC:2902,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e73a08f0-ff3a-4328-9020-89102296e405-2018-08-15T160000.000Z,2018-08-15T16:00:00.000Z,Intellectual Disability and Autism
DLGAP2,HGNC:2906,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_efeafdd5-9105-470f-b332-8c7a3dd65078-2021-10-14T160000.000Z,2021-10-14T16:00:00.000Z,Intellectual Disability and Autism
DPP6,HGNC:3010,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3d41cebe-5490-419d-882d-4f3c6856be07-2021-05-05T160000.000Z,2021-05-05T16:00:00.000Z,Intellectual Disability and Autism
DYRK1A,HGNC:3091,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b336707e-f3a5-4554-9b37-0d29621b3562-2020-07-15T195802.528Z,2020-07-15T19:58:02.528Z,Intellectual Disability and Autism
EED,HGNC:3188,Cohen-Gibson syndrome,MONDO:0060510,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_44531e19-7957-424f-81e9-fc455095f14a-2022-12-06T190000.000Z,2022-12-06T19:00:00.000Z,Intellectual Disability and Autism
EFTUD2,HGNC:30858,mandibulofacial dysostosis-microcephaly syndrome,MONDO:0012516,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_66012775-240c-4640-ac66-12647021eee5-2022-07-20T160000.000Z,2022-07-20T16:00:00.000Z,Intellectual Disability and Autism
EHMT1,HGNC:24650,Kleefstra syndrome,MONDO:0012455,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_db91a861-6a88-4848-b6d5-4772bdef52ff-2018-06-07T040000.000Z,2018-06-07T04:00:00.000Z,Intellectual Disability and Autism
EIF2S3,HGNC:3267,MEHMO syndrome,MONDO:0010258,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bb96fe11-dd31-47b2-820d-9071035ec7b0-2021-11-11T170000.000Z,2021-11-11T17:00:00.000Z,Intellectual Disability and Autism
EN2,HGNC:3343,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_91eb2fc6-864c-4a4a-9b2d-0b2bdd695999-2021-02-16T170000.000Z,2021-02-16T17:00:00.000Z,Intellectual Disability and Autism
EPB41L1,HGNC:3378,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3be1f426-ad87-4540-9582-a9dcf96ffddd-2022-07-06T160000.000Z,2022-07-06T16:00:00.000Z,Intellectual Disability and Autism
EZH2,HGNC:3527,Weaver syndrome,MONDO:0010193,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5dcf5941-6076-4486-94be-7ba3944abaee-2022-08-03T160000.000Z,2022-08-03T16:00:00.000Z,Intellectual Disability and Autism
FBN1,HGNC:3603,Shprintzen-Goldberg syndrome,MONDO:0008426,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_42caf14d-6400-475b-88f3-a8a24a0832c0-2021-12-01T190000.000Z,2021-12-01T19:00:00.000Z,Intellectual Disability and Autism
FGD1,HGNC:3663,"Aarskog-Scott syndrome, X-linked",MONDO:0010589,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4b652280-1291-4166-ac59-62caabd977bb-2017-12-06T170000.000Z,2017-12-06T17:00:00.000Z,Intellectual Disability and Autism
FLNA,HGNC:3754,periventricular nodular heterotopia,MONDO:0020341,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_80bc6280-7c21-4168-8a98-93c31fead5d7-2020-12-27T231155.213Z,2020-12-27T23:11:55.213Z,Intellectual Disability and Autism
FMR1,HGNC:3775,fragile X syndrome,MONDO:0010383,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e491d278-7123-434c-8de3-46e16afb4037-2019-06-03T160000.000Z,2019-06-03T16:00:00.000Z,Intellectual Disability and Autism
FOLR1,HGNC:3791,neurodegenerative syndrome due to cerebral folate transport deficiency,MONDO:0013110,AR,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_22c12588-dc55-4e90-827a-d7a6349e38a9-2017-10-20T160000.000Z,2017-10-20T16:00:00.000Z,Intellectual Disability and Autism
FOXP1,HGNC:3823,intellectual disability-severe speech delay-mild dysmorphism syndrome,MONDO:0013352,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_db1c240c-7ffb-4a95-92ad-da9e8af2adc6-2019-05-09T162756.956Z,2019-05-09T16:27:56.956Z,Intellectual Disability and Autism
FOXP2,HGNC:13875,specific language disorder,MONDO:0016226,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b13348d1-1248-4507-aa29-60559e6b410e-2019-05-21T160000.000Z,2019-05-21T16:00:00.000Z,Intellectual Disability and Autism
FRMPD4,HGNC:29007,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bdc39072-6ab1-4ec6-af69-ce7a2f874f1b-2022-11-02T160000.000Z,2022-11-02T16:00:00.000Z,Intellectual Disability and Autism
FTSJ1,HGNC:13254,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP5,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_9515,2018-01-17T00:00:00,Intellectual Disability and Autism
GATAD2B,HGNC:30778,severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome,MONDO:0014034,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5fb40641-ec79-4fee-9111-d38d2062c15b-2022-02-01T170000.000Z,2022-02-01T17:00:00.000Z,Intellectual Disability and Autism
GDI1,HGNC:4226,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP5,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8afc42b0-6c5e-460b-87d1-035c051fe7ca-2018-05-24T225528.461Z,2018-05-24T22:55:28.461Z,Intellectual Disability and Autism
GNAI1,HGNC:4384,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ea8128fc-f085-492a-b0ef-f37d994bb01b-2021-03-17T160000.000Z,2021-03-17T16:00:00.000Z,Intellectual Disability and Autism
GPC3,HGNC:4451,Simpson-Golabi-Behmel syndrome,MONDO:0010731,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5b8b02d6-1d60-4b4c-bb8a-b976907087c7-2019-12-31T175422.159Z,2019-12-31T17:54:22.159Z,Intellectual Disability and Autism
GRIA3,HGNC:4573,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_25f94660-0a8d-4f3a-8f6c-dde1b38a8ab7-2019-11-06T170000.000Z,2019-11-06T17:00:00.000Z,Intellectual Disability and Autism
GRIK2,HGNC:4580,complex neurodevelopmental disorder,MONDO:0100038,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1939b90b-f1e4-4426-9f8c-5526f9003f10-2022-02-10T180000.000Z,2022-02-10T18:00:00.000Z,Intellectual Disability and Autism
GRIK2,HGNC:4580,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7f1b4733-9b55-401b-bc3b-6ead723e7fcb-2022-02-10T180000.000Z,2022-02-10T18:00:00.000Z,Intellectual Disability and Autism
HCFC1,HGNC:4839,X-linked intellectual disability,MONDO:0100284,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_023defeb-36f4-4e54-ba8f-e2c9537e933c-2021-03-17T160000.000Z,2021-03-17T16:00:00.000Z,Intellectual Disability and Autism
HDAC8,HGNC:13315,Cornelia de Lange syndrome,MONDO:0016033,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7d29159-4c90-488e-a4e1-b006d70ae762-2018-09-11T160000.000Z,2018-09-11T16:00:00.000Z,Intellectual Disability and Autism
HNRNPK,HGNC:5044,neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome,MONDO:0018681,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f1adc74c-9bbc-48fc-bbbf-1159c0944108-2021-12-20T170000.000Z,2021-12-20T17:00:00.000Z,Intellectual Disability and Autism
HNRNPU,HGNC:5048,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b2c82248-c128-4d3e-802a-7f3295d14455-2022-11-10T190000.000Z,2022-11-10T19:00:00.000Z,Intellectual Disability and Autism
HOXA1,HGNC:5099,syndromic intellectual disability,MONDO:0000508,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1e0e605f-c82a-4e34-b913-8dc6b72b4881-2019-06-19T160000.000Z,2019-06-19T16:00:00.000Z,Intellectual Disability and Autism
HPRT1,HGNC:5157,Lesch-Nyhan syndrome,MONDO:0010298,XL,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f60022bb-5679-4766-ac72-2ddfd0b752ee-2022-07-08T160000.000Z,2022-07-08T16:00:00.000Z,Intellectual Disability and Autism
HUWE1,HGNC:30892,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ded2ea2f-63ff-428a-8061-7c62c276163b-2017-10-20T160000.000Z,2017-10-20T16:00:00.000Z,Intellectual Disability and Autism
IDS,HGNC:5389,mucopolysaccharidosis type 2,MONDO:0010674,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_753ba7a6-cef5-4665-81e9-306e11c618c5-2018-02-21T170000.000Z,2018-02-21T17:00:00.000Z,Intellectual Disability and Autism
IGBP1,HGNC:5461,corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome,MONDO:0010333,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dbeb1651-add0-4a44-87ad-a56c7864f076-2021-02-02T170000.000Z,2021-02-02T17:00:00.000Z,Intellectual Disability and Autism
IL1RAPL1,HGNC:5996,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3b5db6b4-94fa-46d1-88a7-bbf382f3a1c6-2021-03-15T135028.460Z,2021-03-15T13:50:28.460Z,Intellectual Disability and Autism
IQSEC2,HGNC:29059,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0916cda1-5213-4f88-9835-34c3931526a2-2019-06-05T160000.000Z,2019-06-05T16:00:00.000Z,Intellectual Disability and Autism
ITPR1,HGNC:6180,spinocerebellar ataxia type 29,MONDO:0007298,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8b938bea-6fcb-46e1-9435-99303d59740e-2021-11-03T160000.000Z,2021-11-03T16:00:00.000Z,Intellectual Disability and Autism
ITPR1,HGNC:6180,aniridia-cerebellar ataxia-intellectual disability syndrome,MONDO:0008795,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a848b265-8aa3-41ee-83cc-9287afe0f9d0-2021-11-03T160000.000Z,2021-11-03T16:00:00.000Z,Intellectual Disability and Autism
KANSL1,HGNC:24565,Koolen-de Vries syndrome,MONDO:0012496,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e89a0e87-314a-49b1-bb50-6b26aeaa1037-2022-02-18T120936.714Z,2022-02-18T12:09:36.714Z,Intellectual Disability and Autism
KAT6A,HGNC:13013,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_86ec74ba-6b12-42ea-bc06-58af4fd6b7a4-2021-10-05T160000.000Z,2021-10-05T16:00:00.000Z,Intellectual Disability and Autism
KATNAL2,HGNC:25387,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eddbdd3e-2f6b-4b55-a951-988ee214b08b-2020-05-20T160000.000Z,2020-05-20T16:00:00.000Z,Intellectual Disability and Autism
KCNH1,HGNC:6250,KCNH1 associated disorder,MONDO:0100485,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9b090a30-6065-4337-b930-d40585b142cd-2022-04-05T160000.000Z,2022-04-05T16:00:00.000Z,Intellectual Disability and Autism
KDM5B,HGNC:18039,intellectual disability,MONDO:0001071,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2ae3441f-82f6-4985-ba48-fd1de8ea6ce4-2022-03-01T170000.000Z,2022-03-01T17:00:00.000Z,Intellectual Disability and Autism
KDM5C,HGNC:11114,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_36896d71-1c04-4176-8cd9-16f5b283ef9c-2018-09-19T160000.000Z,2018-09-19T16:00:00.000Z,Intellectual Disability and Autism
KDM6B,HGNC:29012,syndromic intellectual disability,MONDO:0000508,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_010fe1d1-312f-45fa-93ca-887875c53607-2022-02-18T170000.000Z,2022-02-18T17:00:00.000Z,Intellectual Disability and Autism
KDM6B,HGNC:29012,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_37e4fa5a-05b7-4cee-b43a-eb58488346bd-2022-01-19T170000.000Z,2022-01-19T17:00:00.000Z,Intellectual Disability and Autism
KIF1A,HGNC:888,syndromic intellectual disability,MONDO:0000508,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1d586d93-7066-4db0-b623-8b7e3eafdc06-2020-09-24T134254.893Z,2020-09-24T13:42:54.893Z,Intellectual Disability and Autism
KMT2C,HGNC:13726,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e1dcdd6c-30e0-4d06-8df5-f120b1b02477-2022-03-02T170000.000Z,2022-03-02T17:00:00.000Z,Intellectual Disability and Autism
L1CAM,HGNC:6470,L1 syndrome,MONDO:0017140,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e8541f5b-a166-44cd-a7f3-fce263ef8fde-2019-10-02T160000.000Z,2019-10-02T16:00:00.000Z,Intellectual Disability and Autism
LAMC3,HGNC:6494,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0ff89702-c97e-4ef9-91ce-2e37b66efd84-2020-09-01T160000.000Z,2020-09-01T16:00:00.000Z,Intellectual Disability and Autism
LAS1L,HGNC:25726,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c5b85dbb-3d49-4924-8294-e518ff56f048-2021-09-21T160000.000Z,2021-09-21T16:00:00.000Z,Intellectual Disability and Autism
MAGEL2,HGNC:6814,Schaaf-Yang syndrome,MONDO:0014243,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aa89f10b-6ccf-4c69-aef3-fc2f6c8e6ea9-2021-06-01T160000.000Z,2021-06-01T16:00:00.000Z,Intellectual Disability and Autism
MAN1B1,HGNC:6823,MAN1B1-congenital disorder of glycosylation,MONDO:0018349,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e0f50bc5-f7ac-4e0a-9762-d6cad9cc4585-2020-08-04T114702.993Z,2020-08-04T11:47:02.993Z,Intellectual Disability and Autism
MAOA,HGNC:6833,Brunner syndrome,MONDO:0010379,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_20ffc014-ef31-4693-91c4-424bbe1e48dd-2020-04-14T203950.820Z,2020-04-14T20:39:50.820Z,Intellectual Disability and Autism
MBD5,HGNC:20444,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_952cb4f8-e59b-4edb-a393-0266e0008963-2018-11-21T170000.000Z,2018-11-21T17:00:00.000Z,Intellectual Disability and Autism
MBTPS2,HGNC:15455,IFAP syndrome with or without BRESHECK syndrome,MONDO:0100213,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_13a8a124-1071-4150-b6ea-0165cbf41c2d-2021-05-17T145233.620Z,2021-05-17T14:52:33.620Z,Intellectual Disability and Autism
MED12,HGNC:11957,MED12-related intellectual disability syndrome,MONDO:0100000,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_afba0573-9f47-4814-bf3a-ef41f5512dee-2018-04-27T193808.041Z,2018-04-27T19:38:08.041Z,Intellectual Disability and Autism
MED13,HGNC:22474,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e82f63b1-ed0f-4dd0-8168-3aa4e0a4c2a9-2022-05-17T180000.000Z,2022-05-17T18:00:00.000Z,Intellectual Disability and Autism
MED13L,HGNC:22962,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_41758f8d-1f99-47fa-beb6-c327fa6cb940-2021-04-21T040000.000Z,2021-04-21T04:00:00.000Z,Intellectual Disability and Autism
MED23,HGNC:2372,syndromic intellectual disability,MONDO:0000508,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6e8c75f0-39ae-4967-b95d-a92c55739876-2020-04-01T160000.000Z,2020-04-01T16:00:00.000Z,Intellectual Disability and Autism
MEF2C,HGNC:6996,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_34354e8f-4343-4fba-82ba-e49579e504bb-2019-02-06T170000.000Z,2019-02-06T17:00:00.000Z,Intellectual Disability and Autism
MEIS2,HGNC:7001,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fe156246-6e64-4096-a4c5-a83a3e70dbb9-2022-04-06T160000.000Z,2022-04-06T16:00:00.000Z,Intellectual Disability and Autism
MET,HGNC:7029,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d55c61af-ef8e-475d-9ff7-454496cb6462-2021-01-19T170000.000Z,2021-01-19T17:00:00.000Z,Intellectual Disability and Autism
MID1,HGNC:7095,X-linked Opitz G/BBB syndrome,MONDO:0010222,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b2471967-d6b3-4ffb-a9fd-e3dbd089cb20-2018-03-21T160000.000Z,2018-03-21T16:00:00.000Z,Intellectual Disability and Autism
MSL3,HGNC:7370,Basilicata-Akhtar syndrome,MONDO:0026730,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f700593e-b7c1-4149-810d-7e71fbea61d0-2022-01-18T170000.000Z,2022-01-18T17:00:00.000Z,Intellectual Disability and Autism
MYT1L,HGNC:7623,syndromic intellectual disability,MONDO:0000508,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_32897f25-e36a-4ec8-9401-0374a95e06a5-2020-08-18T160000.000Z,2020-08-18T16:00:00.000Z,Intellectual Disability and Autism
NAA10,HGNC:18704,NAA10-related syndrome,MONDO:0100124,XL,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fcdd3d02-82f3-4ea3-a2b0-8ac2d4c40b1b-2023-01-10T170000.000Z,2023-01-10T17:00:00.000Z,Intellectual Disability and Autism
NAA15,HGNC:30782,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f9732e0c-1306-4fb5-b1b3-873258903e75-2022-01-05T170000.000Z,2022-01-05T17:00:00.000Z,Intellectual Disability and Autism
NBEA,HGNC:7648,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f40357db-6cc2-4240-8771-1206cd27298a-2020-12-02T170000.000Z,2020-12-02T17:00:00.000Z,Intellectual Disability and Autism
NDP,HGNC:7678,Norrie disease,MONDO:0010691,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_335ce5aa-7f87-4b91-a447-928399f40f11-2018-03-21T160000.000Z,2018-03-21T16:00:00.000Z,Intellectual Disability and Autism
NEXMIF,HGNC:29433,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_191437ab-2e73-4a0b-a660-ab5eab4c1066-2020-02-05T170000.000Z,2020-02-05T17:00:00.000Z,Intellectual Disability and Autism
NHS,HGNC:7820,Nance-Horan syndrome,MONDO:0010545,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7f57ca3-efb2-4333-9ae1-732aa429f37a-2017-10-20T040000.000Z,2017-10-20T04:00:00.000Z,Intellectual Disability and Autism
NIPBL,HGNC:28862,Cornelia de Lange syndrome,MONDO:0016033,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4ecc430-6562-4d58-9118-c5253dc95ae9-2018-06-20T144433.262Z,2018-06-20T14:44:33.262Z,Intellectual Disability and Autism
NLGN3,HGNC:14289,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP5,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b6e7e531-093b-4216-8c56-0c94e63c2811-2018-08-15T040000.000Z,2018-08-15T04:00:00.000Z,Intellectual Disability and Autism
NLGN4X,HGNC:14287,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bed32aec-b1a6-41ff-9607-b4172888c46a-2018-08-01T160000.000Z,2018-08-01T16:00:00.000Z,Intellectual Disability and Autism
NR2F1,HGNC:7975,Bosch-Boonstra-Schaaf optic atrophy syndrome,MONDO:0014320,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1aa4efce-b5b8-4cbd-b043-bb89c5283e3c-2022-02-16T170000.000Z,2022-02-16T17:00:00.000Z,Intellectual Disability and Autism
NR4A2,HGNC:7981,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c8923fda-35f3-47e3-a987-8ca2b86e4b92-2021-05-05T160000.000Z,2021-05-05T16:00:00.000Z,Intellectual Disability and Autism
NRXN1,HGNC:8008,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14bb833a-eefd-4f02-b112-c74b6866d5be-2019-07-10T160000.000Z,2019-07-10T16:00:00.000Z,Intellectual Disability and Autism
NSD1,HGNC:14234,Sotos syndrome,MONDO:0019349,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aa1a412a-ee7d-4517-81ba-0ceead9668d1-2018-10-26T160000.000Z,2018-10-26T16:00:00.000Z,Intellectual Disability and Autism
NSD2,HGNC:12766,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_de3c113b-0a7d-454d-88e3-faf4f1fdb9ac-2021-06-02T160000.000Z,2021-06-02T16:00:00.000Z,Intellectual Disability and Autism
NSDHL,HGNC:13398,CK syndrome,MONDO:0010441,XL,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d94406f0-a459-47ed-aabc-80c7b6be9293-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Intellectual Disability and Autism
NSUN2,HGNC:25994,intellectual disability,MONDO:0001071,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c6878f90-f485-4c44-95d3-a33b0ec9f66f-2019-02-06T170000.000Z,2019-02-06T17:00:00.000Z,Intellectual Disability and Autism
NTNG1,HGNC:23319,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2c648acf-5801-481b-a1c4-f950e99d4d96-2021-02-02T170000.000Z,2021-02-02T17:00:00.000Z,Intellectual Disability and Autism
OCRL,HGNC:8108,oculocerebrorenal syndrome,MONDO:0010645,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5140c756-fac0-435b-8f59-a5d4a0b0adb3-2020-07-10T160000.000Z,2020-07-10T16:00:00.000Z,Intellectual Disability and Autism
OFD1,HGNC:2567,ciliopathy,MONDO:0005308,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_15e32789-4f24-4870-94d3-b5618e67509f-2018-04-27T165136.294Z,2018-04-27T16:51:36.294Z,Intellectual Disability and Autism
PACS1,HGNC:30032,Schuurs-Hoeijmakers syndrome,MONDO:0014006,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f5fb6cba-cff6-4498-a725-3f863a910cf1-2020-06-26T182716.855Z,2020-06-26T18:27:16.855Z,Intellectual Disability and Autism
PAK3,HGNC:8592,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c2f13863-a52d-49bd-b7f6-294edd73717a-2018-07-31T160000.000Z,2018-07-31T16:00:00.000Z,Intellectual Disability and Autism
PHF21A,HGNC:24156,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1312f4b-fcc2-46ca-9132-7592e46ae05f-2022-04-06T160000.000Z,2022-04-06T16:00:00.000Z,Intellectual Disability and Autism
PHF6,HGNC:18145,Borjeson-Forssman-Lehmann syndrome,MONDO:0010537,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_94ea5014-0a83-49ea-b001-fc2a8c24c0d9-2018-02-21T170000.000Z,2018-02-21T17:00:00.000Z,Intellectual Disability and Autism
PHF8,HGNC:20672,syndromic X-linked intellectual disability Siderius type,MONDO:0010286,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9e94640-1950-4438-bcda-4859545d83d1-2018-11-07T170000.000Z,2018-11-07T17:00:00.000Z,Intellectual Disability and Autism
PHIP,HGNC:15673,PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome,MONDO:0035133,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0635f61b-d8aa-428a-b4d3-0b2d116ece39-2022-04-19T160000.000Z,2022-04-19T16:00:00.000Z,Intellectual Disability and Autism
PLP1,HGNC:9086,Pelizaeus-Merzbacher disease,MONDO:0010714,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c1a44c5f-744e-4d02-a08f-e7c687531b21-2018-03-07T170000.000Z,2018-03-07T17:00:00.000Z,Intellectual Disability and Autism
POGZ,HGNC:18801,intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome,MONDO:0014606,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c5742d94-0642-4598-9fbd-fd43a2c21559-2020-03-09T160000.000Z,2020-03-09T16:00:00.000Z,Intellectual Disability and Autism
PORCN,HGNC:17652,focal dermal hypoplasia,MONDO:0010592,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_20fc3afa-d10d-4239-885f-24e91cbb31a8-2020-08-05T124432.168Z,2020-08-05T12:44:32.168Z,Intellectual Disability and Autism
PPM1D,HGNC:9277,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a93ec2cb-1632-4439-bdd9-4bcae1bb779f-2022-02-15T170000.000Z,2022-02-15T17:00:00.000Z,Intellectual Disability and Autism
PPP2R1A,HGNC:9302,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1aae8155-7cb1-44ee-9cee-17bb22e6a0ad-2022-11-16T170000.000Z,2022-11-16T17:00:00.000Z,Intellectual Disability and Autism
PPP2R5D,HGNC:9312,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4b43ff91-1ea4-475b-97d9-6fbda924ea16-2022-01-12T055053.721Z,2022-01-12T05:50:53.721Z,Intellectual Disability and Autism
PQBP1,HGNC:9330,Renpenning syndrome,MONDO:0010653,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8128f36b-f273-49ee-bfd8-bee64b4df921-2018-11-09T170000.000Z,2018-11-09T17:00:00.000Z,Intellectual Disability and Autism
PRSS12,HGNC:9477,non-syndromic intellectual disability,MONDO:0000509,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d98f99d6-b1df-4cad-a53b-c94cfb532167-2021-08-04T160000.000Z,2021-08-04T16:00:00.000Z,Intellectual Disability and Autism
PTCHD1,HGNC:26392,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_05d36fe2-0026-4bbc-af4b-6d952490969b-2018-08-15T160000.000Z,2018-08-15T16:00:00.000Z,Intellectual Disability and Autism
PUF60,HGNC:17042,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_661c140f-11a3-46f8-b001-14a2314582e4-2021-12-15T170000.000Z,2021-12-15T17:00:00.000Z,Intellectual Disability and Autism
QRICH1,HGNC:24713,syndromic intellectual disability,MONDO:0000508,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ccc6c6f-da19-4e86-88a8-5e7a1794efae-2022-06-15T170000.000Z,2022-06-15T17:00:00.000Z,Intellectual Disability and Autism
RAB39B,HGNC:16499,early-onset parkinsonism-intellectual disability syndrome,MONDO:0010709,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_01dc73a8-fbd2-4081-95cd-ab7cb59236d7-2018-06-04T040000.000Z,2018-06-04T04:00:00.000Z,Intellectual Disability and Autism
RAB40AL,HGNC:25410,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP8,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_126405bb-ecf5-49a3-b7d5-bb1b45a65e26-2021-06-15T160000.000Z,2021-06-15T16:00:00.000Z,Intellectual Disability and Autism
RAD21,HGNC:9811,Cornelia de Lange syndrome,MONDO:0016033,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_30ad5023-6c68-42ab-b8ea-a601a134eaf6-2020-01-08T170000.000Z,2020-01-08T17:00:00.000Z,Intellectual Disability and Autism
RAI1,HGNC:9834,Smith-Magenis syndrome,MONDO:0008434,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1e576e58-debf-49c6-a86d-c599806180ff-2018-09-05T160000.000Z,2018-09-05T16:00:00.000Z,Intellectual Disability and Autism
RELN,HGNC:9957,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c654081c-5abd-4f86-a3f7-90d7f117b93d-2021-03-17T160000.000Z,2021-03-17T16:00:00.000Z,Intellectual Disability and Autism
RPL10,HGNC:10298,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_974ac8bb-f7b1-4480-869a-e9ef4b8b3fa3-2021-01-20T170000.000Z,2021-01-20T17:00:00.000Z,Intellectual Disability and Autism
RPS6KA3,HGNC:10432,Coffin-Lowry syndrome,MONDO:0010561,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_af32a931-1d55-432f-82cf-ce87f6c26580-2019-05-28T040000.000Z,2019-05-28T04:00:00.000Z,Intellectual Disability and Autism
SATB2,HGNC:21637,SATB2 associated disorder,MONDO:0100147,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_44d14081-fa32-4159-9049-35f510d2351a-2020-09-15T160000.000Z,2020-09-15T16:00:00.000Z,Intellectual Disability and Autism
SET,HGNC:10760,intellectual disability,MONDO:0001071,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4d7c9aa2-0a9a-4359-af98-6097cc6a3b91-2021-11-17T170000.000Z,2021-11-17T17:00:00.000Z,Intellectual Disability and Autism
SETBP1,HGNC:15573,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_70505ca8-8869-4fa9-9965-fc8e03a19b28-2020-10-20T160000.000Z,2020-10-20T16:00:00.000Z,Intellectual Disability and Autism
SETBP1,HGNC:15573,Schinzel-Giedion syndrome,MONDO:0010010,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_71885c03-b578-4baf-a17c-4817349eaf36-2021-02-16T170000.000Z,2021-02-16T17:00:00.000Z,Intellectual Disability and Autism
SHANK2,HGNC:14295,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_911cb9ff-e68e-4b47-8639-f6a63ab11b3e-2019-07-17T160000.000Z,2019-07-17T16:00:00.000Z,Intellectual Disability and Autism
SHANK3,HGNC:14294,Phelan-McDermid syndrome,MONDO:0011652,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e941703a-0f30-4f4c-a997-bc3b4295f289-2018-12-12T170000.000Z,2018-12-12T17:00:00.000Z,Intellectual Disability and Autism
SHROOM4,HGNC:29215,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a94d20f8-9909-48b2-9860-d17c6dc73ec3-2021-01-13T170000.000Z,2021-01-13T17:00:00.000Z,Intellectual Disability and Autism
SIN3A,HGNC:19353,SIN3A-related intellectual disability syndrome,MONDO:0044699,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8c6bb2ed-0912-4d60-9faa-39be27ecf4c7-2022-01-19T070000.000Z,2022-01-19T07:00:00.000Z,Intellectual Disability and Autism
SLC16A2,HGNC:10923,Allan-Herndon-Dudley syndrome,MONDO:0010354,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b9242e32-a339-4426-8ef5-39df0960d390-2018-08-09T170000.000Z,2018-08-09T17:00:00.000Z,Intellectual Disability and Autism
SLC2A1,HGNC:11005,GLUT1 deficiency syndrome,MONDO:0000188,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a20a0bc0-49d5-41fc-9507-cec19a43bd81-2019-04-18T123454.696Z,2019-04-18T12:34:54.696Z,Intellectual Disability and Autism
SLC6A4,HGNC:11050,autism spectrum disorder,MONDO:0005258,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cc4b0612-0a53-4e36-b737-5c0f49a387a1-2021-01-06T170000.000Z,2021-01-06T17:00:00.000Z,Intellectual Disability and Autism
SLC9A9,HGNC:20653,autism spectrum disorder,MONDO:0005258,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_463ee005-1264-45da-bd85-3776a6637c68-2020-10-08T160000.000Z,2020-10-08T16:00:00.000Z,Intellectual Disability and Autism
SMAD4,HGNC:6770,Myhre syndrome,MONDO:0007688,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a5a082cc-c214-4bfa-8cb8-caead239d129-2021-12-30T170000.000Z,2021-12-30T17:00:00.000Z,Intellectual Disability and Autism
SMARCA1,HGNC:11097,X-linked intellectual disability,MONDO:0100284,XL,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ce97120a-5094-4768-b305-941353791584-2022-08-03T160000.000Z,2022-08-03T16:00:00.000Z,Intellectual Disability and Autism
SMARCA2,HGNC:11098,intellectual disability-sparse hair-brachydactyly syndrome,MONDO:0011053,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5cde86bc-f99f-40cf-8c32-eac9f8f8a67d-2020-08-18T160000.000Z,2020-08-18T16:00:00.000Z,Intellectual Disability and Autism
SMARCA4,HGNC:11100,Coffin-Siris syndrome,MONDO:0015452,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_61d29c73-9a30-4664-9df2-2f5831219221-2020-06-17T160000.000Z,2020-06-17T16:00:00.000Z,Intellectual Disability and Autism
SMARCC2,HGNC:11105,Coffin-Siris syndrome,MONDO:0015452,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aa645aa6-3a03-4ab7-9d09-b17be3184259-2022-02-02T170000.000Z,2022-02-02T17:00:00.000Z,Intellectual Disability and Autism
SMC1A,HGNC:11111,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c281f5fd-d868-4425-a7b4-8e39e3b2090e-2019-06-19T160000.000Z,2019-06-19T16:00:00.000Z,Intellectual Disability and Autism
SMC3,HGNC:2468,Cornelia de Lange syndrome,MONDO:0016033,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9467eaad-a86a-4b24-8cd4-98ebb57121c1-2020-04-07T160000.000Z,2020-04-07T16:00:00.000Z,Intellectual Disability and Autism
SMS,HGNC:11123,syndromic X-linked intellectual disability Snyder type,MONDO:0010664,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8f1ca85b-ad57-4c64-9abf-9ae5d915703f-2018-05-16T195543.428Z,2018-05-16T19:55:43.428Z,Intellectual Disability and Autism
SNAP25,HGNC:11132,developmental and epileptic encephalopathy,MONDO:0100062,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5696dbd2-dfe5-4c96-baec-c9d963959b28-2022-03-24T160000.000Z,2022-03-24T16:00:00.000Z,Intellectual Disability and Autism
SOX5,HGNC:11201,Lamb-Shaffer syndrome,MONDO:0014778,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_781f21f2-d01a-457c-913e-8687a7c2650d-2022-01-27T170000.000Z,2022-01-27T17:00:00.000Z,Intellectual Disability and Autism
ST3GAL3,HGNC:10866,complex neurodevelopmental disorder,MONDO:0100038,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e151129d-46fc-4f7e-a434-e423a3fb644b-2020-06-03T160000.000Z,2020-06-03T16:00:00.000Z,Intellectual Disability and Autism
SYN1,HGNC:11494,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca5a3e64-5daa-4a2f-876d-4e7648c53ff8-2018-12-05T170000.000Z,2018-12-05T17:00:00.000Z,Intellectual Disability and Autism
SYP,HGNC:11506,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b0d770a5-873c-4a55-98da-fa8d235ff93b-2020-12-16T170000.000Z,2020-12-16T17:00:00.000Z,Intellectual Disability and Autism
TANC2,HGNC:30212,"intellectual developmental disorder with autistic features and language delay, with or without seizures",MONDO:0030051,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b3d3d067-5a78-44b4-9c57-25cc784123bf-2022-09-07T160000.000Z,2022-09-07T16:00:00.000Z,Intellectual Disability and Autism
TAOK1,HGNC:29259,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_79c712d0-ac0e-4bf0-8e68-bd598b3bca42-2021-08-04T160000.000Z,2021-08-04T16:00:00.000Z,Intellectual Disability and Autism
TBL1XR1,HGNC:29529,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8352a921-43c0-4097-9147-2618a4165b57-2020-07-07T170000.000Z,2020-07-07T17:00:00.000Z,Intellectual Disability and Autism
TBR1,HGNC:11590,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_853c90ef-34a8-4d7d-931d-5fb4add3e4d0-2020-03-25T160000.000Z,2020-03-25T16:00:00.000Z,Intellectual Disability and Autism
TCF7L2,HGNC:11641,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b11a5317-868b-49a9-b051-721940fb5936-2021-12-15T170000.000Z,2021-12-15T17:00:00.000Z,Intellectual Disability and Autism
TECR,HGNC:4551,intellectual disability,MONDO:0001071,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8c7adee2-6a14-4348-a018-9097954bd39d-2022-03-10T170000.000Z,2022-03-10T17:00:00.000Z,Intellectual Disability and Autism
TELO2,HGNC:29099,TELO2-related intellectual disability-neurodevelopmental disorder,MONDO:0014848,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6995e858-919b-4a08-be40-54a56371a408-2022-06-01T160000.000Z,2022-06-01T16:00:00.000Z,Intellectual Disability and Autism
TMLHE,HGNC:18308,autism spectrum disorder,MONDO:0005258,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7a780ea6-ad4e-417a-a596-27188e327aad-2021-03-02T050000.000Z,2021-03-02T05:00:00.000Z,Intellectual Disability and Autism
TNRC6B,HGNC:29190,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a806c490-788f-49b6-b437-6970f5888c07-2021-01-06T170000.000Z,2021-01-06T17:00:00.000Z,Intellectual Disability and Autism
TRAPPC9,HGNC:30832,intellectual disability-obesity-brain malformations-facial dysmorphism syndrome,MONDO:0018123,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_456bfabf-5cad-4a08-bf21-3611a6fbf9b1-2020-08-15T160000.000Z,2020-08-15T16:00:00.000Z,Intellectual Disability and Autism
TRIM8,HGNC:15579,focal segmental glomerulosclerosis and neurodevelopmental syndrome,MONDO:0100111,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_457fd90a-dad8-4711-97d0-59eb240a299e-2021-10-06T160000.000Z,2021-10-06T16:00:00.000Z,Intellectual Disability and Autism
TRIO,HGNC:12303,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ff3b6c9b-4c51-4414-b92c-20e45758ab61-2021-11-18T192046.961Z,2021-11-18T19:20:46.961Z,Intellectual Disability and Autism
TRIP12,HGNC:12306,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_011b99b3-0d17-4615-800e-36f4bacd8117-2022-04-05T063000.000Z,2022-04-05T06:30:00.000Z,Intellectual Disability and Autism
TRRAP,HGNC:12347,complex neurodevelopmental disorder with or without congenital anomalies,MONDO:0100465,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_03424cde-a847-4bd0-91eb-9707a7e51fa2-2022-07-19T180000.000Z,2022-07-19T18:00:00.000Z,Intellectual Disability and Autism
TSPAN7,HGNC:11854,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2716e7b3-e038-421a-b584-55f6797502a4-2020-12-02T170000.000Z,2020-12-02T17:00:00.000Z,Intellectual Disability and Autism
TUSC3,HGNC:30242,intellectual disability,MONDO:0001071,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_db38ed95-d1fe-43d6-bf80-c5e3f24f7d1b-2020-04-07T160000.000Z,2020-04-07T16:00:00.000Z,Intellectual Disability and Autism
UBE2A,HGNC:12472,syndromic X-linked intellectual disability Nascimento type,MONDO:0010461,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_94765cdb-fe12-4098-b28e-20cd58744271-2018-07-02T160000.000Z,2018-07-02T16:00:00.000Z,Intellectual Disability and Autism
UPF3B,HGNC:20439,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1caf030-ef58-4f8f-ba40-aabbf81cf6b1-2019-07-03T160000.000Z,2019-07-03T16:00:00.000Z,Intellectual Disability and Autism
USP9X,HGNC:12632,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bd411e83-8373-44b7-8ad5-00894c873880-2021-11-17T180000.000Z,2021-11-17T18:00:00.000Z,Intellectual Disability and Autism
VPS13B,HGNC:2183,Cohen syndrome,MONDO:0008999,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ccfc68bc-9f00-4565-b2c7-70ad9f8e2002-2018-11-13T153457.342Z,2018-11-13T15:34:57.342Z,Intellectual Disability and Autism
WAC,HGNC:17327,DeSanto-Shinawi syndrome,MONDO:0018760,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6a1f3c78-d7d2-4a8c-8dbf-ddda78769bd7-2022-11-10T170000.000Z,2022-11-10T17:00:00.000Z,Intellectual Disability and Autism
WDFY3,HGNC:20751,syndromic intellectual disability,MONDO:0000508,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a9300a41-dcac-4842-855d-01804e18d599-2022-01-19T170000.000Z,2022-01-19T17:00:00.000Z,Intellectual Disability and Autism
ZC4H2,HGNC:24931,X-linked syndromic intellectual disability,MONDO:0020119,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_64ba9cd6-bdfd-4b85-9bdd-1b317715230d-2020-10-21T002026.894Z,2020-10-21T00:20:26.894Z,Intellectual Disability and Autism
ZDHHC15,HGNC:20342,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a2519945-2acd-4484-9811-487ff5189da9-2021-07-30T160000.000Z,2021-07-30T16:00:00.000Z,Intellectual Disability and Autism
ZDHHC9,HGNC:18475,syndromic X-linked intellectual disability Raymond type,MONDO:0010427,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2156b925-1ee6-4edb-a514-3650aa5b780e-2020-05-19T160000.000Z,2020-05-19T16:00:00.000Z,Intellectual Disability and Autism
ZEB2,HGNC:14881,Mowat-Wilson syndrome,MONDO:0009341,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cb06ff0d-1cc6-494c-9ce5-f7cb26f34620-2018-05-24T160000.000Z,2018-05-24T16:00:00.000Z,Intellectual Disability and Autism
ZMIZ1,HGNC:16493,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a6047476-9d50-4b42-a00a-e983c7481f19-2022-07-05T020000.000Z,2022-07-05T02:00:00.000Z,Intellectual Disability and Autism
ZNF292,HGNC:18410,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dba438b7-23f9-4c15-a8aa-f70431a193e2-2020-05-06T160000.000Z,2020-05-06T16:00:00.000Z,Intellectual Disability and Autism
ZNF41,HGNC:13107,non-syndromic X-linked intellectual disability,MONDO:0019181,XL,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6d705685-78a3-4925-8a1b-e00d39d63f87-2021-03-16T171235.415Z,2021-03-16T17:12:35.415Z,Intellectual Disability and Autism
ZNF674,HGNC:17625,X-linked intellectual disability,MONDO:0100284,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5105ab37-4f59-44dc-a8b1-f28e6ed3b704-2021-05-04T170000.000Z,2021-05-04T17:00:00.000Z,Intellectual Disability and Autism
ZNF711,HGNC:13128,X-linked complex neurodevelopmental disorder,MONDO:0100148,XL,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_80a6e42d-f8ce-4bce-8bb4-579b78c94d21-2022-09-22T060000.000Z,2022-09-22T06:00:00.000Z,Intellectual Disability and Autism
ZNF81,HGNC:13156,X-linked intellectual disability,MONDO:0100284,XL,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a3ada757-6500-46a1-a89e-42668bbdb934-2021-01-26T170000.000Z,2021-01-26T17:00:00.000Z,Intellectual Disability and Autism
ADAMTS9,HGNC:13202,ciliopathy,MONDO:0005308,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a31b47e0-c9a5-4bdd-99d7-2d7f0d2a3bc8-2022-05-11T160000.000Z,2022-05-11T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
ALG8,HGNC:23161,polycystic liver disease 3 with or without kidney cysts,MONDO:0054743,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_13259bf6-e954-4159-b247-c9685638e537-2020-07-29T160000.000Z,2020-07-29T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
ALG9,HGNC:15672,ALG9-associated autosomal dominant polycystic kidney disease,MONDO:0700000,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_38d817af-0a28-4453-a00f-ffccadbd9936-2020-08-26T160000.000Z,2020-08-26T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
ANKS6,HGNC:26724,nephronophthisis 16,MONDO:0014158,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_62df8a40-0b65-46a4-89c8-51f26424c523-2021-08-25T160000.000Z,2021-08-25T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
CC2D2A,HGNC:29253,ciliopathy,MONDO:0005308,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0acbae16-a383-4345-978c-9d28dda80d02-2022-08-24T160000.000Z,2022-08-24T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
CEP164,HGNC:29182,ciliopathy,MONDO:0005308,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_961b81f6-7ad1-49e2-b675-c035b4d8d35d-2021-10-27T160000.000Z,2021-10-27T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
CSPP1,HGNC:26193,Joubert syndrome 21,MONDO:0014288,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e24d1591-91b7-4c2f-bd79-d4dc8be0974d-2021-06-23T160000.000Z,2021-06-23T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
CYS1,HGNC:18525,polycystic kidney disease,MONDO:0020642,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9b3fd5b2-e89e-409a-9802-35cf6ac26913-2022-04-27T160000.000Z,2022-04-27T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
DCDC2,HGNC:18141,ciliopathy,MONDO:0005308,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_477c8aba-eeba-43dc-a5e2-f6f84b127b8f-2021-10-13T160000.000Z,2021-10-13T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
DNAJB11,HGNC:14889,polycystic kidney disease 6 with or without polycystic liver disease,MONDO:0054842,AD,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dbbe08a1-2f13-445d-9492-d1f070e66c0c-2021-02-26T152748.643Z,2021-02-26T15:27:48.643Z,Kidney Cystic and Ciliopathy Disorders
DZIP1L,HGNC:26551,autosomal recessive polycystic kidney disease,MONDO:0009889,AR,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f1e2d1d2-b77c-4f1a-b185-31e3a95aae9b-2022-03-09T170000.000Z,2022-03-09T17:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
GANAB,HGNC:4138,polycystic kidney disease 3 with or without polycystic liver disease,MONDO:0010916,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e6392961-a64a-4818-903a-0bf88b32e736-2020-09-09T160000.000Z,2020-09-09T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
GLIS2,HGNC:29450,nephronophthisis 7,MONDO:0012680,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c51be76f-59d3-4884-9df3-4416686848ab-2021-05-26T160000.000Z,2021-05-26T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
IFT140,HGNC:29077,autosomal dominant polycystic kidney disease,MONDO:0004691,AD,SOP9,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_40ced6e2-4d01-46b5-acd3-3964013add3b-2022-04-13T160000.000Z,2022-04-13T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
INPP5E,HGNC:21474,Joubert syndrome 1,MONDO:0008944,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a5fb970a-8747-4c3e-8465-d8cb007c1428-2021-09-08T160000.000Z,2021-09-08T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
INVS,HGNC:17870,nephronophthisis 2,MONDO:0011190,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6bdaee2a-144d-4bdf-a5c7-78001b991174-2021-02-24T170000.000Z,2021-02-24T17:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
LRP5,HGNC:6697,polycystic liver disease 4 with or without kidney cysts,MONDO:0044327,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dd2a14d4-0c98-4b0d-bee8-a0c5f3550009-2020-08-12T160000.000Z,2020-08-12T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
MAPKBP1,HGNC:29536,nephronophthisis 20,MONDO:0014997,AR,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b8542450-d48b-45ba-bd5f-4e55d210aa6b-2021-05-26T160000.000Z,2021-05-26T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
NEK8,HGNC:13387,renal-hepatic-pancreatic dysplasia 2,MONDO:0014174,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6888a91a-6589-42a9-9622-553b4918bed6-2021-09-08T160000.000Z,2021-09-08T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
NPHP1,HGNC:7905,nephronophthisis 1,MONDO:0009728,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_abc69434-e9e6-4a2b-96b6-b7186f40021f-2021-01-27T170000.000Z,2021-01-27T17:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
NPHP3,HGNC:7907,nephronophthisis,MONDO:0019005,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_47c3a0f1-9c14-4c92-83f2-e1105d528097-2021-07-24T160000.000Z,2021-07-24T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
NPHP4,HGNC:19104,nephronophthisis 4,MONDO:0011752,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cafd0d51-dd5d-4691-8725-86518345b097-2021-02-10T170000.000Z,2021-02-10T17:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
PKD1,HGNC:9008,autosomal dominant polycystic kidney disease,MONDO:0004691,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_09d61dec-314b-4c5f-af2e-f22fc5992c12-2021-02-26T151356.823Z,2021-02-26T15:13:56.823Z,Kidney Cystic and Ciliopathy Disorders
PKD2,HGNC:9009,autosomal dominant polycystic kidney disease,MONDO:0004691,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ae0ae123-be04-4ba2-b685-594ca47a3467-2021-02-26T151635.009Z,2021-02-26T15:16:35.009Z,Kidney Cystic and Ciliopathy Disorders
PKHD1,HGNC:9016,autosomal recessive polycystic kidney disease,MONDO:0009889,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_06fb7576-e842-4e52-9284-0762bb7a05c6-2020-11-11T170000.000Z,2020-11-11T17:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
PRKCSH,HGNC:9411,polycystic liver disease 1,MONDO:0008265,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_83607ef3-6ec2-4d63-991a-4aeb3f7c2a25-2020-07-08T040000.000Z,2020-07-08T04:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
REN,HGNC:9958,renal tubular dysgenesis of genetic origin,MONDO:0009970,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9a9a43c4-771a-4a73-b66f-dd99ab76aeec-2020-10-28T160000.000Z,2020-10-28T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
REN,HGNC:9958,familial juvenile hyperuricemic nephropathy type 2,MONDO:0013128,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cae92b57-f5b9-4000-9a42-72161f2d7dd3-2020-10-28T160000.000Z,2020-10-28T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
SEC61B,HGNC:16993,SEC61B-related polycystic liver disease,MONDO:0550003,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0fc2c7f6-caef-4f23-82ba-2360a5eb0990-2020-07-08T160000.000Z,2020-07-08T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
SEC63,HGNC:21082,polycystic liver disease 2,MONDO:0014860,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_76312e16-e3b1-400a-8a22-4c0cca5e6918-2020-09-23T040000.000Z,2020-09-23T04:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
SLC41A1,HGNC:19429,kidney disorder,MONDO:0005240,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1a853a0-854a-4b61-8b12-eaf8edeabee7-2022-05-11T160000.000Z,2022-05-11T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
TMEM231,HGNC:37234,ciliopathy,MONDO:0005308,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_52100cfc-22b6-47c5-9b9c-512a1a4f1cfc-2022-01-12T170000.000Z,2022-01-12T17:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
TMEM67,HGNC:28396,ciliopathy,MONDO:0005308,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8f380d4b-6d0b-4c09-a3ae-ec34bc8ecb8d-2021-07-14T160000.000Z,2021-07-14T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
TTC21B,HGNC:25660,nephronophthisis 12,MONDO:0013442,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_60f93fe0-145f-47a7-9ecf-613b1b1dfa7f-2021-11-10T170000.000Z,2021-11-10T17:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
TULP3,HGNC:12425,ciliopathy,MONDO:0005308,AR,SOP9,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6f45b6a3-7f38-436f-bfde-beac067fdb88-2022-07-27T160000.000Z,2022-07-27T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
UMOD,HGNC:12559,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,MONDO:0008264,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_39233b4e-a491-47b4-8407-2e15dda89221-2021-01-13T170000.000Z,2021-01-13T17:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
WDR19,HGNC:18340,ciliopathy,MONDO:0005308,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_418a6e41-45ad-411f-a40d-2f7cb61ff589-2022-05-25T160000.000Z,2022-05-25T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
XPNPEP3,HGNC:28052,nephronophthisis-like nephropathy 1,MONDO:0013163,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c1fd65c6-6010-4ee7-bb1c-e347c539127c-2021-06-23T150426.493Z,2021-06-23T15:04:26.493Z,Kidney Cystic and Ciliopathy Disorders
ZNF423,HGNC:16762,nephronophthisis,MONDO:0019005,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c61623dd-07b1-41c5-b445-3f9f8575cc06-2022-03-23T160000.000Z,2022-03-23T16:00:00.000Z,Kidney Cystic and Ciliopathy Disorders
ANO5,HGNC:27337,autosomal recessive limb-girdle muscular dystrophy,MONDO:0015152,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cecfa828-c192-44ae-9f3f-9dd5a99a5e5a-2020-09-09T120214.822Z,2020-09-09T12:02:14.822Z,Limb Girdle Muscular Dystrophy
CAPN3,HGNC:1480,limb-girdle muscular dystrophy,MONDO:0016971,SD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6f7dbd92-77a0-4fe7-9308-98ce7f4cc383-2021-06-15T185919.142Z,2021-06-15T18:59:19.142Z,Limb Girdle Muscular Dystrophy
DAG1,HGNC:2666,qualitative or quantitative defects of alpha-dystroglycan,MONDO:0018282,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_61b73fd7-5578-447b-9482-ea64d62dae1d-2021-07-27T163613.141Z,2021-07-27T16:36:13.141Z,Limb Girdle Muscular Dystrophy
DMD,HGNC:2928,progressive muscular dystrophy,MONDO:0016106,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b528435f-dc16-45e0-9f0f-2da3f293ab4c-2021-04-09T185212.943Z,2021-04-09T18:52:12.943Z,Limb Girdle Muscular Dystrophy
DYSF,HGNC:3097,autosomal recessive limb-girdle muscular dystrophy,MONDO:0015152,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_94042756-2e7a-4cfa-812c-1b88b703eeea-2020-05-01T193204.280Z,2020-05-01T19:32:04.280Z,Limb Girdle Muscular Dystrophy
FKRP,HGNC:17997,muscular dystrophy-dystroglycanopathy,MONDO:0018276,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6cb46400-ca4b-48cd-aaf7-dd493f0d2971-2020-08-11T185912.538Z,2020-08-11T18:59:12.538Z,Limb Girdle Muscular Dystrophy
FKTN,HGNC:3622,muscular dystrophy-dystroglycanopathy,MONDO:0018276,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_54e23f1a-3b1b-49ef-aa02-6b46374b1546-2020-07-01T150411.449Z,2020-07-01T15:04:11.449Z,Limb Girdle Muscular Dystrophy
HNRNPDL,HGNC:5037,limb-girdle muscular dystrophy,MONDO:0016971,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_10c69d38-c981-4679-81ab-c656f435e1ed-2022-08-08T160000.000Z,2022-08-08T16:00:00.000Z,Limb Girdle Muscular Dystrophy
POMGNT1,HGNC:19139,muscular dystrophy-dystroglycanopathy,MONDO:0018276,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_03bb8479-2ed3-4b15-9e54-378ea0729ab2-2020-09-09T120352.877Z,2020-09-09T12:03:52.877Z,Limb Girdle Muscular Dystrophy
POMGNT2,HGNC:25902,muscular dystrophy-dystroglycanopathy,MONDO:0018276,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_522f3d3f-8026-439f-9318-2e4df6097a2e-2020-09-10T122353.145Z,2020-09-10T12:23:53.145Z,Limb Girdle Muscular Dystrophy
POMT1,HGNC:9202,myopathy caused by variation in POMT1,MONDO:0700070,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_146ee85f-a6c2-468f-aacb-a320767de36e-2022-02-16T043713.150Z,2022-02-16T04:37:13.150Z,Limb Girdle Muscular Dystrophy
POPDC3,HGNC:17649,autosomal recessive limb-girdle muscular dystrophy,MONDO:0015152,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bb7755df-a1e3-4398-a771-cd6c2d112b68-2021-01-13T194210.166Z,2021-01-13T19:42:10.166Z,Limb Girdle Muscular Dystrophy
SGCA,HGNC:10805,autosomal recessive limb-girdle muscular dystrophy,MONDO:0015152,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e60e8b70-857e-4dae-bc45-da7db0dd5bf1-2020-04-14T184243.590Z,2020-04-14T18:42:43.590Z,Limb Girdle Muscular Dystrophy
SGCB,HGNC:10806,autosomal recessive limb-girdle muscular dystrophy,MONDO:0015152,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c90753f2-8252-400f-b7b3-9d0b04e1e12c-2020-02-11T170000.000Z,2020-02-11T17:00:00.000Z,Limb Girdle Muscular Dystrophy
SGCD,HGNC:10807,autosomal recessive limb-girdle muscular dystrophy,MONDO:0015152,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1ad12a23-af71-4b3b-8a79-831b4d338c97-2020-04-14T183000.400Z,2020-04-14T18:30:00.400Z,Limb Girdle Muscular Dystrophy
SGCG,HGNC:10809,autosomal recessive limb-girdle muscular dystrophy,MONDO:0015152,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dc0d70af-ecb5-4755-a840-9e8bb6f4e0a7-2020-04-14T185145.093Z,2020-04-14T18:51:45.093Z,Limb Girdle Muscular Dystrophy
TCAP,HGNC:11610,autosomal recessive limb-girdle muscular dystrophy type 2G,MONDO:0011170,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f3c6c72e-7c2b-42d4-963b-aeddbbe0e4fc-2021-10-12T160000.000Z,2021-10-12T16:00:00.000Z,Limb Girdle Muscular Dystrophy
TNPO3,HGNC:17103,"muscular dystrophy, limb-girdle, autosomal dominant",MONDO:0015151,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9cd2cbd3-46da-490c-9765-40b52750dded-2021-06-15T185556.261Z,2021-06-15T18:55:56.261Z,Limb Girdle Muscular Dystrophy
TRIM32,HGNC:16380,autosomal recessive limb-girdle muscular dystrophy,MONDO:0015152,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fbabe4ea-579e-4d98-a4b7-5ff84ee7f245-2020-11-05T210106.630Z,2020-11-05T21:01:06.630Z,Limb Girdle Muscular Dystrophy
AKAP9,HGNC:379,long QT syndrome,MONDO:0002442,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_786eac72-8014-4fdf-b279-10a5faaa09b8-2020-12-15T002607.349Z,2020-12-15T00:26:07.349Z,Long QT Syndrome
ANK2,HGNC:493,long QT syndrome,MONDO:0002442,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dd577817-d668-413c-95f9-d3e08a8cf5d3-2020-12-15T002719.834Z,2020-12-15T00:27:19.834Z,Long QT Syndrome
CACNA1C,HGNC:1390,long QT syndrome,MONDO:0002442,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c496551d-c7a7-4e49-ad41-8cfd49840dc1-2020-04-24T160000.000Z,2020-04-24T16:00:00.000Z,Long QT Syndrome
CALM1,HGNC:1442,long QT syndrome,MONDO:0002442,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4a150cd9-e16b-4992-8cc7-5ccec44b4d6b-2018-09-25T160000.000Z,2018-09-25T16:00:00.000Z,Long QT Syndrome
CALM2,HGNC:1445,long QT syndrome,MONDO:0002442,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_86e4b783-3b60-4a1d-ab34-e61d27751ca6-2018-09-25T160000.000Z,2018-09-25T16:00:00.000Z,Long QT Syndrome
CALM3,HGNC:1449,long QT syndrome,MONDO:0002442,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3cc2a1ae-5f3d-445c-b124-f3d38fdd070a-2018-09-25T160000.000Z,2018-09-25T16:00:00.000Z,Long QT Syndrome
CAV3,HGNC:1529,long QT syndrome,MONDO:0002442,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_74aabddc-3402-46de-ba1e-f66aa273cd9c-2020-12-15T002855.870Z,2020-12-15T00:28:55.870Z,Long QT Syndrome
KCNE1,HGNC:6240,long QT syndrome 5,MONDO:0013372,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_957550ae-d91c-49e7-be7c-ff5a13faa3ff-2020-12-15T002142.973Z,2020-12-15T00:21:42.973Z,Long QT Syndrome
KCNE2,HGNC:6242,long QT syndrome,MONDO:0002442,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9912be79-b172-46ca-a67c-99698de5590b-2020-12-15T002341.412Z,2020-12-15T00:23:41.412Z,Long QT Syndrome
KCNH2,HGNC:6251,long QT syndrome,MONDO:0002442,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_462eeb4e-357d-4c3d-89f0-e386ac0d011b-2018-09-25T040000.000Z,2018-09-25T04:00:00.000Z,Long QT Syndrome
KCNJ2,HGNC:6263,long QT syndrome,MONDO:0002442,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5dc2acbc-8dbe-4142-8f71-89f1576dde08-2020-12-15T002535.799Z,2020-12-15T00:25:35.799Z,Long QT Syndrome
KCNJ5,HGNC:6266,long QT syndrome,MONDO:0002442,AD,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6fa6a520-ae6b-4638-a092-a61831d481bf-2020-12-15T002641.568Z,2020-12-15T00:26:41.568Z,Long QT Syndrome
KCNQ1,HGNC:6294,long QT syndrome,MONDO:0002442,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dff8874e-98a1-472b-9cc2-3f441b1c1064-2018-09-25T040000.000Z,2018-09-25T04:00:00.000Z,Long QT Syndrome
SCN4B,HGNC:10592,long QT syndrome,MONDO:0002442,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0e276096-21ab-42bc-866a-b1b4dcb01753-2018-09-25T160000.000Z,2018-09-25T16:00:00.000Z,Long QT Syndrome
SCN5A,HGNC:10593,familial long QT syndrome,MONDO:0019171,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ab19e69c-50fb-41e3-8adf-4d27617f3d55-2018-09-25T160000.000Z,2018-09-25T16:00:00.000Z,Long QT Syndrome
SNTA1,HGNC:11167,long QT syndrome,MONDO:0002442,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_03c758a6-9290-4e14-9501-0ffb0fbfe8ce-2020-04-24T160000.000Z,2020-04-24T16:00:00.000Z,Long QT Syndrome
TRDN,HGNC:12261,long QT syndrome,MONDO:0002442,AR,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1278bd6a-6ac7-4556-87ea-f860027b2da5-2020-04-24T160000.000Z,2020-04-24T16:00:00.000Z,Long QT Syndrome
ABHD5,HGNC:21396,Dorfman-Chanarin disease,MONDO:0010155,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_19bf65b3-0c75-46e2-8796-5664ce6dd371-2022-08-02T160000.000Z,2022-08-02T16:00:00.000Z,Lysosomal Diseases
AGA,HGNC:318,aspartylglucosaminuria,MONDO:0008830,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1f315b4a-1a3b-4deb-90fd-2b73f732a4ba-2022-09-02T160000.000Z,2022-09-02T16:00:00.000Z,Lysosomal Diseases
ARSB,HGNC:714,mucopolysaccharidosis type 6,MONDO:0009661,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2a850717-e21b-495d-8542-de4fdb142647-2022-04-17T160000.000Z,2022-04-17T16:00:00.000Z,Lysosomal Diseases
ATG5,HGNC:589,"spinocerebellar ataxia, autosomal recessive 25",MONDO:0033115,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b47796b8-3811-4411-b0f0-5b703755f08b-2022-07-21T160000.000Z,2022-07-21T16:00:00.000Z,Lysosomal Diseases
ATG7,HGNC:16935,"spinocerebellar ataxia, autosomal recessive 31",MONDO:0030323,AR,SOP9,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bfee65a8-cbc9-4f1a-a4f7-5973ecff593d-2022-09-02T160000.000Z,2022-09-02T16:00:00.000Z,Lysosomal Diseases
CTSA,HGNC:9251,galactosialidosis,MONDO:0009737,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b46b7e30-216e-4f8a-a4b9-67d59b9ca655-2022-09-02T160000.000Z,2022-09-02T16:00:00.000Z,Lysosomal Diseases
CTSK,HGNC:2536,pycnodysostosis,MONDO:0009940,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8135617e-f334-4c22-aa9e-b1efd50e9326-2022-11-11T180000.000Z,2022-11-11T18:00:00.000Z,Lysosomal Diseases
FUCA1,HGNC:4006,fucosidosis,MONDO:0009254,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e88e0ef6-e788-40e2-bbd4-7fb3efb6b0ea-2022-08-02T160000.000Z,2022-08-02T16:00:00.000Z,Lysosomal Diseases
GALC,HGNC:4115,Krabbe disease,MONDO:0009499,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d17202fb-89c4-4bf6-ad57-4b8c541dc808-2022-06-15T160000.000Z,2022-06-15T16:00:00.000Z,Lysosomal Diseases
GALNS,HGNC:4122,mucopolysaccharidosis type 4A,MONDO:0009659,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c58d08e9-dc6d-45fc-a21a-54be3bc438d9-2022-06-16T160000.000Z,2022-06-16T16:00:00.000Z,Lysosomal Diseases
GM2A,HGNC:4367,Tay-Sachs disease AB variant,MONDO:0010099,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7c793bd3-8433-4632-a571-a3fc07e84c10-2022-08-12T160000.000Z,2022-08-12T16:00:00.000Z,Lysosomal Diseases
GNPTG,HGNC:23026,mucolipidosis type III gamma,MONDO:0009652,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_71d1d916-4c96-4d09-a66b-1c7ccb55c353-2023-01-02T170000.000Z,2023-01-02T17:00:00.000Z,Lysosomal Diseases
GNS,HGNC:4422,mucopolysaccharidosis type 3D,MONDO:0009658,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_63312833-baef-4b11-9769-c93957decef6-2022-09-02T160000.000Z,2022-09-02T16:00:00.000Z,Lysosomal Diseases
GUSB,HGNC:4696,mucopolysaccharidosis type 7,MONDO:0009662,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aae0c8bd-5ff2-48a1-90e9-9038dcb44bc3-2022-07-05T160000.000Z,2022-07-05T16:00:00.000Z,Lysosomal Diseases
HEXB,HGNC:4879,Sandhoff disease,MONDO:0010006,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7f53d03d-f936-4628-ab75-351ae4da012a-2022-09-15T160000.000Z,2022-09-15T16:00:00.000Z,Lysosomal Diseases
HYAL1,HGNC:5320,mucopolysaccharidosis type 9,MONDO:0011093,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_01141943-dabb-4218-a147-657c69679ec3-2022-12-06T170000.000Z,2022-12-06T17:00:00.000Z,Lysosomal Diseases
MAN2B1,HGNC:6826,alpha-mannosidosis,MONDO:0009561,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ef3b8e84-1f36-4aae-b167-b50dd074bf2b-2022-09-02T160000.000Z,2022-09-02T16:00:00.000Z,Lysosomal Diseases
MANBA,HGNC:6831,beta-mannosidosis,MONDO:0009562,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d70d38aa-f7e9-4c93-8160-58dec9cec010-2022-08-02T160000.000Z,2022-08-02T16:00:00.000Z,Lysosomal Diseases
MCOLN1,HGNC:13356,mucolipidosis type IV,MONDO:0009653,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_baf3301d-214e-46b5-8053-5217b52fe6c2-2022-09-14T160000.000Z,2022-09-14T16:00:00.000Z,Lysosomal Diseases
NAGA,HGNC:7631,alpha-N-acetylgalactosaminidase deficiency,MONDO:0017779,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_94962878-05e3-4cc0-a6d7-e9cd86f49b1d-2022-09-29T160000.000Z,2022-09-29T16:00:00.000Z,Lysosomal Diseases
NAGLU,HGNC:7632,mucopolysaccharidosis type 3,MONDO:0018937,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7ee5629a-f6c2-4187-a802-d570f7180478-2022-08-02T160000.000Z,2022-08-02T16:00:00.000Z,Lysosomal Diseases
NEU1,HGNC:7758,sialidosis,MONDO:0017734,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_01f588c4-4fef-493d-b5e0-a76fb9492244-2022-09-02T160000.000Z,2022-09-02T16:00:00.000Z,Lysosomal Diseases
NPC1,HGNC:7897,"Niemann-Pick disease, type C1",MONDO:0009757,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e8459873-2577-43ff-966c-e5180683d4f4-2022-03-01T170000.000Z,2022-03-01T17:00:00.000Z,Lysosomal Diseases
NPC2,HGNC:14537,"Niemann-Pick disease, type C2",MONDO:0011873,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_82bb23dd-d3bc-478d-bb3d-d1928e810029-2022-04-06T130135.185Z,2022-04-06T13:01:35.185Z,Lysosomal Diseases
PNPLA2,HGNC:30802,neutral lipid storage myopathy,MONDO:0012545,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fd21d68b-7688-4164-ba13-1ced669c4dfa-2022-07-21T160000.000Z,2022-07-21T16:00:00.000Z,Lysosomal Diseases
SGSH,HGNC:10818,mucopolysaccharidosis type 3A,MONDO:0009655,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_438dab6d-abf4-44e8-a176-bb39ae128052-2022-06-15T160000.000Z,2022-06-15T16:00:00.000Z,Lysosomal Diseases
SLC38A9,HGNC:26907,lysosomal storage disease,MONDO:0002561,Undetermined,SOP9,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_34c72694-90be-4ba1-a876-4f77562e7e72-2022-08-02T160000.000Z,2022-08-02T16:00:00.000Z,Lysosomal Diseases
SMPD1,HGNC:11120,acid sphingomyelinase deficiency,MONDO:0100464,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ccda7e6a-1cd6-45e2-971f-528a13589e1c-2022-07-08T160000.000Z,2022-07-08T16:00:00.000Z,Lysosomal Diseases
SUMF1,HGNC:20376,mucosulfatidosis,MONDO:0010088,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2d64d13d-c2dc-4749-8330-fade259ca381-2022-09-06T160000.000Z,2022-09-06T16:00:00.000Z,Lysosomal Diseases
AARS2,HGNC:21022,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_583e237c-18f6-4427-a04f-82ea0f020daf-2022-04-18T160000.000Z,2022-04-18T16:00:00.000Z,Mitochondrial Diseases
ADAR,HGNC:225,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_03f538b5-43af-4699-9ddb-264077de21c9-2020-08-27T164642.352Z,2020-08-27T16:46:42.352Z,Mitochondrial Diseases
AIFM1,HGNC:8768,Leigh syndrome,MONDO:0009723,XL,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e917f93b-01ef-42e3-bf8d-b50a91f83f9c-2021-06-14T135732.582Z,2021-06-14T13:57:32.582Z,Mitochondrial Diseases
ATP5MK,HGNC:30889,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ff19a86d-404a-464e-8da6-8824ce45ed20-2020-08-27T164252.070Z,2020-08-27T16:42:52.070Z,Mitochondrial Diseases
BCS1L,HGNC:1020,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3b50d7db-1144-4187-a60c-72b45adb80bd-2019-09-19T155315.896Z,2019-09-19T15:53:15.896Z,Mitochondrial Diseases
BTD,HGNC:1122,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_74599afe-02f9-4225-9e50-63306f04a552-2021-06-14T140327.018Z,2021-06-14T14:03:27.018Z,Mitochondrial Diseases
C1QBP,HGNC:1243,mitochondrial disease,MONDO:0044970,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8e98e3a8-77f2-4011-96cb-6bcc54f36a8b-2022-08-15T160000.000Z,2022-08-15T16:00:00.000Z,Mitochondrial Diseases
CARS2,HGNC:25695,mitochondrial disease,MONDO:0044970,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a07aaa07-ad0d-4dac-8751-18242a3f36a9-2022-05-19T160000.000Z,2022-05-19T16:00:00.000Z,Mitochondrial Diseases
CLPB,HGNC:30664,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_789c591d-1de7-4652-a0d1-f895b639233e-2020-11-23T201057.415Z,2020-11-23T20:10:57.415Z,Mitochondrial Diseases
COA3,HGNC:24990,mitochondrial disease,MONDO:0044970,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_83ca0cfa-10b9-4bd5-86dd-83bef18e33dc-2022-08-15T160000.000Z,2022-08-15T16:00:00.000Z,Mitochondrial Diseases
COQ9,HGNC:25302,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cebc5501-5d36-4767-98bc-edc4ddab3527-2021-04-09T140634.407Z,2021-04-09T14:06:34.407Z,Mitochondrial Diseases
COX10,HGNC:2260,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_48794019-db9d-47c2-9977-4dc76a7d07b3-2019-05-20T182801.393Z,2019-05-20T18:28:01.393Z,Mitochondrial Diseases
COX14,HGNC:28216,mitochondrial disease,MONDO:0044970,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8899dbb6-9769-4d93-83fb-e95b6775962c-2022-03-21T040000.000Z,2022-03-21T04:00:00.000Z,Mitochondrial Diseases
COX15,HGNC:2263,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5c8d1e1-24d0-4b88-8c04-023197db14f3-2019-05-20T183321.284Z,2019-05-20T18:33:21.284Z,Mitochondrial Diseases
COX20,HGNC:26970,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2391b81d-cfd2-4862-b71b-0418794539c3-2022-02-17T170000.000Z,2022-02-17T17:00:00.000Z,Mitochondrial Diseases
COX4I1,HGNC:2265,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d56c1fe4-7711-45f4-992c-7e9586b9efc6-2021-04-09T135824.042Z,2021-04-09T13:58:24.042Z,Mitochondrial Diseases
COX6B1,HGNC:2280,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bc374fc3-050b-4985-9f2f-a2972bb795fe-2022-03-21T040000.000Z,2022-03-21T04:00:00.000Z,Mitochondrial Diseases
COX8A,HGNC:2294,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_70763eb9-40f7-4f71-a64b-ab0c6ad536b0-2021-04-09T135510.592Z,2021-04-09T13:55:10.592Z,Mitochondrial Diseases
CYC1,HGNC:2579,mitochondrial disease,MONDO:0044970,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0d620451-2b96-409b-a109-ceb035e1e68e-2022-03-21T160000.000Z,2022-03-21T16:00:00.000Z,Mitochondrial Diseases
DARS2,HGNC:25538,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c3fc3cd8-48aa-4e02-8324-b3412fcfa64f-2022-05-04T160000.000Z,2022-05-04T16:00:00.000Z,Mitochondrial Diseases
DLAT,HGNC:2896,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_78e45dbe-ea30-434d-9522-aa1731b9a764-2021-01-14T212056.234Z,2021-01-14T21:20:56.234Z,Mitochondrial Diseases
DLD,HGNC:2898,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_990dd96f-16ec-4c0f-a46b-ce4a647b7a50-2021-03-11T171246.198Z,2021-03-11T17:12:46.198Z,Mitochondrial Diseases
DNM1L,HGNC:2973,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0a922695-f136-44f8-ab1a-6581e0efafec-2021-06-30T144517.300Z,2021-06-30T14:45:17.300Z,Mitochondrial Diseases
DNM1L,HGNC:2973,Leigh syndrome,MONDO:0009723,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c22e9c6b-f04d-4d56-acb3-baa308c596b7-2021-06-30T144120.695Z,2021-06-30T14:41:20.695Z,Mitochondrial Diseases
EARS2,HGNC:29419,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_774e378c-2636-41ad-be48-a2c00328ab9c-2020-03-19T190729.531Z,2020-03-19T19:07:29.531Z,Mitochondrial Diseases
ECHS1,HGNC:3151,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1d443f3c-fe02-4104-9e92-ca1c73b85a81-2021-04-09T142601.823Z,2021-04-09T14:26:01.823Z,Mitochondrial Diseases
ETHE1,HGNC:23287,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d29d908d-ea85-4eb4-a6a5-400c95511c9a-2019-04-08T161759.443Z,2019-04-08T16:17:59.443Z,Mitochondrial Diseases
FARS2,HGNC:21062,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2cf7594a-d934-4b6c-8052-94066d608c5a-2019-11-25T144756.827Z,2019-11-25T14:47:56.827Z,Mitochondrial Diseases
FASTKD2,HGNC:29160,mitochondrial disease,MONDO:0044970,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_82883e8c-7ee6-447e-bdc6-8898c4848e7a-2022-07-21T160000.000Z,2022-07-21T16:00:00.000Z,Mitochondrial Diseases
FBXL4,HGNC:13601,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fed67104-182c-48f2-85c0-ecb05cd6dd72-2020-11-23T193117.246Z,2020-11-23T19:31:17.246Z,Mitochondrial Diseases
FOXRED1,HGNC:26927,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c74ba0cb-ccef-4a19-9fef-ef9996f72290-2019-10-16T143453.574Z,2019-10-16T14:34:53.574Z,Mitochondrial Diseases
GFM1,HGNC:13780,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_154a8f96-7062-49c7-9aaa-b23a98655f40-2019-12-19T185108.232Z,2019-12-19T18:51:08.232Z,Mitochondrial Diseases
GFM2,HGNC:29682,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0736b760-ca37-4d0a-93a4-c71bbb8cd41a-2019-12-19T185449.252Z,2019-12-19T18:54:49.252Z,Mitochondrial Diseases
GTPBP3,HGNC:14880,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0d1b0a47-e62d-48dd-8e0d-f2b1aff014a7-2020-02-12T203256.857Z,2020-02-12T20:32:56.857Z,Mitochondrial Diseases
HIBCH,HGNC:4908,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_079ed613-0c28-494f-9852-9baf495f26ba-2021-06-14T142317.786Z,2021-06-14T14:23:17.786Z,Mitochondrial Diseases
HPDL,HGNC:28242,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d1a484ba-cba2-4a63-8c81-7a8a41c93f9c-2021-06-30T215754.231Z,2021-06-30T21:57:54.231Z,Mitochondrial Diseases
IARS2,HGNC:29685,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_50877212-c671-406b-8cb6-195c7369a96c-2019-11-25T154442.667Z,2019-11-25T15:44:42.667Z,Mitochondrial Diseases
LIAS,HGNC:16429,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec6f6c96-262d-4ab8-ab7a-b09d585689ca-2021-03-11T171936.261Z,2021-03-11T17:19:36.261Z,Mitochondrial Diseases
LIPT1,HGNC:29569,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_55d66b81-fe31-4965-b5fc-483393af820d-2021-04-09T142912.496Z,2021-04-09T14:29:12.496Z,Mitochondrial Diseases
LONP1,HGNC:9479,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3da0a308-3a7e-4101-b40b-1f23db106aea-2021-04-09T140215.539Z,2021-04-09T14:02:15.539Z,Mitochondrial Diseases
LRPPRC,HGNC:15714,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_79691365-1911-423c-ab14-73a1f509ed22-2019-12-19T190157.942Z,2019-12-19T19:01:57.942Z,Mitochondrial Diseases
LYRM7,HGNC:28072,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ac7b4d77-f1e5-4b7a-a7c4-e37db6c49026-2022-04-04T160000.000Z,2022-04-04T16:00:00.000Z,Mitochondrial Diseases
MARS2,HGNC:25133,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b65af5c2-f03e-4e10-a2c4-e4524b64f1cc-2022-05-04T160000.000Z,2022-05-04T16:00:00.000Z,Mitochondrial Diseases
MECR,HGNC:19691,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_75fcef99-f3fe-43b3-a544-a91f04ed1285-2021-06-14T142534.349Z,2021-06-14T14:25:34.349Z,Mitochondrial Diseases
MFF,HGNC:24858,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4484881f-277f-47a2-b1dd-70072ec941e0-2021-04-09T141836.756Z,2021-04-09T14:18:36.756Z,Mitochondrial Diseases
MORC2,HGNC:23573,Leigh syndrome,MONDO:0009723,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_23358115-fe60-41c7-b01e-44d1cb8329b1-2021-06-14T142952.247Z,2021-06-14T14:29:52.247Z,Mitochondrial Diseases
MRPL3,HGNC:10379,mitochondrial disease,MONDO:0044970,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2164ee6c-0956-4453-8d0a-afc21b691232-2022-08-15T160000.000Z,2022-08-15T16:00:00.000Z,Mitochondrial Diseases
MRPL44,HGNC:16650,mitochondrial disease,MONDO:0044970,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4a5d4050-143c-42ed-b3b8-1742fc86bd28-2022-09-07T160000.000Z,2022-09-07T16:00:00.000Z,Mitochondrial Diseases
MRPS16,HGNC:14048,mitochondrial disease,MONDO:0044970,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1bc34eb8-8f60-4fad-892b-11929760cae6-2022-06-16T160000.000Z,2022-06-16T16:00:00.000Z,Mitochondrial Diseases
MRPS22,HGNC:14508,mitochondrial disease,MONDO:0044970,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ac32e0eb-0906-406f-9d1d-baca4e5096c3-2022-07-18T160000.000Z,2022-07-18T16:00:00.000Z,Mitochondrial Diseases
MRPS34,HGNC:16618,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_41d20487-f150-41b6-947c-ce77e405e8de-2020-08-27T162259.700Z,2020-08-27T16:22:59.700Z,Mitochondrial Diseases
MT-ATP6,HGNC:7414,Leigh syndrome,MONDO:0009723,MT,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e492464b-cb98-4bf4-a12e-169b59576b04-2021-06-28T145350.161Z,2021-06-28T14:53:50.161Z,Mitochondrial Diseases
MT-CO1,HGNC:7419,Leigh syndrome,MONDO:0009723,MT,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_227922e2-1f4e-4bd5-9fc2-d48bac5d394f-2021-06-28T143540.269Z,2021-06-28T14:35:40.269Z,Mitochondrial Diseases
MT-CO2,HGNC:7421,Leigh syndrome,MONDO:0009723,MT,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_41d6a25c-4300-4e43-b0f8-1923ff3ddad8-2021-06-28T144136.451Z,2021-06-28T14:41:36.451Z,Mitochondrial Diseases
MT-CO3,HGNC:7422,Leigh syndrome,MONDO:0009723,MT,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_996428ee-5af2-458b-afb7-6e29348c585a-2021-06-28T144716.059Z,2021-06-28T14:47:16.059Z,Mitochondrial Diseases
MT-ND1,HGNC:7455,Leigh syndrome,MONDO:0009723,MT,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8bb99c59-15c9-4e19-ba8b-df6cb800c32d-2021-04-14T040000.000Z,2021-04-14T04:00:00.000Z,Mitochondrial Diseases
MT-ND2,HGNC:7456,Leigh syndrome,MONDO:0009723,MT,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_80f1dcc9-aaf3-45f7-987a-4e0d83140913-2021-04-14T040000.000Z,2021-04-14T04:00:00.000Z,Mitochondrial Diseases
MT-ND4,HGNC:7459,Leigh syndrome,MONDO:0009723,MT,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f05be3e5-352f-49a5-84af-8846d6839373-2021-05-17T040000.000Z,2021-05-17T04:00:00.000Z,Mitochondrial Diseases
MT-ND5,HGNC:7461,Leigh syndrome,MONDO:0009723,MT,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e941d385-716f-4264-8f24-ffe3022579e2-2021-06-14T155537.548Z,2021-06-14T15:55:37.548Z,Mitochondrial Diseases
MT-ND6,HGNC:7462,Leigh syndrome,MONDO:0009723,MT,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_836f975f-27f5-47c9-a58e-35089b6b39e6-2021-05-17T040000.000Z,2021-05-17T04:00:00.000Z,Mitochondrial Diseases
MT-TI,HGNC:7488,Leigh syndrome,MONDO:0009723,MT,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_69991755-b62f-42aa-bbe3-30ac10e4311d-2021-02-03T050000.000Z,2021-02-03T05:00:00.000Z,Mitochondrial Diseases
MT-TK,HGNC:7489,Leigh syndrome,MONDO:0009723,MT,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3f237644-83f5-412e-9bfa-01fbd280c15a-2021-06-28T155537.306Z,2021-06-28T15:55:37.306Z,Mitochondrial Diseases
MT-TL1,HGNC:7490,Leigh syndrome,MONDO:0009723,MT,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_efef782a-88db-470d-9687-23629c75e05a-2021-06-28T154710.419Z,2021-06-28T15:47:10.419Z,Mitochondrial Diseases
MT-TL2,HGNC:7491,Leigh syndrome,MONDO:0009723,MT,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8cee9c77-e47a-4b2f-8029-b1da28799df6-2021-04-14T040000.000Z,2021-04-14T04:00:00.000Z,Mitochondrial Diseases
MT-TV,HGNC:7500,Leigh syndrome,MONDO:0009723,MT,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_42f2fc91-c26d-416c-8d93-448e4a52983b-2021-04-14T040000.000Z,2021-04-14T04:00:00.000Z,Mitochondrial Diseases
MT-TW,HGNC:7501,Leigh syndrome,MONDO:0009723,MT,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3dc54202-27f3-4bf4-883f-5273a49dcb70-2021-06-28T150550.120Z,2021-06-28T15:05:50.120Z,Mitochondrial Diseases
MTFMT,HGNC:29666,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0e7a00ee-ef09-443f-9d66-03128e1fb225-2020-03-19T194517.723Z,2020-03-19T19:45:17.723Z,Mitochondrial Diseases
MTPAP,HGNC:25532,mitochondrial disease,MONDO:0044970,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ffdfbc2d-29c5-4077-a871-940abdb27cb7-2022-08-01T160000.000Z,2022-08-01T16:00:00.000Z,Mitochondrial Diseases
MTRFR,HGNC:26784,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_78f97463-d8b2-411a-9292-1908646dac77-2021-04-01T174500.572Z,2021-04-01T17:45:00.572Z,Mitochondrial Diseases
NARS2,HGNC:26274,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8874861d-9d28-440d-a751-54c22df0d4ad-2019-12-19T190722.572Z,2019-12-19T19:07:22.572Z,Mitochondrial Diseases
NAXE,HGNC:18453,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a062b287-a561-4c3e-942a-3379dee307c8-2021-04-09T142130.880Z,2021-04-09T14:21:30.880Z,Mitochondrial Diseases
NDUFA1,HGNC:7683,Leigh syndrome,MONDO:0009723,XL,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_497170a6-a042-46cb-9809-3c3094fcd05e-2019-05-20T184847.372Z,2019-05-20T18:48:47.372Z,Mitochondrial Diseases
NDUFA10,HGNC:7684,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e40eec3c-0ce0-442e-9058-6bf4d90d6dc3-2019-11-25T162049.949Z,2019-11-25T16:20:49.949Z,Mitochondrial Diseases
NDUFA11,HGNC:20371,mitochondrial disease,MONDO:0044970,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_210108ec-da38-4a32-80b6-8d88f4d22677-2022-02-17T050000.000Z,2022-02-17T05:00:00.000Z,Mitochondrial Diseases
NDUFA12,HGNC:23987,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_81f38f43-5e0c-4cb8-9be8-091f2c8a2c71-2019-11-25T160815.348Z,2019-11-25T16:08:15.348Z,Mitochondrial Diseases
NDUFA13,HGNC:17194,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0bc56951-c454-4e79-95f3-7ffda20482b7-2021-01-21T005411.435Z,2021-01-21T00:54:11.435Z,Mitochondrial Diseases
NDUFA2,HGNC:7685,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3f40eb04-1cc3-477c-ab0a-c8162958fd4f-2019-05-20T190623.871Z,2019-05-20T19:06:23.871Z,Mitochondrial Diseases
NDUFA4,HGNC:7687,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2854d105-0d20-4a19-9dee-d7aa6a60ed99-2021-01-14T214439.481Z,2021-01-14T21:44:39.481Z,Mitochondrial Diseases
NDUFA9,HGNC:7693,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_87c6c5c5-7bf7-4bd2-94f0-2d529a512e74-2019-11-25T162851.567Z,2019-11-25T16:28:51.567Z,Mitochondrial Diseases
NDUFAF1,HGNC:18828,mitochondrial disease,MONDO:0044970,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_20bd44f6-360d-42ef-ba08-549773282d2e-2022-02-17T170000.000Z,2022-02-17T17:00:00.000Z,Mitochondrial Diseases
NDUFAF2,HGNC:28086,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7c26c06d-17dc-4783-8145-5de35c9a73f5-2020-11-23T193634.959Z,2020-11-23T19:36:34.959Z,Mitochondrial Diseases
NDUFAF4,HGNC:21034,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2df4e73b-a8a5-4ce2-bab6-2be732d3c542-2020-02-12T194734.160Z,2020-02-12T19:47:34.160Z,Mitochondrial Diseases
NDUFAF5,HGNC:15899,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_55a2c102-f05d-4ff1-9527-3a55fb3f00c3-2021-04-09T135236.631Z,2021-04-09T13:52:36.631Z,Mitochondrial Diseases
NDUFAF6,HGNC:28625,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f7b6ace1-5b89-41c7-83a6-d6f37826d8c5-2020-11-23T194212.660Z,2020-11-23T19:42:12.660Z,Mitochondrial Diseases
NDUFAF8,HGNC:33551,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3459bec0-88a8-463b-a135-54670357137a-2021-04-01T195856.777Z,2021-04-01T19:58:56.777Z,Mitochondrial Diseases
NDUFB10,HGNC:7696,mitochondrial disease,MONDO:0044970,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2bff63e5-63a2-44fe-9a3e-561442d9c931-2022-02-07T170000.000Z,2022-02-07T17:00:00.000Z,Mitochondrial Diseases
NDUFB11,HGNC:20372,mitochondrial disease,MONDO:0044970,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b349c412-dba4-4b4d-91ba-47d72f8f910f-2022-01-20T170000.000Z,2022-01-20T17:00:00.000Z,Mitochondrial Diseases
NDUFB3,HGNC:7698,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5d93728e-eda7-4f4a-bd64-a1f545476ee8-2022-02-07T170000.000Z,2022-02-07T17:00:00.000Z,Mitochondrial Diseases
NDUFB8,HGNC:7703,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bef2c930-4b79-4938-8325-94a0f58cdfd9-2021-01-21T004458.566Z,2021-01-21T00:44:58.566Z,Mitochondrial Diseases
NDUFC2,HGNC:7706,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3d819bce-43ed-45a3-a16b-74033d432272-2021-01-21T004055.963Z,2021-01-21T00:40:55.963Z,Mitochondrial Diseases
NDUFS1,HGNC:7707,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b6995e66-f840-485a-a635-b64cb9f45cd9-2019-06-20T161718.750Z,2019-06-20T16:17:18.750Z,Mitochondrial Diseases
NDUFS2,HGNC:7708,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6df726c1-2897-46f8-aed1-f9939b9acf0c-2021-04-09T143144.546Z,2021-04-09T14:31:44.546Z,Mitochondrial Diseases
NDUFS3,HGNC:7710,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4ae2af25-4fc1-48c3-a289-fae04977b192-2019-06-20T162502.779Z,2019-06-20T16:25:02.779Z,Mitochondrial Diseases
NDUFS4,HGNC:7711,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1ed6ae7f-8c64-4ca3-a71b-6e97ae21d71d-2019-04-08T162953.550Z,2019-04-08T16:29:53.550Z,Mitochondrial Diseases
NDUFS6,HGNC:7713,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_04cdc50a-1ce4-410e-88bb-9d75ed33bb46-2022-01-31T050000.000Z,2022-01-31T05:00:00.000Z,Mitochondrial Diseases
NDUFS7,HGNC:7714,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b702a150-de60-429e-bb12-ba8cde1483e7-2019-11-25T160008.570Z,2019-11-25T16:00:08.570Z,Mitochondrial Diseases
NDUFS8,HGNC:7715,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_01a27520-f92a-4b81-b63b-c15132c873be-2019-11-25T152406.734Z,2019-11-25T15:24:06.734Z,Mitochondrial Diseases
NDUFV1,HGNC:7716,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b96e332-59c4-4636-8bdf-bf893ea059f1-2019-11-26T163430.120Z,2019-11-26T16:34:30.120Z,Mitochondrial Diseases
NDUFV2,HGNC:7717,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1266aed1-8c25-4b28-bf8a-a0e16d9b3da9-2019-11-25T145748.766Z,2019-11-25T14:57:48.766Z,Mitochondrial Diseases
NUBPL,HGNC:20278,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4365ffcd-637c-4862-9fa0-fb8a780a6d25-2020-03-19T195115.036Z,2020-03-19T19:51:15.036Z,Mitochondrial Diseases
NUP62,HGNC:8066,Leigh syndrome,MONDO:0009723,AR,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8441b4db-da7d-49a2-816c-9f868a96ffab-2020-12-16T050000.000Z,2020-12-16T05:00:00.000Z,Mitochondrial Diseases
OPA1,HGNC:8140,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7e72abd1-4b0a-4f66-b681-7a51d4467026-2021-06-14T152117.821Z,2021-06-14T15:21:17.821Z,Mitochondrial Diseases
PARS2,HGNC:30563,mitochondrial disease,MONDO:0044970,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b8d59b26-84ba-413d-a79f-27903c863356-2022-06-16T160000.000Z,2022-06-16T16:00:00.000Z,Mitochondrial Diseases
PDHA1,HGNC:8806,Leigh syndrome,MONDO:0009723,XL,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a579324c-3586-4636-9192-c2ea29391a4e-2019-04-08T161203.224Z,2019-04-08T16:12:03.224Z,Mitochondrial Diseases
PDHB,HGNC:8808,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_133f688f-b498-4f5e-bd9b-b3406880ddd4-2021-03-11T172853.362Z,2021-03-11T17:28:53.362Z,Mitochondrial Diseases
PDHX,HGNC:21350,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3608ac5e-4b1f-4bb5-aa0c-cc42a2262304-2021-03-11T174226.092Z,2021-03-11T17:42:26.092Z,Mitochondrial Diseases
PDSS2,HGNC:23041,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e0928f3-2b7d-4622-bc96-68a4d0078826-2021-03-11T172336.036Z,2021-03-11T17:23:36.036Z,Mitochondrial Diseases
PET100,HGNC:40038,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_33c546f5-a285-424b-9ae2-9ca4fc718c67-2019-05-20T191347.510Z,2019-05-20T19:13:47.510Z,Mitochondrial Diseases
PET117,HGNC:40045,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_69d9bbe0-ba3f-44f0-b340-d6d824cb969f-2019-05-20T191805.361Z,2019-05-20T19:18:05.361Z,Mitochondrial Diseases
PNPT1,HGNC:23166,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6ed99943-2ab9-417d-b0ec-ddbfa11c8645-2020-03-19T191429.965Z,2020-03-19T19:14:29.965Z,Mitochondrial Diseases
POLG,HGNC:9179,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1212393e-b517-4430-a8d7-df7e32295aff-2021-06-30T144955.983Z,2021-06-30T14:49:55.983Z,Mitochondrial Diseases
PTCD3,HGNC:24717,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ac3d1e08-56f0-43b6-a2fa-0d06571ba121-2019-06-20T164419.242Z,2019-06-20T16:44:19.242Z,Mitochondrial Diseases
PUS1,HGNC:15508,mitochondrial disease,MONDO:0044970,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_821f6d18-025f-477b-8ba2-b4aad502670c-2022-08-01T160000.000Z,2022-08-01T16:00:00.000Z,Mitochondrial Diseases
RANBP2,HGNC:9848,Leigh syndrome,MONDO:0009723,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_183be314-face-471f-9643-9cc1a302636f-2021-06-30T145342.020Z,2021-06-30T14:53:42.020Z,Mitochondrial Diseases
RARS2,HGNC:21406,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1bdeaf04-f6ce-42f1-9ee0-037f1ead77fb-2022-05-04T160000.000Z,2022-05-04T16:00:00.000Z,Mitochondrial Diseases
RMND1,HGNC:21176,mitochondrial disease,MONDO:0044970,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7e709765-beac-4f19-bcc0-181d0ce36f1b-2022-09-07T160000.000Z,2022-09-07T16:00:00.000Z,Mitochondrial Diseases
RNASEH1,HGNC:18466,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fcf8b7a4-7bd5-45fe-824c-6a90825620f7-2021-01-14T213824.328Z,2021-01-14T21:38:24.328Z,Mitochondrial Diseases
SARS2,HGNC:17697,mitochondrial disease,MONDO:0044970,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d49e2a27-bd5f-4bc5-8d41-e3f0b4b043ad-2022-06-06T160000.000Z,2022-06-06T16:00:00.000Z,Mitochondrial Diseases
SCO1,HGNC:10603,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90d9d757-a45e-4d35-af68-c1345e1d8c65-2022-02-17T170000.000Z,2022-02-17T17:00:00.000Z,Mitochondrial Diseases
SCO2,HGNC:10604,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_011dd1c7-94bb-4a70-8b95-cc25432a5ea2-2019-03-28T154245.471Z,2019-03-28T15:42:45.471Z,Mitochondrial Diseases
SDHA,HGNC:10680,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4c5801d0-5839-47d9-81cc-a53cea959b57-2019-05-20T190935.665Z,2019-05-20T19:09:35.665Z,Mitochondrial Diseases
SDHAF1,HGNC:33867,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0baf56d2-40f8-465a-9b50-22f57481a5cb-2020-02-12T201133.569Z,2020-02-12T20:11:33.569Z,Mitochondrial Diseases
SDHB,HGNC:10681,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53015cfb-c54a-4436-9ebd-79ae3fdbf613-2022-03-07T170000.000Z,2022-03-07T17:00:00.000Z,Mitochondrial Diseases
SDHC,HGNC:10682,mitochondrial disease,MONDO:0044970,Undetermined,SOP8,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_909982e0-a53c-4a87-bf28-cdb563c8ae62-2022-03-07T170000.000Z,2022-03-07T17:00:00.000Z,Mitochondrial Diseases
SDHD,HGNC:10683,mitochondrial disease,MONDO:0044970,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9010c629-a86c-4f55-a45b-212b7aabdb6f-2022-04-04T160000.000Z,2022-04-04T16:00:00.000Z,Mitochondrial Diseases
SERAC1,HGNC:21061,Leigh syndrome,MONDO:0009723,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bf6861ce-e13a-42c9-a4ff-942a83874bfd-2021-01-14T213356.750Z,2021-01-14T21:33:56.750Z,Mitochondrial Diseases
SLC19A3,HGNC:16266,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e3907183-4cb2-4df7-bace-ecc1821b3acc-2019-01-14T170000.000Z,2019-01-14T17:00:00.000Z,Mitochondrial Diseases
SLC25A19,HGNC:14409,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6ae17da7-86b0-4aba-a401-de1ccb6ecb83-2020-08-27T162850.918Z,2020-08-27T16:28:50.918Z,Mitochondrial Diseases
SLC25A4,HGNC:10990,Leigh syndrome,MONDO:0009723,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0a6890a4-e2d5-4895-956d-3f3103ec6a2b-2021-06-14T151738.675Z,2021-06-14T15:17:38.675Z,Mitochondrial Diseases
SLC25A46,HGNC:25198,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6e456b6d-7a9b-42d2-ab51-0531f5184b41-2020-08-27T163757.565Z,2020-08-27T16:37:57.565Z,Mitochondrial Diseases
SLC39A8,HGNC:20862,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5fddaae4-d982-49e7-9e83-b84d15f3cf2c-2020-11-23T195104.867Z,2020-11-23T19:51:04.867Z,Mitochondrial Diseases
SQOR,HGNC:20390,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_09ea3b0c-cc3a-44d1-a702-9f1674c33040-2021-01-21T005124.845Z,2021-01-21T00:51:24.845Z,Mitochondrial Diseases
SSBP1,HGNC:11317,Leigh syndrome,MONDO:0009723,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6ef6f4e7-6e59-4eaf-b303-7f975542d1b9-2021-06-14T144803.625Z,2021-06-14T14:48:03.625Z,Mitochondrial Diseases
SUCLA2,HGNC:11448,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eedc8c99-a02a-4a34-ba72-1b0fc975e63f-2019-04-18T180100.762Z,2019-04-18T18:01:00.762Z,Mitochondrial Diseases
SUCLG1,HGNC:11449,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fd0a5a96-69b8-47fb-9b7b-17de29439ecc-2019-04-18T181448.882Z,2019-04-18T18:14:48.882Z,Mitochondrial Diseases
SURF1,HGNC:11474,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2ed17d9b-e746-4f1f-9c39-26f46bb2eadc-2019-04-08T160338.698Z,2019-04-08T16:03:38.698Z,Mitochondrial Diseases
TACO1,HGNC:24316,Leigh syndrome,MONDO:0009723,AR,SOP6,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ae2fd0e4-db4e-4e17-bfc8-c43719066f97-2019-10-16T150433.004Z,2019-10-16T15:04:33.004Z,Mitochondrial Diseases
TARS2,HGNC:30740,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_475a994f-8420-45bb-8f14-9fe85cdcdbbc-2021-06-14T144425.888Z,2021-06-14T14:44:25.888Z,Mitochondrial Diseases
TIMMDC1,HGNC:1321,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_83d26d62-2863-46d9-ad7d-96c086e65e8e-2021-06-30T220013.257Z,2021-06-30T22:00:13.257Z,Mitochondrial Diseases
TMEM126B,HGNC:30883,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f9df6705-7638-45c1-b3ec-db19fe0d39b9-2022-03-07T170000.000Z,2022-03-07T17:00:00.000Z,Mitochondrial Diseases
TMEM70,HGNC:26050,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5be60130-254d-4af4-aca0-eb8cd88a143c-2022-06-16T160000.000Z,2022-06-16T16:00:00.000Z,Mitochondrial Diseases
TPK1,HGNC:17358,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_74e89426-cb27-4474-b892-dc303a9de644-2021-01-14T212800.773Z,2021-01-14T21:28:00.773Z,Mitochondrial Diseases
TRIT1,HGNC:20286,mitochondrial disease,MONDO:0044970,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0473ea4b-40cb-4f4c-b986-e96b1ae18a9f-2022-09-13T160000.000Z,2022-09-13T16:00:00.000Z,Mitochondrial Diseases
TRMT10C,HGNC:26022,mitochondrial disease,MONDO:0044970,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f5406ef5-ce74-4762-9709-8791775bccac-2022-09-13T160000.000Z,2022-09-13T16:00:00.000Z,Mitochondrial Diseases
TRMT5,HGNC:23141,mitochondrial disease,MONDO:0044970,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4d1268d1-4c34-4ab0-a7fd-ef5ccc90415f-2022-07-18T160000.000Z,2022-07-18T16:00:00.000Z,Mitochondrial Diseases
TRMU,HGNC:25481,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d1d9d958-be13-4018-ab9c-305788171d1e-2021-01-21T004755.799Z,2021-01-21T00:47:55.799Z,Mitochondrial Diseases
TSFM,HGNC:12367,Leigh syndrome,MONDO:0009723,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e3d30a3f-a054-4812-9b97-116a8834fcb1-2020-02-12T195529.785Z,2020-02-12T19:55:29.785Z,Mitochondrial Diseases
TTC19,HGNC:26006,Leigh syndrome,MONDO:0009723,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8dc9dcb6-1f63-41b1-80f1-a0f2a87b5ec4-2019-09-19T160132.570Z,2019-09-19T16:01:32.570Z,Mitochondrial Diseases
UQCRC2,HGNC:12586,mitochondrial disease,MONDO:0044970,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_82ab14de-02cb-477a-89dd-20210c103ead-2022-01-20T170000.000Z,2022-01-20T17:00:00.000Z,Mitochondrial Diseases
UQCRQ,HGNC:29594,Leigh syndrome,MONDO:0009723,AR,SOP6,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9bf205a2-6eb3-40aa-b3dd-54c19ce6e6f7-2019-10-16T144656.909Z,2019-10-16T14:46:56.909Z,Mitochondrial Diseases
VARS2,HGNC:21642,mitochondrial disease,MONDO:0044970,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca9dc1e7-f79c-472e-b6ea-5d38aaf61bea-2022-05-19T160000.000Z,2022-05-19T16:00:00.000Z,Mitochondrial Diseases
VPS13D,HGNC:23595,Leigh syndrome,MONDO:0009723,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7f179add-fcdb-4ea0-bc3c-506f825d2dac-2021-06-14T143234.435Z,2021-06-14T14:32:34.435Z,Mitochondrial Diseases
WARS2,HGNC:12730,mitochondrial disease,MONDO:0044970,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3fae4b08-08dc-42da-86a0-2d63ad202ef0-2022-06-16T160000.000Z,2022-06-16T16:00:00.000Z,Mitochondrial Diseases
ABCC8,HGNC:59,monogenic diabetes,MONDO:0015967,SD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_33c0dfa5-c6ea-42fd-8118-be6ff97beb3e-2022-07-24T160000.000Z,2022-07-24T16:00:00.000Z,Monogenic Diabetes
APPL1,HGNC:24035,monogenic diabetes,MONDO:0015967,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5e2bc680-f1d4-4b65-baaa-22b4ff22b56e-2021-12-15T170000.000Z,2021-12-15T17:00:00.000Z,Monogenic Diabetes
BLK,HGNC:1057,monogenic diabetes,MONDO:0015967,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_072e29f7-db97-40d9-9280-819706203c24-2023-01-17T170000.000Z,2023-01-17T17:00:00.000Z,Monogenic Diabetes
CEL,HGNC:1848,maturity-onset diabetes of the young type 8,MONDO:0012348,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_06571680-3730-4075-8e65-f6de7ddd3e62-2022-05-06T135524.986Z,2022-05-06T13:55:24.986Z,Monogenic Diabetes
GCK,HGNC:4195,monogenic diabetes,MONDO:0015967,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c7291ae0-3356-4c7b-832a-edae5176739f-2020-05-13T160000.000Z,2020-05-13T16:00:00.000Z,Monogenic Diabetes
HNF1A,HGNC:11621,monogenic diabetes,MONDO:0015967,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2f6d71c6-6595-49bf-a50e-fce726b22088-2018-10-05T160000.000Z,2018-10-05T16:00:00.000Z,Monogenic Diabetes
HNF1B,HGNC:11630,renal cysts and diabetes syndrome,MONDO:0007669,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4174ea0a-6901-4070-ad93-d92614fd55c0-2021-01-19T170000.000Z,2021-01-19T17:00:00.000Z,Monogenic Diabetes
HNF4A,HGNC:5024,monogenic diabetes,MONDO:0015967,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_98cb808e-02d3-4378-8e6b-9b1b2883cc65-2019-02-27T170000.000Z,2019-02-27T17:00:00.000Z,Monogenic Diabetes
INS,HGNC:6081,monogenic diabetes,MONDO:0015967,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9c21ba4d-785f-486f-84f8-511b9c89c137-2020-05-13T160000.000Z,2020-05-13T16:00:00.000Z,Monogenic Diabetes
INS,HGNC:6081,monogenic diabetes,MONDO:0015967,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c5224322-637e-40a8-89eb-d44e01536f25-2020-05-13T160000.000Z,2020-05-13T16:00:00.000Z,Monogenic Diabetes
KCNJ11,HGNC:6257,monogenic diabetes,MONDO:0015967,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9353379e-564a-43bc-a859-7d27ab640e9e-2023-01-05T170000.000Z,2023-01-05T17:00:00.000Z,Monogenic Diabetes
KLF11,HGNC:11811,monogenic diabetes,MONDO:0015967,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1e38a49-7c12-4514-a2a1-109e04da146f-2020-02-12T170000.000Z,2020-02-12T17:00:00.000Z,Monogenic Diabetes
NEUROD1,HGNC:7762,monogenic diabetes,MONDO:0015967,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8f4e7f54-becc-432e-9827-514c783e6bc1-2021-10-13T170637.558Z,2021-10-13T17:06:37.558Z,Monogenic Diabetes
NEUROD1,HGNC:7762,monogenic diabetes,MONDO:0015967,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9ace1b58-44d4-4479-9328-0871a8fb0e9f-2021-03-10T172754.003Z,2021-03-10T17:27:54.003Z,Monogenic Diabetes
PAX4,HGNC:8618,monogenic diabetes,MONDO:0015967,AD,SOP9,Refuted,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e2e54103-c1c4-4095-8a12-d602e5326d90-2022-12-13T170000.000Z,2022-12-13T17:00:00.000Z,Monogenic Diabetes
PDX1,HGNC:6107,monogenic diabetes,MONDO:0015967,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5487c912-a653-411d-b640-a51c60f51fa6-2022-06-16T160000.000Z,2022-06-16T16:00:00.000Z,Monogenic Diabetes
PDX1,HGNC:6107,pancreatic agenesis 1,MONDO:0024547,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_76ea8c1e-88ba-436a-8eca-0de131027033-2022-06-16T160000.000Z,2022-06-16T16:00:00.000Z,Monogenic Diabetes
BRWD1,HGNC:12760,primary ciliary dyskinesia,MONDO:0016575,AR,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9f74ee87-e640-4604-9bb7-e7617907f92c-2022-11-10T110000.000Z,2022-11-10T11:00:00.000Z,Motile Ciliopathy
CCDC103,HGNC:32700,primary ciliary dyskinesia 17,MONDO:0013854,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9974aaef-9082-4bcd-b05a-28869447b5de-2022-12-30T120000.000Z,2022-12-30T12:00:00.000Z,Motile Ciliopathy
CCDC39,HGNC:25244,primary ciliary dyskinesia 14,MONDO:0013434,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_79c47f13-dd33-45e4-a170-6ff26aa2732c-2021-11-02T204310.116Z,2021-11-02T20:43:10.116Z,Motile Ciliopathy
CCDC40,HGNC:26090,primary ciliary dyskinesia 15,MONDO:0013435,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e9c192c6-9f74-4beb-85ba-a42199e9794a-2021-12-10T031508.185Z,2021-12-10T03:15:08.185Z,Motile Ciliopathy
CCNO,HGNC:18576,primary ciliary dyskinesia 29,MONDO:0014378,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_20a78ac7-91a7-44a6-b42e-22611de2d170-2022-08-19T160000.000Z,2022-08-19T16:00:00.000Z,Motile Ciliopathy
CFAP300,HGNC:28188,"ciliary dyskinesia, primary, 38",MONDO:0054843,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6bcfa4e4-37a3-43a7-9b4d-60554bc7600c-2022-09-08T110000.000Z,2022-09-08T11:00:00.000Z,Motile Ciliopathy
CFAP43,HGNC:26684,spermatogenic failure 19,MONDO:0054723,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a5055c70-e22e-47e5-af3b-04f3f2a0ed34-2022-12-14T200000.000Z,2022-12-14T20:00:00.000Z,Motile Ciliopathy
CFAP43,HGNC:26684,primary ciliary dyskinesia,MONDO:0016575,Undetermined,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f2622390-3981-4f40-8c28-194fb13dd35a-2022-12-29T200000.000Z,2022-12-29T20:00:00.000Z,Motile Ciliopathy
CFAP43,HGNC:26684,normal pressure hydrocephalus,MONDO:0009366,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ff67c788-1b69-4da8-84df-f37741c9913f-2022-12-13T200000.000Z,2022-12-13T20:00:00.000Z,Motile Ciliopathy
CFAP57,HGNC:26485,primary ciliary dyskinesia,MONDO:0016575,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_50ed292f-0044-4c82-9419-a040cbcaf205-2022-06-23T160000.000Z,2022-06-23T16:00:00.000Z,Motile Ciliopathy
DNAAF3,HGNC:30492,primary ciliary dyskinesia 2,MONDO:0011718,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_40329b6f-2d65-49dd-863b-f79dcd1b5a23-2022-05-09T155600.823Z,2022-05-09T15:56:00.823Z,Motile Ciliopathy
DNAH1,HGNC:2940,spermatogenic failure 18,MONDO:0054615,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4a5dff5a-ff66-4e80-9eca-cb5f924edb73-2022-05-26T160000.000Z,2022-05-26T16:00:00.000Z,Motile Ciliopathy
DNAH1,HGNC:2940,"ciliary dyskinesia, primary, 37",MONDO:0033204,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a07c8b6e-a558-498b-975c-b12e96878a44-2022-04-14T013721.941Z,2022-04-14T01:37:21.941Z,Motile Ciliopathy
DNAH11,HGNC:2942,primary ciliary dyskinesia 7,MONDO:0012748,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_84088c46-0763-4ed6-9352-530d846e8b24-2021-10-25T190427.941Z,2021-10-25T19:04:27.941Z,Motile Ciliopathy
DNAH17,HGNC:2946,spermatogenic failure 39,MONDO:0032845,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ef0cbb29-220d-45ae-828c-ab233dcf4824-2022-09-08T110000.000Z,2022-09-08T11:00:00.000Z,Motile Ciliopathy
DNAH5,HGNC:2950,primary ciliary dyskinesia 3,MONDO:0012085,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4390dba1-012d-4e08-a841-ffc08ebdc737-2022-01-07T190607.723Z,2022-01-07T19:06:07.723Z,Motile Ciliopathy
DNAH8,HGNC:2952,primary ciliary dyskinesia,MONDO:0016575,AR,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0c98a44d-6d43-48fc-8286-9e499bf04a1b-2022-06-23T160000.000Z,2022-06-23T16:00:00.000Z,Motile Ciliopathy
DNAH8,HGNC:2952,spermatogenic failure 46,MONDO:0033673,AR,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e740f4af-53fe-4c51-99f6-6111fe343d7f-2022-06-23T160000.000Z,2022-06-23T16:00:00.000Z,Motile Ciliopathy
DNAI1,HGNC:2954,primary ciliary dyskinesia 1,MONDO:0009484,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_396be572-5b2c-4859-90dd-434a91c1ce96-2022-06-30T160000.000Z,2022-06-30T16:00:00.000Z,Motile Ciliopathy
DNAI2,HGNC:18744,primary ciliary dyskinesia 9,MONDO:0012906,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_225300ab-ad49-4043-875b-a27a54d37b72-2022-08-11T160000.000Z,2022-08-11T16:00:00.000Z,Motile Ciliopathy
DNAL1,HGNC:23247,primary ciliary dyskinesia 16,MONDO:0013525,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_54088550-2704-4c1b-ac1b-51b62353a223-2022-09-13T170000.000Z,2022-09-13T17:00:00.000Z,Motile Ciliopathy
FOXJ1,HGNC:3816,"ciliary dyskinesia, primary, 43",MONDO:0032874,AD,SOP9,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53a48f3c-42fc-4c60-becb-149019b1e4bf-2022-07-14T160000.000Z,2022-07-14T16:00:00.000Z,Motile Ciliopathy
GAS2L2,HGNC:24846,"ciliary dyskinesia, primary, 41",MONDO:0032757,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_91afae37-4cfc-4aeb-af0f-26a9596611f3-2022-02-08T134933.616Z,2022-02-08T13:49:33.616Z,Motile Ciliopathy
HYDIN,HGNC:19368,primary ciliary dyskinesia 5,MONDO:0012088,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6c491ab7-496f-43b9-9bca-500901cb686d-2022-02-22T183411.247Z,2022-02-22T18:34:11.247Z,Motile Ciliopathy
MCIDAS,HGNC:40050,"ciliary dyskinesia, primary, 42",MONDO:0032872,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_866c87d2-9c7d-4f5e-bd7f-358d8e44fa54-2022-12-29T200000.000Z,2022-12-29T20:00:00.000Z,Motile Ciliopathy
MNS1,HGNC:29636,primary ciliary dyskinesia,MONDO:0016575,AR,SOP8,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_255ba802-ece2-43c7-9089-6e54672b4f4a-2022-09-13T170000.000Z,2022-09-13T17:00:00.000Z,Motile Ciliopathy
ODAD1,HGNC:26560,primary ciliary dyskinesia 20,MONDO:0014030,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_999e752a-e549-447f-b142-265be7dd5935-2022-08-17T110000.000Z,2022-08-17T11:00:00.000Z,Motile Ciliopathy
ODAD2,HGNC:25583,primary ciliary dyskinesia 23,MONDO:0014193,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4ac46902-bffa-46f9-bc0d-081e6461d5e2-2022-12-14T170000.000Z,2022-12-14T17:00:00.000Z,Motile Ciliopathy
ODAD4,HGNC:25280,primary ciliary dyskinesia 35,MONDO:0014910,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_547fed6e-47df-44b5-bf4a-e31f7b045862-2022-12-08T170000.000Z,2022-12-08T17:00:00.000Z,Motile Ciliopathy
RSPH1,HGNC:12371,primary ciliary dyskinesia 24,MONDO:0014202,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f2bdb2e5-9659-46af-b306-e01207f31174-2022-06-07T110000.000Z,2022-06-07T11:00:00.000Z,Motile Ciliopathy
RSPH4A,HGNC:21558,primary ciliary dyskinesia 11,MONDO:0012978,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6f876804-e14a-4c7e-a826-232c7f445c7f-2022-04-05T150444.668Z,2022-04-05T15:04:44.668Z,Motile Ciliopathy
SPAG1,HGNC:11212,primary ciliary dyskinesia 28,MONDO:0014216,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c0d43e40-0aa3-41cf-9e3a-8311e685c7be-2022-06-22T190000.000Z,2022-06-22T19:00:00.000Z,Motile Ciliopathy
GBA,HGNC:4177,Parkinson disease,MONDO:0005180,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9201c03f-10de-447c-9b84-194f14b549b6-2022-05-03T134810.206Z,2022-05-03T13:48:10.206Z,Parkinson's disease
LRRK2,HGNC:18618,Parkinson disease,MONDO:0005180,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2728e13a-b95a-4c55-8cba-082260094ecd-2021-05-03T160000.000Z,2021-05-03T16:00:00.000Z,Parkinson's disease
PARK7,HGNC:16369,Parkinson disease,MONDO:0005180,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d79439d2-844b-4ba6-aceb-e6b179eaaa01-2022-06-27T160000.000Z,2022-06-27T16:00:00.000Z,Parkinson's disease
PINK1,HGNC:14581,Parkinson disease,MONDO:0005180,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1999e6c4-eb15-438a-a4ea-98989112dcbb-2023-01-18T190000.000Z,2023-01-18T19:00:00.000Z,Parkinson's disease
PRKN,HGNC:8607,Parkinson disease,MONDO:0005180,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6b39c4a0-f6bd-4afc-b2a7-f234eab5a667-2023-01-18T190000.000Z,2023-01-18T19:00:00.000Z,Parkinson's disease
SNCA,HGNC:11138,Parkinson disease,MONDO:0005180,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d21593ae-ed10-4442-8167-24f96f917302-2022-05-03T134931.425Z,2022-05-03T13:49:31.425Z,Parkinson's disease
VPS35,HGNC:13487,Parkinson disease,MONDO:0005180,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b0e546d6-8a44-4e9d-83aa-f781ec4ec166-2021-11-03T134517.796Z,2021-11-03T13:45:17.796Z,Parkinson's disease
ABCD1,HGNC:61,adrenoleukodystrophy,MONDO:0018544,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_815e0f84-b530-4fd2-81a9-02e02bf352ee-2020-12-18T050000.000Z,2020-12-18T05:00:00.000Z,Peroxisomal Disorders
ABCD3,HGNC:67,congenital bile acid synthesis defect 5,MONDO:0014564,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f8d82e6f-8ee8-4944-898b-165916c13cac-2022-04-15T160000.000Z,2022-04-15T16:00:00.000Z,Peroxisomal Disorders
ACBD5,HGNC:23338,acyl-CoA binding domain containing protein 5 deficiency,MONDO:0100112,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8ac052f6-de8d-4c14-adf2-bbecb624defd-2022-04-15T160000.000Z,2022-04-15T16:00:00.000Z,Peroxisomal Disorders
ACOX1,HGNC:119,Mitchell syndrome,MONDO:0030073,AD,SOP9,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2efeef00-0803-472b-8e25-080e4728c018-2022-12-29T170000.000Z,2022-12-29T17:00:00.000Z,Peroxisomal Disorders
ACOX1,HGNC:119,peroxisomal acyl-CoA oxidase deficiency,MONDO:0009919,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_96026ae4-050d-4eb5-849c-178c703a556e-2022-11-04T160000.000Z,2022-11-04T16:00:00.000Z,Peroxisomal Disorders
AGPS,HGNC:327,alkylglycerone-phosphate synthase deficiency,MONDO:0100274,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aba640e2-c95d-414b-8c72-d22769e4366a-2022-04-22T160000.000Z,2022-04-22T16:00:00.000Z,Peroxisomal Disorders
AGXT,HGNC:341,alanine glyoxylate aminotransferase deficiency,MONDO:0100278,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8460f17d-4d94-4a0c-ac46-41c86ce32e83-2020-02-07T170000.000Z,2020-02-07T17:00:00.000Z,Peroxisomal Disorders
AMACR,HGNC:451,alpha-methylacyl-CoA racemase deficiency,MONDO:0013681,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3fb8a3ea-cf06-4788-841f-e787f3780a49-2022-03-31T040000.000Z,2022-03-31T04:00:00.000Z,Peroxisomal Disorders
BAAT,HGNC:932,bile acid CoA:amino acid N-acyltransferase deficiency,MONDO:0100305,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9b732497-a853-45af-bf8e-b3ad663159f1-2022-04-15T160000.000Z,2022-04-15T16:00:00.000Z,Peroxisomal Disorders
CAT,HGNC:1516,acatalasia,MONDO:0013571,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7381d0cc-74d3-4dfc-bc2e-62416afbb0ee-2022-10-21T160000.000Z,2022-10-21T16:00:00.000Z,Peroxisomal Disorders
DNM1L,HGNC:2973,encephalopathy due to mitochondrial and peroxisomal fission defect,MONDO:0054865,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_320f4ab3-19c3-458e-9e81-0f380cbfebbd-2022-04-15T160000.000Z,2022-04-15T16:00:00.000Z,Peroxisomal Disorders
FAR1,HGNC:26222,fatty acyl-CoA reductase 1 dysregulation,MONDO:0100230,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1068b8e8-36a1-4110-9ab4-45f9d4ece894-2021-08-20T160000.000Z,2021-08-20T16:00:00.000Z,Peroxisomal Disorders
FAR1,HGNC:26222,fatty acyl-CoA reductase 1 deficiency,MONDO:0014510,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_91f6f864-5d07-4891-94b5-7f73bd71752c-2022-04-15T160000.000Z,2022-04-15T16:00:00.000Z,Peroxisomal Disorders
GNPAT,HGNC:4416,glyceronephosphate O-acyltransferase deficiency,MONDO:0100273,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ba96f922-5ec9-4404-b2e4-66c31c2dcda6-2020-02-07T170000.000Z,2020-02-07T17:00:00.000Z,Peroxisomal Disorders
HSD17B4,HGNC:5213,d-bifunctional protein deficiency,MONDO:0009855,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b992de69-49b3-496d-a83a-5bcc427fdf98-2020-04-17T160000.000Z,2020-04-17T16:00:00.000Z,Peroxisomal Disorders
MFF,HGNC:24858,encephalopathy due to mitochondrial and peroxisomal fission defect,MONDO:0054865,AR,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_021d15d7-dbf0-4b71-bbb5-48dc4a4b5ee6-2022-04-15T160000.000Z,2022-04-15T16:00:00.000Z,Peroxisomal Disorders
PEX1,HGNC:8850,peroxisome biogenesis disorder,MONDO:0019234,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a345ba65-9dcd-43dd-a1c2-1778c1a921ea-2019-05-17T160000.000Z,2019-05-17T16:00:00.000Z,Peroxisomal Disorders
PEX10,HGNC:8851,peroxisome biogenesis disorder,MONDO:0019234,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c0f7f094-ac3b-4309-ad8f-8e604f006485-2019-12-06T050000.000Z,2019-12-06T05:00:00.000Z,Peroxisomal Disorders
PEX11A,HGNC:8852,peroxisome biogenesis disorder,MONDO:0019234,AR,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9f83cdb0-7fca-4bc5-b896-3201000364f9-2020-07-17T040000.000Z,2020-07-17T04:00:00.000Z,Peroxisomal Disorders
PEX11B,HGNC:8853,peroxisome biogenesis disorder,MONDO:0019234,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_93eacb33-b099-485d-bf8a-782479dc0a3b-2020-01-17T170000.000Z,2020-01-17T17:00:00.000Z,Peroxisomal Disorders
PEX11G,HGNC:20208,peroxisome biogenesis disorder,MONDO:0019234,AR,SOP7,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_932d75de-89f1-4ba6-8a2a-05f53ecdf097-2020-08-06T040000.000Z,2020-08-06T04:00:00.000Z,Peroxisomal Disorders
PEX12,HGNC:8854,peroxisome biogenesis disorder,MONDO:0019234,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_124c97b0-92ed-4921-a0b9-2ff33135139d-2019-12-06T170000.000Z,2019-12-06T17:00:00.000Z,Peroxisomal Disorders
PEX13,HGNC:8855,peroxisome biogenesis disorder,MONDO:0019234,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0c662669-4eb8-45e3-8540-c394ea40c1b2-2019-10-04T160000.000Z,2019-10-04T16:00:00.000Z,Peroxisomal Disorders
PEX14,HGNC:8856,peroxisome biogenesis disorder,MONDO:0019234,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_846efcc3-5456-4db3-9bc2-e441acb768cd-2019-09-20T160000.000Z,2019-09-20T16:00:00.000Z,Peroxisomal Disorders
PEX16,HGNC:8857,peroxisome biogenesis disorder,MONDO:0019234,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7506d938-efb4-416c-aafd-221251d00e6e-2020-01-13T170000.000Z,2020-01-13T17:00:00.000Z,Peroxisomal Disorders
PEX19,HGNC:9713,peroxisome biogenesis disorder,MONDO:0019234,AR,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fa073c77-0623-4e82-b5b2-9fcd0eb0dc6e-2020-01-17T050000.000Z,2020-01-17T05:00:00.000Z,Peroxisomal Disorders
PEX2,HGNC:9717,peroxisome biogenesis disorder,MONDO:0019234,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_17bf1c4a-1775-40c6-a499-774c93827343-2020-02-07T170000.000Z,2020-02-07T17:00:00.000Z,Peroxisomal Disorders
PEX26,HGNC:22965,peroxisome biogenesis disorder,MONDO:0019234,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bf6af95e-6696-420c-8731-d2e37ca6e692-2020-02-07T170000.000Z,2020-02-07T17:00:00.000Z,Peroxisomal Disorders
PEX3,HGNC:8858,peroxisome biogenesis disorder,MONDO:0019234,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d53df483-c31a-4672-8a11-04d33d6df336-2019-11-01T160000.000Z,2019-11-01T16:00:00.000Z,Peroxisomal Disorders
PEX5,HGNC:9719,peroxisome biogenesis disorder,MONDO:0019234,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b49d9cfd-0e51-4219-84bb-76b4c9b99fa9-2020-01-17T170000.000Z,2020-01-17T17:00:00.000Z,Peroxisomal Disorders
PEX6,HGNC:8859,peroxisome biogenesis disorder,MONDO:0019234,AR,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_54df6fb2-b692-4ece-a525-ae0cfe243826-2019-09-06T160000.000Z,2019-09-06T16:00:00.000Z,Peroxisomal Disorders
PEX7,HGNC:8860,peroxisome biogenesis disorder,MONDO:0019234,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d0796d69-b304-4670-b4a2-8785ff6fd161-2020-02-14T170000.000Z,2020-02-14T17:00:00.000Z,Peroxisomal Disorders
PHYH,HGNC:8940,phytanoyl-CoA hydroxylase deficiency,MONDO:0100258,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8c50f8ab-65d8-493d-a800-52af1fa13339-2020-02-07T050000.000Z,2020-02-07T05:00:00.000Z,Peroxisomal Disorders
SCP2,HGNC:10606,sterol carrier protein 2 deficiency,MONDO:0013391,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ea6abbdb-3724-4d1e-a31e-c61b0157a86a-2022-11-04T160000.000Z,2022-11-04T16:00:00.000Z,Peroxisomal Disorders
TRIM37,HGNC:7523,mulibrey nanism,MONDO:0009664,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0faa569d-4e0c-4809-a1b2-a93d460751e8-2020-05-01T160000.000Z,2020-05-01T16:00:00.000Z,Peroxisomal Disorders
ABCC8,HGNC:59,pulmonary arterial hypertension,MONDO:0015924,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14b1739d-8890-4927-8efb-e909f48bad5a-2022-10-10T160000.000Z,2022-10-10T16:00:00.000Z,Pulmonary Hypertension
AQP1,HGNC:633,pulmonary arterial hypertension,MONDO:0015924,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29eda804-13df-4fe9-bbb3-9494b11edc92-2021-01-11T145519.495Z,2021-01-11T14:55:19.495Z,Pulmonary Hypertension
ATP13A3,HGNC:24113,pulmonary arterial hypertension,MONDO:0015924,SD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5024e74a-fe6e-4eb2-89df-d07ff18e439c-2021-11-09T173936.225Z,2021-11-09T17:39:36.225Z,Pulmonary Hypertension
BMP10,HGNC:20869,pulmonary arterial hypertension,MONDO:0015924,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_98be8b85-16ad-46d3-9736-2b240803da21-2022-10-18T160000.000Z,2022-10-18T16:00:00.000Z,Pulmonary Hypertension
BMPR1A,HGNC:1076,pulmonary arterial hypertension,MONDO:0015924,Undetermined,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e810879d-f635-4851-b20e-86998b000fcc-2022-10-18T160000.000Z,2022-10-18T16:00:00.000Z,Pulmonary Hypertension
BMPR1B,HGNC:1077,pulmonary arterial hypertension,MONDO:0015924,Undetermined,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a21917a1-31d3-42dd-b6d3-ea5fa6edd6c1-2022-10-18T160000.000Z,2022-10-18T16:00:00.000Z,Pulmonary Hypertension
BMPR2,HGNC:1078,pulmonary arterial hypertension,MONDO:0015924,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a20ce78b-18ba-436c-877e-a08d092ac7c7-2020-12-07T172318.621Z,2020-12-07T17:23:18.621Z,Pulmonary Hypertension
CAV1,HGNC:1527,pulmonary arterial hypertension,MONDO:0015924,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1f4c3d64-7993-4196-a002-6cc9904a4360-2022-11-23T170000.000Z,2022-11-23T17:00:00.000Z,Pulmonary Hypertension
EIF2AK4,HGNC:19687,pulmonary veno-occlusive disease and/or pulmonary capillary haemangiomatosis,MONDO:0018554,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9d20386c-ad1a-4c88-9f43-4ca3cedbfd6f-2022-12-02T170000.000Z,2022-12-02T17:00:00.000Z,Pulmonary Hypertension
FBLN2,HGNC:3601,pulmonary arterial hypertension,MONDO:0015924,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_db9581b7-ed36-4995-aebc-839225dd0666-2022-11-03T160000.000Z,2022-11-03T16:00:00.000Z,Pulmonary Hypertension
GDF2,HGNC:4217,pulmonary arterial hypertension,MONDO:0015924,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2d2e83fa-0af1-450f-af9c-5c61d4bc3106-2022-05-26T221514.154Z,2022-05-26T22:15:14.154Z,Pulmonary Hypertension
GGCX,HGNC:4247,pulmonary arterial hypertension,MONDO:0015924,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8ac82a47-d6c3-4cbb-ae29-b6044a9a624e-2022-11-04T160000.000Z,2022-11-04T16:00:00.000Z,Pulmonary Hypertension
KCNK3,HGNC:6278,pulmonary arterial hypertension,MONDO:0015924,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e20d0ee0-4a14-4569-a451-729348ce8d23-2021-05-08T152719.928Z,2021-05-08T15:27:19.928Z,Pulmonary Hypertension
KDR,HGNC:6307,pulmonary arterial hypertension,MONDO:0015924,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_07a11f06-0904-4a38-9fd3-0aec2bece699-2021-05-12T165601.478Z,2021-05-12T16:56:01.478Z,Pulmonary Hypertension
KLF2,HGNC:6347,pulmonary arterial hypertension,MONDO:0015924,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1544c7bb-410b-4340-ab70-0bd431426c04-2022-11-03T160000.000Z,2022-11-03T16:00:00.000Z,Pulmonary Hypertension
KLK1,HGNC:6357,pulmonary arterial hypertension,MONDO:0015924,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8d29c7f8-ced6-43b3-b124-8d4039c6f99b-2022-11-04T160000.000Z,2022-11-04T16:00:00.000Z,Pulmonary Hypertension
NOTCH3,HGNC:7883,pulmonary arterial hypertension,MONDO:0015924,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d59e2823-a923-4c3e-8976-c3451eaa8666-2022-11-03T160000.000Z,2022-11-03T16:00:00.000Z,Pulmonary Hypertension
PDGFD,HGNC:30620,pulmonary arterial hypertension,MONDO:0015924,AD,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a5da6fc7-e3a0-4de1-b69d-b86f312b48a1-2022-11-03T160000.000Z,2022-11-03T16:00:00.000Z,Pulmonary Hypertension
SMAD1,HGNC:6767,pulmonary arterial hypertension,MONDO:0015924,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_804f2eeb-7328-45c2-947b-cb9c4da0fecc-2022-11-21T170000.000Z,2022-11-21T17:00:00.000Z,Pulmonary Hypertension
SMAD4,HGNC:6770,pulmonary arterial hypertension,MONDO:0015924,AD,SOP9,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_12d82f9f-8ab2-4012-a5d5-20de99f23c07-2022-11-21T170000.000Z,2022-11-21T17:00:00.000Z,Pulmonary Hypertension
SMAD9,HGNC:6774,pulmonary arterial hypertension,MONDO:0015924,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14f5a0c2-f82c-4571-a161-fb7ce61ae6d4-2021-05-14T192954.557Z,2021-05-14T19:29:54.557Z,Pulmonary Hypertension
TBX4,HGNC:11603,pulmonary arterial hypertension,MONDO:0015924,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1b8cc228-67d2-4530-8129-ebafee7fafa1-2021-03-10T214611.990Z,2021-03-10T21:46:11.990Z,Pulmonary Hypertension
TET2,HGNC:25941,pulmonary arterial hypertension,MONDO:0015924,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0c056edd-f72b-43e9-ba40-7504f285cf5a-2022-11-03T160000.000Z,2022-11-03T16:00:00.000Z,Pulmonary Hypertension
TOPBP1,HGNC:17008,pulmonary arterial hypertension,MONDO:0015924,AD,SOP9,No Known Disease Relationship,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8dfd5fc5-a4cb-4beb-8486-eae7675d08af-2022-11-22T170000.000Z,2022-11-22T17:00:00.000Z,Pulmonary Hypertension
A2ML1,HGNC:23336,Noonan syndrome,MONDO:0018997,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d910a9d8-516e-443d-acba-8d61f7574792-2018-06-07T160000.000Z,2018-06-07T16:00:00.000Z,RASopathy
BRAF,HGNC:1097,Noonan syndrome,MONDO:0018997,AD,SOP5,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_47cf08d5-efc6-4d42-b031-a06619873161-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
BRAF,HGNC:1097,Noonan syndrome with multiple lentigines,MONDO:0007893,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_888875a8-5654-486b-8e64-e1382ccc6650-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
BRAF,HGNC:1097,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a53e5a92-126f-4b00-a89b-af55d4f342ca-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
BRAF,HGNC:1097,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f229eceb-8f5e-4ecb-a484-7863b8dc7d19-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
CBL,HGNC:1541,CBL-related disorder,MONDO:0013308,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4a1a76fd-7e23-44a7-b2fc-4495bc5d5ee6-2019-04-29T160000.000Z,2019-04-29T16:00:00.000Z,RASopathy
HRAS,HGNC:5173,Costello syndrome,MONDO:0009026,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6a40ab43-3c9f-45c0-9ec0-0371d6f0d5c8-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
HRAS,HGNC:5173,Noonan syndrome-like disorder with loose anagen hair,MONDO:0011899,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_94630309-c540-48b3-a27f-0ee1891091c1-2018-07-25T160000.000Z,2018-07-25T16:00:00.000Z,RASopathy
KAT6B,HGNC:17582,RASopathy,MONDO:0021060,AD,SOP6,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fb3c40d8-3aea-45bf-949e-c3ba7d96a6b4-2019-02-04T170000.000Z,2019-02-04T17:00:00.000Z,RASopathy
KRAS,HGNC:6407,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_248e0d6b-9300-4d17-a350-f742fa92c82c-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
KRAS,HGNC:6407,Noonan syndrome,MONDO:0018997,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6476a5fd-8f66-462b-b17a-43540dad3c1f-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
KRAS,HGNC:6407,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bc9a82d0-8447-454c-8d54-def792d20e1d-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
LZTR1,HGNC:6742,Noonan syndrome,MONDO:0018997,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6f21db9c-87ea-4095-96ca-4277eaa21232-2020-04-23T170000.000Z,2020-04-23T17:00:00.000Z,RASopathy
LZTR1,HGNC:6742,Noonan syndrome,MONDO:0018997,AR,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7aa1e103-4f77-4c50-99c5-621a6a837b95-2020-09-11T170000.000Z,2020-09-11T17:00:00.000Z,RASopathy
MAP2K1,HGNC:6840,Noonan syndrome,MONDO:0018997,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1eafd4b1-29b1-4a17-a7ac-2c555f2e2648-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
MAP2K1,HGNC:6840,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8d28301c-df25-4c10-9edb-34be26f2838d-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
MAP2K1,HGNC:6840,Noonan syndrome with multiple lentigines,MONDO:0007893,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ee3071d5-ea0d-4804-ad61-3c6471f6a47e-2018-05-29T160000.000Z,2018-05-29T16:00:00.000Z,RASopathy
MAP2K1,HGNC:6840,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f8c7a090-0a97-4653-bd51-702a9f9144b9-2018-05-29T160000.000Z,2018-05-29T16:00:00.000Z,RASopathy
MAP2K2,HGNC:6842,Noonan syndrome,MONDO:0018997,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6a0eeefd-9105-435d-9daf-c748e52b0941-2018-06-01T160000.000Z,2018-06-01T16:00:00.000Z,RASopathy
MAP2K2,HGNC:6842,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7765e2a4-19e4-4b15-9233-4847606fc501-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
MRAS,HGNC:7227,Noonan syndrome,MONDO:0018997,AD,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_04ca29c1-6b44-474c-b54b-1c8be52de172-2022-12-14T170000.000Z,2022-12-14T17:00:00.000Z,RASopathy
NRAS,HGNC:7989,Costello syndrome,MONDO:0009026,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_28526e91-0db9-4724-94f3-e4222ace602c-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
NRAS,HGNC:7989,Noonan syndrome,MONDO:0018997,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_34419b69-59c3-458b-a2a5-38a401679deb-2018-05-30T160000.000Z,2018-05-30T16:00:00.000Z,RASopathy
NRAS,HGNC:7989,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d466df2a-8e3d-4d4a-bb96-8e483d4c56e7-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
NRAS,HGNC:7989,Noonan syndrome with multiple lentigines,MONDO:0007893,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e5622684-4367-4d90-b769-f7205ee1cac8-2018-05-30T160000.000Z,2018-05-30T16:00:00.000Z,RASopathy
NSUN2,HGNC:25994,RASopathy,MONDO:0021060,AR,SOP6,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6442d764-3ff8-41f4-984d-776254226b05-2019-02-04T170000.000Z,2019-02-04T17:00:00.000Z,RASopathy
PPP1CB,HGNC:9282,Noonan syndrome-like disorder with loose anagen hair,MONDO:0011899,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_16bcb316-090f-420d-9c89-b7642d3dc725-2020-04-23T160000.000Z,2020-04-23T16:00:00.000Z,RASopathy
PTPN11,HGNC:9644,Noonan syndrome,MONDO:0018997,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2bb08565-4669-4633-b6ed-c04e2a431cf9-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
PTPN11,HGNC:9644,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_72fca24b-243b-49de-9ceb-ae76e12f60a8-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy
PTPN11,HGNC:9644,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1a2133e-4ce8-45b7-87da-1c52990d3890-2018-05-30T160000.000Z,2018-05-30T16:00:00.000Z,RASopathy
PTPN11,HGNC:9644,Noonan syndrome with multiple lentigines,MONDO:0007893,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e6c41f3b-c2d1-4d66-a1a3-a5beaa304578-2018-07-25T160000.000Z,2018-07-25T16:00:00.000Z,RASopathy
RAF1,HGNC:9829,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_67081421-a4a3-4b62-88e0-4a78d19859ba-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
RAF1,HGNC:9829,Noonan syndrome,MONDO:0018997,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_85645d27-2056-4ad3-9593-8d7739aa4121-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
RAF1,HGNC:9829,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b1e7c802-14d7-435c-b396-637b728a3ae2-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy
RAF1,HGNC:9829,Noonan syndrome with multiple lentigines,MONDO:0007893,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cda0bf05-836b-40bb-99f5-e1dbfd0f6741-2018-07-25T160000.000Z,2018-07-25T16:00:00.000Z,RASopathy
RASA1,HGNC:9871,Noonan syndrome,MONDO:0018997,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a957c2df-eeec-4bdf-b423-6f1667f66abd-2018-06-07T160000.000Z,2018-06-07T16:00:00.000Z,RASopathy
RASA2,HGNC:9872,Noonan syndrome,MONDO:0018997,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9635e391-79b6-4054-824e-1c607a02cd07-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
RIT1,HGNC:10023,Noonan syndrome,MONDO:0018997,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_240565fc-61b9-4ff8-9f5a-85938f17cdd9-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
RRAS,HGNC:10447,Noonan syndrome,MONDO:0018997,AD,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_96280a14-d8cd-4c9b-b3e0-d5fcd8bf9ef6-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
RRAS2,HGNC:17271,Noonan syndrome,MONDO:0018997,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c5742615-3820-41dd-a523-e660a498f9e8-2022-12-14T170000.000Z,2022-12-14T17:00:00.000Z,RASopathy
SHOC2,HGNC:15454,Noonan syndrome-like disorder with loose anagen hair,MONDO:0011899,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0ecc1335-fb21-4d65-8df2-19558e8f5c07-2018-07-25T160000.000Z,2018-07-25T16:00:00.000Z,RASopathy
SHOC2,HGNC:15454,Noonan syndrome,MONDO:0018997,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_185c93c8-e875-46a2-83af-a8575b19a228-2018-05-31T160000.000Z,2018-05-31T16:00:00.000Z,RASopathy
SHOC2,HGNC:15454,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7035ea3-d556-4aa4-b525-5ed6c02866df-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
SHOC2,HGNC:15454,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fd8e5069-4023-4763-9b41-03350b03ee7f-2018-06-01T160000.000Z,2018-06-01T16:00:00.000Z,RASopathy
SOS1,HGNC:11187,Noonan syndrome,MONDO:0018997,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9781b6bf-9b1e-4a10-a0a9-7e56562a6e3a-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
SOS1,HGNC:11187,Costello syndrome,MONDO:0009026,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cf0ea291-849a-4bd9-a12a-cd9daad7e214-2018-07-24T160000.000Z,2018-07-24T16:00:00.000Z,RASopathy
SOS1,HGNC:11187,cardiofaciocutaneous syndrome,MONDO:0015280,AD,SOP5,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ee5b916f-82ef-4738-82c8-46ee2fad131b-2018-06-01T160000.000Z,2018-06-01T16:00:00.000Z,RASopathy
SOS2,HGNC:11188,Noonan syndrome,MONDO:0018997,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f20a1034-e29d-49bb-aed9-b4ba63dc5968-2020-08-27T160000.000Z,2020-08-27T16:00:00.000Z,RASopathy
SPRED1,HGNC:20249,Legius syndrome,MONDO:0012669,AD,SOP6,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ba44430-8f71-4b94-a6f1-7f66d3a27897-2019-01-24T050000.000Z,2019-01-24T05:00:00.000Z,RASopathy
ABCA4,HGNC:34,ABCA4-related retinoapthy,MONDO:0800406,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_38729563-bf36-48ae-929e-fa69a225de39-2022-10-06T160000.000Z,2022-10-06T16:00:00.000Z,Retina
ADAM9,HGNC:216,ADAM9-related retinopathy,MONDO:0800398,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c648ec73-186d-4680-93ea-29f5fdf91812-2022-09-01T160000.000Z,2022-09-01T16:00:00.000Z,Retina
ADAMTS18,HGNC:17110,microcornea-myopic chorioretinal atrophy,MONDO:0014195,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_95caeabe-f92c-4884-87b4-ed97f15769f3-2022-03-02T212447.170Z,2022-03-02T21:24:47.170Z,Retina
ATF6,HGNC:791,ATF6-related retinopathy,MONDO:0100447,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_649d690a-8457-4c95-8d27-978daf4ac877-2021-10-07T160000.000Z,2021-10-07T16:00:00.000Z,Retina
CAPN5,HGNC:1482,CAPN5-related vitreoretinopathy,MONDO:0100450,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7d39e430-b1fc-43f1-957b-1c02eb66a69c-2021-08-05T160000.000Z,2021-08-05T16:00:00.000Z,Retina
CDH3,HGNC:1762,EEM syndrome,MONDO:0009155,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5791d618-93bf-4517-9c60-48e6490319a6-2021-08-05T160000.000Z,2021-08-05T16:00:00.000Z,Retina
CEP290,HGNC:29021,CEP290-related ciliopathy,MONDO:0100451,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec24317e-70bc-48a0-999b-f960f951e8dd-2022-02-03T170000.000Z,2022-02-03T17:00:00.000Z,Retina
CERKL,HGNC:21699,CERKL-related retinopathy,MONDO:0800401,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a3003820-dc03-4eb1-921a-6eaee749fa9f-2022-09-01T160000.000Z,2022-09-01T16:00:00.000Z,Retina
CHM,HGNC:1940,choroideremia,MONDO:0010557,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d84b01d6-8b3c-4a1e-bd25-68ee6962f374-2020-10-26T124704.094Z,2020-10-26T12:47:04.094Z,Retina
CNGA1,HGNC:2148,CNGA1-related retinopathy,MONDO:0800405,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bdf9374a-2ec6-4852-ac0b-ec1a3e638245-2022-10-06T160000.000Z,2022-10-06T16:00:00.000Z,Retina
CNGA3,HGNC:2150,CNGA3-related retinopathy,MONDO:0800102,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_39fe36b7-54c3-486b-a9f9-19bce71f096e-2022-02-03T170000.000Z,2022-02-03T17:00:00.000Z,Retina
CNGB1,HGNC:2151,CNGB1-related retinopathy,MONDO:0800403,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_664a3eaa-0139-4f5a-8f97-a4a7e00ddfd3-2022-09-01T160000.000Z,2022-09-01T16:00:00.000Z,Retina
CNGB3,HGNC:2153,CNGB3-related retinopathy,MONDO:0100446,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aa7bad05-3d4d-4a69-b4e9-82f9224a77f4-2022-05-24T171317.094Z,2022-05-24T17:13:17.094Z,Retina
CNNM4,HGNC:105,Jalili syndrome,MONDO:0009007,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e3cedd07-df9e-4838-8a6b-b24b2802f223-2021-08-06T154836.361Z,2021-08-06T15:48:36.361Z,Retina
CYP4V2,HGNC:23198,Bietti crystalline corneoretinal dystrophy,MONDO:0008865,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_da577a4b-5c65-43fa-9a03-b275eaacb6eb-2021-04-01T160000.000Z,2021-04-01T16:00:00.000Z,Retina
EFEMP1,HGNC:3218,Doyne honeycomb retinal dystrophy,MONDO:0007471,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2859008e-eeb1-4af4-8a6e-1bf5372bb3ab-2021-08-05T160000.000Z,2021-08-05T16:00:00.000Z,Retina
EYS,HGNC:21555,EYS-related retinopathy,MONDO:0800391,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7f70860e-464d-4d26-aee0-07ef03e4da1b-2022-11-03T160000.000Z,2022-11-03T16:00:00.000Z,Retina
FLVCR1,HGNC:24682,FLVCR1-related retinopathy with or without ataxia,MONDO:0100449,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7e53e1a9-b1b9-4617-be3a-012399a06ef6-2021-08-05T160000.000Z,2021-08-05T16:00:00.000Z,Retina
GNAT2,HGNC:4394,GNAT2-related retinopathy,MONDO:0800392,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6888747f-55ae-4f8e-a3a8-c77bcd543689-2022-11-03T160000.000Z,2022-11-03T16:00:00.000Z,Retina
GPR143,HGNC:20145,inherited retinal dystrophy,MONDO:0019118,XL,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_41096b60-bbfb-469e-9695-8a23986f467c-2022-10-06T160000.000Z,2022-10-06T16:00:00.000Z,Retina
GPR179,HGNC:31371,GPR179-related retinopathy,MONDO:0800396,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_53ab184d-9f73-42b6-b407-7d72f7b44c8a-2022-06-02T160000.000Z,2022-06-02T16:00:00.000Z,Retina
GRK1,HGNC:10013,Oguchi disease,MONDO:0019152,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b6e159cb-c02a-417c-9c60-a9b66db41c73-2021-01-07T170000.000Z,2021-01-07T17:00:00.000Z,Retina
GRM6,HGNC:4598,GRM6-related retinopathy,MONDO:0800397,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1d65aebc-d4af-49ca-9682-9fde5f56bbef-2022-09-01T160000.000Z,2022-09-01T16:00:00.000Z,Retina
GUCY2D,HGNC:4689,GUCY2D-related dominant retinopathy,MONDO:0100441,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8816f73d-0432-4d50-bbb6-74a8f1da96ae-2022-05-28T195616.735Z,2022-05-28T19:56:16.735Z,Retina
GUCY2D,HGNC:4689,GUCY2D-related recessive retinopathy,MONDO:0100453,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_dcb8350d-c57f-43e3-9e9f-d059ebbf61c9-2022-03-27T232210.761Z,2022-03-27T23:22:10.761Z,Retina
HMX1,HGNC:5017,oculoauricular syndrome,MONDO:0012802,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ebf66ec9-77a4-4e48-83a4-970639ad5373-2021-05-06T160000.000Z,2021-05-06T16:00:00.000Z,Retina
IDH3B,HGNC:5385,IDH3B-related retinopathy,MONDO:0800393,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5617e337-aa89-44a0-afe0-e142ced68619-2022-12-01T170000.000Z,2022-12-01T17:00:00.000Z,Retina
IFT140,HGNC:29077,IFT140-related recessive ciliopathy,MONDO:0100509,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b4bc5837-07d2-46e5-836e-500a978bbf25-2022-07-07T160000.000Z,2022-07-07T16:00:00.000Z,Retina
KIF11,HGNC:6388,"microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability",MONDO:0007918,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aabff7c5-06ad-4602-a6f7-fef1bca0d1df-2021-07-01T160000.000Z,2021-07-01T16:00:00.000Z,Retina
LCA5,HGNC:31923,LCA5-related retinopathy,MONDO:0100445,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ece57d88-4307-420a-aedb-4b5900248ea1-2021-10-07T160000.000Z,2021-10-07T16:00:00.000Z,Retina
MERTK,HGNC:7027,MERTK-related retinopathy,MONDO:0800394,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b09e0755-aae3-47ef-b438-802285d5963b-2022-07-07T160000.000Z,2022-07-07T16:00:00.000Z,Retina
NMNAT1,HGNC:17877,NMNAT1-related retinopathy,MONDO:0800101,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a6733bc3-489d-413d-9dbe-1bca25f48d49-2021-11-04T160000.000Z,2021-11-04T16:00:00.000Z,Retina
NYX,HGNC:8082,NYX-related retinoapthy,MONDO:0800407,XL,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c48083c5-2ef8-45ee-a97f-dc973d5d5072-2022-03-03T170000.000Z,2022-03-03T17:00:00.000Z,Retina
PCARE,HGNC:34383,PCARE-related retinopathy,MONDO:0800404,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_afbc5168-51f6-4f69-bf41-41b9a1d9d665-2022-10-06T160000.000Z,2022-10-06T16:00:00.000Z,Retina
PCYT1A,HGNC:8754,spondylometaphyseal dysplasia-cone-rod dystrophy syndrome,MONDO:0012160,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eff306ea-95ff-4b4e-8597-f50849b1b4c2-2021-07-26T183711.748Z,2021-07-26T18:37:11.748Z,Retina
PDE6A,HGNC:8785,inherited retinal dystrophy,MONDO:0019118,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_165bc0fc-d0ce-4a74-a953-8d4687fbaa96-2022-12-01T170000.000Z,2022-12-01T17:00:00.000Z,Retina
PPT1,HGNC:9325,neuronal ceroid lipofuscinosis 1,MONDO:0009744,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8f72e2d3-f951-44da-a052-555d4f680114-2021-09-02T160000.000Z,2021-09-02T16:00:00.000Z,Retina
PRPF31,HGNC:15446,PRPF31-related retinopathy,MONDO:0800395,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_81f354cf-29c2-4955-a09d-735463f16a35-2022-07-07T160000.000Z,2022-07-07T16:00:00.000Z,Retina
RAB28,HGNC:9768,RAB28-related retinopathy,MONDO:0100448,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e8e3c7bd-3ee5-404d-98b0-75af6ec257d1-2021-11-04T160000.000Z,2021-11-04T16:00:00.000Z,Retina
RCBTB1,HGNC:18243,RCBTB1-related retinopathy,MONDO:0014955,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f356649e-e6d6-4ab6-9e78-3774404794ff-2022-06-02T160000.000Z,2022-06-02T16:00:00.000Z,Retina
RDH12,HGNC:19977,RDH12-related recessive retinopathy,MONDO:0800099,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bd51db77-53c3-4f89-9a4c-c92bbe182d7e-2022-03-03T170000.000Z,2022-03-03T17:00:00.000Z,Retina
RDH5,HGNC:9940,RDH5-related retinopathy,MONDO:0100443,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5399fd62-ca69-4665-b3ba-c15ceefbf6d9-2021-09-02T160000.000Z,2021-09-02T16:00:00.000Z,Retina
RGS9,HGNC:10004,bradyopsia,MONDO:0012033,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f90aa6cd-9e08-4fab-b6c3-570beb8232dd-2021-09-08T160000.000Z,2021-09-08T16:00:00.000Z,Retina
RLBP1,HGNC:10024,RLBP1-related retinopathy,MONDO:0100444,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d8c69db5-8d29-40af-85f0-59471ce0c62c-2021-06-03T160000.000Z,2021-06-03T16:00:00.000Z,Retina
RP1,HGNC:10263,RP1-related dominant retinopathy,MONDO:0800400,SD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_12feacf6-5c08-4cf7-9879-0ed6c134bf81-2022-09-01T160000.000Z,2022-09-01T16:00:00.000Z,Retina
RP1,HGNC:10263,RP1-related recessive retinopathy,MONDO:0800399,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8cbd531f-7c23-4745-a3da-38a2db421fc3-2022-07-07T160000.000Z,2022-07-07T16:00:00.000Z,Retina
RP2,HGNC:10274,RP2-related retinopathy,MONDO:0100442,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_75e3203d-3841-49eb-84d4-e6238eda55ea-2022-03-02T214941.540Z,2022-03-02T21:49:41.540Z,Retina
RPE65,HGNC:10294,RPE65-related recessive retinopathy,MONDO:0100368,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_375ffa04-a8d9-427e-8948-f913bc8ff68d-2022-05-24T214158.160Z,2022-05-24T21:41:58.160Z,Retina
RPE65,HGNC:10294,RPE65-related dominant retinopathy,MONDO:0100452,AD,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a45f0ada-a32b-406e-b714-790a0cd4a6a2-2022-02-07T024303.928Z,2022-02-07T02:43:03.928Z,Retina
RPGR,HGNC:10295,RPGR-related retinopathy,MONDO:0100437,XL,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_57ad94c7-d914-4a84-ab33-597c8d4bafdd-2022-08-05T160000.000Z,2022-08-05T16:00:00.000Z,Retina
RS1,HGNC:10457,X-linked retinoschisis,MONDO:0010725,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_061adaaf-8b09-42e4-ae31-9b9c03d6e944-2020-12-18T165803.135Z,2020-12-18T16:58:03.135Z,Retina
SNRNP200,HGNC:30859,SNRNP200-related dominant retinopathy,MONDO:0800098,AD,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_41acb15c-18a0-412b-a308-66a7f4e2837a-2022-05-24T160000.000Z,2022-05-24T16:00:00.000Z,Retina
TIMP3,HGNC:11822,Sorsby fundus dystrophy,MONDO:0007640,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8594a02c-c0f3-4542-b6d3-f089ba94417e-2021-07-02T174320.328Z,2021-07-02T17:43:20.328Z,Retina
TRPM1,HGNC:7146,TRPM1-related retinoapthy,MONDO:0800402,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5ecc95d2-f47b-4238-9475-2bd96f4b92db-2022-10-06T160000.000Z,2022-10-06T16:00:00.000Z,Retina
TSPAN12,HGNC:21641,TSPAN12-related vitreoretinopathy,MONDO:0100484,SD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9c7915a6-c4eb-47c7-9c51-a81279b6e6a4-2022-03-02T222900.086Z,2022-03-02T22:29:00.086Z,Retina
VCAN,HGNC:2464,Wagner disease,MONDO:0007740,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d1ea2623-463f-40f1-befb-5dfde7abc784-2021-07-26T183919.943Z,2021-07-26T18:39:19.943Z,Retina
CDKL5,HGNC:11411,CDKL5 disorder,MONDO:0100039,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a80cd86d-b085-4f35-9379-12a53ef367e2-2018-07-02T145731.072Z,2018-07-02T14:57:31.072Z,Rett and Angelman-like Disorders
FOXG1,HGNC:3811,FOXG1 disorder,MONDO:0100040,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3f14c6c5-b051-4c94-b9c6-3b80771eed22-2018-07-02T140827.839Z,2018-07-02T14:08:27.839Z,Rett and Angelman-like Disorders
MECP2,HGNC:6990,Rett syndrome,MONDO:0010726,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2df006ff-5ab4-4926-9b72-48909b09e608-2018-05-02T132629.570Z,2018-05-02T13:26:29.570Z,Rett and Angelman-like Disorders
SLC9A6,HGNC:11079,Christianson syndrome,MONDO:0010278,XL,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1d97fc8d-e744-449a-939c-386895c121cd-2018-05-02T160000.000Z,2018-05-02T16:00:00.000Z,Rett and Angelman-like Disorders
TCF4,HGNC:11634,Pitt-Hopkins syndrome,MONDO:0012589,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_096f830c-0065-456a-9e26-db54fd157981-2018-05-02T170000.000Z,2018-05-02T17:00:00.000Z,Rett and Angelman-like Disorders
UBE3A,HGNC:12496,Angelman syndrome,MONDO:0007113,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_df25de82-ea9a-4d86-8b42-6587a39650e3-2018-05-02T132344.716Z,2018-05-02T13:23:44.716Z,Rett and Angelman-like Disorders
ADA,HGNC:186,"severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",MONDO:0007064,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_664ba77c-3db6-47da-941e-316ac819432a-2020-11-19T170000.000Z,2020-11-19T17:00:00.000Z,SCID-CID
AK2,HGNC:362,reticular dysgenesis,MONDO:0009973,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_aba98528-8032-4dd4-bd1d-5381b102323c-2021-05-20T150257.066Z,2021-05-20T15:02:57.066Z,SCID-CID
CD247,HGNC:1677,immunodeficiency 25,MONDO:0012426,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_438b6c1f-edc0-4a81-9c82-39627e5a69cd-2022-03-11T140552.812Z,2022-03-11T14:05:52.812Z,SCID-CID
CD3D,HGNC:1673,immunodeficiency 19,MONDO:0014280,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3d59cf46-9acb-42f7-92da-d17113d39b38-2022-05-10T185446.511Z,2022-05-10T18:54:46.511Z,SCID-CID
CD3E,HGNC:1674,immunodeficiency 18,MONDO:0014278,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_29d6bb32-65b3-4c78-9c94-da71cc591565-2021-01-26T172908.775Z,2021-01-26T17:29:08.775Z,SCID-CID
CD3G,HGNC:1675,combined immunodeficiency due to CD3gamma deficiency,MONDO:0014276,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8ea83aa7-473b-4670-88dd-36b1abe277f8-2021-07-15T160000.000Z,2021-07-15T16:00:00.000Z,SCID-CID
CD40LG,HGNC:11935,hyper-IgM syndrome type 1,MONDO:0010626,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4184ad10-d95f-4027-b75d-e4e11127febf-2021-03-22T154242.503Z,2021-03-22T15:42:42.503Z,SCID-CID
CD8A,HGNC:1706,susceptibility to respiratory infections associated with CD8alpha chain mutation,MONDO:0012161,AR,SOP9,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f770ad34-1c95-4454-92c7-26bff4404cc2-2022-08-18T160000.000Z,2022-08-18T16:00:00.000Z,SCID-CID
CIITA,HGNC:7067,MHC class II deficiency,MONDO:0008855,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0dab225e-0bdd-4f96-a351-4e490601ba15-2022-11-03T170000.000Z,2022-11-03T17:00:00.000Z,SCID-CID
CORO1A,HGNC:2252,severe combined immunodeficiency due to CORO1A deficiency,MONDO:0014168,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f55fde93-1b6e-4d03-b737-ecad8aa89ecf-2022-06-03T160000.000Z,2022-06-03T16:00:00.000Z,SCID-CID
DCLRE1C,HGNC:17642,severe combined immunodeficiency due to DCLRE1C deficiency,MONDO:0011225,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_603e0855-2b57-4463-a9b7-1c5d70089a4f-2021-02-18T154301.245Z,2021-02-18T15:43:01.245Z,SCID-CID
DOCK2,HGNC:2988,DOCK2 deficiency,MONDO:0014637,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_63c0fb9c-33a6-4590-91a1-8ebe3967c4a6-2022-11-17T180000.000Z,2022-11-17T18:00:00.000Z,SCID-CID
FOXN1,HGNC:12765,"T-cell immunodeficiency, congenital alopecia, and nail dystrophy",MONDO:0011132,SD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4518c986-fb1d-4f9a-a24a-ab38891a0162-2021-11-05T181626.460Z,2021-11-05T18:16:26.460Z,SCID-CID
IL2RG,HGNC:6010,T-B+ severe combined immunodeficiency due to gamma chain deficiency,MONDO:0010315,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e4a8be06-e082-47c7-b005-956b51424fd2-2021-04-22T191103.318Z,2021-04-22T19:11:03.318Z,SCID-CID
IL7R,HGNC:6024,immunodeficiency 104,MONDO:0012163,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6bab0c36-592e-439c-bedf-4ec095fd47e8-2021-06-22T164843.040Z,2021-06-22T16:48:43.040Z,SCID-CID
JAK3,HGNC:6193,T-B+ severe combined immunodeficiency due to JAK3 deficiency,MONDO:0010938,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_669dcacf-8423-4507-a36c-feab049737b3-2020-12-18T200520.841Z,2020-12-18T20:05:20.841Z,SCID-CID
KDM6A,HGNC:12637,Kabuki syndrome 2,MONDO:0010465,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fb0b5b0f-d4c9-4c46-b4cc-2e516be7908d-2021-07-26T202903.760Z,2021-07-26T20:29:03.760Z,SCID-CID
KMT2D,HGNC:7133,Kabuki syndrome 1,MONDO:0007843,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_15029985-0c1a-4835-95fe-eb05dedaf85c-2021-10-21T145501.022Z,2021-10-21T14:55:01.022Z,SCID-CID
LAT,HGNC:18874,severe combined immunodeficiency due to LAT deficiency,MONDO:0044721,AR,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_bf4a8572-c5ab-4a57-a9b3-ef1059180e8a-2022-05-10T135616.950Z,2022-05-10T13:56:16.950Z,SCID-CID
LCK,HGNC:6524,severe combined immunodeficiency due to LCK deficiency,MONDO:0014334,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3e301c04-c0a1-4e0f-a9e4-69a6bd4be915-2022-06-20T160000.000Z,2022-06-20T16:00:00.000Z,SCID-CID
LIG4,HGNC:6601,DNA ligase IV deficiency,MONDO:0011686,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3ec863c8-d668-4ebf-806e-e01f5a6407fe-2021-04-16T230148.883Z,2021-04-16T23:01:48.883Z,SCID-CID
MALT1,HGNC:6819,combined immunodeficiency due to MALT1 deficiency,MONDO:0014197,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_537efc87-5f45-489b-9aa0-6bd3e029754e-2022-07-21T160000.000Z,2022-07-21T16:00:00.000Z,SCID-CID
NHEJ1,HGNC:25737,Cernunnos-XLF deficiency,MONDO:0012650,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_765b118e-c60a-4696-b401-f63b3349d6d2-2021-05-20T151233.276Z,2021-05-20T15:12:33.276Z,SCID-CID
PRKDC,HGNC:9413,severe combined immunodeficiency due to DNA-PKcs deficiency,MONDO:0014423,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fff25ca1-bbe5-47d3-b672-4b675a9fa6f7-2022-02-01T151658.605Z,2022-02-01T15:16:58.605Z,SCID-CID
PTPRC,HGNC:9666,immunodeficiency 104,MONDO:0012163,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f4b09bbc-c749-45be-9f2a-1a54813b2906-2021-12-22T205504.201Z,2021-12-22T20:55:04.201Z,SCID-CID
RAG1,HGNC:9831,recombinase activating gene 1 deficiency,MONDO:0000572,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f08ada81-650b-4764-99e4-f3156f67cbc9-2021-06-17T160000.000Z,2021-06-17T16:00:00.000Z,SCID-CID
RAG2,HGNC:9832,recombinase activating gene 2 deficiency,MONDO:0000573,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4e9918ba-b94a-4526-bd99-09abef894225-2021-08-19T140520.555Z,2021-08-19T14:05:20.555Z,SCID-CID
RFXANK,HGNC:9987,MHC class II deficiency,MONDO:0008855,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fbfd1148-ab31-4ab2-97bb-9b95387e9313-2022-11-17T180000.000Z,2022-11-17T18:00:00.000Z,SCID-CID
RMRP,HGNC:10031,cartilage-hair hypoplasia,MONDO:0009595,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c7328b31-364b-4a7c-aaed-731b582cb716-2021-07-27T155213.681Z,2021-07-27T15:52:13.681Z,SCID-CID
RNF168,HGNC:26661,RIDDLE syndrome,MONDO:0012764,AR,SOP9,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2eab353f-d7ed-4f22-883e-0b62c7bc4f9b-2022-08-08T170000.000Z,2022-08-08T17:00:00.000Z,SCID-CID
STAT3,HGNC:11364,STAT3-related early-onset multisystem autoimmune disease,MONDO:0014414,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_47daba8d-d94b-4efc-ac42-28d9dd81e891-2022-02-16T181712.967Z,2022-02-16T18:17:12.967Z,SCID-CID
STAT3,HGNC:11364,hyper-IgE recurrent infection syndrome 1,MONDO:0007818,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_beb3aa5b-240e-45d7-969a-9de3e5564457-2021-12-24T160548.234Z,2021-12-24T16:05:48.234Z,SCID-CID
STK4,HGNC:11408,combined immunodeficiency due to STK4 deficiency,MONDO:0013934,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0febeeb3-1a55-41c2-905c-c1d0619aa45b-2022-06-02T160000.000Z,2022-06-02T16:00:00.000Z,SCID-CID
TAPBP,HGNC:11566,MHC class I deficiency,MONDO:0011476,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a75f4ea4-61e9-4a22-a6e9-d67c8b7a02e4-2022-11-03T170000.000Z,2022-11-03T17:00:00.000Z,SCID-CID
TFRC,HGNC:11763,TFRC-related combined immunodeficiency,MONDO:0014760,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5d4f6437-081d-41e9-992a-afb73b72ef3b-2022-10-13T160000.000Z,2022-10-13T16:00:00.000Z,SCID-CID
TRAC,HGNC:12029,TCR-alpha-beta-positive T-cell deficiency,MONDO:0014160,AR,SOP9,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a49ea507-7acb-4bed-be28-140120adf9fe-2022-08-18T160000.000Z,2022-08-18T16:00:00.000Z,SCID-CID
TTC7A,HGNC:19750,multiple intestinal atresia,MONDO:0009465,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_80cadac5-067c-49e7-a021-ee4eec83984a-2021-10-21T184517.744Z,2021-10-21T18:45:17.744Z,SCID-CID
WAS,HGNC:12731,X-linked severe congenital neutropenia,MONDO:0010294,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_49c66050-ab36-4359-8d78-b7ba5bef80d2-2021-11-18T171012.085Z,2021-11-18T17:10:12.085Z,SCID-CID
ZAP70,HGNC:12858,combined immunodeficiency due to ZAP70 deficiency,MONDO:0010023,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_486c47d2-e5a9-4527-a2cc-aaa43cd5c42f-2022-02-08T044813.125Z,2022-02-08T04:48:13.125Z,SCID-CID
CACNA1C,HGNC:1390,short QT syndrome,MONDO:0000453,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_51dae85e-8745-48c1-8fb9-cabc2501d3fb-2020-08-03T160000.000Z,2020-08-03T16:00:00.000Z,Short QT Syndrome
CACNA2D1,HGNC:1399,short QT syndrome,MONDO:0000453,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_896733cc-c686-4279-affb-e1860fd10ca2-2020-09-05T160000.000Z,2020-09-05T16:00:00.000Z,Short QT Syndrome
CACNB2,HGNC:1402,short QT syndrome,MONDO:0000453,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_eaa3adbb-5e58-4e9a-a142-76c93c65b917-2020-08-03T160000.000Z,2020-08-03T16:00:00.000Z,Short QT Syndrome
KCNH2,HGNC:6251,short QT syndrome,MONDO:0000453,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6b033c3f-04de-4806-a9f3-0b318082b32e-2020-08-03T160000.000Z,2020-08-03T16:00:00.000Z,Short QT Syndrome
KCNJ2,HGNC:6263,short QT syndrome,MONDO:0000453,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9111653a-7d9c-4d0e-94d9-daaa208a0b05-2020-10-27T160000.000Z,2020-10-27T16:00:00.000Z,Short QT Syndrome
KCNQ1,HGNC:6294,short QT syndrome,MONDO:0000453,AD,SOP7,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5000dde0-156c-45b0-87db-35a935c69cb7-2020-10-27T160000.000Z,2020-10-27T16:00:00.000Z,Short QT Syndrome
SCN5A,HGNC:10593,short QT syndrome,MONDO:0000453,AD,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c89660b5-d048-48fb-9d35-6f78f8c2ff01-2020-10-27T160000.000Z,2020-10-27T16:00:00.000Z,Short QT Syndrome
SLC22A5,HGNC:10969,short QT syndrome,MONDO:0000453,AR,SOP7,Disputed,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b23b9707-bb3c-423d-b68e-54c57b991db6-2020-08-03T160000.000Z,2020-08-03T16:00:00.000Z,Short QT Syndrome
SLC4A3,HGNC:11029,short QT syndrome,MONDO:0000453,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b5f6fcca-f8a9-47c2-bae9-a72df92f3bd1-2020-08-03T160000.000Z,2020-08-03T16:00:00.000Z,Short QT Syndrome
ALPL,HGNC:438,obsolete adult hypophosphatasia,MONDO:0007798,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_03912003-38e1-45cc-a005-099e00dd3eec-2021-05-19T070000.000Z,2021-05-19T07:00:00.000Z,Skeletal Disorders
ALPL,HGNC:438,obsolete childhood hypophosphatasia,MONDO:0009428,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_354366d0-a7f6-472d-a7b2-4b16f6e328ac-2019-01-21T200000.000Z,2019-01-21T20:00:00.000Z,Skeletal Disorders
ALPL,HGNC:438,obsolete childhood hypophosphatasia,MONDO:0009428,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_52e23281-c9c5-42fe-a089-2652c3b849f8-2021-03-03T080000.000Z,2021-03-03T08:00:00.000Z,Skeletal Disorders
ALPL,HGNC:438,obsolete infantile hypophosphatasia,MONDO:0009427,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_64fd43a0-1c7d-4f34-906c-570d800492bc-2021-06-02T205406.157Z,2021-06-02T20:54:06.157Z,Skeletal Disorders
COL1A1,HGNC:2197,osteogenesis imperfecta type 2,MONDO:0008147,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0b093295-1c7c-4526-90eb-d6a9fff1cc75-2021-03-22T211103.977Z,2021-03-22T21:11:03.977Z,Skeletal Disorders
COL1A1,HGNC:2197,osteogenesis imperfecta type 1,MONDO:0008146,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_74914fec-a5c4-437c-8c83-66c9f1df3e6e-2021-03-16T235154.009Z,2021-03-16T23:51:54.009Z,Skeletal Disorders
COL1A1,HGNC:2197,osteogenesis imperfecta type 3,MONDO:0009804,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a51b8f9f-0e11-4d82-b454-15d27e974dd7-2021-06-24T204605.941Z,2021-06-24T20:46:05.941Z,Skeletal Disorders
COL2A1,HGNC:2200,spondyloepiphyseal dysplasia congenita,MONDO:0008471,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0f217fba-a78c-4f9f-ad2a-301f0d53f046-2021-06-07T170000.000Z,2021-06-07T17:00:00.000Z,Skeletal Disorders
COL2A1,HGNC:2200,achondrogenesis type II,MONDO:0008702,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_14640c06-c66e-4dc7-86ea-9b0850e51474-2020-10-05T170000.000Z,2020-10-05T17:00:00.000Z,Skeletal Disorders
COL2A1,HGNC:2200,Kniest dysplasia,MONDO:0007987,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_25a49ec9-69ab-4e51-a13a-fe1eaa50ae56-2021-12-15T183542.376Z,2021-12-15T18:35:42.376Z,Skeletal Disorders
COL2A1,HGNC:2200,"platyspondylic dysplasia, Torrance type",MONDO:0007895,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a4c42c43-7b6a-4456-aeb1-7a00302a468b-2021-02-01T180000.000Z,2021-02-01T18:00:00.000Z,Skeletal Disorders
COL2A1,HGNC:2200,spondyloperipheral dysplasia,MONDO:0010078,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4da6e1f-5aad-4541-a3ae-76ed4782a023-2022-01-06T154807.494Z,2022-01-06T15:48:07.494Z,Skeletal Disorders
COL2A1,HGNC:2200,spondylometaphyseal dysplasia,MONDO:0016763,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e5315530-5b3c-42f1-b18c-1884a0b767f6-2021-06-07T160000.000Z,2021-06-07T16:00:00.000Z,Skeletal Disorders
COMP,HGNC:2227,multiple epiphyseal dysplasia,MONDO:0016648,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0e93c534-284e-40eb-9076-343a825d3a46-2020-03-24T170000.000Z,2020-03-24T17:00:00.000Z,Skeletal Disorders
COMP,HGNC:2227,pseudoachondroplasia,MONDO:0008322,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_630905e9-0f42-452b-81fa-7fad4eae08f9-2020-02-07T180000.000Z,2020-02-07T18:00:00.000Z,Skeletal Disorders
FGFR3,HGNC:3690,thanatophoric dysplasia type 2,MONDO:0008547,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1d5f870f-048e-4741-b5e0-2fcf70ed1b88-2022-01-31T170913.018Z,2022-01-31T17:09:13.018Z,Skeletal Disorders
FGFR3,HGNC:3690,camptodactyly-tall stature-scoliosis-hearing loss syndrome,MONDO:0012504,SD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d-2022-06-07T160000.000Z,2022-06-07T16:00:00.000Z,Skeletal Disorders
FGFR3,HGNC:3690,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,MONDO:0014658,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a7daa910-8226-46cc-8a65-034c0833d9cc-2022-05-09T160000.000Z,2022-05-09T16:00:00.000Z,Skeletal Disorders
FGFR3,HGNC:3690,thanatophoric dysplasia type 1,MONDO:0008546,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_db0459d9-c5cc-455d-a6b2-e6ea81511336-2021-12-23T221850.458Z,2021-12-23T22:18:50.458Z,Skeletal Disorders
SLC26A2,HGNC:10994,diastrophic dysplasia,MONDO:0009107,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_311c9799-169e-4409-98bd-74b6d414904c-2020-06-01T160000.000Z,2020-06-01T16:00:00.000Z,Skeletal Disorders
SLC26A2,HGNC:10994,achondrogenesis type IB,MONDO:0010966,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_392a7ac1-7ef5-45c7-97e0-2c1c1bd7884d-2020-08-03T160000.000Z,2020-08-03T16:00:00.000Z,Skeletal Disorders
SLC26A2,HGNC:10994,multiple epiphyseal dysplasia,MONDO:0016648,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b53d2317-709a-4b12-b846-fa51bfddf7e1-2020-04-06T160000.000Z,2020-04-06T16:00:00.000Z,Skeletal Disorders
SLC26A2,HGNC:10994,atelosteogenesis type II,MONDO:0009727,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_da79a651-9fc7-453e-a1c1-145771baa2f9-2020-07-14T160000.000Z,2020-07-14T16:00:00.000Z,Skeletal Disorders
SOX9,HGNC:11204,isolated Pierre-Robin syndrome,MONDO:0009869,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_951f7fcd-2b6a-46cd-be1d-7993ee5119c1-2020-09-16T170000.000Z,2020-09-16T17:00:00.000Z,Skeletal Disorders
SOX9,HGNC:11204,Cooks syndrome,MONDO:0007134,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a1fdeca1-a725-4ccb-a7f6-e77c2d6158aa-2020-09-16T170000.000Z,2020-09-16T17:00:00.000Z,Skeletal Disorders
SOX9,HGNC:11204,campomelic dysplasia,MONDO:0007251,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ca6e2118-28d5-4a6f-8333-ee30994d41cd-2020-06-01T170000.000Z,2020-06-01T17:00:00.000Z,Skeletal Disorders
TRPV4,HGNC:18083,brachyolmia,MONDO:0015262,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1507b13c-d089-47e8-88cb-b3b4399581a6-2021-12-15T200032.687Z,2021-12-15T20:00:32.687Z,Skeletal Disorders
TRPV4,HGNC:18083,"spondyloepimetaphyseal dysplasia, Maroteaux type",MONDO:0008473,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_17fcb720-754a-429a-b1f8-90db6d423a89-2021-05-19T160000.000Z,2021-05-19T16:00:00.000Z,Skeletal Disorders
TRPV4,HGNC:18083,metatropic dysplasia,MONDO:0007986,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_70f8ac2b-5570-4672-b0ee-2f3a342ccd44-2020-12-08T170000.000Z,2020-12-08T17:00:00.000Z,Skeletal Disorders
TRPV4,HGNC:18083,"spondylometaphyseal dysplasia, Kozlowski type",MONDO:0008477,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d93031fa-8ea5-465a-a903-6e7ae36a5faa-2021-06-07T160000.000Z,2021-06-07T16:00:00.000Z,Skeletal Disorders
ANOS1,HGNC:6211,hypogonadotropic hypogonadism 1 with or without anosmia,MONDO:0010635,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2b7650b6-f2b6-4ac3-a967-3e631c98d7b1-2022-05-17T223152.758Z,2022-05-17T22:31:52.758Z,Syndromic Disorders
ARL13B,HGNC:25419,Joubert syndrome,MONDO:0018772,AR,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f6c474c9-4035-498c-a902-03be50d36205-2020-06-03T210114.719Z,2020-06-03T21:01:14.719Z,Syndromic Disorders
ARSL,HGNC:719,X-linked chondrodysplasia punctata 1,MONDO:0010555,XL,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2c48d88b-d100-4203-8abf-03f3199bf3e0-2020-08-25T132456.576Z,2020-08-25T13:24:56.576Z,Syndromic Disorders
ATP1A3,HGNC:801,ATP1A3-associated neurological disorder,MONDO:0700002,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2a572fef-35c5-46dd-8a69-af436b3ecdcc-2022-05-22T063513.942Z,2022-05-22T06:35:13.942Z,Syndromic Disorders
BCOR,HGNC:20893,"microphthalmia, syndromic 2",MONDO:0010261,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3da06b77-1ed0-4197-948c-a9bbf80b6ed4-2020-12-17T171347.861Z,2020-12-17T17:13:47.861Z,Syndromic Disorders
CAMK2G,HGNC:1463,intellectual developmental disorder 59,MONDO:0032795,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_525f1ddb-a662-4baf-b877-45fc26e07b71-2021-07-30T130229.547Z,2021-07-30T13:02:29.547Z,Syndromic Disorders
CENPJ,HGNC:17272,microcephaly 6 with or without short stature,MONDO:0700054,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c10510c1-2c0e-466e-928a-77d896159d06-2022-05-21T104414.354Z,2022-05-21T10:44:14.354Z,Syndromic Disorders
CPLANE1,HGNC:25801,Joubert syndrome 17,MONDO:0013824,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_954cdc22-7834-4876-a64e-27d56615c1ff-2022-05-20T114241.088Z,2022-05-20T11:42:41.088Z,Syndromic Disorders
CSNK2B,HGNC:2460,Poirier-Bienvenu neurodevelopmental syndrome,MONDO:0032889,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_64552de0-3f81-4110-90f7-97de14b0387b-2022-04-08T050921.681Z,2022-04-08T05:09:21.681Z,Syndromic Disorders
DCAF17,HGNC:25784,Woodhouse-Sakati syndrome,MONDO:0009419,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6a1d7719-4261-494d-87aa-745518580673-2021-07-27T153526.827Z,2021-07-27T15:35:26.827Z,Syndromic Disorders
EP300,HGNC:3373,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,MONDO:0013364,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5559f540-f08e-4446-bc8b-a241bb3a4a8e-2022-05-20T044017.803Z,2022-05-20T04:40:17.803Z,Syndromic Disorders
ESCO2,HGNC:27230,Roberts-SC phocomelia syndrome,MONDO:0100253,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_4020105e-bc43-4365-9540-9a8f77b37fae-2021-07-30T142327.055Z,2021-07-30T14:23:27.055Z,Syndromic Disorders
HSPG2,HGNC:5273,Schwartz-Jampel syndrome type 1,MONDO:0100435,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a69e83a2-d914-4829-b285-c0ab0e4798d3-2022-05-21T030306.062Z,2022-05-21T03:03:06.062Z,Syndromic Disorders
HSPG2,HGNC:5273,Silverman-Handmaker type dyssegmental dysplasia,MONDO:0009140,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b601b27a-7ba4-4111-a524-b55cbb86eaa5-2022-05-21T030011.112Z,2022-05-21T03:00:11.112Z,Syndromic Disorders
IFT122,HGNC:13556,cranioectodermal dysplasia 1,MONDO:0021093,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6e4b420a-5df1-4c3c-aca8-a5359de25a5d-2021-10-21T040941.926Z,2021-10-21T04:09:41.926Z,Syndromic Disorders
IKBKG,HGNC:5961,incontinentia pigmenti,MONDO:0010631,XL,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_092ed3e1-8a02-4c71-8134-24c4dc8d3a69-2022-06-23T160000.000Z,2022-06-23T16:00:00.000Z,Syndromic Disorders
KMT2A,HGNC:7132,Wiedemann-Steiner syndrome,MONDO:0011518,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a002e1eb-0420-4889-b3f1-b8fe226786f9-2022-05-22T002824.468Z,2022-05-22T00:28:24.468Z,Syndromic Disorders
KMT5B,HGNC:24283,complex neurodevelopmental disorder,MONDO:0100038,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_885d56b0-a2b0-4a3d-9f11-4034298e074e-2022-04-08T072351.945Z,2022-04-08T07:23:51.945Z,Syndromic Disorders
LIFR,HGNC:6597,obsolete Stve-Wiedemann syndrome,MONDO:0011108,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9e336431-a56a-4144-8554-6fe62e4cb298-2021-07-27T145127.876Z,2021-07-27T14:51:27.876Z,Syndromic Disorders
LMX1B,HGNC:6654,nail-patella syndrome,MONDO:0008061,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c89e1a52-3ef8-4a61-bf56-1e43cf88fc6e-2021-07-27T144211.405Z,2021-07-27T14:42:11.405Z,Syndromic Disorders
MAPK8IP3,HGNC:6884,neurodevelopmental disorder with or without variable brain abnormalities; NEDBA,MONDO:0032755,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7af4bd87-1d3d-4e52-929f-c3893f81c38a-2022-05-22T063958.942Z,2022-05-22T06:39:58.942Z,Syndromic Disorders
MYMK,HGNC:33778,Carey-Fineman-Ziter syndrome,MONDO:0009700,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_570cb879-d299-41b0-87ba-406bf9567266-2022-04-08T040057.342Z,2022-04-08T04:00:57.342Z,Syndromic Disorders
MYO5A,HGNC:7602,Griscelli syndrome type 1,MONDO:0008962,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_792cf7b2-5ca7-4d85-95a5-a43eaa52b180-2021-07-27T144901.941Z,2021-07-27T14:49:01.941Z,Syndromic Disorders
NOD2,HGNC:5331,Blau syndrome,MONDO:0008523,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1fd650d7-6a84-4b33-b86e-d34cab5b7d57-2020-10-07T171807.983Z,2020-10-07T17:18:07.983Z,Syndromic Disorders
OGT,HGNC:8127,"intellectual disability, X-linked 106",MONDO:0030907,XL,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_07776d36-7494-4ee4-992e-c6fb82c36749-2021-07-27T145857.330Z,2021-07-27T14:58:57.330Z,Syndromic Disorders
PAX7,HGNC:8621,congenital myopathy with myasthenic-like onset,MONDO:0018528,AR,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_684596b8-b8c4-40e5-8ab6-8b23cac49be5-2021-07-27T145321.701Z,2021-07-27T14:53:21.701Z,Syndromic Disorders
PCGF2,HGNC:12929,turnpenny-fry syndrome,MONDO:0032707,AD,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_58b289b7-f842-4a32-a1fa-2777455fbd27-2022-04-08T074229.379Z,2022-04-08T07:42:29.379Z,Syndromic Disorders
PIGU,HGNC:15791,glycosylphosphatidylinositol biosynthesis defect 21,MONDO:0032824,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_06c208ae-ed82-4b3e-88b6-a9a144ef7775-2022-06-23T160000.000Z,2022-06-23T16:00:00.000Z,Syndromic Disorders
POLR2A,HGNC:9187,neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities,MONDO:0032829,AD,SOP7,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_45cab675-1ca5-4c25-97a9-bfeeeb1e112a-2020-08-25T131429.407Z,2020-08-25T13:14:29.407Z,Syndromic Disorders
PPP1R12A,HGNC:7618,genitourinary and/or brain malformation syndrome,MONDO:0032934,AD,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_93fa5165-a907-4ca8-b0d3-bb174bf3fca9-2021-07-27T145458.008Z,2021-07-27T14:54:58.008Z,Syndromic Disorders
PRG4,HGNC:9364,camptodactyly-arthropathy-coxa vara-pericarditis syndrome,MONDO:0008828,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3b4be938-664c-421e-922b-dc6ac83e5dec-2021-07-30T130737.801Z,2021-07-30T13:07:37.801Z,Syndromic Disorders
RAB27A,HGNC:9766,Griscelli syndrome type 2,MONDO:0011872,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_85b7d8d2-1d22-44f3-9b24-580b42d69300-2020-12-17T171600.737Z,2020-12-17T17:16:00.737Z,Syndromic Disorders
SMARCAL1,HGNC:11102,Schimke immuno-osseous dysplasia,MONDO:0009458,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_58700233-acb6-4ea8-911b-b3f474906aaa-2021-07-30T130548.284Z,2021-07-30T13:05:48.284Z,Syndromic Disorders
SMCHD1,HGNC:29090,"arhinia, choanal atresia, and microphthalmia",MONDO:0011323,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b2f2b442-3afa-4427-8e9b-3dc2485790aa-2022-05-20T042139.263Z,2022-05-20T04:21:39.263Z,Syndromic Disorders
SPTBN4,HGNC:14896,"neurodevelopmental disorder with hypotonia, neuropathy, and deafness",MONDO:0060496,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ff8934be-15d6-474e-b5fa-30328f633170-2022-06-22T160000.000Z,2022-06-22T16:00:00.000Z,Syndromic Disorders
TBX5,HGNC:11604,Holt-Oram syndrome,MONDO:0007732,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_24e6c85a-33cf-4248-be1f-6431c7c6b1e5-2021-07-27T145706.838Z,2021-07-27T14:57:06.838Z,Syndromic Disorders
TCF20,HGNC:11631,developmental delay with variable intellectual impairment and behavioral abnormalities,MONDO:0032745,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_619ae2be-5ab6-418d-8824-373369337faa-2020-10-07T172001.182Z,2020-10-07T17:20:01.182Z,Syndromic Disorders
TMEM237,HGNC:14432,Joubert syndrome 14,MONDO:0013745,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d6b843c9-8fc3-4d61-8195-29aed5e7d700-2021-04-26T121051.373Z,2021-04-26T12:10:51.373Z,Syndromic Disorders
TSHZ1,HGNC:10669,"aural atresia, congenital",MONDO:0011921,AD,SOP7,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_cfbe0bb6-f9c6-447b-bec9-911af6a67566-2020-08-25T130420.457Z,2020-08-25T13:04:20.457Z,Syndromic Disorders
UBE3B,HGNC:13478,"oculocerebrofacial syndrome, Kaufman type",MONDO:0009485,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5604d13c-a46a-4a83-87ec-e4e94bbed3f0-2021-07-30T130354.346Z,2021-07-30T13:03:54.346Z,Syndromic Disorders
UNC80,HGNC:26582,"hypotonia, infantile, with psychomotor retardation and characteristic facies 2",MONDO:0014777,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7639160a-1761-4dcb-98de-2aeb61b2b080-2021-07-30T134337.292Z,2021-07-30T13:43:37.292Z,Syndromic Disorders
USP7,HGNC:12630,Hao-Fountain syndrome,MONDO:0014805,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7e4961fa-f972-4e82-ac29-a511ff954529-2021-09-03T182145.545Z,2021-09-03T18:21:45.545Z,Syndromic Disorders
WASHC5,HGNC:28984,hereditary spastic paraplegia 8,MONDO:0011339,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_26ef81c5-17e8-4d87-b7ee-627f3f083955-2022-05-21T025058.214Z,2022-05-21T02:50:58.214Z,Syndromic Disorders
WASHC5,HGNC:28984,Ritscher-Schinzel syndrome 1,MONDO:0009073,AR,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9920b2c1-29bd-42db-be54-b9757f7c4f6b-2022-05-21T024905.204Z,2022-05-21T02:49:05.204Z,Syndromic Disorders
WDR35,HGNC:29250,short-rib thoracic dysplasia 7 with or without polydactyly,MONDO:0013569,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9e3f8578-6df2-4503-9e38-c110a9f00924-2022-04-08T012255.670Z,2022-04-08T01:22:55.670Z,Syndromic Disorders
WDR35,HGNC:29250,cranioectodermal dysplasia 2,MONDO:0013323,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e7e56d33-315b-40a0-9ec5-0a99e12cf369-2022-05-29T144812.294Z,2022-05-29T14:48:12.294Z,Syndromic Disorders
WNT10A,HGNC:13829,ectodermal dysplasia WNT10A related,MONDO:0100358,SD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_e2a537f1-f04c-4e08-9cca-80122e36f51a-2022-05-21T025524.674Z,2022-05-21T02:55:24.674Z,Syndromic Disorders
WNT5A,HGNC:12784,autosomal dominant Robinow syndrome,MONDO:0008389,AD,SOP8,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0fb2940f-f0e0-442c-beb8-72fc959d5a43-2021-02-03T142016.299Z,2021-02-03T14:20:16.299Z,Syndromic Disorders
ZMPSTE24,HGNC:12877,mandibuloacral dysplasia with type B lipodystrophy,MONDO:0012074,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3aecf4af-4d2d-4d50-a681-9f4973cc985a-2022-06-23T160000.000Z,2022-06-23T16:00:00.000Z,Syndromic Disorders
ZMPSTE24,HGNC:12877,obsolete lethal restrictive dermopathy,MONDO:0010143,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a85a92bd-afed-4e4e-99a5-e9902993c62e-2022-06-23T160000.000Z,2022-06-23T16:00:00.000Z,Syndromic Disorders
ZNF462,HGNC:21684,weiss-kruszka syndrome,MONDO:0032836,AD,SOP7,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9fb3ee56-12be-4418-bd85-56e7958ac601-2020-08-25T131051.689Z,2020-08-25T13:10:51.689Z,Syndromic Disorders
CUL3,HGNC:2553,pseudohypoaldosteronism type 2E,MONDO:0013782,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_f697fb5e-72de-4116-9cad-706e2d651268-2021-12-01T013000.000Z,2021-12-01T01:30:00.000Z,Tubulopathy
NR3C2,HGNC:7979,pseudohyperaldosteronism type 2,MONDO:0011517,AD,SOP8,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_26410755-d552-4111-9f23-14dbeaa99293-2021-07-15T023000.000Z,2021-07-15T02:30:00.000Z,Tubulopathy
NR3C2,HGNC:7979,autosomal dominant pseudohypoaldosteronism type 1,MONDO:0008329,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8c78e824-d77d-4635-a181-6139b8e9c028-2021-07-15T023000.000Z,2021-07-15T02:30:00.000Z,Tubulopathy
SCNN1A,HGNC:10599,autosomal recessive pseudohypoaldosteronism type 1,MONDO:0009917,AR,SOP8,Strong,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_38f18fef-1443-4005-a358-31f7d3a96ee0-2021-11-18T013000.000Z,2021-11-18T01:30:00.000Z,Tubulopathy
SCNN1G,HGNC:10602,Liddle syndrome,MONDO:0008323,AD,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_60ce148e-eb8b-49c4-adec-ae98071f9cc2-2021-06-17T023000.000Z,2021-06-17T02:30:00.000Z,Tubulopathy
WDR72,HGNC:26790,amelogenesis imperfecta,MONDO:0019507,AR,SOP8,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_af7fe285-29ab-4f6c-bba1-a582d03972af-2021-12-16T013000.000Z,2021-12-16T01:30:00.000Z,Tubulopathy
AQP5,HGNC:638,"palmoplantar keratoderma, Bothnian type",MONDO:0010849,AD,SOP5,Moderate,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_77aa086c-5551-4e23-9e35-7c4ff072e238-2017-11-08T170000.000Z,2017-11-08T17:00:00.000Z,UNC Biocuration Core
ARL2BP,HGNC:17146,retinitis pigmentosa with or without situs inversus,MONDO:0014186,AR,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_afe2baae-73d8-4f77-a106-a9163dbde4ce-2017-11-08T050000.000Z,2017-11-08T05:00:00.000Z,UNC Biocuration Core
PIK3R1,HGNC:8979,SHORT syndrome,MONDO:0010026,AD,SOP5,Definitive,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_194f9130-2529-4016-a689-47ec259f941c-2017-10-11T040000.000Z,2017-10-11T04:00:00.000Z,UNC Biocuration Core
SERPINB8,HGNC:8952,exfoliative ichthyosis,MONDO:0017339,AR,SOP5,Limited,https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2e02ec85-306f-4465-b8f9-a6eb7e4e8056-2017-11-08T050000.000Z,2017-11-08T05:00:00.000Z,UNC Biocuration Core
